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Abstract
Women born with only a single X chromosome (XO) have Turner syndrome (TS);
and they are invariably of short stature. XO female mice are also small: during
embryogenesis, female mice with a paternally-inherited X chromosome (XPO) are
smaller than XX littermates; whereas during early postnatal life, both XPO and
XMO (maternal) mice are smaller than their XX siblings. Here I look to further
understand the genetic bases of these phenotypes, and potentially inform areas of
future investigation into TS.
Mouse pre-implantation embryos preferentially silence the XP via the non-coding
RNA Xist. XPO embryos are smaller than XX littermates at embryonic day (E)
10.5, whereas XMO embryos are not. Two possible hypotheses explain this obser-
vation. Inappropriate expression of Xist in XPO embryos may cause transcriptional
silencing of the single X chromosome and result in embryos nullizygous for X gene
products. Alternatively, there could be imprinted genes on the X chromosome that
impact on growth and manifest in growth retarded XPO embryos. In contrast, dur-
ing the first three weeks of postnatal development, both XPO and XMO mice show
a growth deficit when compared with XX littermates. This deficit is not observed
in the presence of a second sex chromosome - i.e. in normal XX female mice, or
in females with a Y chromosome that lacks Sry - suggesting haploinsufficiency of
genes with homologues present on, and expressed from, both sex chromosomes as
a cause.
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In this thesis I have investigated the role of Xist in XPO embryonic growth retarda-
tion; and utilised mouse stem cells to perform an in vitro screen to identify X-linked
imprinted genes. To characterise postnatal haploinsufficiency, I identify four can-
didate genes and, utilising CRISPR-Cas genome editing, delineate the role of each
in the growth deficit phenotype. I further use these X-linked mutants to investigate
the functional divergence of the X and Y chromosomes in the context of postnatal
survival.
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Chapter 1
Introduction
Fundamental differences exist between males and females, encompassing areas in-
cluding anatomy, physiology, and behaviour. Such differences undoubtedly play
a part in the well documented, yet poorly understood, disparity in disease suscep-
tibility between the sexes. Although traditionally attributed to differences in sex
hormone levels, recent work has begun to shed more light on the contribution of
genetics - and in particular the sex chromosomes - to this sexual dimorphism. This
chapter begins with an overview of sex chromosome evolution, before focusing on
topics most pertinent to this thesis, including dosage compensation, aneuploidy, and
growth.
1.1 Sex
Sexual reproduction - meiotic recombination and the subsequent production and
fusion of gametes - is widespread throughout the eukaryotic kingdom. This encom-
passes all mammals and birds, most reptiles, fish and amphibia, and about 99.9% of
flowering plant species (Charlesworth, 2006). Whilst many plant species combine
male and female sex organs within individuals as hermaphrodites, most animals
have, through the evolution of anisogamy, segregated these organs into different in-
dividuals, thus resulting in two sexes (Bachtrog et al., 2014). During development,
these sexes must be accurately differentiated. Evolution has resulted in multiple
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solutions to this sex determination problem, which can be broadly grouped into
environmental and genotypic. Environmental sex determination is exemplified by
external stimuli - such as social factors or temperature - determining the sex of
the offspring. Such a mechanism has been shown to be favoured over a genetic
mechanism when specific environments benefit one sex. Conversely, genetic sex
determination is found when the environment is either unpredictable or not varied
enough, and is mediated by elements ranging in size from genes through chromo-
somes to entire genomes (Bachtrog et al., 2014). Mammalian sex determination is
a primary example of this mechanism.
1.1.1 Sex determination and the evolution of the mammalian sex
chromosomes
Hermann Muller posited the first theory of sex chromosome evolution following
observations that at least one gene could be linked to each of the Drosophila auto-
somes but not the Y chromosome (Muller, 1914). He hypothesised that the X and
Y chromosomes evolved from an ordinary pair of autosomes. The Y chromosome
subsequently accumulated deleterious mutations that, due to a lack of recombina-
tion, could not be repaired, leading to the dearth of reported Y linked genes. This
was consistent with observations from human genetics: whilst multiple traits were
mapped to the X chromosome, everything attributed to the Y was publicly discred-
ited (Stern, 1957). Following the development of karyotyping techniques in the
1950s, a role for the Y chromosome in sex determination was firmly established. It
was shown that individuals with only a single X chromosome are phenotypically fe-
male (XO; Turner syndrome(TS)), whereas those with an XXY karyotype are male
(Klinefelter syndrome, Ford et al., 1959a; Jacobs and Strong, 1959). Ohno built on
this work, and that of Muller, in arguing that a spontaneous mutation producing a
proto sex determining gene (see section 1.2.1) had arisen on one of the ancestral
vertebrate autosomes to create a pair of heteromorphic sex chromosomes (Ohno,
1967). He went on to suggest that a pericentric inversion containing this proto sex
determining gene would suppress crossing over between the nascent sex chromo-
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somes. The resulting pair of heteromorphic sex chromosomes would in turn cause
isolation of the sex specific chromosome, thereby facilitating divergence through
either innovation or degeneration.
Figure 1.1: Evolution of the mammalian sex chromosomes from autosomes. A sex de-
termining locus (white) was acquired around 180-200 million years ago (mya). Sexually
antagonistic alleles (purple) then evolved at nearby loci, selecting for recombination sup-
pression between the X and Y chromosomes, and resulting in the first X chromosome evolu-
tionary stratum (I), and the so called male specific Y. Following the end of recombination in
a given region, genes without sex specific benefits often become pseudogenes (dark blue).
The appearance and selection for sexually antagonistic alleles, followed by further recom-
bination suppression, then becomes iterative and, as the non recombining region expands,
further strata appear (II-V). Between the evolution of strata I and II/III, a fusion event took
place between the sex chromosomes and a pair of autosomes, resulting in the expansion of
both sex chromosomes in the X added region (XAR) and Y added region (YAR). Over evo-
lutionary time, the lack of recombination leads to the accrual of repetitive DNA sequences
and a short term increase in the size of the chromosomes; though this eventually results in
large deletions and explains the relatively diminutive size of the Y chromosome in most
mammals.
Innovation in sequencing technology provided the first sequences of the human sex
chromosomes. These sequences added weight to the theory of a common evolu-
tionary origin, which was based on nucleotide divergence patterns (Lahn and Page,
1999). By comparing nucleotide divergence between Y linked and X linked gene
copies, Lahn and Page highlighted a strong correlation with the position of the X
linked gene. X-Y gene pairs were shown to be present in at least four groups of
increasing divergence, from the short to the long arm of the X chromosome. Thus,
the authors posited the existence of distinct evolutionary strata (Lahn and Page,
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1999). These strata represent genes isolated by the same recombination event (see
Figure 1.1), and are likely the physical evidence for Ohno’s inversion hypothesis
(Ohno, 1967). Subsequent work supports these conclusions, and further extends the
data across eutherians and into metatherians, monotremes, and birds, where similar
strata have also be identified (Bellott et al., 2014; Cortez et al., 2014).
1.2 The mammalian Y chromosome
As previously highlighted, the Y mammalian chromosome contains the sex deter-
mining gene, and genes that have survived the process of Y degeneration (X de-
generate, Bellott and Page, 2009) in the strata identified by X-Y divergence. Addi-
tionally, the Y chromosome also harbours genes that have been transposed from the
X chromosome later in history, and genes that have become ampliconic (Skaletsky
et al., 2003; Bellott et al., 2014; Cortez et al., 2014).
1.2.1 The Testis Determining Factor: Sry
Following on from the confirmation that presence of a Y chromosome genetically
determines maleness in humans (Ford et al., 1959a; Jacobs and Strong, 1959), the
identity of a specific locus was sought. This search for a testis determining factor
(TDF) utilised sex reversed patients, i.e. XX males and XY females, hoping to iso-
late the smallest fragment of Y chromosome required for a male phenotype. Sex
determining region on the Y chromosome, or SRY, was identified first in human and
mouse, then shown to be present in a "Noah’s Ark" (Gubbay et al., 1990; Sinclair
et al., 1990) of mammals. This conservation extends across eutherians, and the se-
quence is present in therians and prototherians (Cortez et al., 2014), though whether
it retains a role in sex determination in these clades remains an open question.
Sry is expressed for a brief period at E11.5 in XY mouse embryonic gonads, pre-
ceding the morphological differentiation of the testes (Gubbay et al., 1990). A 14kb
transgene containing the Sry open reading frame (ORF), along with 8kb of upstream
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and 5 kb of downstream sequence, has been shown sufficient to induce testis forma-
tion (though not spermatogenesis) in XX mice (Koopman et al., 1991).
1.2.2 Transposed and ampliconic genes
The first resolved examples of ampliconic genes were found on the human Y chro-
mosome, where there are nine multicopy gene families. Two of these families orig-
inated on the pre-degenerate Y, and seven have been transposed from autosomes
(Skaletsky et al., 2003). More recently, sequencing of the mouse Y chromosome
has identified massively ampliconic sequence comprising >95% of the euchromatin
and containing three protein coding gene families with significant homology to au-
tosomal genes (Soh et al., 2014). Ampliconic genes on the Y chromosome were
originally thought to be important in intrachromosomal recombination and gene
conversion to slow degeneration of the Y (Rozen et al., 2003). It was later hy-
pothesised that the high copy number inherent to these ampliconic genes might
also facilitate high levels of protein expression, specifically in the testis (Mueller
et al., 2013). An alternative explanation cites the presence of the same gene fami-
lies amplified on the mouse X chromosome (Mueller et al., 2013), and suggests that
genomic conflict between the two sex chromosomes during spermatogenesis to in-
crease transmission is the driving force behind amplification (Bachtrog, 2014). The
latter hypothesis serves to contradict the hypothesis often popularised in the press
that the Y chromosome will lose all protein coding genes within the next 10 million
years (Aitken and Graves, 2002).
1.2.3 X degenerate genes
Following the publication of the first complete sequence of the human Y chromo-
some in 2003 (Skaletsky et al., 2003), it became clear that only around 3% of ances-
tral genes survived 200 million years of sex chromosome evolution on the human
Y, in stark contrast to 98% on the X chromosome (Mueller et al., 2013). This de-
cay has been observed in the sex specific chromosomes across therian mammals.
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It is especially true of the mouse Y chromosome, which has fewer ancestral genes
than most other mammals studied. Given this extensive loss of genes from mam-
malian Y chromosomes, are the survivors simply lucky, or do they carry biological
importance?
The evolutionary significance of the X degenerate genes lies in their convergent
survival and longevity across not only primates (Hughes et al., 2005, 2010, 2012),
but also eutherians and the wider therian subclass (Bellott et al., 2014; Cortez et al.,
2014). This convergent survival is exemplified by KDM5D and UBE1Y. The stratum
containing both genes evolved independently in eutherian and metatherian lineages,
containing a combined 184 shared genes. The former lineage has retained three Y
linked genes, and in the latter nine survived on the Y chromosome. Remarkably,
KDM5D and UBE1Y are still present in both lineages, an event unlikely to happen
under the assumption of random genetic decay (Bellott et al., 2014).
1.3 The mammalian X chromosome
Ohno (1967) hypothesised that dosage compensation keeps the X chromosome con-
stant in terms of gene content. This prediction was initially borne out by sequencing
data, as high conservation was noted within eutherians at the gene level (Carver and
Stubbs, 1997; Ross et al., 2005), and fewer interchromosomal translocations were
uncovered than on the mammalian autosomes (Carver and Stubbs, 1997). Changes
have, however, undoubtedly taken place. The rate of global X chromosome expres-
sion adjusted quickly during early sex chromosome evolution, perhaps in order to
enact faster functional adaptation (Brawand et al., 2011). Moreover, events such
as translocations from the pseudoautosomal region (PAR, see section 1.3.2) to the
autosomes in mouse have served to reshape the gene content of the X chromosome
towards enrichment for specific physiological functions (Palmer et al., 1997; Carver
and Stubbs, 1997; Rugarli et al., 1995).
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1.3.1 Sexual antagonism drives X chromosome evolution
The X chromosome spends two thirds of its time in females, and one third in males
(Fisher, 1931; Rice, 1984). Therefore if a mutation arises with significant fitness
effect on heterozygous carriers that benefits females and is deleterious in males,
it will be subject to positive selection more often than negative selection, and will
increase in frequency. A recessive, or partially recessive, mutation that is beneficial
to males and deleterious to females can spread by virtue of positive selection in
male carriers, and masking in female carriers (Vicoso and Charlesworth, 2006).
These theoretical examples of sexual antagonism explain the accumulation of either
male or female biased genes on the X chromosome relative to the autosomes, via
processes such as retrotransposition and gene duplication.
Reverse transcription and integration via a mature mRNA intermediate - retrotrans-
position - has generated and recruited a disproportionately high number of func-
tional genes from and to the X chromosome relative to the autosomes (Emerson
et al., 2004). A significant number of X to autosome transposition events involved
genes with testis biased expression (Emerson et al., 2004). This bias has been ex-
plained by both mutational bias and natural selection for expression in germ cells,
possibly resulting from need to maintain gene expression during meiotic sex chro-
mosome inactivation (MSCI, Turner, 2007).
A further driver of enrichment for testis biased genes has been noted in the form
of gene duplication events on the X chromosome. Duplication of existing genes
has created vast swathes of ampliconic sequence which, in human, often take the
form of cancer testis antigens (CTAs, Warburton et al., 2004). CTA genes exist in
families that have expanded independently in both primate and rodent lineages, in
a somewhat similar manner to the expansion of ampliconic sequence on the mam-
malian Y chromosome (Chomez et al., 2001; Birtle et al., 2005; Ross et al., 2005).
They are usually expressed only in male germ cells, but also aberrantly in certain
cancers (Simpson et al., 2005).
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In addition to enrichment for genes expressed in testis, the human and mouse X
chromosomes show over representation of genes expressed in brain; and a correla-
tion has been reported between patterns of X linked gene expression in these two
tissues (Guo et al., 2003, 2005). It has been suggested that this relates to females
selecting more intelligent males (Zechner et al., 2001). A more likely explanation
puts forward that genes involved in cognition and fertility are especially important
in the evolution of mammals, and are therefore more likely to experience positive
selection (Vicoso and Charlesworth, 2006). Finally, the X chromosome also shows
specific enrichment for genes expressed in the ovary (Khil et al., 2004), and the
placenta (Hemberger, 2002).
1.3.2 Pseudoautosomal region (PAR)
The PAR is the only region of continuous sequence homology between the two
heteromorphic mammalian sex chromosomes, where evolutionary divergence has
not taken hold. This conservation enables pairing, synapsis, and recombination
during meiosis (Koller and Darlington, 1934; Moses et al., 1975; Solari, 1974), as
also takes place on the autosomes, hence the derivation of the name PAR (Bur-
goyne, 1982). The state of diploidy with reference to loci located within the PAR
also means that there is no requirement for dosage compensation by XCI (Ellis and
Goodfellow, 1989; Ross et al., 2005). The PAR is, therefore, also subject to the
effects of aneuploidy (see section 1.5).
As all eutherian pseudoautosomal genes are autosomal in metatherians, it is thought
that the PAR evolved following a large autosome to sex chromosome translocation
between 80 and 130 MYA (Park et al., 2005; Waters et al., 2007). PAR evolution
has since proceeded at significantly different rates in mammalian species. Humans
are the only known eutherian species to have two PARs, with 25 genes annotated
in PAR1 and four genes in PAR2 (Hughes et al., 2012). In the mouse PAR, which
shares very little homology with either human PAR, there are five known protein
coding genes (Mueller et al., 2013; Bellott et al., 2014).
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1.4 Dosage compensation
Both Muller (1964) and Ohno (1967) predicted that the evolution of a heterogametic
sex would require a system of dosage compensation to avoid the "...great peril..." of
hemizygous gene expression: effectively a form of natural aneuploidy, the negative
impact of disrupted chromosome balance has long been noted (see 1.5). The ap-
pearance across multiple species of efficient and stable mechanisms to relieve this
situation attests to its significance (reviewed by Disteche, 2012). Two distinct aims
of dosage compensation have been identified: i) to balance sex chromosome gene
expression with that of the autosomes; and ii) to balance sex linked gene expression
between the homogametic and heterogametic sexes. Ohno hypothesised that this
could be achieved by two fold transcriptional upregulation of the X chromosome
in males, X chromosome upregulation (XUR). However, this would leave females
expressing X linked genes at twice the level of autosomal genes. Therefore a further
step is the inactivation of one X chromosome in the homogametic sex - XCI (Figure
1.2).
1.4.1 X upregulation(XUR)
Initial evidence for XUR in mouse was limited to one gene, Clcn4-2 (Adler et al.,
1997), before a the appearance of more data produced by microarray in the mid
2000s (Nguyen and Disteche, 2006; Gupta et al., 2006). Assays across several tis-
sues in multiple species supported increased expression of X linked genes relative to
autosomal genes, thus resulting in an X:autosome expression ratio of 0.8-1.0. RNA
sequencing (RNA-seq) analyses then appeared to contradict the previous data, with
X:autosome expression ratios of 0.5 (Xiong et al., 2010), and subsequent work has
seen the balance of evidence constantly shift. What has become clear is that the
parameters surrounding the analysis, particularly normalisation, play a significant
part in the outcome. Even expression levels between different autosomes can vary
substantially (Castagné et al., 2011). A number of ways around this problem have
been suggested. X:autosome expression ratios were shown to increase following
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Figure 1.2: The theory of dosage compensation in eutherian mammals. (i) To balance gene
dosage between the autosomes (A) and sex chromosomes, eutherian mammals upregulate
gene expression from one X chromosome (X in males and Xa in females). This is depicted
in the figure as increased size of the X chromosome relative to the autosomes. X upreg-
ulation in females leads to excess X chromosome gene expression relative to males. To
balance X chromosome gene expression between males and females, one X chromosome is
transcriptionally silenced in females by X chromosome inactivation (Xi). The inactivated
chromosome is depicted as a white chromosome. (ii) Dosage compensation in numbers.
The gene expression from a single autosome is arbitrarily represented as 1.
the exclusion of low/non expressed testis specific genes (Deng et al., 2011). Fur-
thermore, when certain idiosyncracies of the X chromosome are accounted for -
such as treating multi copy gene families differently to single copy genes - evidence
for XUR in multiple tissues mounts (Sangrithi et al., 2017; Jue et al., 2013). Alter-
native approaches have also been trialled. Two recent studies compared expression
of conserved ancestral genes on the mammalian X chromosome to the expression
of autosomal orthologues in species where the sex chromosomes diverged before
the origin of the X, i.e. chicken (Julien et al., 2012; Lin et al., 2012a). Although
inter species comparisons are complicated by different levels of reference sequence
annotation, neither of these studies found evidence for chromosome wide XUR.
However, Lin and colleagues did find evidence to support a refinement to Ohno’s
hypothesis (Lin et al., 2012a). Along with a second study (Pessia et al., 2012),
each provides transcriptomic and proteomic data showing upregulation of X linked
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genes encoding the members of multi protein complexes. Additionally, comparing
X linked genes to autosomal orthologues in divergent species has revealed a down-
regulation of autosomal genes whose protein products interact with those from X
linked genes (Julien et al., 2012). Taken together, these data suggest that XUR,
and possibly autosomal downregulation, are important for specific dosage sensi-
tive genes where the stoichiometry of protein products involved in macromolecu-
lar complexes affects function, as reviewed by Veitia (Veitia and Birchler, 2010).
Whether or not this equalising of X:autosome gene products was sufficient to drive
the evolution of equalisation between XX females and XY males through XCI re-
mains to be shown.
1.4.2 X chromosome inactivation (XCI)
XCI balances sex chromosome dosage between XX females and XY males in mam-
mals via transcriptional inactivation of one X chromosome in the homogametic sex.
The first cytological evidence was presented by Barr and Bertram (1949), whereby
they observed nucleolar satellites in female but not male cat motor neurons. Ohno
& Hauschka suggested that these satellites were heteropyknotic X chromosomes
(Ohno and Hauschka, 1960), and Lyon was able to show that such a heteropyknotic
X chromosome could be inherited from either parent, and was transcriptionally
silent (Lyon, 1961). She went on to posit that the random inactivation of one of
two different X linked coat colour alleles in each cell would result in the tortoishell
coat of the cat, and thus began a field of research that has matured to become a
fundamental paradigm in epigenetics.
XCI is mediated by the long non-coding RNA (lncRNA) Xist in eutherian mam-
mals (Brown et al., 1991; Borsani et al., 1991; Brockdorff et al., 1991), and Rsx
in metatherians (Grant et al., 2012). Following transcriptional upregulation of Xist
from the future inactive X chromosome, a series of events takes place to ensure that
the subsequent transcriptional silencing is locked in and stably transmitted to future
cell progeny. Xist RNA coats the chromosome in cis, leading to the creation of an
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inactive domain containing silenced genes, and excluding RNA polymerase II and
transcription factors (Okamoto et al., 2005). Following the removal of active his-
tone marks, PRC 1 and 2 are recruited (Silva et al., 2003; Schoeftner et al., 2006;
Tavares et al., 2012), possibly via the repA domain in Xist (Wutz et al., 2002; Zhao
et al., 2008), to add repressive marks such as H3K27me3 to histone tails (Plath
et al., 2003; Okamoto et al., 2004). Finally, replication timing of the entire chromo-
some during mitosis changes relative to the rest of the nucleus (Takagi et al., 1982;
Sugawara et al., 1983), and methylation of CpG islands situated at the 5’ end of
genes on the inactive X chromosome functions to stably maintain the inactive state
(Norris et al., 1991; Pfeifer et al., 1990a,b).
In the mouse, Xist is first expressed from the paternally inherited X chromosome
(XP) at approximately the four cell stage (Okamoto et al., 2004, 2005). This im-
printed XCI (iXCI) is maintained across the whole embryo until the first lineage
specifications take place. It continues in the trophectoderm (Takagi and Sasaki,
1975; Mak et al., 2004), which goes on to contribute to the placenta, and in the
primitive endoderm (PE) (Takagi and Sasaki, 1975; West et al., 1977). In the epi-
blast of the inner cell mass (ICM), Xist is downregulated. This downregulation
results in a transient two active X state, followed by Xist mediated inactivation of
either XM or XP (Takagi et al., 1982; Rastan, 1982): random XCI (rXCI). Both of
these are now described in more detail and summarised in Figure 1.3.
1.4.2.1 Imprinted XCI
Imprinted inactivation, i.e. inactivation in a parent of origin dependent manner,
of the Xp is found in all tissues of metatherian mammals (Sharman, 1971; Cooper
et al., 1971; Richardson et al., 1971), and the extraembryonic tissue of some euthe-
rians, i.e. mice (Takagi and Sasaki, 1975).
iXCI is necessary for embryonic survival in mouse. XMXPXist- female embryos
show transcriptional activity from both X chromosomes in the early embryo (Boren-
sztein et al., 2017) and in trophoblast, become severely growth retarded from E6.5,
1.4. Dosage compensation 34
Figure 1.3: X chromosome inactivation in the mouse. From top, XCI is initiated in the XX
female embryo at the 4 cell stage by expression of Xist (in red) from the paternally inherited
X chromosome (Xp, purple). Xist RNA spreads to coat the Xp by the 8-16 cell stage which,
with subsequent modifications, establishes XCI. The Xp remains inactivated until lineage
specification takes place, concurrent with blastocyst formation. In the part of the inner cell
mass (ICM) that goes on to form the embryo proper, the epiblast, Xist is downregulated, and
this is followed by the process of random XCI, which is passed through to the adult mouse.
In the primitive endoderm (PE) and the trophectoderm (TE), which contribute largely to
the extraembryonic tissue, XCI is maintained on the Xp. Each of these lineages gives rise
to a population of stem cells that can be used as in vitro models with different XCI states:
mouse embryonic stem cells (mESCs) represent the preimplantation ICM, and have two
active X chromosomes; and mouse trophoblast stem cells (mTSCs) and extraembryonic
endoderm stem cells (mXENs) are derived from the TE and and PE respectively, and both
show imprinted XCI of the Xp. mESCs can be used to derive cells representative of the post
implantation epiblast, epiblast like cells (mEpiLCs), which have randomly inactivated one
X chromosome. This process of differentiation can be used to model rXCI in vitro
.
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and die before E12.5 (Marahrens et al., 1997). This phenotype is similar to that
shown by PRC protein EED deficient embryos (Wang et al., 2001a), implicating
a role for histone modifications in iXCI in the extraembryonic tissue. Extraem-
bryonic tissue is known to show reduced methylation (Manes and Menzel, 1981;
Rossant et al., 1986). This has been correlated with incomplete silencing of the
inactive X in vivo, as assayed via either endogenous (Patrat et al., 2009) or trans-
gene expression (Hadjantonakis et al., 2001). Such a state has also been observed
in vitro in trophoblast stem cells (Dubois et al., 2014), in addition to a transient
two active X chromosome state (Prudhomme et al., 2015). These instances of plas-
ticity could result from the co existence of both heterochromatic and euchromatic
marks, as observed in trophoblast giant cells (Corbel et al., 2013); and may serve to
compensate for occurrences of pertubation of X linked monoallelic gene expression
(Prudhomme et al., 2015). Other work has shown the presence of low level methy-
lation of CpG islands at promoter regions in trophoblast tissues when compared to
epiblast (Senner et al., 2012). When an enzyme responsible for the maintenance
of this mark is removed (Dnmt1), reactivation of a reporter transgene is detected
in the embryo but not in the extraembryonic tissue (Sado et al., 2000). Interpreted
with evidence showing that neither Dnmt1, Dnmt3a, or Dnmt3b are required for
survival and proliferation of mTSCs (Sakaue et al., 2010), it can be concluded that
DNA methylation is not the primary epigenetic mark "locking in" the inactive state
in extraembryonic iXCI. Much work remains still to be done on the role of histone
modifications in this context.
Mechanism of iXCI
Although it has previously been thought that the XP may be pre-inactivated in the
preimplantation embryo as a result of MSCI (Huynh and Lee, 2003), subsequent
work has shown active XP transcription at the two cell stage (Okamoto et al., 2005).
Multiple alternative mechanisms have been proposed to explain the data, a number
of which are now reviewed.
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A priori, an imprint could protect the XM from silencing, or target the XP to be
inactivated. Early evidence from experiments utilising parthenogenetic embryos
(XMXM) strongly supports the former hypothesis, as development is stalled in the
early postimplantation stages following the failed growth of extraembryonic tissue
(Shao and Takagi, 1990; Goto and Takagi, 1998, 2000). Furthermore, it seems that
such an imprint is imposed during oogenesis, as combining maternal genomes from
non-growing (ng) and fully-grown (fg) oocytes always resulted in inactivation of the
ng derived genome in extraembryonic tissue. This observation is consistent with a
mark imposed on the fg oocyte during maturation (Tada et al., 2000), though unlike
classical genomic imprinting, this is independent of DNA methylation (McDonald
et al., 1998; Liu et al., 2010). Recent work has implicated the H3K9me3 histone
mark in XM-Xist silencing, showing that reduction of H3K9me3 levels via over-
expression of its specific demethylase Kdm4b, in addition to a histone deacetylase
inhibitor trichostatin, results in detectable XM-Xist de-repression (Fukuda et al.,
2014). However, no difference in H3K9me3 levels was found when comparing ng
and fg oocytes at the XM-Xist locus (Fukuda et al., 2015). Most recently, the same
authors showed that both transient histone alterations and chromatin decondensa-
tion are able to partially rescue the embryonic lethality that results from XMXPXist-
(Fukuda et al., 2015, 2016).
Also utilising histone alterations, Federici and colleagues reported partial rescue of
XMXPXist- female embryonic lethality (Federici et al., 2016). Using round sper-
matid injection, they were able to achieve fertilisation without the protamine asso-
ciated condensation and decondensation of the paternal genome. Taken together,
these results implicate a role for H3K9me3 in iXCI, though it seems likely this is
within a wider context of genome organisation in the regulation of gene expres-
sion.
Namekawa and colleagues suggest that iXCI in mouse can be separated into two
steps, with silencing of repetitive sequences preceding that of genic sequences
(Namekawa et al., 2010). Using FISH and immunofluorescence (IF), they identified
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a Cot1-, Pol-II-, Pol-III- silent compartment within which the repeat sequences of
the XP are localised at the two cell stage. The formation of this silent compartment
is Xist-independent. In contrast, the inactivation of genic regions takes place a num-
ber of cell divisions later (reasonably consistent with other data: Okamoto et al.,
2004, 2005, 2011), and this requires Xist expression. They favour a model whereby
repeats arrive in the embryo pre-inactivated following MSCI. These repeats could
comprise an imprint on the XP predisposing to inactivation, independent of any XM
imprint laid down in the oocyte.
Experiments utilising Xist transgenes suggest a role for hemizygosity in iXCI. A
200-kb Xist locus transgene present in a multicopy array on an autosome is sufficient
for ectopic Xist expression and chromatin silencing in the hemizygous state, but not
the homozygous state (Sun et al., 2015). It is possible that chromatin modifications
(like in MSCI) resulting from the unpaired state of the Xist transgenes are directly
responsible for Xist imprinting in next generation (Sun et al., 2015). However, this
is in contrast to previous work (Okamoto et al., 2005). Using a single copy 460-
kb transgene, no difference was observed between homozygous and hemizygous
males in terms of ectopic Xist expression. Moreover, there was also no evidence of
the Xist transgene associating with the sex body, as would be expected if passage
through the XY body is required for iXCI (Okamoto et al., 2005). Payer suggests
that the differences observed may be due to the multicopy nature of the transgene
in the former study, which might more completely reflect the endogenous situation
(Payer, 2016). This has previously been reported when using Xist transgenes to
recapitulate rXCI, whereby multicopy transgenes suceed whilst single copies failed
(Heard et al., 1996, 1999b; Lee et al., 1999).
1.4.2.2 Random XCI
Early biochemical and cytogenetic evidence provided the first link between cellular
differentiation and XCI in vivo (Rastan, 1982; Monk and Harper, 1979). It showed
that both X chromosomes are active in the peri implanation mouse embryo until
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rXCI takes place in the epiblast around E4.5. This event is re captured in the most
well used model of XCI in vitro, mouse embryonic stem cells (mESCs). XX female
mESCs have two active X chromosomes, and undergo XCI upon differentiation
(Martin et al., 1978; Takagi and Martin, 1984), thereby facilitating investigation of
the mechanisms underlying rXCI.
Regulation of Xist expression
XCI is controlled by the X inactivation centre (Xic), a region of around 1Mb shown
to be both necessary and sufficient to trigger XCI when present in at least two copies
(Heard et al., 1996; Lee et al., 1996; Heard et al., 1999a). Within the Xic locus are
situated a number of genes - protein coding and non coding - that are involved in
the process, many of which have been characterised using the mESC model.
Tsix is a negative regulator of Xist: it is a non-coding RNA that overlaps with and
is transcribed antisense to Xist (Lee et al., 1999). Current evidence suggests that
the act of Tsix transcription, as opposed to the RNA itself, represses Xist expression
(Stavropoulos et al., 2001; Shibata and Lee, 2004; Sado et al., 2006). Heterozygous
deletion of Tsix results in skewed XCI of the mutated chromosome in XX female
cells, but deletion does not cause inactivation in XY male cells. This suggests that
Tsix is involved in the choice of which chromosome to inactivate, but not the count-
ing that ensures one X chromosome is left active (Lee and Lu, 1999; Lee, 2002;
Stavropoulos et al., 2001). Mechanistically, it has been proposed that pairing ob-
served between the Tsix and Xpr loci might mediate this choice process (Xu et al.,
2006, 2007; Bacher et al., 2006). However, recent work using heterokaryons has
provided evidence that pairing is not essential for XCI initiation, as XCI can take
place in different nuclei within the same cytoplasm via trans acting factors (Barakat
et al., 2014).
Tsix has also been implicated in iXCI. It is downregulated in the postimplantation
embryo, but expression from the XM persists in the extraembryonic tissue. Dis-
ruption of this allele results in ectopic Xist expression and early embryonic lethality
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following Xist mediated inactivation of the single X in males and both Xs in females
(Sado et al., 2001). Recent work has cast doubt on this interpretation, suggesting
Tsix is not required for initiation of iXCI, but instead is involved in the differenti-
ation of mouse trophoblast stem cells (mTSCs) towards a giant cell fate (Maclary
et al., 2014). A further role for Tsix has been highlighted in mouse epiblast stem
cells, where it is required to silence Xist on the active X chromosome (Xa) in vivo
and in vitro as they differentiate (Gayen et al., 2015).
Loci upstream of Xist have also been proposed to play roles in the regulation of its
expression, either in cis or in trans. Jpx was initially thought unlikely to regulate
XCI (Chureau et al., 2002), however, later chromosome conformation capture (3C)
analysis suggested a relationship between Jpx and Xist (Tian et al., 2008). The Jpx
locus produces a long non coding RNA (lncRNA) that may act in trans to regulate
Xist expression from the Xi (Tian et al., 2010) via dose dependent eviction of CTCF
at the promoter (Sun et al., 2013a). Alternatively, the lncRNA could act in cis to
coactivate Xist through promoter contacts (Barakat et al., 2014), though Sun and
colleagues (2013) suggest that such contacts are not significant to XCI. Barakat et
al. (2014) reached similar conclusions for the lncRNA Ftx. Whilst initial work in
male mESCs suggested that Ftx deletion reduced expression of Xist and resulted
in dysregulation of other loci across the Xic (Chureau et al., 2011), subsequent
evidence from female mESCs and in vivo showed that Ftx deletion does not affect
Xist expression or iXCI (Soma et al., 2014). Taken together, these data suggest
that both Jpx and Ftx may act in cis to play a part in Xist regulation, lowering
the threshold for activation by trans acting factors such as Rnf12 (Barakat et al.,
2014). It is, however, clear that neither acts alone, and whether the mechanism of
regulation is driven by the act of transcription, the transcript itself, or at the DNA
level, remains to be investigated. Finally, existence of two microRNAs within the
Xic has recently been identified, though work is ongoing to explore their function
(Kobayashi et al., 2013).
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Pluripotency and XCI
The pluripotent state inhibits XCI (Minkovsky et al., 2012) via a number of pluripo-
tency associated transcription factors that can be loosely grouped as either repress-
ing Xist expression or promoting Tsix. Xist intron 1 can be bound by OCT4, SOX2,
NANOG, and PRDM14 (Payer et al., 2013), and can also spatially associate with
the Xist promoter (Tsai et al., 2008), repressing Xist transcription and therefore
XCI (Navarro et al., 2008). However, whilst deletion of intron 1 in male and female
mESC lines carrying a Xist transgene led to slightly increased Xist expression (Nes-
terova et al., 2011), recent work has removed endogenous intron 1 in both mESCs
and mice without obvious effect on Xist expression or phenotype (Minkovsky et al.,
2013). OCT4 has also been shown to bind to the promoter of Tsix and stimulate
transcription, in addition to KLF4, c-MYC and REX1 (Navarro et al., 2008; Dono-
hoe et al., 2009; Nesterova et al., 2011).
Rex1 likely sits in both groups as an Xist repressor and an activator of Tsix (Gontan
et al., 2012). During differentiation, REX1 is targeted for degradation by the E3
ubiquitin ligase Rnf12(RLIM), which has been proposed to behave as a trans acting
factor, working dosage dependently to trigger XCI (Gontan et al., 2012). Male
mESCs usually have a single copy of Rnf12 and therefore do not inactivate the single
X chromosome; however, when extra copies are added, XCI is aberrently initiated
(Jonkers et al., 2009). The picture in female mESCs is not so clear. Homozygous
inheritance of an allele producing a 340 amino acid mutant protein (Jonkers et al.,
2009) abolished XCI in differentiating cells; whereas production of a 83 amino acid
mutant peptide (Shin et al., 2010) had no effect in vitro. The latter allele also had no
effect on rXCI (Shin et al., 2014), but did perturb iXCI when inherited maternally
(Shin et al., 2010).
Exit from the pluripotent state through differentiation is affected by X linked gene
dosage. In female mESCs, when both X chromosomes are active, X linked genes
show on average 2-fold higher expression than in male cells (Lin et al., 2007). This
seems to stabilise the pluripotent state by inhibiting MAPK/Erk signaling and stim-
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ulating Akt (Schulz et al., 2014). As differentiation requires MAPK signaling, the
only way to exit pluripotency is for the cell to undergo XCI (Schulz et al., 2014).
Utilising multiple mESC lines in serum and leukemia inhibitory factor (LIF) culture
conditions, Schulz and colleagues showed that XX female cells are delayed in exit-
ing the pluripotent state, following the induction of differentiation, when compared
to XY and XO cells. They observed reduced activity of MAPK signaling, correlated
with DNA hypomethylation, and suggest that these factors result in a population of
cells shifted towards naive ground state pluripotency. Following induced expres-
sion of Xist, female cells were able to differentiate with similar kinetics to XY and
XO cells. These observations support the hypothesis that two active X chromo-
somes inhibit downregulation of pluripotency factors, and only following feedback
from XCI - indicative of X chromosome dosage compensation - is this inhibition
released.
Further support for the link between exit from pluripotency and XCI can be iden-
tified from mouse development data, where it was first noted that XY male em-
bryos show slightly accelerated growth relative to XX female embryos (Tsunoda
et al., 1985). Paul Burgoyne utilised a plethora of different mutant mouse crosses to
show the Y chromosome of most strains accelerates preimplantation development
(Burgoyne, 1993); and furthermore that embryos with two X chromosomes show
slightly delayed post implantation development (Thornhill and Burgoyne, 1993;
Burgoyne et al., 1995). Intriguingly, this observation was true when comparing
XX embryos to XY and XMO embryos (with a single X chromosome inherited
maternally). However, XPO embryos (with a single X chromosome inherited pater-
nally) showed delayed development relative to XX, XY and XMO embryos at E10.5
(Thornhill and Burgoyne, 1993). This phenotypic difference suggests that XM and
XP are not equal in terms of their effects on embryonic development, and warrants
further attention. The aneuploid XO model system isolates maternal and paternal X
chromosomes efficiently in order to address this (see section 1.5).
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1.4.3 Escape from X chromosome inactivation
A number of X-linked genes are not silenced during the process of XCI. In humans,
it has been estimated that around 12% show consistent escape, and a further 8%
escape variably in different individuals and different tissues (Schultz et al., 2015;
Carrel and Willard, 1999); whereas in mouse, the numbers are 3% and 4% respec-
tively (Berletch et al., 2015). These genes have been found to lack the Xist coating
and repressive histone marks usually characteristic of the inactive X (Simon et al.,
2014; Goto and Takagi, 2000; Yang et al., 2010; Marks et al., 2015), in addition to
displaying unique methylation marks (reviewed in Balaton and Brown, 2016).
Whether these differences are the cause of escape or simply a result of escape has
yet to be determined. Interestingly, large clones incorporating the locus of escapee
gene Kdm5c can be integrated at different X linked locations and still show ex-
pression, suggesting that escape is a locus intrinsic property (Li and Carrel, 2008).
Further work deleting a non-coding region within the cloned locus resulted in ex-
pression from genes outside the integrated clone, showing that the escape property
can spread (Horvath et al., 2013).
It has previously been put forward that specific DNA sequences, such as long in-
terspersed nuclear elements (LINEs) or CTCF binding domains, might be enriched
around those genes subject to or escaping from XCI (Bailey et al., 2000; Chow
et al., 2010; Dixon et al., 2012). Most recently, work on nuclear ultrastructure has
described the existence of topologically associating domains (TADs), intra chro-
mosomal compartments thought to represent functional domains of gene regulation
(Dekker and Heard, 2015). Groups of human and mouse genes escaping XCI have
been shown to exist within the same TADs (Marks et al., 2015), and in naturally oc-
curing autosomal translocations onto the inactive X chromosome, the translocated
gene(s) followed the general pattern of the TAD, i.e. subject to or escape from XCI
(Cotton et al., 2014). The significant question of why these genes escape chromo-
some wide silencing remains unanswered.
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1.5 Aneuploidy
Aneuploidy - a deviation from euploidy, i.e. not having a normal number of chro-
mosomes - is a term that encompasses loss and gain of chromosomes, both of which
are usually problematic to the organism. One of the first reports was in 1920, when
it was shown that the flowering plant Datura stramonium exhibited fewer nega-
tive phenotypic effects from duplication of the whole genome than duplication of
a single chromosome (Blakeslee et al., 1920). This result suggested that the bal-
ance between chromosomes is more important that the overall number of copies of
the genome. Further examples can be found in human disease. The only mono-
somy compatible with perinatal life is monosomy X (TS), whereas three autosomal
trisomies are compatible with perinatal life - trisomy 13 (Patau syndrome), 18 (Ed-
wards syndrome), and 21 (Down’s syndrome, Tybulewicz, 2006). Those afflicted
with the latter present with severe phenotypes including developmental abnormal-
ities, mental retardation and shortened life expectancy (weeks, months and around
50 years, respectively, Tybulewicz, 2006). Sex chromosome trisomies are signf-
icantly less severe, possible due to the transcriptional inactivation of all but one
X chromosomes (with the exception of XCI escapees: see section 1.4.3), and the
relative paucity of widely expressed genes from the Y chromosome.
1.5.1 Sex chromosome aneuplodies
A brief description of the salient features of the most prevalent sex chromosome
aneuploidies are summarised in Table 1.1
1.5.1.1 Klinefelter syndrome: XXY
First described in 1942 as male patients presenting primarily with small testes and
gynaecomastia, Klinefelter syndrome has a prevalence of around 0.1-0.2% of males
(Klinefelter et al., 1942; Lanfranco et al., 2004). It is the most common cause of
genetic infertility (Lanfranco et al., 2004). There is some evidence to suggest that
XXY embryos are selected against in utero, as one study showed that only 55%
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Aneuploidy Prevalence (birth) Infertility Intellectual
disability
Congenital
abnormali-
ties
Growth
phenotype
Karyotype
Klinefelter syndrome 0.1-0.2% of males Yes Mild No Tall XXY
Triple X syndrome 0.1% of females No Mild No Tall XXX
XYY syndrome 0.1-0.2% of males Variable Mild No Tall XYY
Turner syndrome 0.04% of females Yes Mild-
moderate
Heart,
kidney
Short XO
Table 1.1: Key features of human sex chromosome aneuploidies.
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survive to term (Jacobs, 1990). Karyotypic analysis revealed the aetiology as an
abnormal sex chromosome complement of XXY (Jacobs et al., 1959; Ford et al.,
1959b) in around 80% of cases, with higher grade aneuploidies and structurally ab-
normal chromosomes making up the further 20% (Bonomi et al., 2017). Subsequent
characterisation has added a number of other features to the syndrome, including
osteoporosis, sexual dysfunction, and tall stature (Bonomi et al., 2017). It is likely
that at least part of the spectrum of phenotypes attributed to Klinefelter syndrome
result from abnormal dosage of genes escaping XCI, or those present in the PAR
(see below, section 1.5.2).
1.5.1.2 Triple X syndrome
Originally described as a human "super female" (Jacobs et al., 1959), Triple X syn-
drome was reported only after the development of karyotyping techniques, as many
cases, then and now, go undiagnosed due to the lack of clinical signs and symp-
toms (Otter et al., 2009). With a prevalence of around 0.1% of female births, Jacobs
(1990) estimates that this represents around 70% of XXX fertilisation events; i.e.
some negative in utero selection takes place. The relatively mild reported phenotype
of slight developmental delay during childhood, possible correlation with increased
psychiatric diagnoses in adulthood, and tall stature (Otter et al., 2009), suggest that
this aneuploidy is at least partly compensated for by XCI.
1.5.1.3 Y chromosome aneuploidies
Whilst other Y chromosome aneuploidies exist as case reports, by far the most
prevalent is XYY, which is detected at a rate of 0.1% of live male births (Geerts
et al., 2003), with no detected selection in utero (Jacobs, 1990). Some individuals
show delayed language acquisition and motor development, along with above av-
erage height, weight and head circumference from birth onwards. There is also an
increased risk of child psychiatric disorders, including autism (Geerts et al., 2003),
and variable rates of infertility (Kim et al., 2013).
1.5. Aneuploidy 46
1.5.2 Turner syndrome: XO
The clinical entity of Turner syndrome (TS) was first reported by Ullrich (Ullrich,
1930), before later being made eponymous by Henry Turner in his 1938 address
to The Association for the Study of Internal Secretions (Turner, 1938). TS encom-
passes a core phenotype of short stature, streak ovaries, webbing of the neck, and
congenital cardiovascular and renal defects (Ranke and Saenger, 2001). Notably,
the severity of each of these shows significant inter individual variation (Ranke and
Saenger, 2001). In 1959, Ford and colleagues linked karyotype with phenotype and
thus formally identified TS as monosomy X (Ford et al., 1959a). TS is the most
commonly diagnosed sex chromosome abnormality in humans, occurring in 1-2%
of clinically recognised pregnancies (Hassold et al., 1992); though survival to term
only occurs in about 1% of XO foetuses (Hook and Warburton, 1983). Such high in
utero lethality supports the case for the importance of X linked genes in embryonic
development. There are a number of mechanistic hypothesis that account for this,
and the subsequent variable postnatal phenotype in survivors, including genomic
imprinting and haploinsufficiency. These are now explored in further detail.
1.5.2.1 Genomic imprinting
In therian mammals, embryos derived solely from paternal genomes (androgenotes)
or from maternal genomes (gynogenotes) do not survive in utero development. An-
drogenotes are characterised by poor progression in the embryo proper, but signif-
icant development of the extraembryonic tissue (Barton et al., 1984). Gynogenetic
embryos progress further with some growth defects, though show pronounced ab-
normalities in the extraembryonic derivatives (Kaufman et al., 1977; Surani and
Barton, 1983; Surani et al., 1984; McGrath and Solter, 1984). This requirement for
one copy each of the paternal and maternal genome to initiate successful embryonic
development is explained by genomic imprinting, the process whereby a group of
genes is epigenetically regulated to show monoallelic expression in a parent of ori-
gin specific manner (Cleaton et al., 2014). In mouse, around 100 autosomal genes
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are regulated in this way: they are usually found in small groups clustered around an
imprinting control region (ICR) that is differentially methylated in either the male
or female germline during development (Cleaton et al., 2014). Autosomal genomic
imprinting is also found in humans - attested to by a number of severe disease phe-
notypes related to erroneous imprinting (see Soejima and Higashimoto, 2013) - and
across the wider mammalian class, with the exception of monotremes. This obser-
vation has led to the hypothesis that the process evolved alongside evolution of the
placenta (Smith et al., 2011). Interestingly, of the small number of X linked im-
printed genes reported in mouse, most are expressed in placenta (Li and Behringer,
1998; Rodriguez et al., 2004; Shi et al., 2004), with brain being the other tissue
(Davies et al., 2005). No related X linked ICR has been reported.
Genomic imprinting in TS
The parental origin of the X chromosome in XO spontaneous abortuses, late foetal
deaths, and liveborn females is relatively constant, with approximately 70% mater-
nal and 30% paternal (Hassold et al., 1985, 1988; Cockwell et al., 1991; Sanger
et al., 1977; Jacobs et al., 1990). Hook and Warburton (2014) hypothesise that this
deviation from 50:50 can be partly explained by a post conception mitotic sex chro-
mosome loss. An XX embryo can lose either XM or XP, whereas an XY embryo
must lose the Y and retain the XM because YO embryos are not viable (Morris,
1968a; Burgoyne and Biggers, 1976). Jacobs further suggests that the paternal X
chromosome from XX embryos may also be lost before pronuclear fusion, and that
the Y chromosome may be lost due to its small size (Jacobs et al., 1997).
As the available data show a bias towards a maternally inherited X chromosome in
individuals living with TS, does this manifest as a difference in phenotype? Ev-
idence has been presented that skills mediating social interactions are better de-
veloped in XPO females, and it was hypothesised this could be explained by the
existence of an X linked imprinted locus (Skuse et al., 1997; Bishop et al., 2000).
However, no specific loci were found. Further suggestion of X linked imprinting in
humans was provided by studying the transmission of X linked maternal alleles in
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families free of detectable genetic disease (Naumova et al., 1998). A significant de-
viation from the Mendelian ratio resulted in distorted inheritance at a specific locus
among male offspring, though no follow up has since been published.
1.5.2.2 Haploinsufficiency
Ferguson-Smith (Ferguson-Smith, 1965) suggested that the phenotype observed in
patients with an XO karyotype could be explained by the presence of homologous
genes on the X and Y chromosomes that escape XCI, and thus are haploinsuffi-
cient in patients lacking a second sex chromosome. Following their identification,
the PARs became an obvious location for such genes (Canki et al., 1988). In hu-
man, the short stature homeobox containing gene (SHOX) certainly influences the
growth deficit observed in TS patients (see next section); however, it does not seem
to be involved in any of the other phenotypic abnormalities (Ellison et al., 1997).
More recently, Urbach and Benevisty used XX and XO human embryonic stem cells
(hESCs) differentiated towards various lineages to propose that CSF2RA, located in
PAR1, is haploinsufficient when present in only one copy in the placenta; and is
therefore responsible for the embryonic lethality (Urbach and Benvenisty, 2009).
This is in keeping with the concept of the existence of a karyotypically normal res-
cue line in all liveborn XO individuals. In 1983, Hook and Warburton suggested
that the difference between viable and non viable XO conceptuses could be the
existence of undetected mosaicism for a karyotypically viable cell line, e.g. XX,
suggesting haploinsufficiency at key sex linked loci as the underlying reason for
death in utero (Hook and Warburton, 1983, 2014). This position was supported by
extensive abortion datasets from New York and New Jersey, highlighting the ratio
of apparent non mosaic XO to XO/XX mosaics was higher in embryonic and foetal
deaths than in living individuals, 13.5:1 and 3.6:1, respectively (Hook and Warbur-
ton, 1983). Subsequent work has specifically searched for such hidden mosaicism
in living patients with a diagnosis of TS, with varying success. Jacobs initially
counted 100 cells from peripheral blood (greater than the usual 30 used for clinical
diagnosis), and found 2/84 mosaics (Jacobs et al., 1997). Cells from buccal smears
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were then counted, and no further mosaicism was found. More recent work used
FISH on buccal smears (subsequent to the initial diagnostic 30 cells from peripheral
blood) and reported a detection rate of 30% (Freriks et al., 2013). These data are
largely consistent with the cryptic mosaicism hypothesis: if the patients with "com-
plete monosomy" (Hook and Warburton, 2014) have a more severe phenotype than
those with rescue lines, they would be more likely to present with symptoms and
signs for medical investigation, and thus the rate of undetected mosaicism is rela-
tively low. Furthermore, screening for mosaicism in these patients using peripheral
blood and buccal swabs will not detect placental mosaicism, and it is the latter that
could explain their survival (Hook and Warburton, 2014).
Turner syndrome as an experimental paradigm
In order to more fully understand the role of X linked genes in development and,
more specifically, differences between XM and XP, a measurable characteristic is re-
quired: the most quantifiable aspect of the TS phenotype is the growth deficit.
Short stature has long been recognised as an ever present feature of TS (Brook
et al., 1974), starting with intrauterine growth retardation, as identified by sono-
graphic studies. Using data resulting from prenatal screening, it has been shown
that alongside the TS diagnostic anomalies of cystic hygroma and fetal hydrops,
foetuses are generally small for gestational age (Wladimiroff et al., 1995). This
continues postnatally, as evidenced by a retrospective study of an Italian cohort of
patients with reduced birth weight (Larizza et al., 2002; Wisniewski et al., 2007).
Children show a decline in growth velocity that is not rescued by a pubertal growth
spurt, and adults are typically ~2.5-3.5 standard deviations below normal female
height (Brook et al., 1974; Robles Valdés et al., 2003).
A number of other sex chromosome abnormalities have been associated with short
stature, primarily including deletions of the short arms of the X or Y chromosome
(Curry et al., 1984; Zuffardi et al., 1982). Further work localised the locus respon-
sible to the PAR1 (Ballabio et al., 1989), and the gene was subsequently identified
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as SHOX. Deficiency in this gene could explain the short stature observed in indi-
viduals with TS (Rao et al., 1997; Ellison et al., 1997). These individuals carry only
one copy of SHOX, whereas individuals with a normal XX or XY karyotype carry
two copies. Furthermore, some patients with idiopathic short stature (Rao et al.,
1997; Fukami et al., 2016) and others with limb bone abnormalities (Belin et al.,
1998; Chen et al., 2009; Benito-Sanz et al., 2005; Barca-Tierno et al., 2011) have
mutations in the SHOX gene, independent of specific sex chromosome abnormal-
ities. SHOX expression has since been observed in the developing limb, mainly
in perichondrial layer, and in the pharyngeal arches (Clement-Jones et al., 2000;
Rao et al., 2001). In vitro work suggests SHOX is an activator of the aggrecan
enhancer in chondrogenesis and skeletal development (Aza-Carmona et al., 2011),
thus supporting significant involvement in the TS phenotype. There is, however,
some evidence to suggest that individuals with TS are generally shorter than those
with SHOX mutations, and that other loci may be involved in the short stature phe-
notype (Ross et al., 2001; Fukami et al., 2016; Zinn and Ross, 1998).
1.5.3 XO aneuploid mice
The deduction that the female mouse can also harbour an XO sex chromosome com-
plement came contemporaneously with the first reported human karyotype in 1959
(Welshons and Russell, 1959). A line was subsequently developed by Cattanach and
colleagues in Edinburgh, UK (Cattanach, 1962). Animals of this karyotype showed
no gross difference in growth from XX littermates, and were used for breeding, with
apparently fewer XO daughters from XO mothers than expected. This observation
was explained by the hypothesis that many oocytes segregated the chromosome set
lacking an X chromosome to the polar body (Cattanach, 1962). Further work has
gone on to show that XO female mice have reduced fertility when compared to XX
females, both in terms of litter size and reproductive lifespan (Morris, 1968b; Bur-
goyne and Biggers, 1976; Burgoyne and Baker, 1981). This reduction is largely due
to the presence of an unpaired X chromosome during meiosis (Burgoyne and Baker,
1985).
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Originally reported as phenotypically normal (Welshons and Russell, 1959; Cat-
tanach, 1962), XO female mice were subsequently found to recapitulate at least one
aspect of the TS phenotype, with growth deficits occurring during embryonic and
postnatal development. XPO embryos have a developmental lag relative to XX lit-
termates at preimplantation (Banzai et al., 1995a) and egg cylinder (E7.25) stages
(Burgoyne et al., 1983b; Ishikawa et al., 1999). This lag could be explained, at least
in part, by the reduced volume of the ectoplacental cone (Jamieson et al., 1998),
part of the early placenta (Gardner et al., 1973). In contrast, the XPO placenta dur-
ing late development is increased in volume (Burgoyne et al., 1983b). Interestingly,
placentas from XMO and XY conceptuses also showed this hyperplastic phenotype
(Ishikawa et al., 2003; Zechner et al., 1996, 2002). These apparently contradictory
data can be reconciled by two separate explanations. The reduced ectoplacental
cone volume in XPO embryos was suggested to be a result of genomic imprint-
ing, and late development placenta hyperplasticity was attributed to X chromosome
dosage (Ishikawa et al., 2003).
Imprinting in XO mice
Further, more detailed work has identified additional evidence for a potential X
chromosome imprinting effect, showing that the embryonic developmental lag is
present only in XPO embryos at E10.5. XMO embryos and XY embryos are signif-
icantly larger than XX littermates at the same stage, and all are significantly larger
than XPO embryos (Thornhill and Burgoyne, 1993). Alternatively, this could be
explained by inappropriate expression of Xist in the preimplantation embryo. Xist
expression is imprinted in the early mouse embryo, such that it is always expressed
from the XP at 4-8 cell stage (Okamoto et al., 2005). Notably, Xist expression also
occurs in XPO embryos, which only have a single X chromosome (Matsui et al.,
2001). Xist is then downregulated in the epiblast of all embryos at the blastocyst
stage prior to random XCI, whereas imprinted XCI continues in the trophectoderm.
Downregulation of Xist was found to take place in all cell types of XPO embryos
at the blastocyst stage. It is therefore conceivable that inappropriate Xist expres-
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sion results in XPO embryos functionally nullizygous for embryo derived X linked
gene products for a number of cell cycles during this key developmental time win-
dow. This functional nullizygosity for an entire chromosome would likely have a
significant impact on embryonic development.
Haploinsufficiency in XO mice
Whilst there is no growth deficit observed in XO mice during late embryonic devel-
opment, and reports contrast about birth weight data (Burgoyne et al., 1983b; Deck-
ers and Van der Kroon, 1981; Burgoyne et al., 1983a, 2002), it is clear that a post-
natal growth deficit exists (Burgoyne et al., 1983a, 2002). In the earlier study, Bur-
goyne and colleagues compared XPO female mice to XX littermates, and showed
that the rate of growth differed significantly during the first three weeks of postnatal
life. This difference disappeared during subsequent phases of growth (Burgoyne
et al., 1983a). The follow up study sought to determine whether this effect could
be attributable to imprinting, i.e. is it present in the XMO, or X linked gene dosage
deficiency (Burgoyne et al., 2002). By comparing the weights of XPO and XMO
female mice with their XX littermates during the first five weeks of postnatal life, it
was shown that a small but significant growth deficit exists regardless of the parental
origin of the X chromosome. Reasoning that this could be due to haploinsuffiency
of PAR localised genes, they utilised sex chromosome variant mice to show that
two copies of the PAR did not rescue the growth deficit. Interestingly, a growth
deficit was not observed in female mice carrying a Y chromosome deficient in Sry
(an XYTdy female, Lovell-Badge and Robertson, 1990; Gubbay et al., 1992). The
authors concluded that the postnatal growth deficit observed in XO female mice is
not the result of genomic imprinting on the X chromosome, or of haploinsufficiency
for genes localised to the PAR. The growth deficit was likely caused by haploinsuf-
ficiency of X linked genes that escape XCI, and that have homologues on the Y
chromosome (Burgoyne et al., 2002). The identification of these genes - Ddx3x/y,
Kdm5c/d, Kdm6a/Uty, and Eif2s3x/y - as likely candidates for a haploinsuffiency
hypothesis is consistent with the conclusions made from the recent Y chromosome
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sequencing data (Bellott et al., 2014). At least three of the four are highly conserved
regulators of global gene activity, likely required for male viability, and responsible
for male:female sexual dimorphism in health and disease (Bellott et al., 2014). A
cartoon depicting the relative positions of these genes on their respective chromo-
somes is provided for reference (Figure 1.4).
1.6 X-Y gene pairs with candidate roles in postnatal
growth
1.6.1 Kdm5c
KDM5C (lysine demethylase 5C) was the first gene described to escape XCI, ini-
tially in human, and very shortly after in mouse, showing ubiquitous expression in
both organisms (Wu et al., 1994; Agulnik et al., 1994b; Sheardown et al., 1996;
Carrel et al., 1996). Also known as Smcx and Jarid1c, the protein has a number of
significant domains suggestive of histone lysine demethylase function: JmjC, a his-
tone lysine demethylase domain (Chen et al., 2006; Klose et al., 2006), supported by
a JumjN domain (Chen et al., 2006); an AT rich domain interacting domain (ARID)
associates with DNA in both sequence specific and sequence independent manners
(Kortschak et al., 2000; Wilsker et al., 2002); and C5HC2 and PHD zinc finger
domains provide histone methyl lysine binding motifs (Shi et al., 2006; Wysocka
et al., 2006; Horton et al., 2009).
Confirmation of histone lysine demethylase function was provided by a number of
reports, showing activity at both H3K4 me3 and me2, and highlighting a key role
in repression of transcription (Iwase et al., 2007; Christensen et al., 2007; Tahiliani
et al., 2007). Work in Drosophila on the orthologue Little imaginal discs (LID, Eis-
senberg et al., 2007; Lee et al., 2007a) and in C. elegans on rbr-2 has indicated that
this function is highly conserved across species (Christensen et al., 2007). It is at
least partly mediated by association with the transcriptional repressor REST in multi
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protein complexes (Tahiliani et al., 2007). KDM5C and REST were shown to co
occupy neuron restrictive silencing elements, and RNA-interference (RNAi) medi-
ated knockdown of Kdm5c de-repressed several downstream targets (Tahiliani et al.,
2007). Independently, a role for Kdm5c in neural development was shown utilising
zebrafish morpholinos, and isolated primary granule neurons from rat pups manifest
impaired dendritic growth following Kdm5c RNAi (Iwase et al., 2007).
The link between reduced KDM5C activity and impaired neuronal function in hu-
mans was first noted in a subset of patients with X linked intellectual disability
(XLID) syndrome carrying mutations in KDM5C (Jensen et al., 2005; Tzschach
et al., 2006; Santos et al., 2006; Abidi et al., 2008; Rujirabanjerd et al., 2010; Õu-
nap et al., 2012; Peng et al., 2015; Fieremans et al., 2015). In XLID syndrome,
affected individuals have an IQ<70 (Roeleveld et al., 1997). Some patients with
mutations in KDM5C also have diagnoses of autism spectrum disorders, and many
are of short stature (Adegbola et al., 2008). Patients reported in these papers are
almost always male, and females carrying one copy of the mutation are usually de-
scribed as phenotypically normal. There are, however, some reports of KDM5C
mutant females with mild intellectual disability and XCI skewed to silence the mu-
tation harbouring X chromosome. Where parental origin has been reported, the
mutant allele is always maternally inherited (Abidi et al., 2008; Santos-Reboucas
et al., 2011; Õunap et al., 2012). This case based evidence supports the hypothesis
that dosage of KDM5C is important. Although the gene escapes XCI, expression
from the inactive X allele has been estimated at between 20%-70% of that on the
active X (Sheardown et al., 1996). Moreover, expression analysis in mouse brain
indicates that Kdm5c is expressed more highly in adult females than adult males,
and expression of the Y linked homologue Kdm5d does not fully compensate (Xu
et al., 2002). This is consistent with the significantly higher incidence of XLID in
males than females, suggesting that either the Y linked homologue does not pro-
vide complete functional compensation for loss of KDM5C, or it is not expressed at
equivalent levels in correct subset of cells required for normal development.
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Interestingly, and supporting a fundamental housekeeping role for KDM5C across
multiple cell types, mutations are associated with a wide spectrum of cancers. In
renal cell carcinoma (RCC), KDM5C could act as a tumour suppressor (Dalgliesh
et al., 2010; Niu et al., 2012). KDM5C it is abundantly expressed in hepatocellular
carcinoma (HCC) cell lines, and depletion reduced migration and epithelial mes-
enchymal transition (Ji et al., 2015). KDM5C is significantly upregulated in breast
cancer, and levels positively correlate with metastasis (Wang et al., 2015). Finally,
DNA methylation is significantly reduced in the leukocytes of these individuals car-
rying these mutations (Grafodatskaya et al., 2013).
1.6.2 Kdm5d
First described as an H Y antigen responsible for the rejection of male skin grafts
by female mice of the same strain (Koo et al., 1977; Simpson, 1986; Simpson et al.,
1987), KDM5D was then named SMCY following mapping in mouse and human,
where it was shown to be expressed widely (Agulnik et al., 1994a; Scott et al.,
1995). Work utilising both Drosophila and human cells lines has shown that in ad-
dition to functional conservation with KDM5C with regards to H3K4 demethylase
activity, KDM5D associates with Ring6a/MBLR, which enhances demethylation
activity (Lee et al., 2007a). Furthermore, KDM5D is implicated in the regulation
of Engrailed 2. Depletion by RNAi led to increased H3K4 di- and tri-methylation
levels at Engrailed 2 promoter, increased transcription of this gene, and enhanced
recruitment of the chromatin remodelling complex NURF (Lee et al., 2007a). This
evidence suggests a more general role for KDM5D in transcriptional regulation. A
similar role has also been implicated in mouse, where KDM5D co localises with
MSH5, a meiosis regulator, during spermatogenesis (Akimoto et al., 2008). Finally,
mutations in KDM5D have been found in a significant proportion of prostate cancer
cases; and knockdown in prostate cancer cell lines resulted in an increased rate of
growth alongside reduced apoptosis (Perinchery et al., 2000).
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1.6.3 Kdm6a
Kdm6a (lysine demethylase 6a), also referred to by its former name Ubiquitously
transcribed Tetratricopeptide repeat on chromosome X (Utx), was first described in
1998 in both mouse and human tissue as showing ubiquitous expression and escap-
ing from XCI (Greenfield et al., 1998). A decade later, histone lysine demethylase
function was attributed to this previously under annotated protein, and subsequent
work has shown it essential for normal development.
Both UTX and the closely related Jumonji D3 (JMJD3) have been shown to catalyse
the removal of di- and trimethyl moieties on histone H3 lysine 27, thus providing
a counter balance for the activity of Polycomb Repressor Complex 2 (PRC2), a
H3K27 methyltransferase (Agger et al., 2007; Lan et al., 2007; Lee et al., 2007b).
Whether the Y linked homologue Uty also has in vivo demethylase remains an open
question (see section 1.6.4). The H3K27 methylation mark is a highly significant
mediator of transcriptional repression, involved in a plethora of biological processes
including genomic imprinting (Greenberg et al., 2017), XCI (Plath et al., 2003), and
cancer (Conway et al., 2015). UTX demethylase activity is effected by a JmjC cat-
alytic domain (Lan et al., 2007), and specificity towards H3K27me3 over the highly
similar H3K9me3 results from the presence of a zinc binding domain (Sengoku and
Yokoyama, 2011). Protein protein interactions are thought to be mediated by the
tetratricopeptide repeat domains (TPRs), though these are not present in JMJD3,
suggesting a slight functional divergence (Lan et al., 2007). Despite subtle changes
between family members, the H3K27 demethylases are generally well conserved
across multiple model organisms, including mouse (Utx, Uty, Jmjd3), Drosophila
(dUTX), and C. elegans (UTX1 - closest to mouse Utx, and UTX2, 3 and 4 - closest
to Jmjd3, Greenfield et al., 1998; Herz et al., 2010; Jin et al., 2011).
KDM6A has been shown to contribute to multiple protein complexes involved
in the remodelling of chromatin via histone modifications. Complexes involving
mixed lineage leukaemia protein 2 (MLL2) and KDM6A exhibit H3K4 methyl-
transferase activity, thus promoting transcription in humans (Issaeva et al., 2007;
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Cho et al., 2007), Drosophila (Mohan et al., 2012), and C. elegans (Vandamme
et al., 2012). This suggests a dynamic relationship between transcriptional de re-
pression via H3K27 demethylation and transcriptional activation via H3K4 methy-
lation. KDM6A, along with JMJD3, also interacts with the ATP dependent chro-
matin remodelling complex SWI/SNF (Miller et al., 2010). The authors showed
that either KDM6A or JMJD3 demethylase is necessary for regulating inducible T-
box factor mediated transcription independent of the demethylase activity. Finally,
an interaction has also been demonstrated between dUTX and the histone acetylase
Creb binding protein (CBP) (Tie et al., 2012). As histone acetylation functions to
promote active chromatin, the co precipitation of dUTX, CBP and the ATPase Brm
at Polycomb target genes enriched for H3K27ac might be interpreted as collective
antagonism of PRC activity.
In C. elegans UTX-1 is required for progression to adulthood, as mutants lacking
the protein die in late embryogenesis or early larval stages (Vandamme et al., 2012).
Similarly, in Drosophila, dUTX is essential for survival: <5% of homozygous mu-
tants pass the pupal stage but then die immediately after eclosion (Herz et al., 2010).
dUTX homozygous mutant males have fewer teeth within the sex combs than wild-
type males, along with rough eyes and wing defects (Herz et al., 2010). Such phe-
notypic features are reminiscent of Trithorax mutants, suggesting that dUTX is a
Trithorax group gene, counteracting repression by Polycomb genes in the regulation
of Hox genes. Unsurprisingly, H3K27me3 levels are increased in dUTX mutants
and, consistent with previous work in vitro (Mohan et al., 2012), H3K4me1 levels
are also affected, in a JmjC independent manner. Mutant tissue was shown to have
an H3K27me3 dependent growth advantage when compared to wildtype in the de-
veloping eye. This increased proliferation was caused by increased Notch activity,
and inactivation of the Drosophila orthologue of tumour supressor Retinoblastoma,
Rbf, contributes to this phenotype (Herz et al., 2010).
In order to address the function of Kdm6a in mammalian development, a number
of models have been created, first in mESCs and hESCs, and then subsequently in
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mice. KDM6A is not required for ESC maintenance (Lee et al., 2012; Jiang et al.,
2013), though there is evidence for a role in the differentiation of all germ cell lay-
ers. For example, KDM6A knockdown results in impaired endoderm differentiation
via WNT signaling (Jiang et al., 2013). In the mesoderm, Kdm6a deficient cells
show defects in cardiac differentiation (Wang et al., 2012; Welstead et al., 2012;
Morales Torres et al., 2013), independent of demethylase activity (Lee et al., 2012).
Moreover, Kdm6a is involved in the specification of ectoderm, which is also in-
dependent of demethylase activity (Morales Torres et al., 2013). Recent work has
implicated Kdm6a in maintenance of DNA integrity, as use of a KDM6A inhibitor,
along with knockdown of the gene, activated the DNA damage response in differ-
entiating but not undifferentiated mESCs (Hofstetter et al., 2016). Interestingly,
two independent groups have reported that in mESCs, but not in embryos, KDM6A
regulates expression of Uty (Lee et al., 2012; Wang et al., 2012).
Several different Kdm6a knockout mouse lines have been created, all exhibiting
relatively consistent phenotypes. Most prominently, female homozygous mutant
embryos have severe cardiac malformations, neural tube closure defects, and re-
duced somite counts. A reduction in number of somites is indicative of retarded
development (Tam, 1981). These embryos also show anaemia, myelodysplasia, and
aberrant splenic haematopoiesis (Thieme et al., 2013), and invariably die between
E9.5 and E13.5 (Lee et al., 2012; Wang et al., 2012; Shpargel et al., 2012; Welstead
et al., 2012; Mansour et al., 2012; Thieme et al., 2013). Finally, there is some sug-
gestion of disrupted primordial germ cell (PGC) development in Kdm6a knockout
female embryos at E12.5, leading to reduced transmission of Kdm6a deficient germ
cells in chimeras produced from targeted mESCs (Mansour et al., 2012).
Mutations in KDM6A have generally been detected in the context of either XLID or
cancer. Many patients with Kabuki syndrome (KS) have complete deletion or loss
of function mutations in KDM6A, or the H3K4 methyltransferase MLL2 (Miyake
et al., 2012; Lederer et al., 2012; Priolo et al., 2012; Banka et al., 2013). KS is a
developmental disorder, signs of which include craniofacial abnormalities, skele-
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tal and visceral defects, mental retardation and short stature (Adam and Hudgins,
2005). Males with KS and a mutation in KDM6A show a more severe phenotype
than females, suggesting UTY has functionally diverged from KDM6A (Miyake
et al., 2012). Whilst the pathogenesis of KS is still not understood, a number
of case reports have described predisposition to multiple different malignancies;
and a number patients with malignancy have a KDM6A mutation but do not have
KS. This was first shown in a study involving multiple tumour types (van Haaften
et al., 2009), and later work has provided more detail on specific cancers includ-
ing clear cell renal cell carcinoma (ccRCC, Dalgliesh et al., 2010), chronic myeloid
leukaemia (CML, Jankowska et al., 2011), acute lymphoblastic leukaemia (ALL,
Van der Meulen et al., 2015), and medulloblastoma (Jones et al., 2012; Robinson
et al., 2012; Dubuc et al., 2012; Bunt et al., 2012). Initial mechanistic work suggests
that KDM6A is putatively a tumour suppressor gene (Arcipowski et al., 2016), and
the broad range of cell types affected by mutations here attest to the importance of
regulated chromatin remodelling in health (Plass et al., 2013).
1.6.4 Uty
Uty (Ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome)
is the Y linked homologue of Kdm6a, with expression reported across multiple
tissues and developmental stages in male mice (Greenfield et al., 1996) and humans
(Lahn and Page, 1997). Although there is a high degree of sequence conservation
between the two genes, conflicting in vitro evidence exists regarding whether or
not Uty has histone demethylase activity. Walport and colleagues support common
functionality, whereas separate reports by Lan and Hong do not (Walport et al.,
2014; Lan et al., 2007; Hong et al., 2007).
UTY is required for normal spermatogenesis in human (Foresta et al., 2000), and
the protein also has a role in self recognition as part of the innate immune reponse.
An epitope of UTY forms an MHC peptide (Warren et al., 2000) that contributes to
graft rejection after HLA identical sex mismatched stem cell transplantation (Vogt
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et al., 2000). Furthermore, in a male donor/female recipient situation, UTY specific
peptides show gender specific antitumour effect in vitro (Ivanov et al., 2005; Riddell
et al., 2002; Warren et al., 2000).
In the mouse mutant, UTY partially compensates for the absence of UTX in male
embryos, suggesting some degree of functional conservation between the homo-
logues. Whether this is demethylase dependent remains an open question (Shpargel
et al., 2012; Walport et al., 2014). Utx mutant embryos are born at a sub Mendelian
ratio and show life long growth retardation, though have normal fertility (Shpargel
et al., 2012). The Utx/Uty compound mutant phenocopies the homozygous mutant
female and is embryonic lethal (Shpargel et al., 2012).
1.6.5 Eif2s3x
Eukaryotic initiation factor 2 (eIF-2) is made up of three subunits, α,β , and γ . In
the presence of guanosine triphosphate (GTP), the three subunits form a ternary
complex with Met-tRNA and recruit it to the 40S ribosomal complex for transla-
tion initiation (Merrick, 1992). Subunit 2γ was initially described by Gaspar and
colleagues (Gaspar et al., 1994), and subsequent work recognised that whilst this is
a single X linked gene in human, there are two highly homologous genes on the X
and Y chromosomes in mouse, Eif2s3x and Eif2s3y, respectively (Ehrmann et al.,
1998).
Both mouse and human X linked orthologues are expressed ubiquitously and es-
cape XCI (Ehrmann et al., 1998). Interestingly, higher concentrations of Eif2s3x
transcript were found in XX females in both developing (Armoskus et al., 2014)
and adult brain, and adult liver, when compared to XY males (Xu et al., 2006).
However, this did not translate into differences at the protein level in adult brain
or kidney (Xu et al., 2006). It is certainly possible that the low number of tissues
and timepoints assayed in the latter experiment could have failed to detect relevant
biological differences.
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Similar to a number of other ubiquitously expressed X linked genes, EIF2S3X
functions in multi protein complexes, and mutations are implicated in causation
of XLID (Borck et al., 2012). Three male patients of Moroccan Jewish ancestry
showed microcephaly, facial dysmorphism, and short stature, along with more spe-
cific neurological signs (Borck et al., 2012). Using human cells overexpressing one
of these patient derived γ mutations, and yeast with an equivalent mutation, a de-
fect in binding between the β and γ subunits was uncovered (Borck et al., 2012).
In the yeast model, this defect impaired translation start codon selection and eIF2
function; and was rescued by overexpression of the β subunit. Although there is no
Y linked homologue in human, an autosomally transposed copy of the gene exists
(Ehrmann et al., 1998; Hughes et al., 2015), and it would be interesting to sequence
this gene in the context of these patients to assess the degree of functional conserva-
tion. Eif2s3x is able to compensate for the loss of Eif2s3y in mouse spermatogenesis
when present as a transgene in high copy number (Yamauchi et al., 2016), support-
ing the hypothesis that dosage of the X-Y gene pairs is critical in certain stages in
certain tissues.
1.6.6 Eif2s3y
Eif2s3y was mapped to the mouse Y chromosome concurrent with the identifica-
tion of Eif2s3x (Ehrmann et al., 1998). It is the only Y linked gene required to
complete the first meiotic division in male mouse gametogenesis (Mazeyrat and
Mitchell, 1998; Mazeyrat et al., 2001). Like Eif2s3x, Eif2s3y also shows ubiqui-
tous expression (Xu et al., 2002). In mouse brain, three isoforms of the gene have
been detected, compared to one isoform of the X linked homologue; with the for-
mer showing a higher ratio of embryonic:adult expression than the latter (Xue et al.,
2002). There is no human orthologue of Eif2s3y. It is hypothesised that the loss is
partly compensated for by retrotransposition to an autosome, which has occurred
on three independent occasions in primates (Hughes et al., 2015); and that DDX3Y
has an equivalent role in human spermatogenesis (Ditton et al., 2004).
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1.6.7 Ddx3x
The first Ddx3x sequence was identified in mouse erythroid cells as mDEAD3 dur-
ing a screen for RNA helicase genes (Gee and Conboy, 1994). This family had been
previously been characterised as ATP dependent remodellers of nucleic acid sec-
ondary structure, all having in common the amino acid sequence D-E-A-D within
the ATP binding domain (Linder et al., 1989), and showing high degrees of DNA se-
quence conservation from yeast to mammals (Gee and Conboy, 1994; Linder, 2006;
Chu et al., 2006). The human orthologue, originally known as DBX, was mapped to
the X chromosome (Park et al., 1998), shortly after its Y homologue was identified
in a somatic cell hybrid search (Lahn, 1997). Both human and mouse genes have
been shown to escape XCI, and are expressed ubiquitously (Lahn, 1997; Disteche
et al., 2002).
As a member of the DEAD box protein family of RNA helicases, DDX3X has
nine conserved structural motifs that facilitate its involvement in a wide variety of
cellular processes (Cordin et al., 2006), including: pre mRNA splicing (Deckert
et al., 2006), nuclear export and transport of RNA (Yedavalli et al., 2004; Kanai
et al., 2004), translation initiation and regulation (Beckham et al., 2008; Shih et al.,
2008), cell cycle regulation (Chang et al., 2005; Chao et al., 2006; Huang et al.,
2004; Sekiguchi et al., 2007), and apoptosis (Sun et al., 2008). Likely resulting
from this key role in RNA homeostasis, DDX3X is a host factor required for the
replication of human immunodeficiency virus (HIV, Yedavalli et al., 2004; Sharma
and Bhattacharya, 2010; Liu et al., 2011; Garbelli et al., 2011) and hepatitis C virus
(HCV, Owsianka and Patel, 1999; Mamiya and Worman, 1999; Ariumi et al., 2007;
Li et al., 2009b; Sun et al., 2010), in addition to its interaction with tank binding
kinase 1 (TBK1) that results in the production of antiviral type I interferons (Soulat
et al., 2008).
The ubiquitous expression and wide ranging involvement of DDX3X in multiple
intracellular processes raises the question of what happens when a mutation arises,
both experimentally and in the context of human health. The first reported work
1.6. X-Y gene pairs with candidate roles in postnatal growth 63
in mouse embryos suggested an essential role for Ddx3x in early development (Li
et al., 2014). Using short interfering RNA (siRNA) microinjection into mouse zy-
gotes, a reduction in cell numbers was observed, which correlated with an increase
in apoptosis and decreased progression to blastocyst when compared to scramble
controls. The authors also noted that this phenotype was associated with p53 accu-
mulation (Li et al., 2014), confirmed by later work (Chen et al., 2016a). Chen and
colleagues created a conditional allele by inserting loxP sites 5’ to exon 3 and 3’
to exon 17 of Ddx3x, and initially showed that F1 animals inheriting the floxed al-
lele on the Xp had a normal phenotype. When this same floxed allele was inherited
maternally, females showed growth retardation from E12.5, then perished between
E14.5 and E16.5, concurrent with evidence of oedema and peripheral haemorrhage.
On further analysis of the placenta in these mutants, the labyrinth was vascularised
abnormally, the spongiotrophoblast was thinner, and all placentas were smaller than
wildtype littermates. A Sox2-Cre was then used to target the deletion specifically to
the embryo and not the extraembryonic tissue, and these embryos were grossly nor-
mal with no significant deviation from Mendelian ratio at birth. Male conceptuses
carrying the deleted allele died around E9.5, and those with the Sox2-Cre floxed
allele in just the embryo were found to have abnormalities in neural tube closure,
cardiac development, and chorio allantoic fusion, along with increased apoptosis in
the embryo proper. Taken together, these results suggest that Ddx3x either shows
tissue and developmental time specific variable escape from XCI; or that although
the paternal allele escapes, expression is not sufficient to compensate for the lack
of the maternal allele. Moreover, at least one copy of Ddx3x is required for nor-
mal embryonic development in the mouse, and the presence of Ddx3y alone is not
sufficient.
Mutations in DDX3X have been associated with a variety of cancers, including HCC
(Chang et al., 2005), head and neck squamous cell carcinoma (Stransky et al., 2011),
oral squamous cell carcinoma (Koshio et al., 2013), lung cancer (Bol et al., 2015a),
chronic lympocytic leukaemia (CLL, Wang et al., 2012), colorectal cancer (Su et al.,
2015), and medulloblastoma (Jones et al., 2012; Pugh et al., 2012; Robinson et al.,
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2012). Whilst there seems to be no consensus over the exact role of DDX3X in
cancer pathogenesis, a number of small molecule inhibitors are being developed
(Samal et al., 2015; Bol et al., 2015a,b).
Finally, DDX3X mutations have also been correlated with incidence of XLID and
autism spectrum disorders, as part of a syndromic disorder with significant neu-
rological involvement (Blok et al., 2015). The authors suggest functional mo-
saicism results in haploinsufficiency and a dose dependent phenotype (Blok et al.,
2015).
1.6.8 Ddx3y
DDX3Y, also known as DBY, is ubiquitously transcribed in both human and mouse
(Lahn and Page, 1997; Ditton et al., 2004; Foresta et al., 2000). Similar to UTY,
DDX3Y was first recognised as a Y linked antigen, responsible for the rejection
of human leucocyte antigen (HLA) matched allografts (Chen et al., 2004b). In
vitro data suggest that it is able to functionally compensate for the loss of its X
linked homologue DDX3X (Sekiguchi et al., 2004), thus implicating the protein
in RNA folding and metabolism (for full description see section 1.6.7). DDX3Y
is almost exclusively detected in the cytoplasm of spermatogonia, and individu-
als carrying mutations have severe germ cell loss (Ditton et al., 2004). In order
to model this phenotype in vitro, human induced pluripotent stem cells (iPSCs)
can be directed to differentiate into germ cell like cells. This ability is compro-
mised in cells carrying DDX3Y mutant allele, but can be rescued by the addition
of DDX3Y (Ramathal et al., 2015). Furthermore, during a neuronal differentiation
programme, siRNA knockdown of DDX3Y reduced cell growth, proliferation and
viability, and increased apoptosis (Vakilian et al., 2015), though humans with re-
duced levels of/mutations in DDX3Y show no apparent somatic phenotype (Ditton
et al., 2004): this discrepancy remains to be explained.
1.6. X-Y gene pairs with candidate roles in postnatal growth 65
1.6.9 X-Y gene pairs: summary
As these X-Y gene pairs have persisted across evolutionary space and through time,
it can be deduced that they might have adopted a common survival strategy, im-
plying a collective functional significance. A number of lines of evidence support
this conclusion (summarised in Table 1.2). Following a gene expression analysis in
eight mammalian species across multiple tissues and through developmental time,
it was shown that X-Y pair genes are more broadly expressed than other ances-
tral survivors on the Y chromosome (Bellott et al., 2014). The authors reasoned
that wide expression could constrain selection to prevent both loss of the Y linked
gene and the appearance of a dosage compensated X linked replacement. Most
X linked genes of the X-Y pairs escape X chromosome inactivation (see section
1.4.2) in human, mouse and opossum, thus preserving biallelic expression (Carrel
and Willard, 2005; Yang et al., 2010; Wang et al., 2014). These genes are subject
to stronger purifying selection than genes subject to XCI (Bellott et al., 2014; Park
et al., 2010; Slavney et al., 2016). When added to the observation that all have func-
tions pertaining to transcription, translation, splicing, chromatin modification, and
ubiquitination (see above, and Bellott et al., 2014; Cortez et al., 2014), it becomes
clear that the common factor is preservation of dosage.
Figure 1.4: Cartoon depicting relative positions of X-Y gene pairs on mouse X and Y
chromosomes. Banding is representative and not to scale.
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Mouse gene (alterna-
tive names)
XCI status Y homologue (alterna-
tive names)
%AA homology Expression
pattern
Mutant phenotype
Heterozygous female Homozygous female Hemizygous
male
Ddx3x (Dbx) Escapes Ddx3y (Dby) 88 Ubiquitous No phenotype when in-
herited paternally; growth
retardation and embryonic
lethality when inherited
paternally; specifically re-
quired for ExE develop-
ment
Not generated: likely
lethal
Early embryonic
lethality
Eif2s3x Escapes Eif2s3y 98 Ubiquitous None reported None reported None reported
Kdm5c (Jarid1c,
Smcx)
Escapes Kdm5d (HY, Jarid1d,
Smcy)
80 Ubiquitous None reported None reported None reported
Kdm6a (Utx) Escapes Uty 76 Ubiquitous No phenotype Cardiac malformation,
neural tube closure de-
fects, embryonic lethality
Reduced peri-
natal viability,
life long growth
deficit
Human gene (alter-
native names)
XCI status Y homologue (alterna-
tive names)
%AA homology Expression
pattern
Mutant phenotype
Female Male
DDX3X (DBX) Escapes DDX3Y (DBY) 92 Ubiquitous XLID XLID
EIF2S3X Escapes n/a n/a Ubiquitous Mutations reported, no obvious phenotype XLID, short
stature
KDM5C (JARID1C,
SMCX)
Escapes KDM5D (HY, JARID1D,
SMCY)
85 Ubiquitous Mild XLID, skewed XCI to inactivate mutation harbouring X XLID
KDM6A (UTX) Escapes UTY 83 Ubiquitous XLID, short stature, Kabuki syndrome As female, more
severe
Table 1.2: Extant X-Y gene pairs in mouse and human.
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1.7 Aims
In conclusion, there is abundant evidence that sex chromosome genes control
growth at two stages of mammalian development. In utero, the growth deficit ob-
served in XPO embryos is likely explained either by genomic imprinting or inap-
propriate imprinted Xist expression. Postnatally, haploinsufficiency underlies the
growth deficit seen in all XO mice relative to XX littermates. However, the genetic
bases of these effects is not known.
The overall aim of my thesis is to identify possible mechanisms for both phenotypes,
which could subsequently open new avenues of exploration to further understand
the phenotypic effects of Turner syndrome for the three million women with the
condition worldwide.
• In Chapter 3, I will test whether inappropriate Xist expression is responsible
for the embryonic growth deficit in XPO embryos.
• In Chapter 4, I will describe experiments carried out to identify X linked
imprinted genes expressed in mouse trophoblast stem cells as a model for
mouse placenta.
• In Chapter 5, I will test whether haploinsufficiency for Ddx3x, Kdm5c,
Kdm6a, or Eif2s3x are responsible for the postnatal growth deficit in XO fe-
male mice.
• Chapter 6 describes initial experiments to address the functional divergence
of X encoded genes Ddx3x, Kdm5c, Kdm6a, and Eif2s3x from their Y homo-
logues Ddx3y, Kdm5d, Uty, and Eif2s3y.
Chapter 2
Materials and Methods
2.1 Mouse work
2.1.1 Mouse strains
All mice used were generated and maintained on an outbred albino MF1 back-
ground (originating from MRC National Institute for Medical Research and Harlan
(Blackthorn, UK)), unless otherwise stated. Specific crosses are detailed within
the relevant chapters, and a summary of the origin of their constituent mutants is
provided below.
2.1.1.1 In(X)1H: a large inversion in the X chromosome
The In(X)1H mutation was first reported in the offspring of a male that had re-
ceived a fractionated dose of X rays to the spermatogonia (Russell, 1961; Evans and
Phillips, 1975). It was noted that In(X)1H heterozygous females produced greater
than expected numbers of XPO progeny (Evans and Phillips, 1975). Furthermore,
the presence of an In(X)1H allele suppressed crossing over between previously re-
ported X-linked mutants, including Bpa, Ta, and Blo (Phillips and Kaufman, 1974),
suggesting a structural mutation of the X chromosome (Evans and Phillips, 1975).
Cytogenetic and genetic evidence showed that the inversion spans almost the entire
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length of the chromosome, and further work revealed that the formation of a dicen-
tric chromatid during meiosis leads to the production of nulli-X oocytes (Koehler
et al., 2002). Around 15% of offspring from a XY x In(X)/X cross are XPO (Bur-
goyne et al., 2002).
In this thesis, the In(X)1H line was used to generate XPO embryos for experiments
described in Chapters 3 and 4, and XPO females for experiments described in Chap-
ter 5.
2.1.1.2 Y*: a rearrangement in the Y chromosome
The Y* chromosome is a Y chromosome with a non-Y centromere that is attached
to an inverted region of the Y PAR (Eicher et al., 1991). During male meiosis,
recombination between the Y* and X chromosomes results in the generation of
a large XY* chromosome and a small X*Y chromosome, and additionally a num-
ber of gametes lacking a sex chromosome (Burgoyne and Evans, 2000). The large
chromosome consists of almost the entire X chromosome, in addition to the Y*
chromosome without the Y* centromere. The small X*Y is essentially the cen-
tromeric portion of the Y* chromosome in addition to a PAR (Burgoyne and Evans,
2000).
Offspring inheriting the XY* chromosome develop as males but are sterile, likely
due to the presence of two X chromosomes (Cattanach, 1961). In the absence of
a second X chromosome, i.e. XY*O, a proportion of males carrying the XY* chro-
mosome are fertile (Trent et al., 2012). Offspring inheriting the X*Y chromosome
are female and fertile. Offspring inheriting gametes lacking a sex chromosome will
contribute to forming XMO embryos.
In this thesis, the Y* line was used to generate XMO and XY*X females for experi-
ments described in Chapter 5. It was also used to generate XY*O males for Chapter
4.
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2.1.1.3 YTdym1TgN(Sry-129)2Ei: a deletion in Sry
The YTdym1TgN(Sry-129)2Ei mutation consists of a 14kb deletion in Sry, and was
generated in mESCs before injection into blastocysts to produce chimeric founders
(Lovell-Badge and Robertson, 1990; Gubbay et al., 1992). It can be used to gener-
ate XY female offspring and, when complemented by an autosomally located Sry
transgene, XX male offspring (Mahadevaiah et al., 1998).
In this thesis, the YTdym1TgN(Sry-129)2Ei line was used to generate XY females
(denoted XY-) in Chapter 4. It was complemented by an Sry transgene and used to
generate XX males (denoted XXSry) in Chapter 6.
2.1.2 Timed matings
All animal work was carried out under UK Home Office license. Mice were kept on
a 12:12 light:dark cycle, with food and water available ad libitum. Female and male
mice were housed separately, with stud males alone and females in groups according
to the cage size. Matings were set up as follows: at around 17:00 female mice would
be placed into the male mouse cage, removed early the next morning and checked
for the presence of a vaginal plug, which usually indicates a mating has taken place.
Mating was assumed to take place during the hours of 00:00-02:00.
2.1.3 Blastocyst isolation
For the derivation of cell lines, blastocysts were retrieved at embryonic day (E)
3.5, as follows. Previously plugged females were culled via cervical dislocation,
and death confirmed by severing the carotid artery. The uterine horns were re-
moved into follicle holding medium (FHM, Appendix A ), and flushed with a fur-
ther 0.5-1ml of FHM utilising a 27G steel needle. Blastocysts were visualised on
a Leica MC80 dissecting microscope (Leica: Wetzlar, Germany), collected using a
Stripper® pipette (Origio: Malov, Denmark), and washed through a series of drops
2.1. Mouse work 71
of FHM, before a final wash and plating in the required derivation media (see below:
2.5.1, 2.5.2).
2.1.4 Isolation of post implantation embryos
Pregnant dams were culled as above at the appropriate time post coitum, and the
uterine horns removed and placed in ice cold phosphate buffered saline (PBS,
Thermo Scientific: Waltham, USA). Individual embryo sacs were dissected free
of maternal tissue, and the embryo was freed from the membranes. After weigh-
ing and somite counting (when applicable: see section 2.1.6), representative images
were taken with the Leica IC80 camera attached to Leica MC80 dissecting micro-
scope, and acquired using LeicaAcquire software version 3.1 (all Leica: Wetzlar,
Germany). Embryos were then frozen in liquid nitrogen before storage at 80°C
awaiting genotyping.
2.1.5 Weighing of post implantation embryos
Each embryo was placed on a 30mm Petri dish and fluid removed with the corner of
a lint free tissue, before weighing on a Sartorius Cubis analytical balance MSE225P
(Sartorius: Gottingen, Germany).
2.1.6 Somite counting of post implantation embryos
Following imaging, phase contrast was used to obtain the best lighting, and somites
were counted manually.
2.1.7 Generation of CRISPR targeted lines
2.1.7.1 Guide design and synthesis
Guide sequences were designed using MIT CRISPR Designer (Cong et al., 2013);
BbsI restriction sequences were added to the 5’ end; and oligonucleotides were
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ordered (Appendix B, Eurofins: Ebersberg, Germany). Oligonucleotides were then
cloned into plasmid PX330 (Cong et al., 2013), and this was transformed into chem-
ically competent E. coli. Clones were screened for positive ligation by Sanger se-
quencing. A T7 promoter was then added to the guide sequence via PCR amplifi-
cation, and sgRNA was produced by in vitro transcription using HiScribe T7 High
Yield RNA Synthesis Kit (NEB: Ipswich, USA), and purified by MEGAclear Tran-
scription Clean-Up (Thermo Scientific: Waltham, USA). Cas9 mRNA was synthe-
sised using the same method with alternative primers.
2.1.7.2 Microinjection of pronuclear mouse embryos
Cas9 mRNA and sgRNA were mixed at 100ng/ul and 50ng/ul respectively, cen-
trifuged at 13,000rpm for 15 minutes at 4°C, and the supernatant moved to a new
tube to remove any contamination from cleaning column fibres. Microinjection was
performed by Genetic Manipulation Service Science Technology Platform (STP)
into pronuclear stage mouse embryos following on from a standard superovulation
protocol and in vitro fertilisation. Injected embryos were cultured overnight before
transfer to pseudopregnant females.
2.1.7.3 Analysis of founder animals
Pups were ear biopsied at three weeks of age and, following DNA extraction, PCR
(see 2.2.4) was carried out to amplify the locus surrounding the CRISPR target site.
During early stages of the project PCR products were TA cloned (see 2.2.6) and
Sanger sequenced; subsequently this was replaced by the Illumina MiSeq platform
(see 2.6.1).
2.1.8 Weighing postnatal animals
Following successful mating, pregnant dams were housed alone and, on the day of
birth, pups were weighed following tattooing/toe clipping (see below), and weekly
until 35 days old, using a Scout Pro balance (Ohaus: New Jersey, USA). Pups were
2.2. Molecular biology 73
housed with the dam until weaning at three weeks of age, and subsequently male
and female pups were housed separately.
2.1.9 Identification of individuals
In initial experiments, new born pups were marked using a subcutaneous injec-
tion of black pigment (VWR: Lutterworth, UK) as follows: pups were incubated
in a 10cm plastic dish on ice water for three minutes to provide light anaesthe-
sia/analgesia; skin was cleaned with 70% EtOH and sterile gauze, and a 33G needle
and glass syringe (Hamilton Company: Nevada, USA) were used to inject 2ul pig-
ment subcutaneously into the paw pad; pups were kept on a heat pad until righting
reflex was re gained.
In subsequent experiments, toe clipping was performed in order to identify individ-
ual animals: this method was faster and provided tissue for genotyping where re-
quired, removing the requirement for a subsequent ear biopsy procedure later. Local
anaesthesia was applied to the paw. After an appropriate time, the distal phalanx
was removed from one digit per animal, and any bleeding cauterised chemically
with silver nitrate. Pups were again kept on a heat pad until return to the dam.
2.2 Molecular biology
For PCR, primer sequences were either obtained from previously published work
or designed using Primer3 (Untergasser et al., 2007). All PCR primer sequences
are provided in Appendix B; where commercial sources have been used, this is
indicated.
2.2.1 Genomic DNA (gDNA) extraction
Generally, gDNA was extracted from mouse tissue samples lysed in KT buffer (Ap-
pendix A), by overnight incubation at 55°C, followed by 15 minutes at 95°C and five
minutes centrifugation at 13,000rpm, room temperature (RT). For qRT-PCR (sec-
2.2. Molecular biology 74
tion 2.2.5.2), gDNA was extracted using PureLink (Thermo Scientific, Waltham,
USA), as per the manufacturer’s protocol.
2.2.2 RNA extraction
Total RNA was extracted from frozen tissue samples and cell cultures using TRIzol
(Thermo Fisher: Waltham, USA) or TRI reagent (Sigma-Aldrich: St Louis, USA)
as per the manufacturers’ protocols. When amount of available tissue was limited
(i.e. E10.5 embryo) and both RNA and DNA were required, DNA was extracted
from the lower phase, also per manufacturer’s instructions. Extracted RNA was
dissolved in ddH2O and quantified using a Nanodrop spectrophotometer (Thermo
Fisher: Waltham, USA).
2.2.3 cDNA synthesis
Synthesis of cDNA for qRT-PCR was described in section 2.2.5.2. For general
cDNA synthesis, total RNA was added to oligo(dT) (Thermo Fisher: Waltham,
USA) and 10mM dNTPs and incubated at 65°C for five minutes. First strand buffer,
DTT and RNAse Out (all Thermo Fisher) were then added and, following a further
two minute incubation at 42°C, Superscript II (Thermo Fisher: Waltham, USA) was
added, and the mixture incubated at 42°C for another 60 minutes. The enzyme was
heat inactivated at 70°C for 15 minutes.
2.2.4 Polymerase Chain Reaction (PCR)
For standard genotyping, 0.5ul of tissue lysis supernatant was added to 2X MyTaq
Redmix (Bioline: London, UK). Primers (Eurofins MWG: Ebersberg, Germany)
were used at a final concentration of 0.2nM. For PCR to be followed by sequencing,
the high fidelity q5 Taq polymerase was used, as per the manufacturer’s protocol
(NEB: Ipswich, USA). Product was loaded onto an agarose (Sigma-Aldrich: St
Louis, USA) gel with 1kb ladder (Thermo Scientific: Waltham, USA) and run at
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around 85V for an appropriate time. Images were then acquired using AlphaImager
2200 (ProteinSimple: California, USA) with AlphaImager software.
2.2.5 Quantitative real time PCR
2.2.5.1 qRT-PCR on gDNA
To assess X chromosome copy number, gDNA was quantified using qRT-PCR, as
previously described (Yamauchi et al., 2015), but with minor variation. gDNA ex-
tracted using PureLink was amplified with primers targeting Amelx and Prdx4 on
the X chromosome, and Myogenin as an autosomal control. Both X linked gene
products were normalised to the autosomal control (to generate ∆Ct values), be-
fore comparison with a known XX sample (to generate ∆∆Ct values, as per Livak
method (Livak and Schmittgen, 2001)). The reaction was performed using Sen-
siMix LoRox polymerase (Bioline: London, UK), on a ABI 7500 thermal cycler
(Thermo Scientific: Waltham, USA).
2.2.5.2 qRT-PCR on cDNA
RNA was extracted as described (section 2.2.2). For relative quantification of gene
expression, RNA was converted to cDNA using the Maxima First Strand cDNA
Synthesis Kit following the manufacturer’s protocol (Thermo Scientific: Waltham,
USA). Briefly, between 500ng and 5ug total RNA was first treated with double
stranded DNase, before conversion to cDNA using reverse transcriptase with a mix
of random hexamer and oligo(dT) 18 primers. Minus reverse transcription controls
were utilised to detect the presence of contaminating genomic DNA. Primers were
first tested for specificity and efficiency via melt curve analysis and standard curve
methods, respectively: the pairs that showed a single peak during the melt curve
analysis and an efficiency of 2 +/- 0.1 were deemed suitable for use. On occasion,
multiple primer pairs designed to amplify a given locus failed testing, so a commer-
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cial alternative was sought and used following manufacturer’s protocol (Taqman,
Thermo Scientific: Waltham, USA).
384 plates were prepared with Lightcycler 480 Sybr Green I mastermix (Roche:
Basel, Switzerland) as per the manufacturer’s protocol; reactions were performed
in triplicate and run on the Lightcycler 480 II thermal cycler (Roche: Basel, Switzer-
land). Data were exported from the proprietary software to Excel (Microsoft:
Washington, USA) for statistical testing based on the Livak method (previous sec-
tion).
2.2.6 TA cloning
PCR products were TA cloned (TOPO, Thermo Fisher: Waltham, USA). Cultures
were grown from colonies in Luria Broth (LB), DNA was extracted by mini prep
according to the manufacturer’s instructions (Qiagen: Manchester, UK), and clones
were Sanger sequenced by Beckman-Coulter genomics (Takley: Essex, UK) using
M13 primers.
2.2.7 RFLP digest
SNPs were selected using the Mouse Genomes Project online browser (Well-
come Trust Sanger Institute), DNA sequences were acquired from UCSC Genome
Browser (build GRCm38/mm10). Restriction enzymes were selected using NEB-
cutter (NEB: Ipswich, USA). Total RNA was extracted from mouse brain and liver
and transcribed into cDNA as described (see 2.2.2, 2.2.5.2). Following PCR, prod-
ucts were run on a 2% agarose gel, isolated using a scalpel blade and UV light box,
and purified using NucleoSpin ® PCR Gel and PCR Clean-up (Machery Nagel:
Duren, Germany) according to the manufacturer’s instructions. Products were then
digested with restriction enzymes (all NEB: Ipswich, USA) as per manufacturer’s
guidelines, run on a 2% agarose gel, and visualised as described (2.2.4).
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2.3 Cytology
2.3.1 Metaphase chromosome spreads for karyotyping
Mice were culled as described above. Using a 1ml syringe filled with HEPES
buffered RPMI medium (Thermo Fisher: Waltham, USA) supplemented with col-
cemid (0.1ug/ul; Sigma-Aldrich: St Louis, USA), a 27G needle was inserted into
the distal end of the femur, and bone marrow was flushed into a 15ml round bot-
tomed polypropylene tube (Greiner Bio-One: Stonehouse, UK) with 0.5ml solution
per femur. The tube was incubated horizontally for 10 minutes at 31°C, vortexed
briefly and centrifuged at 180 x g for five minutes in a swinging rotor centrifuge
at RT. The supernatant was drained, the pellet re suspended in 1-2ml 0.56% w/v
potassium chloride (Sigma-Aldrich: St Louis, USA) dissolved in ddH2O, and the
tube incubated at RT for at least 20 minutes. Following a further brief vortex and
spin as previously, the supernatant was carefully drained, methanol:glacial acetic
acid (3:1; MA) was added down the side of the tube, drop wise, until the pellet was
coated, and the tube rotated to ensure even coverage. 1ml of MA was then added,
and the tube vortexed briefly to re suspend the pellet, quickly followed by further
centrifugation as before. The supernatant was drained carefully, 1-2ml of MA was
added, and the tube incubated for 15 minutes at RT. Two further consecutive washes
were carried out: first, the tubes were centrifuged as previously, followed by drain-
ing of the supernatant, fresh 1ml MA added, and the solution vortexed. After the
second drainage step, a suitable amount of MA was added to result in a good final
density of cells on the slides (judged based on experience, around 1ml); the tube
was vortexed, left to settle for 30 seconds, and then three drops were spread onto
a cleaned (98% EtOH/2% acetic acid) glass slide (VWR: Lutterworth, UK), from
a height of about 30cm. After air drying, the slides were stained in 4% Giemsa
buffered in PBS (pH 6.8, Sigma-Aldrich: St Louis, USA) for eight minutes, then
viewed under an Olympus BH2 microscope (Olympus: Tokyo, Japan), and imaged
using a Leica camera (Leica: Wetzlar, Germany). When used for DNA FISH, one
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drop of the final MA fixed cell suspension was spread onto multi well glass slides
(Thermo Scientific: Waltham, USA) and left to air dry.
2.3.2 DNA FISH
2.3.2.1 BAC extraction
BAC clones (Appendix C) were selected using Ensembl genome browser (Mouse,
GRCm38) and obtained as stabs from CHORI BACPAC (California, USA). Cul-
tures were set up using 20ml LB inoculated with chloramphenicol (25ug/ml, dis-
solved in 100% EtOH) and incubated at 37°C, 200rpm overnight. Glycerol stock
was made using 500ul culture and 500ul 100% glycerol (autoclaved; Sigma-
Aldrich: St Louis, USA), and stored in a 1ml Nunc tube (Thermo Fisher: Waltham,
USA) at -80°C. The cultures were then centrifuged at 4500rpm, 4°C for 15 min-
utes. After discarding the supernatant, the pellet was resuspended in P1 (Appendix
A) by vortexing; P2 (Appendix A) was then added, and the solution was inverted
20 times to mix, followed by an incubation of five minutes at RT. P3 (Appendix A)
was added, and once again the solution was inverted 20 times to mix and incubated
on ice for five minutes. The solution was then centrifuged at RT for 10 minutes at
13,000rpm, the supernatant transferred to fresh tubes, and 0.6 volumes of RT iso-
propanol was added, with inversion to mix; followed by immediate centrifugation
at RT for 15 minutes, 13,000rpm. The supernatant was discarded, the pellet washed
with 75% EtOH, and subsequently centrifuged down at 12,000rpm for 5 minutes
at RT. The EtOH was then discarded and the pellet air dried, followed by resus-
pension in ddH2O. DNA was incubated overnight at 37°C with RNAse A (Sigma
Aldrich: St Louis, USA). The next day, RNAse A was removed using subsequent
washes of equal volume phenol, phenol:chloroform, and chloroform:isoamyl alco-
hol (all Sigma-Aldrich: St Louis, USA). 1:10 3M NaAc at pH5.2 and 2.5X 100%
EtOH were added to the final supernatant, which was centrifuged at 13,000rpm for
15 minutes at 4°C. The supernatant was discarded, and the pellet washed with 75%
EtOH; finally, the DNA was dissolved in ddH2O.
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2.3.2.2 Probe labelling
Approximately 1ug BAC DNA was incubated with Abbott nick translation enzyme
and either Spectrum Green dUTP, Spectrum Red dUTP (all Abbott Molecular: Illi-
nois, USA), or Cy5 dUTP (Jena Bioscience: Jena, Germany) at 15°C for 12 hours.
1/10 of this reaction was run on a 2% agarose gel at 85V for 45 minutes to check for
probe size of around 200bp. If the probe was found to be greater than 300-400bp,
the reaction was incubated for varying times (minutes) at 37°C and the electrophore-
sis step repeated.
In order to prepare one probe for one slide, 1/10 of this reaction was added to 3ul
mouse Cot1 DNA and 1.5ul salmon sperm (both Thermo Fisher: Waltham, USA);
the mix was then precipitated using 2.5X 100% EtOH, mixed, and then centrifuged
at 4°C for 15 minutes, 13,000rpm. The supernatant was removed, the pellet washed
with 70% EtOH, and after centrifugation for five minutes at 13,000rpm, left to air
dry. The probe was then dissolved in deionised formamide (Sigma-Aldrich: St
Louis, USA) and either used immediately or stored at -20°C.
2.3.2.3 Hybridisation
Slides were washed in 2X saturated sodium citrate (SSC, Appendix A), and dena-
tured in 70% formamide/30% 2XSSC at 75°C, before dehydration through a series
of EtOH. Concurrently, the probe was denatured at 75°C and pre hybridised in
hybridisation buffer (Appendix A). Probes were added to slides, followed by cov-
erslips, and hybridisation took place in a formamide humid chamber overnight at
37°C. The following day, slides were washed four times in 2XSSC, then 0.1XSSC,
before transfer to 4XSSC/0.1% Tween (Sigma-Aldrich: St Louis, USA). 4’,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich: St Louis, USA) was then used to
stain the slides for 10 minutes, before a final brief wash in 4XSSC/0.1% Tween, fol-
lowed by mounting in Vectashield (Vector Laboratories: Burlingame, USA). Slides
were visualised using an Olympus IX70 inverted microscope (Olympus: Tokyo,
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Japan) with a 100 W mercury arc lamp and a 1003/1.35 UPLAN APO oil immer-
sion objective; images were analysed using FIJI (ImageJ version 2.0.0).
2.4 Protein extraction and western blotting
2.4.1 Tissue harvest and protein extraction
Tissue was collected by dissection, snap frozen in liquid nitrogen, and stored at
-80°C until required. Upon thawing, tissue was placed into a 2.0ml reinforced plas-
tic tube (Bertin Instruments: Montigny-le-Bretonneux, France) containing RIPA
buffer (Appendix A) and two-three metal beads (Bertin Instruments: Montigny-
le-Bretonneux, France), and stored on ice for 15 minutes. Subsequently the sam-
ples were run on the Precellys 24 (Bertin Instruments: Montigny-le-Bretonneux,
France) and for 45 seconds to break up the tissues. Following centrifugation at
13,000rpm, 4°C for 30 minutes, the supernatant was removed to a new tube and
stored on ice.
2.4.2 Protein quantification
Protein extract supernatant was diluted 1:100 and subjected to a bicinchoninic acid
assay (BCA, Thermo Scientific: Waltham, USA) as per the manufacturer’s protocol.
A standard curve was prepared using bovine serum albumin (BSA, Sigma-Aldrich:
St Louis, USA). Colour change was quantified with Infinite M1000 Pro (Tecan:
Mannedorf, Switzerland), and analysed using proprietary Tecan software. Follow-
ing quantification, protein extract was stored at -80°C until required.
2.4.3 Western blotting
20-30mg protein was prepared for sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) by dilution with Laemmli loading buffer (Appendix
A). Samples were run on a polyacrylamide gel (generally 4-15%, Bio-Rad: Her-
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cules, USA) in running buffer (Appendix A); initially at 85V for 15 minutes and
then 200V until an appropriate separation was achieved. This was judged by the
running of a protein ladder: either Dual Color Standard (Bio-Rad: Hercules, USA),
or PageRuler Prestained (Thermo Scientific: Waltham, USA). Proteins were trans-
ferred from gel to nitrocellulose membrane (GE Healthcare Life Sciences: Amer-
sham, UK) in transfer buffer (Appendix A) at 100V, 4°C for 60 minutes. Following
blocking in Tris buffered saline Tween (TBS-T: Appendix A) with either 5% milk
or BSA (both Sigma-Aldrich: St Louis, USA), membranes were incubated with
primary antibody (see Appendix C for list) by rolling overnight at 4°C. The next
day, washes were performed in TST-T, followed by incubation in secondary anti-
body (Appendix C) at room temperature for 60 minutes. TBS-T washes were again
performed, and signal was generated using enhanced chemiluminescence (ECL)
substrate, as per the manufacturer’s protocol (Bio-Rad: Hercules, USA). Detection
was performed in a dark room with Hyperfilm ECL (GE Healthcare Life Sciences:
Amersham, UK), and film was developed for visualisation.
2.5 Cell culture
Unless otherwise stated, all cell culture plasticware was obtained from Nunc
(Thermo Fisher: Waltham, USA), and media components from Invitrogen (Thermo
Fisher: Waltham, USA).
2.5.1 Mouse trophoblast stem cells (mTSCs)
mTSCs were derived and cultured as described previously (Himeno et al., 2008),
and summarised below.
2.5.1.1 Derivation and maintenance
Gamma irradiated MEFs (section 2.5.3.1) were plated in 4 well plates at 4 x 104
cells per well, using mTSC medium (Appendix A). The next day, human recom-
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binant FGF4 (25ug/ml; Peprotech: London, UK) and heparin (1mg/ml; Sigma-
Aldrich: St Louis, USA) were freshly added to mTSC medium (mTSCM), and this
was applied to the MEFs. Blastocysts were harvested at E3.5 as described above
(section 2.1.3), and one embryo was added per well of MEFs. When embryos were
observed to attach to the MEFs, medium was changed, and then subsequently every
second day. Outgrowths appeared over the next three-five days, and upon reaching a
size of 1mm, were dissociated in 0.1% trypsin/1mM EDTA back into the same well.
Cultures were subsequently fed with a mix of MEF conditioned medium (CM, sec-
tion 2.5.3.1) and fresh mTSC medium at a ratio of 70:30, in addition to 1.5X F4H.
Tight epithelial mTSC like colonies were observed to appear over the next two
weeks, and often differentiation was also noted. In the case of the latter, colonies
were picked, dissociated, and re plated to obtain morphologically consistent mTSC
lines. Upon reaching 50% confluence, colonies were expanded and passed onto
new MEF feeders, and fed mTSCM + 1.5X F4H every second day. This process
continued, with 1:20 passages approximately once per week, until reaching passage
10. At this point, lines became more stable, and could be passed without feeders
using 70CM + 1X F4H medium. Cells could then be genotyped and characterised
via gDNA and RNA extraction and DNA FISH.
2.5.1.2 Differentiation
To induce differentiation of mTSCs, cells were plated feeder free in mTSCM with-
out F4H. RNA was isolated on days two, four, and six using TRI reagent as de-
scribed (section 2.2.2).
2.5.1.3 Freezing
Prior to freezing, supernatant was removed from confluent cultures for Mycoplasma
testing in-house (Cell Services Science Technology Platform, Francis Crick In-
stitute). mTSCs were frozen in mTSCM with 10% dimethyl sulfoxide (DMSO,
Sigma-Aldrich: St Louis, USA): approximately three x 1ml cryovials were ob-
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tained from one confluent well of a 6 well plate. Vials were placed in a cell freezing
container at -80°C overnight, before transfer to permanent storage in liquid nitro-
gen.
2.5.2 Mouse embryonic stem cells (mESCs)
mESCs were derived and maintained as described previously (Ying et al., 2008),
and briefly outlined below.
2.5.2.1 Derivation
Blastocysts were harvested at E3.5 as described above (section 2.1.3), and one em-
bryo was added per well of a 24 well plate containing 2i+LIF (Appendix A). Af-
ter approximately seven-ten days, spherical outgrowths were observed, picked, and
dissociated using TrypLE reagent. This was re plated into one well of a 4 well
plate previously coated with poly-L-ornithine and laminin (as described previously
Hayashi and Saitou, 2013), whilst a small quantity of the dissociated outgrowth
was reserved for PCR genotyping. Upon reaching confluence, cells were expanded
and frozen. X chromosome copy number was assessed via gDNA qRT-PCR and/or
DNA FISH.
2.5.2.2 Freezing
One well of a 6 well plate was frozen in a single vial using 2i+LIF + 20% DMSO.
Supernatant was reserved for Mycoplasma testing as described above.
2.5.2.3 Maintenance
mESCs were passed every two-three days at approximately 1:5. Passage number
was kept low in order to reduce the occurrence of karyotypic abnormalities, as pre-
viously reported (Eggan et al., 2002; Robertson et al., 1983).
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2.5.2.4 Electroporation
Electroporation was used to deliver a vector containing Cas9 and guide sequences,
along with a drug selection cassette (pPGKpuro, Tucker et al., 1996). mESCs in the
early stage of growth were disaggregated into solution and counted using Scepter
2.0 (Merck Millipore: Billerica, USA). 2 x 106 cells were then electroporated using
Mouse ES Cell Nucleofector Kit (Lonza: Basel, Switzerland), as per the manufac-
turer’s protocol. Drug selection was carried out using 1.5ug/ml puromycin (Sigma-
Aldrich: St Louis, USA) to identify clones that had taken up plasmid and, following
a period of growth, colonies were picked, and genotyped by PCR followed by re-
striction digest.
2.5.2.5 Mouse epiblast like cell (mEpiLC) differentiation
mESCs were differentiated towards an epiblast-like cell fate according to a pre-
viously published protocol (Hayashi et al., 2011a; Hayashi and Saitou, 2013). In
brief, mESCs were grown to confluence, disaggregated with TrypLE, and plated
at 1 x 105 cells per well of a 12 well plate coated with human plasma fibronectin
(Merck Millipore: Billerica, USA). N2B27 medium (Takara Bio: Tokyo, Japan)
was supplemented with activin A at 20ng/ml (Peprotech: London, UK), FGF2 at
12ng/ml (Peprotech: London, UK), and 1% knockout serum replacement (KSR,
Thermo Fisher: Waltham, USA); and cells were cultured for 48 hours prior to RNA
extraction.
2.5.3 Derivation of MEFs
Gamma irradiated MEFs were used as feeder cells for mTSCs: originating primary
cells were generated according to a published protocol (Xu, 2005). Briefly: 14
days following timed mating, pregnant dams were culled, and uterine were horns
dissected out using sterile instruments followed by a thorough wash in sterile PBS
(Thermo Fisher: Waltham, USA). In a laminar flow hood, the embryos were cleanly
dissected away from the uterus and the viscera and brain were removed. Individual
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embryos were then teased apart using fine forceps in ice cold trypsin EDTA, and
incubated overnight at 4°C. The following morning, most of the trypsin EDTA was
removed without disturbing the settled tissue, and the remainder was incubated at
37°C. Tissues were then dissociated into cells, plated in MEF medium (Appendix
A) as one embryo per plate, and allowed to grow to confluence before freezing in
vials with MEF medium/20% DMSO. Vials were placed in a cell freezing container
at -80°C overnight, before transfer to permanent storage in liquid nitrogen.
2.5.3.1 Gamma irradiation of MEFs and production of conditioned
medium
One vial of primary MEFs was thawed and expanded for two passages, generating
between 5 and 10 x 107 cells. Following dissociation, cells were exposed to a
radiation dose of approximately 35 Gy via a caesium source, counted, and frozen as
described above. For the production of MEF conditioned medium (CM), irradiated
cells were plated at a density of 6 x 106 per 150mm plate. mTSCM was added
for five x three day periods: subsequent to collection of the final batch, all batches
were pooled, centrifuged and filtered to remove cell debris, and stored at -20°C until
use.
2.6 Next generation sequencing
2.6.1 Generation of data to screen CRISPR targeted loci
Illumina MiSeq platform was used to generate sequencing data for genotyping of
CRISPR targeted cells and animals. Primer sequences were designed around the
region of interest using Primer3 (Untergasser et al., 2007), with a maximum ampli-
con size of 500bp and synthesised by Eurofins MWG (Eurofins MWG (Ebersberg,
Germany). Adapter sequence was added to the 5’ and 3’ ends of the forward and
reverse primers, respectively, in order to enable further amplification with Illumina
TruSeq indexing primers (Illumina: San Diego, USA). PCR was performed us-
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ing q5 high fidelity polymerase (NEB: Ipswich, USA), according to manufacturer’s
protocol. Unused polymerase and enzyme was removed from the reaction using
solid phase reverse immobilisation (SPRI) beads, to the specification of AMPure
XP (Beckman-Coulter: Brea, USA), but made in house. Indexing was performed as
per the Illumina protocol, and a further clean up step utilised SPRI beads. Sample
quantification utilised the dsDNA dye Quanti-fluor (Promega: Fitchburg, USA);
signal was recorded with Infinite M1000 Pro (Tecan: Mannedorf, Switzerland),
and analysed using proprietary Tecan software. Samples were then normalised and
pooled before submission to the Advanced Sequencing Facility (ASF) at the Francis
Crick institute. Following quality control - library quantitation via Eco Real-Time
PCR (Illumina: San Diego, USA) and sizing via 2100 Bioanalyzer (Agilent: Santa
Clara, USA) - the library was loaded onto the MiSeq at 2nM, using MiSeq Reagent
Kit v2 (Illumina: San Diego, USA) for 2 x 250bp sequencing.
2.6.2 Data analysis
Fastq files were collapsed using FastX Toolkit (v0.0.13) and aligned to the reference
genome (mm10) using blastn.
2.6.3 RNA-seq
2.6.3.1 Library preparation
Total RNA was extracted as described above (section 2.2.2). 500ng was submitted
to ASF and assessed for RNA integrity (RIN) using Caliper LabChip GX (Perkin
Elmer: Waltham, USA). Samples that passed quality control were prepared for se-
quencing by ASF using TruSeq Stranded mRNA Library Prep Kit as per manufac-
turer’s protocol (Illumina: San Diego, USA). Libraries were sequenced across two
runs on Illumina HiSeq 4500.
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2.6.3.2 Data quality control
Quality control was performed on FASTQ output files using the FastQC package
(Andrews, 2010). Paired end reads from each library were each trimmed of 13 base
pairs from the 5’-end and 3 base pairs from the 3’ end using Trim-Galore (Krueger,
2012), based on output from the Per Base Sequence Quality metric.
2.6.3.3 Mapping and differential expression analysis
Trimmed reads were then aligned to the mm10 genome using HISAT2 (v2.0.6: Kim
et al., 2015). Uniquely mapped reads, (ie. fragments that mapped once only to the
reference genome) and with a MAPQ score > 40 were retained for further analysis.
These were then reverted to FASTQ format using PicardTools SamToFastq prior to
input for further steps.
Transcript abundances were then determined using Salmon (v.0.7.2, Patro et al.,
2017). Mouse Gencode (VM12) transcriptome annotation was used to create a
quasi Salmon index.
Differential gene expression analysis was performed in R (v.3.2.2, R Core Team,
2013) utilising two independent methods. Firstly output from Salmon were passed
to Voom, limma package (Ritchie et al., 2015) using tximport (Soneson et al., 2015),
and gene level differential expression (DE) testing was performed. Secondly, out-
puts from Salmon were also passed onto Sleuth (Pimentel et al., 2017) via kallisto
(Bray et al., 2016), and again gene level DE testing was carried out. A comparison
of XY and XX mESCs was included as a positive control for detection of DE genes,
which guided the setting of filtering thresholds for the exclusion of lowly expressed
genes.
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2.6.3.4 Over representation analysis (ORA)
Over representation analyses were carried out as using the Web based gene set anal-
ysis toolkit (WebGestalt, Zhang et al., 2005; Wang et al., 2017) with standard set-
tings.
2.7 Statistical analysis
2.7.1 Weight data analysis
There are major litter effects on growth during pregnancy and early postnatal life
independent of genotype; therefore comparisons between genotypes were made
within litters (Burgoyne et al., 1983). Mean weighted differences (MWD) were
used in order to compare weight data, thus taking into account varying litter sizes
and numbers of animals per genotype within each litter. The difference between
the required two genotypes was weighted according to the number (n) of animals of
those genotypes (i.e. w = n1 x n2/n1+n2). The MWD was then calculated by divid-
ing the sum of the weighted differences over the sum of the weights (w), and stan-
dard error calculated from estimates of the variances in each genotype in each litter.
MWD over standard error is distributed as Student’s t (Burgoyne et al., 2002).
At E10.5, embryos are growing exponentially, therefore a log transformation was
performed before the MWD calculation to bring the data into a normal distribution.
Additionally, it has previously been noted that some XO embryos are more runted
than expected, and can thus seriously affect XY-XO comparisons (Burgoyne et al.,
1983b). To test for this effect, the differences between XY and XO, and XY and
XXist-O embryos were collated across litters and the distribution checked for outliers
(Grubbs’ test): none were found.
Postnatal growth rates were calculated by plotting each individual animal’s weight
data and fitting a regression line; the gradients from 0-3 weeks and 3-5 weeks were
then compared using MWD as described in (Burgoyne et al., 2002). Data were
2.7. Statistical analysis 89
analysed using Excel (Microsoft: Washington, USA) and Prism (Graphpad: La
Jolla, USA).
2.7.2 Postnatal survival analysis
The statistical significance of the differences between expected and observed num-
bers of each genotype was calculated using Fisher’s Exact Test of Independence,
using the package rcompanion in R (R Core Team, 2013) I corrected for multiple
comparisons, where applicable, using the Holm-Bonferroni method (Holm, 1979).
Mosaic plots were created using the package ggplot2 in R.
Chapter 3
Examining the role of Xist in the
post-implantation growth deficit
observed in XPO embryos
3.1 Introduction
TS is invariably associated with low birth weight, reduced growth during childhood,
and adult short stature. These effects likely manifest from intrauterine growth retar-
dation (IUGR) during embryogenesis. XO mouse embryos are similarly growth re-
tarded during development. There is limited evidence to suggest that this manifests
at the pre-implantation stage, though it is certainly present as a weight deficit by the
egg cylinder stage, at around E7.25 (Banzai et al., 1995b; Burgoyne et al., 1983b).
The weight deficit persists until around E12.25, with a further lag period between
E14.5 and E16.5 (Burgoyne et al., 1983b). Interestingly, subsequent work focusing
on the parent of origin of the single X chromosome in XO mice showed that this
effect is only observed in XPO embryos (Thornhill and Burgoyne, 1993). In con-
trast, at E10.5 XMO embryos were shown to be heavier than XX littermates, and of
equivalent weight to normal XMY males (Thornhill and Burgoyne, 1993). Bringing
these data together, it was hypothesised that the XP carries an imprint that reduces
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X linked gene expression across the whole chromosome, thus delaying growth; and
that the XM is more efficient at supporting early development. This could be ex-
plained by imprinted Xist expression from the XP, thus silencing X linked genes in
early XPO embryos.
These observations were confirmed, and the reduced X linked gene expression hy-
pothesis tested, using a lacZ transgene to assay gene activity from the single X
chromosome in XPO embryos (Jamieson et al., 1998). In XY males and homozy-
gous carrier females, X-gal staining was positive in the embryo proper and in cells
of both extraembryonic ectoderm (ExE) and ectoplacental cone (EPC). Heterozy-
gous female embryos carrying the transgene on the XM showed a similar pattern,
whereas those carrying the transgene on the XP displayed no expression in the ExE
or EPC, in line with imprinted XCI of the XP in these tissues. If the single X chro-
mosome in the XPO showed significantly reduced or absent staining, this would
support a case for chromosome wide downregulated gene expression as a cause of
the growth deficit in these embryos. Intriguingly, XPO embryos stained positively
for X-gal in all tissues, suggesting that the single XP can behave as per the XM in the
absence of a second sex chromosome. The authors also observed that the EPC of
XPO embryos is significantly smaller than XX littermates, likely due to a reduction
in the number of cells, as the packing density was normal (Jamieson et al., 1998).
Taken together, whilst these data show that the XP is transcriptionally active in the
XPO context at E7.5, it is still possible that global transcription across the chromo-
some is reduced, or indeed absent, at an earlier stage, possibly as a result of paternal
Xist expression. Alternatively, specific genes may be required from the XM that are
not expressed from the XP due to epigenetic differences independent of iXCI, and
their absence compromises development.
XCI controls transcription across the X chromosome. In the pre-implantation em-
bryo this process is mediated by Xist in an imprinted manner, such that XP is always
inactivated. Xist expression was assayed by RNA FISH in 8 cell and blastocyst stage
mouse embryos (Matsui et al., 2001). Whereas in XY male embryos no expression
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was observed at either stage - as would be expected in the presence of a single XM- a
distinct signal was present in every cell of the 8 cell XPO embryos, with a decreased
frequency of 20% of cells in fully expanded blastocysts (Matsui et al., 2001). Based
on these data, it can be hypothesised that inappropriate Xist expression in the pre-
implantation XPO embryo results in temporary chromosome wide silencing, and
an embryo nullizygous for X linked gene products. Functional nullisomy for X
linked gene products has previously been shown to be extremely harmful to early
embryonic development (Morris, 1968a; Burgoyne and Biggers, 1976), therefore it
is possible that this causes the growth retardation phenotype observed from E7.25
onwards. I sought to test this hypothesis by asking whether deletion of Xist rescues
the developmental retardation of XPO embryos.
3.2 Results
I set out first to reproduce previously published data confirming that XPO embryos
show significant growth retardation when compared with XX littermates at E10.5.
XPO embryos resulted from cross 1 (Figure3.1 A(i)). Here, I utilised female mice
heterozygous for a large pericentric inversion on the X chromosome, In(X), as a
source of ’O’ gametes (Evans and Phillips, 1975). When mated to an XY male, there
are six possible offspring (Figure3.1 A(i)), five of which survive to E10.5. Four of
these genotypes can be identified by PCR on genomic DNA (Figure 3.1B), whereas
RT-PCR to detect Xist was used to distinguish between XX and XO embryos (see
section 2.2.3).
Preliminary analyses showed no significant difference in weight or somite counts
between XX and InX/X female embryos or between XY and InX/Y male embryos.
These were therefore pooled as "XX" and "XY" for all future analyses. XPO em-
bryos were significantly smaller than XX littermates: this was clear from morphol-
ogy (Figure 3.1D), weight data (Figure 3.1E), and somite counts (Table 3.1). I
then compared XPO embryos with XY littermates to confirm whether a single XM
is able to support development more effectively than a single XP, as shown previ-
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ously (Thornhill and Burgoyne, 1993). XPO embryos are also significantly smaller
than XY littermates (Figure 3.1D, E), and have fewer somites (Table 3.1). Taken
together, these data confirm previous results showing XPO growth retardation at
E10.5, relative to XX littermates. Furthermore, I observed that a single XM is more
capable of supporting normal development than a single XP. This result does not,
however, enable us to determine whether inappropriate Xist expression or X linked
gene imprinting is responsible for the reported embryonic growth deficit.
In order to test the Xist hypothesis, I utilised a male carrying the Xisttm1Jae al-
lele (Marahrens et al., 1997) to produce XPO mice lacking Xist (hereafter denoted
XXist-O). This allele is lethal to all XX females when inherited paternally because
imprinted XCI is ablated, resulting in embryonic death and degradation by E10.5
(Marahrens et al., 1997). Accordingly, there are no XX females available as con-
trols, and only three offspring genotypes are produced in this cross at E10.5 (Figure
3.1A(ii)). As an alternative, I used XYRIII male embryos as controls. Whilst most Y
chromosomes accelerate pre-implantation development, the RIII strain Y chromo-
some has previously been shown to lack this effect (Burgoyne, 1993). In order to
confirm there is no acceleration of development in XYRIII embryos, I compared to
XX littermates in cross 1. No significant difference was observed in either weight
(Figure 3.1E(i)) or somite data (Table 3.1). I therefore utilised XYRIII male embryos
as controls throughout this experiment.
I then assessed the contribution of inappropriate Xist expression to the growth deficit
observed in XPO embryos at E10.5. If the cause of the growth deficit was Xist ex-
pression, no difference in weight or somite count would be expected between XYRIII
and XXistO embryos (Figure 3.1C(ii)). Most XXist-O embryos showed growth retar-
dation when compared to XYRIII littermates, which was clear both from embryo
morphology (Figure 3.1D, right hand side), weights (Figure 3.1E(ii)), and somite
counts (Table 3.1). Based on these data, I conclude that inappropriate expression
of Xist is not responsible for the growth retardation phenotype observed in XPO
embryos at E10.5.
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Embryonic growth controls the kinetics of somitogenesis, both in wildtype and
growth impaired embryos (Tam, 1981; Power and Tam, 1993). When embryo size is
halved prior to the eight cell stage, morphogenesis and pattern formation are appro-
priate for tissue volume as opposed to chronological age (Power and Tam, 1993). I
was interested to see if a similar relationship holds for XPO embryos, thereby gain-
ing further insight into the nature of the growth deficit. I used log weight and somite
count metrics to validate this relationship in the current model (Figure 3.1E(iii)): all
four genotypes showed highly significant correlations (Figure 3.1E(iii)). Utilising
the same data, I then created a linear regression model of developmental progression
(Figure 3.1E(iv)). The gradients of the regression lines were not significantly dif-
ferent between any of the genotypes (p = 0.3310; Figure 3.1E(iv)). I conclude that
the growth retardation and reduced somite counts represent a global developmental
delay in XPO embryos at E10.5, i.e. the somite count is appropriate for the log
weight. This was also true for XXist-O embryos, further supporting my conclusion
that Xist does not play a role in the retardation phenotype.
3.2. Results 95
3.3. Discussion 96
Figure 3.1: Xist KO does not rescue the developmental deficit observed in XPO em-
bryos at E10.5. (A)(i) Cross 1 utilised a XYRIII male and a In(X)1HY female, with five
possible offspring: YRIIIO embryos are not viable. (ii) Cross 2 utilised a XXist-YRIII male and
a In(X)1HY female, with three possible offspring: females with two X chromosomes are
not viable due to a lack of imprinted XCI. (B) Representative genomic DNA PCR results for
the inversion X chromosome (top row); the Y chromosome (middle row); and the mutated
Xist allele (bottom row). (C) (i) and (ii) illustrate experimental hypotheses. (D) Represen-
tative images of all genotypes at E10.5 (scale bar = 100uM). (E) (i) The log weights of XX
and XPO, XX and XYRIII, XYRIII and XPO embryos, and (ii) XYRIII and XXist-O embryos
were compared at E10.5, with P values given by Student’s t; bars represent mean±SEM;
(iii) Somite count was significantly correlated with log weight for all genotypes (r2 for
XYRIII=0.8173, XX=0.9245, XPO=0.8814, XXist-O=0.8248); (iv) linear regression analysis
included somite count and log weight as factors, with no significant difference between the
gradients for different genotypes (p=3.31x10-1).
3.3 Discussion
Whilst it has been known for a number of years that XPO embryos are signifi-
cantly smaller than XX littermates at E10.5 (Burgoyne et al., 1983b; Thornhill and
Burgoyne, 1993; Jamieson et al., 1998), here I show that this is not as a result of
inappropriate Xist expression. The Xist mutant allele has been shown to abolish Xist
expression from the XP (Marahrens et al., 1997). Nevertheless, XPO mice carrying
Xist- still exhibit a significant growth deficit at E10.5.
There are a number of possible explanations that could underlie this result, from
both technical and biological perspectives. Firstly, loss of Xist expression should be
confirmed by transcriptional analysis of XXist- embryos. Secondly, significant vari-
ation exists between mouse litters, largely resulting from the uterine environment
(Hughes, 1979; Holson & Pearce 1992; Lazic and Essioux, 2013). I reduced this
effect by keeping the maternal genotype constant across experiments, and utilising
the MWD statistical technique to compare embryos within litters. However, it was
not possible to generate normal XPO females and XPO females lacking Xist within
the same litter. I cannot therefore fully exclude the effect of inter litter differences.
In the XYRIII male I believe I opted for the best proxy comparison; however, due to
the genetically outbred nature of the MF1 strain, it is formally possible that this is an
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uncontrolled source of variation. A further source of variation lies within develop-
mental timing between litters (Figure 3.1E); i.e. some litters were likely conceived
many hours earlier than others, despite maintaining constant timing by embryonic
day. Again, the mean weighted difference technique helped to ameliorate this ef-
fect in the data by making only relative comparisons within litters. Furthermore,
the logistic regression analysis utilised both somite number and log weight, thus
controlling for developmental timing.
3.3.1 Xist coating may not directly result in imprinted XCI
Previous work has shown by RNA FISH almost complete Xist coating of the pater-
nally derived X chromosome(s) in XPO and XPXP embryos at the 8-16 cell stage
of pre-implantation development (Matsui et al., 2001; Okamoto et al., 2000). This
expression was subsequently reduced at the blastocyst stage such that only around
20% of cells showed inappropriate numbers of Xist foci. Neither of these experi-
ments, however, assayed whether this Xist expression causes X linked gene silenc-
ing.
Utilising a similar model system, but assaying instead by qRT-PCR, Latham and
Rambhatla screened five X linked genes, including Xist, for differential expression
between androgenetic and gynogenetic embryos at both 8 cell and late morula stages
(Latham and Rambhatla, 1995). Androgenetic embryos showed reduced expression
in all genes except Xist, which was more highly expressed. These results should,
however, be explicated in the context of the experiment, which utilised pooled em-
bryos and early qRT-PCR techniques. For example, a population of androgenetic
embryos may include those with two X chromosomes, two Y chromosomes, or one
of each, thus making interpretation of differential expression challenging. Later
work from the same group rectified this ambiguity by using single embryos for ex-
periments, though focusing on mid to late blastocyst stage embryos (Latham et al.,
2000). There was a significant difference in Xist expression between XX and XY
blastocysts in the control group. The same observation was made comparing XPXP
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with XPY embryos, though the difference was not statistically significant. Finally,
they reported no significant difference in Xist expression between XX control and
XPXP androgenetic blastocysts, despite the latter carrying two paternally derived X
chromosomes (Latham et al., 2000). This is consistent with the RNA FISH data
from androgenetic blastocysts (Okamoto et al., 2000). The embryo becomes com-
petent to count at this stage, which effects a reduction in the expression of Xist
appropriately in both androgenetic and control blastocysts (Latham et al., 2000;
Okamoto et al., 2000).
Taken together, these data leave open two possibilities. Firstly, imprinted XCI may
take place in XPO embryos and reduce transcription from the XP. This would be
in keeping with the fact that X linked nullizygosity, as seen in the YO embryo, is
detrimental to pre-implantation embryonic development (Morris, 1968a; Burgoyne
and Biggers, 1976). Alternatively, Xist is expressed, but the downstream pathway
that results in transcriptional inactivation is not complete. This implies that whilst
imprinted expression of Xist from the XP is absolute, i.e. it is blind to the number
of X chromosomes present, a downstream counting or regulatory mechanism must
exist to ensure continued X linked gene expression. Hypothetically, such a mech-
anism could act on XM, so that Xist expression is only converted to transcriptional
inactivation in the presence of at least one XP and one XM. A candidate for the
effector of this mechanism is Rnf12 (also known as Rlim). A maternally expressed
copy of Rnf12 is absolutely required for imprinted XCI in XX female embryos,
as shown by the early post implantation female lethality of an Rnf12 mutant allele
(Shin et al., 2010). These Rnf12 mutant embryos do, however, also display defec-
tive Xist expression at the blastocyst stage, and this defect has not been observed in
XPO embryos (Shin et al., 2010).
In order to distinguish between these two hypotheses, an analysis of X linked tran-
scription in the early embryo is required. RNA FISH would enable a number of
genes to be screened, but RNA-seq would provide a more comprehensive answer.
Recently, single cell RNA-seq has facilitated the study of gene transcription in the
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early embryo in even greater depth, thus providing a transcriptome wide view of
iXCI. Transcription from XP in wildtype XX embryos has been shown equivalent to
that from XM at the 4 cell stage, with a paternal to maternal ratio of 1.0. (Petropou-
los et al., 2016). The ratio then progressively decreased to 0.4 at the early blastocyst
stage (Petropoulos et al., 2016). Xist expression peaked at the 16 cell stage and was
maintained until E4.5 (Deng et al., 2014; Wang et al., 2016). Borensztein and col-
leagues further classified the genes undergoing inactivation into early, intermediate
and late silenced, at 16, 32 and blastocyst stages, respectively (Borensztein et al.,
2017). As these data are entirely consistent with previously reported RNA FISH
datasets, a complementary approach of RNA-seq validated by RNA FISH is ideally
suited to begin to address the role of Xist in imprinted XCI in XPO pre-implantation
embryos.
3.3.2 The X chromosome may harbour imprinted genes that are
primarily expressed in the extraembryonic tissue
Inappropriate Xist expression is not the cause of the growth retardation observed in
XPO embryos at E10.5, therefore I hypothesise the existence of imprinted genes on
the X chromosome that are differentially expressed during embryonic development.
This could also serve to explain the observation that XMO female embryos show
accelerated growth relative to XX littermates at E10.5 (Thornhill and Burgoyne,
1993). Such imprinted genes could function either as a normally silent growth sup-
pressor(s) on the single XP, or as a growth enhancer(s) from the XM. There are a
number of reported examples of X linked genes proposed to to be silenced on XP
due to imprinting, e.g. Esx1 (Li and Behringer, 1998) and Plac1 (Jackman et al.,
2012). However, whether the silencing observed in these reports results from true
imprinting or imprinted XCI remains to be shown. In order to separate the concep-
tually similar occurrences of imprinted XCI and genomic imprinting, the presently
described XO model is required. Imprinted XCI does not occur in this model, thus
any differences observed between XP and XM can be attributed to genomic imprint-
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ing. This approach led to the discovery of the Xlr locus, a group of imprinted genes
expressed in the developing mouse brain (Davies et al., 2005; Raefski and O’Neill,
2005).
Whilst imprinting could affect genes expressed in the embryonic or in the extraem-
bryonic tissue, a number of lines of evidence make the latter more likely. Firstly,
embryos that do not show growth retardation, i.e. XMXP, XMY, and XMO have
an active XM in extraembryonic tissue, whereas XPO has an active XP. Secondly,
one of the recurring themes in the genomic imprinting literature is the correlation
between the evolution of imprinting and the evolution of an invasive, gestation span-
ning placenta (Cleaton et al., 2014; Renfree et al., 2013). A significant number of
the 100 or so currently recognised imprinted genes affect pre natal development
through placental expression (Coan et al., 2005; Keverne, 2015). Thirdly, as previ-
ously described here, the placentas of XO embryos show morphological abnormali-
ties during development. XPO embryos show reduced EPC volume when compared
to XX littermates, while XMO embryos do not (Jamieson et al., 1998). Earlier work
utilising the XO mouse model showed that XPO placentas are larger than placentas
from XX littermates, and further work described this hyperplasia in both XPO and
XMO placentas at E17.5, with the latter larger than the former (Burgoyne et al.,
1983a; Ishikawa et al., 2003). The authors reconcile this apparent contradiction by
suggesting that the growth trajectories are simply maintained from EPC onwards,
and that placentas with one X chromosome are generally larger than those with two
X chromosomes (Ishikawa et al., 2003). Finally, XO mESCs have been shown to
exit the pluripotent state and differentiate faster than XX mESCs, which must trig-
ger XCI before exit from pluripotency (Schulz et al., 2014). If this also applies to
the situation in vivo, it might be expected that the XO embryo proper is actually at
an advantage relative to the XX embryo proper, at least initially.
In order to determine whether an embryonic or extraembryonic defect underlies the
growth deficit in XPO embryos, the definitive experiment would require an analy-
sis of embryos in which sex chromosome complement differs between these two
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lineages. By introducing an XPO embryo into an XX/XY extraembryonic environ-
ment, and vice versa, the effects on development could be assessed. This can be
achieved by either mechanical or chemical means. The cells of a two cell stage
embryo can be electrically fused, thus making the cell tetraploid (4n). These cells
can then be complemented at the four cell stage with donor mESCs, resulting in the
creation of high grade chimeras. The recipient 4n cells form the extraembryonic
compartment, and the mESCs differentiate into the embryo proper (Nagy et al.,
1990, 1993). Alternatively, recipient embryos can be pre-treated with FGF4 and
heparin in order to promote formation of PE and inhibit the development of the epi-
blast (Yamanaka et al., 2010). Very recently it has been shown that donor mESCs
can be injected into FGF/heparin pre-treated embryos at the blastocyst stage, and
that these cells make a significant contribution to the formation of the embryo
proper (Dupont et al., 2017). There are compromises with both techniques. Firstly,
tetraploid complementation has been correlated with a growth deficit in all wild-
type embryos (Tam, 2003). More importantly, the karyotype of the extraembryonic
tissue would be 4n, thus making it no longer possible to assess the contribution
of a single X chromosome. FGF treatment does not currently achieve equivalent
rates of chimerism to the tetraploid method. However, with appropriate controls, it
should still be possible to detect relative changes to embryonic development. These
experiments are in progress.
3.3.3 Mouse trophoblast stem cells can be utilised to identify im-
printed genes in vitro
A tractable model is required to facilitate the search for any X linked imprinted
genes expressed in the extraembryonic compartment. Undoubtedly the gold stan-
dard would be to show differential gene expression (DGE) between XP and XM
chromosomes in vivo, followed by functional experiments to link cause and effect.
However, the placenta is a dynamic tissue that changes significantly during devel-
opment, therefore identifying the correct time and location for DGE may be chal-
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lenging without an initial screen. This could be carried out in mouse trophoblast
stem cells (mTSCs): an ex vivo derived population of multipotent cells originating
from the extraembryonic compartment, amenable to propagation in vitro, manipu-
lations such as overexpression or genome editing, and shown to maintain imprints
originally observed in the embryo (Tanaka et al., 1998; Calabrese et al., 2015). The
derivation and use of mTSCs to identify X linked imprinted genes will be the focus
of the next chapter.
Chapter 4
Using in vitro models to identify
candidates for X linked imprinted
genes in mouse extraembryonic
tissue
4.1 Introduction
4.1.1 Genomic imprinting
Parent of origin biased gene expression - genomic imprinting - has been observed
across fauna and flora, though among vertebrates it is most well characterised in
eutherian mammals. Early studies utilising androgenetic and gynogenetic mouse
embryos established that one copy of the genome from each parent was required
for successful embryonic development (Barton et al., 1984; Kaufman et al., 1977;
Surani and Barton, 1983; Surani et al., 1984). Subsequent work showed that this
uniparental embryonic lethality phenotype resulted from a necessity for expression
of a small subset of genes from a specific parental allele, denoted paternally ex-
pressed genes, Pegs and maternally expressed genes, Megs, respectively (Cleaton
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et al., 2014). These subsets are most often found in groups known as imprinted
domains, which themselves are coordinately regulated by a germline differentially
methylated region (gDMR) or imprinting control region (ICR). gDMRs are CpG
rich, and the two parental alleles are differentially methylated during gametogene-
sis (Iurlaro et al., 2017). The majority of gDMRs are maternally methylated, though
a small number are paternally methylated, including the Igf2-H19 cluster. Whilst
it is clear that such differential methylation drives the imprinting status of the clus-
ter, there are also a number of other mechanisms by which allele specific gene
expression can be achieved, including lncRNA mediated recruitment of epigenetic
modifiers (Nagano et al., 2008).
The biological purpose of imprinting is unknown; though the timing of its appear-
ance in both eutherian mammals and, to a limited extent, metatherians has been cor-
related with the evolution of viviparity through placentation (Smith et al., 2011). It
has previously been suggested that imprinting regulates the balance between the de-
mands of the maternal and paternal genomes via the in utero foetus; the kinship, or
parental conflict hypothesis (Haig and Westoby, 1989). This posits that paternally
derived genes generally enhance foetal growth because they look to increase re-
source grabbing from the mother, thus maximising the probability of further genetic
propagation. Maternally derived genes, in contrast, often suppress foetal growth in
order to balance resources between current and future litters (Haig and Westoby,
1989).
Alternatively, imprinting may serve to regulate the balance of resources in utero be-
tween mother and foetus, with maternal interests represented by the placenta (Reik
et al., 2003). By this hypothesis, nutrient supply is genetically controlled by expres-
sion of imprinted genes in the placenta, and demand is controlled by expression of
imprinted genes in the foetus. Such a hypothesis also accounts for the evolution of
clusters, suggesting that the existence of supply and demand genes in close proxim-
ity (e.g. the region around Igf2) facilitates the fine balance required in expression
during development (Reik et al., 2003).
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A third theory suggests that imprinting evolved because it increases the genetic in-
tegration of co adapted maternal and offspring traits, thereby enhancing the fitness
of offspring (Wolf and Hager, 2006). No single theory fully explains the existence
of all imprinted genes; though it is clear that all theories take into account the evo-
lution of the placenta and the significant number of imprinted genes expressed by
the shortest lived of all organs.
4.1.2 The placenta
The placenta is the physiological interface between mother and foetus (Smith et al.,
2011). It mediates the exchange of nutrients and waste products between foetal
and maternal blood, as well as acting as a centre for the production of hormones
and growth factors during pregnancy (Rossant and Cross, 2001). Whilst the pla-
centa is most commonly associated with eutherian mammals, it is also present in
metatherians, and has been found in diverse vertebrate classes including amniotes
such as Amphibia, Reptilia, and the anamniotic Chondrichthyes (sharks, Blackburn
and Flemming, 2011; Hamlett, 1989). In mammals, and amniotes more generally,
placental development includes the fusion of pairs of the four foetal membranes,
the amnion, the yolk sac, the allantois, and the chorion (Smith et al., 2011). The
amnion directly surrounds the foetus and serves to protect it from shock. The yolk
sac encapsulates the egg yolk in egg bearing species, and carries out many duties of
the placenta before the allantoic placenta is established, including blood synthesis
and blood vessel formation and nutrient and gas exchange. The allantois is contin-
uous with the embryonic bladder; and the chorion is formed by the extraembryonic
mesoderm and a layer of outer trophoblast - it joins with the yolk sac to form the
chorio vitelline placenta or the allantois to form the chorio allantoic placenta (Smith
et al., 2011).
The mature mouse placenta is a chorio allantoic placenta, composed of multiple
cell types across three layers: i) the decidua, formed of maternal tissue; ii) the
junctional zone, and; iii) the labyrinth (John and Hemberger, 2012). Within the
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labyrinth, exchange of nutrients, waste, and gases takes place between maternal and
foetal circulations. The exchange interface is made up of two layers of multinu-
cleated syncytiotrophoblast cells, in addition to sinusoidal trophoblast giant cells
(TGCs, Simmons et al., 2008). TGCs also exist within the decidua, in the form
of spiral artery associated TGCs and canal associated TGCs, and between the lay-
ers as parietal TGCs. They produce a number of endocrine molecules, including
prolactin, that serve to mediate the continuation of pregnancy, maternal vascular
remodelling, and possibly parturition (Hu and Cross, 2010). Placental prolactins
are also produced by spongiotrophoblast cells from within the junctional zone, in
addition to other pregnancy specific glycoproteins thought to have a role in the
immune privileged status of the foetus (Wu et al., 2008). The function of the spon-
giotrophoblast within the junctional zone was previously thought to be primarily
structural (Rossant and Cross, 2001), however, in addition to the production of hor-
mones and glycoproteins, it also produces molecules that affect the maternal brain
to mediate maternal instinct (Glynn and Sandman, 2011). Glycogen cells are also
found within the junctional zone and, by migration, also within the maternal de-
cidua, though the function of these aptly named glycogen heavy cells remains to be
found (Prudhomme and Morey, 2015). A summary of mouse placenta development
is provided in Figure 4.1.
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Figure 4.1: Mouse placenta development. Around the time of implantation (E3.5), the
trophoectodermal cells overlying the ICM, the polar TE, proliferate and give rise to diploid
extraembryonic ectoderm and the ectoplacental cone (EPC). The trophectodermal cells in
contact with the blastocoele cavity, the mural TE, endoreduplicate their DNA to become
polyploid primary trophoblast giant cells (TGCs). Secondary TGCs are formed from the
EPC, which migrate to surround the conceptus. Between E6.0 and E7.5, the extraembry-
onic ectoderm expands and joins with extraembryonic mesoderm to form the chorion, which
itself then makes contact with the mesoderm derived allantois. This attachment is followed
by folding of the chorion, thus marking the sites of foeto placental blood vessel growth
from the allantois. By E12.5, the foetal blood vessels become a densely packed labyrinth
with extensive villous branching, and chorionic trophoblast cells differentiate to become
syncytiotrophoblast cells. These multinucleated cells form two distinct layers which, in ad-
dition to sinusoidal TGCs, form the interface between the maternal and foetal blood within
the placental labyrinth. In order to make contact with the foetal blood supply via the tro-
phoblast villi, the maternal blood passes through the junctional zone, comprised mainly of
spongiotrophoblast cells. This is formed by differentiation from the EPC. After Rossant and
Cross, 2001.
Many imprinted genes are expressed in the placenta (Cleaton et al., 2014; Tunster
et al., 2013). A number of these imprinted genes have been functionally charac-
terised by targeted deletion, often resulting in growth phenotypes affecting either the
placenta and/or the foetus. Placental growth restriction has been reported follow-
ing individual deletion of the paternally expressed genes Igf2, Peg1, and Plag1; in
contrast to deletion of the maternally expressed Igf2r, Cdkn1c, Phlda2 and Grb10,
which resulted in enhanced placenta growth (Cleaton et al., 2014). Foetal over-
growth was observed following targeting of the maternally expressed Igf2r or H19
(Wang et al., 1994; Leighton et al., 1995). An embryonic growth retardation phe-
notype was reported after deletion of Igf2, Peg1/Mest, and Peg3, all normally ex-
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pressed from the paternal allele (DeChiara et al., 1991; Lefebvre et al., 1998; Li
et al., 1999).
XPO female embryos are smaller than XX littermates at E10.5 (Thornhill and Bur-
goyne, 1993). In this thesis, I previously showed that this growth deficit is not
caused by Xist expression (Chapter 3). Furthermore, XPO embryos also have a
smaller ectoplacental cone (EPC) than XX littermates at E7.5 (Jamieson et al.,
1998). Neither of these defects are present in XMO embryos, which are heavier
than XX littermates at E10.5 (Thornhill and Burgoyne, 1993; Jamieson et al., 1998).
This XPO growth deficit is likely to result from genomic imprinting affecting the X
chromosome.
XCI always silences the XP in mouse extraembryonic tissue, whereas in the em-
bryo, XCI randomly affects either XM or XP (Okamoto et al., 2004). Genes from
the XP are therefore expressed in 50% of cells in the normal XX embryo proper,
but are never expressed in the XX, XY, or XMO placenta. I hypothesise that the
absence of the XM in XPO placentas could result in loss of expression of a growth
promoting gene(s) expressed only from XM in placenta. Alternatively, there may
be a gene(s) present on XP that is usually silenced by XCI in the XX placenta,
and whose expression in the XPO is disadvantageous to embryonic growth. It is
also formally possible, though less likely, that the phenotype could be explained by
genes expressed in the embryo proper. In order to search for candidate genes to sup-
port these hypotheses, I performed RNA sequencing (RNA-seq) on XPO and XMO
mouse stem cell lines to model the different embryonic compartments: pluripo-
tent - mouse embryonic stem cells (mESCs); epiblast - mouse epiblast like cells
(mEpiLCs); and the trophectoderm - mouse trophoblast stem cells (mTSCs).
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4.2 Results
4.2.1 Derivation of stem cell lines
First I set out to derive mTSC lines from blastocyst stage embryos, as described pre-
viously (Tanaka et al., 1998; Himeno et al., 2008) and summarised in Figure 4.2A.
In order to generate XPO embryos, I used the cross described in Chapter 3 between
an In(X)/X female and a XYRIII male (Figure 4.2B(i)), here designated Cross I.
XMO embryos were generated by crossing an XY*O male (Burgoyne et al., 1998)
with a wildtype XX female (Figure 4.2B(ii)), hereafter Cross II. After ten passages
supported by mouse embryonic fibroblast (MEF) feeders, mTSC lines stabilised.
Feeders were removed, cell lines were maintained in MEF conditioned media, and
genotyping was carried out. PCR revealed the presence of only female mTSC lines
from Cross I. No XY or InX/Y lines were derived (Figure 4.2C(i)). Three of these
female mTSC lines were determined to be XPO, with the presence of a single X
chromosome shown by DNA FISH (Figure 4.2D) and qRT-PCR. Four mTSC lines
were derived from Cross II outgrowths (Figure 4.2C(ii)), and two of these lines were
determined to be XMO, based on PCR and DNA FISH (Figure 4.2D).
Transcription factors including Cdx2, Eomes, Esrrb, Elf5, and Tfap2c, and the
growth factor Bmp4, have previously been shown to be highly expressed in mTSCs
(Tanaka et al., 1998; Kubaczka et al., 2014). In order to confirm mTSC identity,
expression levels of these key genes were assayed by qRT-PCR, and compared with
expression levels from the EGFP mTSC line, originally derived in the Rossant lab-
oratory and here designated Rossant (Tanaka et al., 1998). All newly derived cell
lines showed equivalent expression to the Rossant line (Figure 4.2E), as measured
by log2 fold change, with the exception of lines XMO 2 and XPO 1. These two
XO lines had increased expression for most of the genes assayed. I conclude that I
had successfully derived XPO and XMO mTSC lines, in addition to female control
lines.
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Figure 4.2: Derivation of mouse trophoblast stem cells (mTSCs). (A) Schematic depict-
ing derivation process. (B) (i) Mouse cross used to generate XX and XPO blastocysts, and
(ii) XMO blastocysts. (C) (i) Number of cell lines derived, corresponding to genotypes in
(B) (i), and (ii) corresponding to (B) (ii). (D) (i) Brightfield microscopy showing feeder
free mTSCs of different sex chromosome genotypes (scale bar = 100uM); (ii) Representa-
tive images of DNA FISH probing for sex chromosomes (scale bar = 10uM). 50 cells were
counted per cell line, with 80% agreement required to denote a sex chromosome genotype.
(E) Heatmap summarising qRT-PCR results following screening of all cell lines for mTSC
marker genes. Results were first normalised to Gapdh and Srp72, before log-fold change
was determined based on a reference cell line (Rossant).
4.2.2 XPO, XMO, and XX mTSCs show equivalent differentia-
tion potential in vitro
The EPC originates from the polar trophectoderm, and later gives rise to the spon-
giotrophoblast in the mature placenta (Cross et al., 1994). Previous work has shown
that the EPC in XPO conceptuses is deficient in size at E7.5 relative to XX litter-
mates (Jamieson et al., 1998). In contrast, XMO EPC was morphologically normal
(Jamieson et al., 1998). As the EPC represents a relatively early, transient progeni-
tor population of cells in the placenta, I was interested to see if the in vivo phenotype
manifests as a differentiation bias in XPO mTSCs in vitro. I hypothesised that, in
an undirected differentiation protocol, XPO mTSCs might be less likely to form the
differentiation products of EPC, i.e. spongiotrophoblast cells, when compared with
XMO and XX mTSCs.
In order to test this hypothesis, three XPO, two XMO, three XX, and the Rossant
EGFP mTSC lines were differentiated by removal of FGF4 and heparin. I first
noted that there were no obvious morphological differences between mTSC geno-
types during the differentiation (Figure 4.3). To assay for the presence of cells from
different placental lineages within the differentiated cultures, I performed qRT-PCR.
If XPO differentiated mTSC cultures are deficient in EPC cells and other cell types
downstream, I would expect to detect reduced expression of markers for these cell
types, relative to XX differentiated mTSC cultures or the Rossant EGFP control. I
might also observe increased expression of markers for other placenta lineages, as
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when Ascl2 function is ablated in vivo, trophoblast giant cells predominate (Guille-
mot et al., 1994, 1995).
I first looked to confirm the effectiveness of the differentiation protocol by assaying
expression of the key mouse trophoblast marker gene Cdx2 (Tanaka et al., 1998;
Niwa et al., 2005). All mTSC genotypes (XPO, XMO, and XX) showed down-
regulation of Cdx2 expression at day two of differentiation when compared to the
Rossant XX EGFP line at day 0 (Figure 4.4) and this was maintained throughout
the six day time course. For each individual timepoint, there were no significant
differences in Cdx2 expression between mTSC genotypes. I conclude that mTSC
genotype does not affect the ability of the cell to exit the multipotent state, as tested
by Cdx2 expression.
Next I tested the ability of the three mTSC genotypes to differentiate into spon-
giotrophoblast via EPC, compared with the Rossant XX EGFP line. EPC is char-
acterised by expression of the basic helix loop helix (bHLH) transcription factor
Ascl2/Mash2 (Guillemot et al., 1994, 1995), and one of the key markers of the spon-
giotrophoblast is Tpbpa/4311 (Carney et al., 1993). Notably, I observed increased
expression of Ascl2 across all mTSC genotypes at day two (Figure 4.4), consis-
tent with the downregulation of Cdx2 and exit from the stem cell state. There was,
however, no significant difference in Ascl2 between genotypes. I also observed
upregulation of the spongiotrophoblast marker Tpbpa, which continued through-
out the differentiation timecourse, though again there was no significant difference
between genotypes. Finally, I found downregulation of the glycogen trophoblast
marker Pcdh12 across all cell lines at day two, and this level of expression was
maintained through to day six. There was no significant difference between the
mTSC genotypes. From these data I conclude that XPO or XMO mTSCs do not
show a differentiation bias away from EPC, or its derivative spongiotrophoblast,
when compared to Rossant XX EGFP mTSCs.
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Although there was no difference in differentiation potential between XPO and XX
mTSCs towards the spongiotrophoblast lineage, I continued to investigate differen-
tial potential towards other placenta lineages.
In order to assay trophoblast giant cell (TGC) differentiation potential, I first mea-
sured Hand1 expression. Hand1 is a bHLH transcription factor co expressed with
Ascl2 in the EPC (Scott et al., 2000), though these two genes have mutually antago-
nistic functions in differentiation. As described above, Ascl2 maintains spongiotro-
phoblast, whereas Hand1 is required for giant cell differentiation. Unsurprisingly,
in mTSCs Hand1 showed a similar expression pattern to Ascl2, with upregulation
at day two, which then reduced almost back to baseline at day six (Figure 4.4).
There was no significant difference in Hand1 expression between XPO, XMO and
XX mTSCs, though all three genotypes showed lower expression than the Rossant
XX EGFP line at all time points.
I next looked for the presence of markers for the terminally differentiated TGC
cell types, including sinusoidal TGCs (s-TGCs) found lining the maternal sinusoids
(Simmons et al., 2007). Pl1, Prl2c2, and Prl3d3 are expressed in TGCs (Simmons
et al., 2007), and were upregulated from day four of differentiation in all cell lines
(Figure 4.4). These three markers were generally less expressed in XX mTSCs than
both XPO and XMO mTSCs, though the differences were not statistically signifi-
cant. Ctsq, a marker of s-TGCs, showed slight upregulation at day two, and became
highly upregulated on days four and six. There was no significant difference in
Ctsq expression between mTSC genotypes. I conclude that, whilst the data suggest
lower expression of TGC markers in XX mTSCs when compared to XO mTSCs
and Rossant XX EGFP mTSCs, these differences were not significant. Therefore
I found no difference in the expression of giant cell lineage markers between XX,
XPO, XMO, and Rossant XX EGFP mTSCs. Notably, both XPO and XMO mTSC
lines generally showed larger confidence intervals than those for XX mTSCs.
Finally I assayed for syncytiotrophoblast (Syn) differentiation. As a marker for
Syn progenitors, I used Rhox4b/Ehox (Watson et al., 2011). Expression relative
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to Rossant XX EGFP was reduced in all cell lines at day zero, and this differ-
ence persisted throughout differentiation (Figure 4.4). Rhox4b was downregulated
in all mTSC lines and, notwithstanding the difference when compared to Rossant
XX EGFP, there was no difference in expression between XX, XPO and XMO
lines.
Coincident with the reduction in Syn progenitors, expression of markers for ter-
minally differentiated syncytiotrophoblast-I (SynT-I) increased at day two, and this
increase persisted through the differentiation timecourse (Figure 4.4). Syna (Sim-
mons et al., 2008) showed marked upregulation at day two, which was maintained,
whereas Snai1 (Watson et al., 2011) showed a small upregulation at day two, which
continued to day six. Expression of Snai1 in Rossant XX EGFP mTSCs was slighly
higher than XX, XPO and XMO mTSCs, though there was no difference between
the latter three genotypes. Expression of Synb, a marker for syncytiotrophoblast-II
(SynT-II, Simmons et al., 2008), was decreased in all cell lines relative to Rossant
XX EGFP at day 0. Synb transcript levels then increased incrementally in all cell
lines to day six. Interestingly, expression of a second marker of SynT-II, Gcm1, de-
creased in all mTSC lines on day two, and continued to decrease in XX and Rossant
XX EGFP mTSC lines through to day six. Expression of Gcm1 in XPO and XMO
cell lines troughed at day two this level was maintained relative to Rossant XX
EGFP day 0. From these data I was able to conclude that there was no difference
between XPO, XMO, and XX mTSCs in their ability to differentiate to all placenta
cell lineages.
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Figure 4.3: Differentiation of mTSCs. Representative brightfield images of mTSC lines
with different sex chromosome genotypes following a six day differentiation timecourse
(scale bars = 100uM).
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Figure 4.4: qRT-PCR analysis of gene expression during mTSC differentiation. Data
are presented in the form of a differentiation tree, whereby Cdx2, a marker for the stem
cell lineage, is at the base; with the three main lineages of the mouse placenta branching
out. Each graph shows the mean logFC and 95% CI at days 0, 2, 4 and 6 for each sex
chromosome genotype per gene, relative to day 0 Rossant EGFP. Data represent values
obtained from three independent XX mTSC lines, three independent XPO mTSC lines, and
two independent XMO mTSC lines.
4.2.3 Derivation of mESC and mEpiLC lines and qRT-
PCR verification of identity
I considered it most likely that X linked imprinting candidates would be expressed
in the extraembryonic tissue (as described in 4.1), making mTSC lines the most
relevant for my screening experiment. However, I also wanted to model the embryo
proper as an alternative hypothesis. To this end, I derived mESC lines to capture the
pluripotent compartment, and differentiated these lines into mEpiLCs to model the
epiblast. XPO and XMO mESC lines were derived from blastocysts from cross 1
and cross 2, respectively. Each embryo was plated individually in 2i+LIF, as previ-
ously described (Ying et al., 2008). Outgrowths were picked after 10-14 days and,
concurrent with genotyping, cell lines were expanded to passage five (Figure 4.5A).
DNA FISH was used to confirm sex chromosome genotype, and three mESC lines
were maintained for each genotype, including XX and XY control lines (Figure
4.5B). A corresponding, isogenic mEpiLC line was differentiated from each mESC
line using bFGF and Activin A (Figure 4.5A), as described (Hayashi et al., 2011b;
Hayashi and Saitou, 2013). EpiLCs have been shown to represent the epiblast of the
mouse blastocyst stage embryo, thus downregulating pluripotency markers includ-
ing Sox2 and Nanog, and upregulating genes associated with exit from pluripotency,
including Dnmt3b and Fgf5 (Hayashi et al., 2011b). I compared expression of these
genes in mEpiLCs with the mESCs from which they were derived by qRT-PCR, and
noted downregulation of pluripotency associated genes and upregulation of epiblast
associated genes (Figure 4.5C). These results were entirely consistent with the liter-
ature, and were taken to confirm the lineage identity of the derived cell lines.
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Figure 4.5: Derivation of mouse embryonic stem cells (mESCs) and mouse epiblast like
stem cells (mEpiLCs). (A) Schematic depicting derivation process. (B) Representative
brightfield images of mESCs and the resultant mEpiLCs following differentiation (scale
bars = 50uM), alongside DNA FISH used for genotyping. 50 cells were counted per cell
line, with 80% agreement required to denote a sex chromosome genotype. (C) Heatmap
summarising qRT-PCR data comparing mEpiLC lines with their originating mESC line for
mEpiLC and mESC marker gene expression. Results were first normalised to Gapdh and
Srp72, before log fold change was determined based on the originating mESC line for each
mEpiLC line.
4.2.4 RNA-seq analysis of gene expression in mTSC, mESC and
mEpiLC lines
In order to look for genes differentially expressed between XPO and XMO cell lines,
and thus identify candidates that may be imprinted, RNA-seq was performed on
RNA isolated from all mTSC, mESCs and mEpiLCs. Sequencing was performed
by the Advanced Sequencing Facility STP at Francis Crick Institute, and returned
between 39-54x106 paired end, strand specific reads per sample (Table 4.1). Data
were analysed and plotted by a Turner lab post doc, Mahesh Sangrithi, as per the
pipeline detailed in Figure 4.6A.
To gain an initial, graphical overview of how the samples related to one another, and
specifically look at the relationship between biological replicates, multi dimensional
scaling (MDS: Figure 4.6B) and t-stochastic neighbour embedding (t-SNE: Figure
4.6C) analyses were performed. Both techniques showed tight clustering of sam-
ples by cell type and, pleasingly, within cell type clustering by genotype. Further
analysis of the mTSC data by unsupervised hierarchical clustering (UHC) showed
with greater resolution that XX mTSCs clustered with the XX Rossant reference
line, and separately from all XO mTSC lines (Figure 4.6D). Within XO mTSCs, all
XPO lines were shown to be more closely related to one another than to the XMO
mTSCs lines.
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Cell type Sample Raw reads Percentage
mapped
mESC XX 2 41552922 87.23
XX 1 43290415 88.83
XX 0 48235209 88.81
XY 2 33649772 91.26
XY 1 39843527 86.18
XY 0 52491568 85.55
XMO 2 50469556 89.3
XMO 1 40778312 78.15
XMO 0 46829273 87.38
XPO 1 46481635 87.34
XPO 0 40710940 93.3
mEpiLC XX 2 55837430 90.82
XX 1 45576928 92.35
XX 0 50715628 90.91
XY 2 51420726 91.85
XY 0 50108108 91.91
XMO 3 33436541 90.62
XMO 2 46689812 91.04
XMO 1 53982073 91.63
XMO 0 48211831 91.39
XPO 2 47362417 91.36
XPO 0 60231527 90.94
mTSC XX 7 41863904 91.89
XX 6 44532910 92.42
XX 5 39112596 93.35
XX 4 41064513 91.62
XX 3 31578074 94.77
XX 2 37020197 92.7
XX 1 41419287 92.11
XX 0 39396116 93.07
Rossant 42482645 93.08
XMO 2 52206246 91.37
XMO 0 54152268 90.27
XPO 3 63225432 91.23
XPO 1 54999428 91.46
XPO 0 43603825 90.46
Table 4.1: RNA-seq mapping percentages
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Figure 4.6: Initial analyses of RNA-seq on mTSC, mESC and mEpiLC. (A) Schematic
of bioinformatic analysis pipeline: tasks are shown in orange and software utilised is shown
in purple. (B) Multi-dimensional scaling plot of all RNA-seq datasets. (C) T-distributed
stochastic neighbour embedding plot of RNA-seq datasets. (D) Unsupervised hierarchical
clustering plot of mTSC RNA-seq data.
Expression of specific marker genes was analysed next. Y linked gene expression
was first used to confirm the XY cell line genotyping data (Figure 4.7A). XY cell
lines showed relatively higher expression of Y linked genes when compared with
either XX or XO cell lines. Notably, Kdm5d appears to be expressed equally in cell
lines of all sex chromosome genotypes, in particular mESCs and mEpiLCs (Figure
4.7A). This artifact is likely the result of mismapping of Kdm5c reads to Kdm5d, an
effect documented for highly expressed genes, such as Kdm5c in mESCs (Conesa
et al., 2016).
As there were no XY mTSC lines available, expression of Xist, the lncRNA that
mediates XCI, was analysed. XCI takes place in XX mTSCs, such that Xist ex-
pression was expected from the XP (Mak et al., 2002). As XO mTSCs carry only a
single X chromosome, XCI is not required, and Xist expression was not expected.
These predictions were met (Figure 4.7A). XCI is imprinted in extraembryonic tis-
sue, such that Xist is always expressed from the XP in XX mTSCs (Kunath et al.,
2005). Notably, this imprinted expression was not maintained in XPO mTSCs, con-
sistent with the requirement for X linked gene expression in extraembryonic tissue.
Furthermore, I observed relatively low level Xist expression in mESCs, likely be-
cause they have not undergone XCI. This process has been initiated in mEpiLCs,
hence the slight upregulation of Xist when compared to mESCs.
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Figure 4.7: Genotyping confirmation from RNA-seq data in all cell types. (A) Heatmap
showing relative expression of Y linked genes and Xist in all RNA-seq datasets. (B) Volcano
plot representing genes differentially expressed in XX mESCs compared to XY mESCs. (C)
Volcano plot representing genes differentially expressed in XX mEpiLCs compared to XY
mEpiLCs.
4.2.5 Identification of candidate imprinted genes by differential
gene expression analysis (DGE)
Before comparing gene expression between XPO and XMO cell lines to identify
potential candidates for the imprinting hypothesis, the differential gene expression
(DGE) analysis pipeline was validated. Expression of genes from the Y chromo-
some sets apart the transcriptomes of XY from XX and XO cell lines. XX and XY
mESC and XX and XY mEpiLC datasets were analysed for differentially expressed
genes (Figure 4.7B,C). These two plots compare XX mESC and mEpiLC lines to
XY mESC and mEpiLC baselines, respectively, therefore relative downregulation
of Y linked genes was predicted. As expected, most highly significantly downreg-
ulated genes were Y linked (Figure 4.7B,C, circled). This provided confirmation
that the bioinformatic pipeline was able to detect biologically relevant differential
expression.
In order to identify all differentially expressed genes within cell type, pairwise com-
parisons were made between all sex chromosome genotypes (Figure 4.9A(i)). Fo-
cusing on the comparison between XPO and XMO lines, I used volcano plots to
visualise the degree of differential expression for each gene and the significance of
the hit (Figure 4.8).
For mESC, the total number of genes differentially expressed between XMO and
XPO was 123, which were split evenly between upregulation and downregulation
(Figure 4.8A). Interestingly, of these 123, 8 were X linked, again distributed evenly
between upregulation and downregulation.
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For mEpiLCs, 244 genes were differentially expressed in XMO relative to XPO,
and more of these were upregulated (Figure 4.8B). Of the 244 total differentially
expressed genes, 10 were X linked genes, mostly upregulated in XMO relative to
XPO EpiLCs.
For mTSCs, 201 genes were differentially expressed in XMO relative to XPO, and
significant number of these were downregulated (Figure 4.8C). Of 201 total differ-
entially expressed genes, 24 were X linked, and these X linked genes were mostly
downregulated in XMO relative to XPO mTSCs.
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Figure 4.8: Differential gene expression analyses. (A) Volcano plot showing DGE be-
tween XMO relative to XPO mESCs, magnified on the right hand side. (B) Volcano plot
showing DGE between XMO relative to XPO mEpiLCs. (C) Volcano plot showing DGE
between XMO relative to XPO mTSCs.
I next compared the lists of differentially expressed genes between cells types to
look for commonality. As mEpiLCs are differentiated from mESCs, and both con-
tribute to the embryo proper, I expected to observe a degree of conservation between
the differentially expressed genes. This proved to be correct, as 20 genes were sig-
nificantly differentially expressed between XPO and XMO mESC and mEpiLC lines
(Figure 4.9A(ii)). In contrast, only two genes were differentially expressed between
XPO and XMO mTSCs and mESCs. Two other genes were differentially expressed
between XPO and XMO in mTSCs and mEpiLCs. There were no genes differen-
tially expressed between XPO and XMO cells common to all three cell types (Figure
4.9A(ii)).
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Figure 4.9: Differential gene expression analyses. (A) (i) Summary data of all genes
differentially expressed between sex chromosome genotypes, within cell type; (ii) Venn
diagram showing cross over between genes differentially expressed in XMO relative to XPO
cell lines; (iii) Summary data of all X linked genes differentially expressed between sex
chromosome genotypes, within cell type; (iv) Venn diagram showing cross over between X
linked genes differentially expressed in XMO relative to XPO cell lines.
The fundamental difference between XPO and XMO cell lines is the parental ori-
gin of the X chromosome, therefore one would expect any candidate genes for the
imprinting hypothesis to be localised to the X chromosome. Autosomal genes may
also be differentially expressed, though these genes would theoretically be down-
stream of any X linked candidates. I therefore chose to focus on the X chromosome,
and looked to see how many of the genes identified in the DGE analysis localised
to the X (Figure 4.9A(iii)). Once again focusing on the XPO and XMO comparison,
I compared the relatively short lists to look for any conservation. Unsurprisingly,
there was only one gene differentially expressed between XPO and XMO in more
than one cell type. Mageb10-ps appeared in both mESC and mEpiLC lists (Table
4.3, 4.4), otherwise all candidates were unique to the cell type.
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Gene Upreg. in XMO
relative to XPO
(logFC)
Downreg. in
XMO relative to
XPO (logFC)
Comments References
Hs6st2$ 4.48 Heparan sulphate 6-O-sulphotransferase, pla-
centa phenotype in homologue Hs6st1
Habuchi et al., 2000,
2007
Srpk3 3.29 Muscle specific protein kinase, myopathy Nakagawa et al., 2005
Etd$ 1.90 Testis, gonad differentiation Menke and Page, 2002;
Bouma et al., 2010;
Correa et al., 2012;
Zhao et al., 2015
Rbmx 1.09 RNA binding protein, spermatogenesis Mazeyrat et al., 1999;
Elliott, 2004
Acot9$ 1.01 Mitochondrial acyl-CoA thioesterase Poupon et al., 1999
Prr32 -1.25 Interacts with miRNAs Diez-Roux et al., 2011
Gm14668 -1.40 None n/a
Gm14988 -1.43 None n/a
Rhox3a2 -1.52
Testis, placenta, DNA-binding domain
MacLean et al., 2005;
Maclean et al., 2006,
2011
Rhox3c -1.53
Rhox3e -1.53
Rhox3f -1.76
Rhox3b-ps -1.80
Gm15367* -2.64 No annotation n/a
Gm8908* -2.92 No annotation n/a
Gm4911* -3.22 No annotation n/a
Pbsn* -3.32 Androgen-related, prostate Johnson et al., 2000
Dmrtc1c2* -3.38 Male-biased expression, lacks DNA methyl
transferase activity
Veith et al., 2006
Gm15023 -3.38 Homology to Pramel3, a cancer testis antigen Zhou et al., 2013, 2014
AV320801* -3.69 None associated Zhou et al., 2014
Mageb18 -4.72 Melanoma antigen, sperm, apoptosis Lin et al., 2012b
Chrdl1* -4.73 Chondrogenesis Nakayama et al., 2001
Tlr7* -4.74 Innate immunity, sex linked neurodegeneration Hemmi et al., 2002;
Traub et al., 2012; Du
et al., 2014
Heph* -5.00 Iron metabolism, sex linked anaemia Vulpe et al., 1999;
Chen et al., 2004a;
Jiang et al., 2015
Table 4.2: X linked genes significantly differentially expressed in XMO vs XPO mTSCs.
* indicates genes also significantly differentially expressed in XPO relative to XX mTSC
analysis. $ indicates genes also significantly differentially expressed in XMO relative to XX
mTSC analysis.
Most of the candidate genes across all three cell types were annotated as either pre-
dicted genes or pseudogenes, and were therefore not analysed further at this point.
Focusing on the mTSCs, some of the annotated candidates with ascribed function
have potential based on what is already known. For example, Hs6st2 was upregu-
lated in XMO mTSCs (Table 4.2). It is a heparan sulphate 6-O-sulphotransferase
enzyme involved in the metabolism of the extracellular matrix (Habuchi et al.,
2000). Its autosomal homologue Hs6st1 is homozygous lethal during development,
and conceptuses showed vascular abnormalities in the labyrinth of the placenta
(Habuchi et al., 2007). Multiple genes from the reproductive homeobox (Rhox)
cluster were highlighted as downregulated in XMO mTSCs. The Rhox genes all
have a conserved homeodomain, and are expressed in placenta, testis, and ovary
(Maclean et al., 2006; Kobayashi et al., 2006). Interestingly, it has been suggested
that a number of genes within this cluster are imprinted, though Rhox3 is not among
these (Maclean et al., 2011).
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Gene Upreg. in XMO
relative to XPO
(logFC)
Downreg. in
XMO relative to
XPO (logFC)
Comments References
Mageb18-ps
3.62 Melanoma-associated antigen, testis De Plaen et al., 1999;
Chomez et al., 2001
Gm14985 1.93 None n/a
Samt2 1.21 None n/a
Gm15142 1.18 None n/a
Fthl17e -2.50 Testis, iron metabolism, ?imprinted Wang et al., 2001b;
Kobayashi et al., 2010
Gm44 -3.02 None n/a
Magea2 -3.25 Melanoma-associated antigen, testis De Plaen et al., 1999;
Chomez et al., 2001
Gm14921 -3.46 None n/a
Table 4.3: X linked genes significantly differentially expressed in XMO vs XPO mESCs
Gene Upreg. in XMO
relative to XPO
(logFC)
Downreg. in
XMO relative to
XPO (logFC)
Comments References
P2ry10 3.61 Identified by screen n/a
Mageb18-ps 2.95 Melanoma-associated antigen, testis De Plaen et al., 1999;
Chomez et al., 2001
Zcchc5 2.51 Retrotranposon derived Brandt et al., 2005a,b
Cdr1 2.36 Cortical thymic epithelial cell Nowell et al., 2011
Gm14736 1.53 None n/a
Gm14448 1.44 None n/a
Gm14581 1.21 None n/a
Gm14957 -1.19 None n/a
Rpl7l1-ps1 -2.03 None n/a
Gm14766 -2.43 None n/a
Table 4.4: X linked genes significantly differentially expressed in XMO vs XPO mEpiLCs
The XPO embryonic growth deficit phenotype has been quantified relative to either
XX or XY littermates (Chapter 3). Any candidate genes that might have an affect on
this XPO phenotype might therefore be expected to also be differentially expressed
in XPO mTSCs relative to XX mTSCs. It would also be interesting to compare
XO to XY mTSCs, however, XY mTSCs were not recovered during the derivation
process. I therefore looked in more detail at the comparisons between XPO and XX
mTSCs, and then XMO and XX mTSCs.
First considering genes downregulated in XMO relative to XPO mTSCs; this result
could either be interpreted as genes downregulated in XMO relative to other geno-
types, or upregulated in XPO relative to other genotypes. Ten genes were found in
common between those downregulated in XMO relative to XPO mTSCs and those
upregulated in XPO relative to XX mTSCs (*, Table 4.2). I conclude that these ten
genes are upregulated in XPO mTSCs. These genes could potentially contribute
to the XPO embryonic growth deficit phenotype, and their expression would merit
further investigation by qRT-PCR.
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I then considered genes upregulated in XMO relative to XPO mTSCs. This result
could be interpreted as either genes downregulated in XPO relative to other geno-
types, or upregulated in XMO relative to other genotypes. Three genes were found
in common to the lists of differentially expressed genes comparing XMO relative to
XPO mTSCs, and XMO relative to XX mTSCs ($, Table 4.2). I conclude that these
three genes are upregulated in XMO mTSCs. As no difference in expression was
observed for these genes between XPO and XX mTSCs, I considered it unlikely that
they would contribute to the XPO embryonic growth deficit phenotype.
4.2.6 A significant number of genes were differentially ex-
pressed between XO and XX mTSCs
The comparisons utilised in the previous section also highlighted the significant
number of genes differentially expressed between XPO and XX mTSCs, and XMO
mTSCs and XX mTSCs: 8124 and 5175, respectively (Figure 4.10A). Following
this unexpected result, I analysed the overlap between the two lists. Given that
the XP is always inactivated in XX mTSCs, XX mTSCs are theoretically more
similar to XMO mTSCs than XPO mTSCs. I therefore expected to observe a greater
number of genes differentially expressed in XPO relative to XX mTSCs than XMO
relative to XX mTSCs, taking into account commonality between the two lists.
I first excluded the 3817 genes commonly differentially expressed between both
XPO and XMO relative to XX mTSCs (Figure 4.9B). There were significantly more
genes specifically differentially expressed in XPO relative to XX mTSCs, than in
XMO relative to XX mTSCs.
The numbers of genes differentially expressed between XO and XX mTSCs rep-
resent a difference of more than an order of magnitude when making the same
comparisons for the mESCs and mEpiLCs (Figure 4.9A(i)). As there is no obvious
biological explanation for the observation, I looked for order or pattern within the
differentially expressed genes by performing over representation enrichment analy-
sis (ORA) using WebGestalt (Zhang et al., 2005). As the observation related to all
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XO mTSCs, I first considered those genes significantly differentially expressed in
both XPO relative to XX and XMO relative to XX.
Analysis
type
over representation
category
Expected
genes
Observed
genes
p value FDR
GO(biological
process)
morphogenesis of an
epithelium
82.27 115 7.04x10-5 4.50x10-2
tube morphogenesis 63.20 91 1.31x10-4 4.50x10-2
cell junction organiza-
tion
31.35 51 1.91x10-4 4.50x10-2
gland development 75.64 104 2.95x10-4 4.50x10-2
cell-substrate adhesion 44.78 67 3.15x10-4 4.50x10-2
GO(cellular
process)
cell-substrate junction 65.08 108 1.59x10-8 2.31x10-6
cell leading edge 55.93 79 5.96x10-4 4.32x10-2
GO(molecular
function)
rRNA binding 9.08 208 3.13x10-4 7.51x10-2
Pathway
(KEGG)
Metabolic pathways 189.32 248 5.95x10-7 1.78x10-4
Lysosome 17.93 36 1.92x10-5 2.86x10-3
Influenza A 24.59 42 2.50x10-4 2.49x10-2
Table 4.5: Gene groups over represented in both DGE analyses comparing XPO with XX
mTSCs and XMO with XX mTSCs. FDR cut off = 0.05.
Chromosome
band
Expected
genes
Observed
genes
p value FDR
11E2 29.54 80 0 0
11B1.3 24.52 45 2.75x10-5 5.27x10-3
4D2.2 20.64 39 4.60x10-5 5.89x10-3
11C 16.49 32 1.23x10-4 1.18x10-2
11D 43.02 65 3.61x10-4 2.59x10-2
12C3 10.47 22 4.05x10-4 2.59x10-2
11B2 7.46 17 6.40x10-4 3.02x10-2
14D2 5.59 14 6.61x10-4 3.02x10-2
4D2.3 6.88 16 7.21x10-4 3.02x10-2
14B 15.20 28 7.87x10-4 3.02x10-2
Table 4.6: Chromosomal locations over represented in DGE analyses comparing XPO with
XX mTSCs and XMO with XX mTSCs. FDR cut off = 0.05.
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Figure 4.10: Genes differentially expressed between XO and XX mTSCs. (A) Venn
diagram showing overlap between genes differentially expressed in XPO relative to XX
mTSCs and genes differentially expressed in XMO relative to XX mTSCs. (B) (i) Ideogram
of the mouse genome showing upregulation or downregulation based on relative log fold
change of genes differentially expressed in XPO relative to XX mTSCs. All genes are
depicted as a single coloured bar in their relative chromosomal location; (ii) Ideogram of the
mouse genome showing upregulation or downregulation based on relative log fold change
of genes differentially expressed in XMO relative to XX mTSCs. All genes are depicted as a
single coloured bar in their relative chromosomal location; (iii, iv) Ideograms of the mouse
genome showing upregulation and downregulation of genes differentially expressed in both
XPO and XMO relative to XX mTSCs. (iii) represents logFC in XPO mTSCs relative to XX
mTSCs; and (iv) represents logFC in XMO relative to XX mTSCs. All genes are depicted as
a single coloured bar in their relative chromosomal location. (B) plotted by Jasmin Zohren.
A limited number of over representation categories were identified per analysis type,
using a relatively conservative false discovery rate of 0.05 (Zhang et al., 2005), as
detailed in Tables 4.5 & 4.6. Most notably, the analysis with the highest num-
ber of significant hits was Chromosomal location (Table 4.6). The results suggest
significant over representation of genes from chromosome 11, in addition to some
bands within chromosomes 4, 12 and 14. In order to determine whether there was a
prevailing general trend of upregulation or downregulation, idiograms were plotted
based on logFC (Jasmin Zohren: Figure 4.10). First, direction of change, i.e. upreg-
ulation or downregulation, was plotted for all genes differentially expressed in XPO
relative to XX mTSCs (Figure 4.10B(i)); and for all genes differentially expressed
in XMO relative to XX mTSCs (Figure 4.10B(ii)). For both comparisons, there was
a mix of upregulation and downregulation. The upregulation and downregulation of
genes common to both comparisons (overlap in Venn, Figure 4.10A) was then plot-
ted for XPO relative to XX mTSCs (Figure 4.10B(iii)), and for XMO relative to XX
mTSCs (Figure 4.10B(iv)). This revealed that the 3817 genes in common to both
comparisons were differentially expressed in the same direction, i.e. upregulated
or downregulated, for all XO mTSCs. Graphical representation of the common
genes also aided visualisation of the regions highlighted in the ORA. For example,
11E2, the most significant chromosomal location identified in the ORA can be seen
as upregulated in both XPO and XMO relative to XX mTSCs. In contrast, 4D2.2
and 4D2.3 were downregulated in both XPO and XMO relative to XX mTSCs. I
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conclude that, based on these results, further work is required in order to further
elucidate the mechanisms underlying this significant differential gene expression
between XO and XX mTSCs.
4.3 Discussion
In mouse extraembryonic tissue, X linked genes are expressed from the XM, and
the XP is always inactivated (Takagi and Sasaki, 1975; Okamoto et al., 2004). This
is true for XX, XY and XMO conceptuses. Embryos with an XPO sex chromosome
genotype, in contrast, only have a single XP and no XM, therefore the XP is ac-
tive in the extraembryonic tissue. When combined with the observations that XPO
embryos are growth retarded relative to XX (Thornhill and Burgoyne, 1993) and
XYRIII (Chapter 3) littermates at E10.5; and that XPO embryos have smaller EPCs
at E7.5 (Jamieson et al., 1996), a causative link is plausible. In this Chapter I set out
to identify genes differentially expressed between XP and XM chromosomes, thus
serving as candidates to potentially explain the XPO embryonic growth deficit phe-
notype. I utilised in vitro models for the extraembryonic, pluripotent and epiblast
compartments of the mouse embryo and, following RNA-seq analysis, highlighted
a number of interesting differentially expressed genes that now require further test-
ing. Prior to addressing the next steps for this experiment, a number of notable
observations will be discussed.
4.3.1 No XY mTSC lines were recovered during the derivation
process
In order to generate XPO mTSCs, I crossed an XYRIII male with an InX/X female.
I expected to recover roughly equal numbers of female (XX;InX/X;XPO) and male
(XYRIII; InX/YRIII) blastocysts, and therefore derive cell lines in approximately
equal proportions. It was therefore surprising to find no male mTSC lines following
genotyping. This could be explained by a number of factors. Firstly, it is possible
that there we no male blastocysts on day 1 of the derivation. However, as the same
4.3. Discussion 138
cross was utilised to derive mESCs, and male lines were recovered, this reasoning
is unlikely to be true. Secondly, the Y chromosome may have a previously un-
characterised deleterious effect on the survival of mTSCs. This explanation is also
unlikely, as I successfully derived XXY mTSC lines as an unused product of the
cross to generate XMO mTSCs (Figure 4.2B(ii)). In these XXY cells, the Y chro-
mosome is physically linked to one of the X chromosomes, with no overt adverse
phenotypic effects reported (Burgoyne et al., 1998; Trent et al., 2012). Moreover,
XY mTSC lines have previously been reported in the literature (Tanaka et al., 1998;
Motomura et al., 2016), though most papers continue to fail to report the sex chro-
mosome karyotype of cell lines used.
A third theoretical explanation for the failure to derive XY mTSCs could be X
chromosome number. However, the successful derivation to XO mTSCs effectively
rules out any single X effect, and derivation specifically of XMO and XPO lines
eliminates the possibility of an X chromosome imprinting effect on XY mTSC sur-
vival. The final explanation is experimental artifact, which asserts that if the exper-
iment were repeated, male mTSCs would be obtained. This could be addressed by
a repeat derivation utilising the same mouse cross, but instead of using feeders of
mixed sex chromosome karyotype, use XX MEFs. Genotyping by PCR could then
be performed around day 28.
4.3.2 Significantly more genes are differentially expressed be-
tween XX and XO cell lines in mTSCs than mESCs or
mEpiLCs
Differential expression analyses comparing XMO with XPO RNA-seq datasets for
mTSCs, mESCs and mEpiLCs identified of a small number of genes for each cell
type. In contrast, the analyses of XPO relative to XX mTSCs, and XMO relative
to XX mTSCs, revealed surprisingly high numbers, at 8124 and 5175, respectively.
3817 genes were common to both lists, and over representation analysis revealed
relative enrichment for genes located on chromosome 11, among others. Several
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possible explanations exist for these observations, including aneuploidy indepen-
dent of the sex chromosomes, and a previously unrecognised effect of sex chromo-
some genotype on mTSC gene expression.
There are very little published data on mTSC karyotypes. A number of studies
found euploid and aneuploid mTSC lines following routine karyotyping, but none
characterised the nature of the aneuploidies (Tanaka et al., 1998; Kubaczka et al.,
2015; Benchetrit et al., 2015). A contributory factor to this apparent oversight may
stem from studies of tetraploidy. Whilst tetraploid embryos do not survive gestation
(Kaufman and Webb, 1990; Henery et al., 1992), diploid embryos with tetraploid
extraembryonic tissue do (Nagy et al., 1990). This could be taken to imply that the
extraembryonic tissue is more tolerant than the epiblast to aneuploidy. However,
duplication of the whole genome has significantly fewer transcriptional, and pheno-
typic, consequences in comparison to loss or gain of single chromosomes (Birchler,
2014).
In contrast, it is well documented that mESC lines have a tendency to develop
karyotypic abnormalities following prolonged culture. Trisomies 8 and 11 are both
common in mESCs and, when present together, result in a recognisable growth ad-
vantage (Sugawara et al., 2006; Rebuzzini et al., 2008; Gaztelumendi and Nogués,
2014; Rebuzzini et al., 2016). The X chromosome is also often affected in XX
mESC lines, with loss resulting in the creation of a pseudo XO line (Robertson
et al., 1983).
Based on the data presented here, if autosomal aneuploidy is present, it is possible
that either all eight independently derived XX mTSC lines carry similar chromoso-
mal abnormalities, or all five independently derived XO mTSC lines carry similar
chromosomal abnormalities. Importantly, I confirmed that the sex chromosome
complements were as reported for all cell lines, by DNA FISH. Autosomal aneu-
ploidy could be investigated first by karyotyping of each cell line, thus revealing
whether the overall ploidy is normal. If there is any doubt, spectral karyotyping,
multiple (M) FISH, or comparative genomic hybridisation would provide more de-
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tailed information on specific chromosomal rearrangements (Liyanage et al., 1996;
Anderson and Brown, 2005; Saldarriaga et al., 2015).
Alternatively, chromosome territories in mTSCs may be disturbed by the sex chro-
mosome aneuploid state. In the nucleus, chromosomes are positioned within de-
fined areas, with gene rich chromosomes located towards the interior and gene poor
chromosomes closer to the periphery (Cremer et al., 2006). This organisation is
altered in disease states such as cancer (Meaburn and Misteli, 2008; Barutcu et al.,
2015), which frequently involves structural chromosomal rearrangements and ane-
uploidy. Such chromosome territory alterations can have a significant impact on
gene expression profiles (Meaburn and Misteli, 2008; Barutcu et al., 2015). Little is
known about the nuclear organisation in mTSCs, as the only study to date focused
on escape from XCI and, as such, only utilised female cell lines. It would therefore
be highly informative to investigate the nuclear organisation of XX, XY, XPO and
XMO mTSCs using techniques such as 3-D FISH and chromosome conformation
capture (Fudenberg and Imakaev, 2017).
A third explanation for the high numbers of differentially expressed genes in XO
mTSCs relative to XX mTSCs is non genetic phenotypic heterogeneity.
4.3.3 Non genetic phenotypic heterogeneity in aneuploid
cells
Recent work has highlighted that aneuploidy may cause phenotypic variability in-
dependent of genetic variation. Working primarily in yeast, Beach and colleagues
created karyotypically homogeneous populations of aneuploid cells that showed
significant phenotypic changes within the population when compared with euploid
cells (Beach et al., 2017). They showed that cells with chronic aneuploidies - de-
fined as a chromosomal gain/loss propagated for more than two cell divisions - ex-
hibited heterogeneity in cell cycle timing, variability in gene expression in response
to cellular stress, and altered protein expression levels relative to wildtype. Data
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are also provided to show phenotypic variability in inbred mice carrying identical
Robertsonian translocations (Beach et al., 2017).
The heterogeneity in gene expression reported in Beach et al. study is likely to ap-
ply equally to sex chromosome aneuploidy as it applies to autosomal aneuploidy.
For example, this phenomenon could underlie the increased variation in gene ex-
pression observed for XO but not XX mTSC lines during the differentiation anal-
ysis (section 4.2.2). It is, therefore, conceivable that such heterogeneity could also
impact on differential gene expression analysis. In the present study I have relied
upon reproducibility between biological replicates to identify genes as differentially
expressed. However, if the findings of Beach and colleagues apply to these cell
lines, there would theoretically be very few conserved differentially expressed genes
found across all XPO biological replicates or across all XMO biological replicates.
Importantly, the number of differentially expressed genes identified here in euploid
cell line comparisons, i.e. XX and XY mESCs (322 genes), is within the same order
of magnitude as the number identified in aneuploid cell line comparisons, i.e. XPO
and XX (109 genes). It therefore seems likely that, despite the reported phenotypic
variability in aneuploid conditions, a core set of genes underlies conserved aspects
of the phenotype. Undoubtedly further work is required to determine the effects of
non genetic phenotypic variability in human aneuplodies, though this could poten-
tially provide an explanation for the highly variable phenotype observed in women
with Turner syndrome (Hook and Warburton, 2014).
4.3.4 Confounding factors in analysis of RNA-seq data from
aneuploid samples
It has previously been assumed that a change in chromosomal complement inside a
cell will only impact on gene expression from the chromosome(s) directly affected,
and thus gene expression from the unaffected chromosomes can be used for normal-
isation. This approach was taken in the analysis of early work on X chromosome
upregulation (XUR), as previously described (section 1.4.1). However, based on
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the Beach et al. (2017) study, in addition to previous work detailing the genomic
instability of aneuploid cells (Nicholson et al., 2015; Blank et al., 2015; Passerini
et al., 2016), and the literature on XUR, this assumption is not supported by the
recent data. It is becomingly increasingly clear that there are global transcriptional
changes in aneuploidy, and these must be taken into account during the data analysis
to enable accurate differential expression analyses (Birchler, 2014).
In the preparation of libraries for sequencing, the total RNA input was equalised
across all samples, and the concentrations of all libraries were equal on the flow
cell. These normalisations assume that total RNA per cell is approximately equal.
Samples were then normalised for sequencing depth by calculating transcripts per
million (tpm). Tpm is defined as the number of trancripts of one specific type
(e.g. GAPDH-001) that would be detected if one sequenced one million full length
transcripts, given the abundance of the other transcripts in the sample (Li et al.,
2009a). It is therefore important that relative transcript abundances for the whole
transcriptome are comparable between samples. In the case of aneuploid cell lines,
the potential global changes in gene expression mean that this criterion may not
be met and, as such, downstream differential gene expression analyses may not be
optimal.
In order to mitigate these difficulties, a number of approaches could be utilised; the
first two as an extension to current work, and the second two in future work. Using
existing data, a ratio of read counts for each transcript in the XPO versus XX could
be calculated, and subsequently plotted in a distribution. This would serve to high-
light if there are any abnormal patterns of potential interest (Sun et al., 2013a, 2010,
2013b). Although relatively low throughput, quantitative RNA FISH allows direct
visualisation of the nascent transcript, facilitating comparison of per cell expression
in two different sex chromosome genotypes (Pal Bhadra, 2005). The addition of
a pre determined concentration of exogenous spike in RNA to every sample prior
to cDNA preparation would provide an absolute reference for across sample RNA
abundance comparisons (Jiang et al., 2011; Lovén et al., 2012). Alternatively, the
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mRNA to genomic DNA relationship could be preserved during sample preparation
such that genomic DNA acts as a control for the calculation of transcriptome size.
This has been developed primarily for polyploid cells, but could effectively be used
in the study of aneuploidies, too (Coate and Doyle, 2010).
4.3.5 Validation of cell lines for the study of imprinted
genes
The primary aim of the derivation and transcriptome analysis of XPO and XMO
stem cell lines was to identify X linked differentially expressed genes. A subset
of these candidate genes could be imprinted, and therefore underlie the XPO em-
bryonic growth deficit phenotype. It has been shown that culture conditions can
influence the maintenance of genomic imprinting in mESCs (Habibi et al., 2013),
and the potential impact of such an effect should have been assessed in my cell
lines. Previously reported imprinted loci, such as Peg3 and Kcnq1ot in both mESCs
and mTSCs (Leitch et al., 2013; Calabrese et al., 2015), could have been used as
positive controls for parent of origin expression. However, in order to determine
the parental origin of a given allele, single nucleotide polymorphisms (SNPs) are
required. I used MF1 strain sex chromosome variant mice to generate both XPO
and XMO blastocysts for cell line derivation. Whilst the MF1 strain is outbred, it
does not have enough SNPs to perform accurate and effective variant calling. As
a consequence, it was not possible to confirm that autosomal imprinting is reliably
maintained within the model. The ability to assess potential X chromosome imprint-
ing was not affected, as two X chromosome monosomic states were used whereby
parent of origin was known a priori.
A number of studies in mESCs have suggested that culture conditions impact the
DNA methylation status of imprinting control regions, creating a potential risk of
culture artifacts (Ficz et al., 2013; Habibi et al., 2013; Blaschke et al., 2013). Cells
derived and maintained in 2iLIF conditions were reported to show faithful mainte-
nance of parental imprints, as per the ICM of the blastocyst stage embryos, at three
4.3. Discussion 144
loci examined (Leitch et al., 2013). However, two other reports found sexually di-
morphic ICR methylation maintenance at the Peg3 and Peg10 loci in both serum and
LIF and 2iLIF conditions (Ooi et al., 2010; Zvetkova et al., 2005). Recently it has
been shown that histone modifications, such as H3K27me3, also play a role in the
regulation of imprinted gene expression in the early mouse embryo independently
of DNA methylation (Inoue et al., 2017). It will therefore be important to deter-
mine whether culture conditions impact on the genes regulated by this mechanism,
too.
There are no reports of culture induced changes in DNA methylation or imprinting
in mTSCs, however, there are also only a small number of reports showing im-
printing in mTSCs. The most comprehensive study to date utilised eight F1 mTSC
lines produced by reciprocal cross between C57BL/6J and Mus musculus castaneus
mouse strains (Calabrese et al., 2015). The authors found evidence for imprinted ex-
pression of 31 previously described imprinted genes and 17 new candidates, based
on RNA-seq and pyrosequencing data. They also noted that several of the known
imprinted genes showed variability in parent of origin expression across their lines,
and suggest this could either be an example of developmental plasticity at imprinted
loci (Radford et al., 2011), or alternatively an artifact of culture.
It would be useful to further understand the mechanisms of imprint maintenance in
mTSCs, as this was not addressed in the Calabrese et al. study. Recently it was
shown that DNA methylation marks originating in the oocyte are important for tro-
phoblast development, and play a role in trophoblast cell adhesion both in vivo and
in vitro (Branco et al., 2016). Furthermore, loci specifically imprinted in extraem-
bryonic tissue are enriched for repressive histone modifications such as H3K27me3
and H3K9me2 (Lewis et al., 2004; Umlauf et al., 2004), and the active histone
mark H3K4me2 (Lewis et al., 2006). However, some placentally imprinted genes
appear to be biallelically expressed in mTSCs and blastocysts, and as such show
no enrichment for histone modifications at these loci (Lewis et al., 2006). More-
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over, following in vitro differentiation, there was no change in allelic expression or
histone modifications.
In summary, the cell lines I have derived as a model for X chromosome imprinting
in the XPO embryo require validation to confirm the expression of known imprinted
genes. It would therefore be useful to perform whole genome bisulphite sequencing
on F1 mESC, mEpiLC, and mTSC lines. This would enable confirmation of the
methylation status of known ICRs based on allele calling data and, furthermore, in
conjunction with RNA-seq data, would facilitate the identification of any imprinted
genes on the X chromosome in mESCs, mEpiLCs, and mTSCs. ChIP-seq analysis
in all cell types for histone modifications such as H3K27me3 would also be im-
portant (Inoue et al., 2017; Lewis et al., 2006), with the caveat that mTSCs have
been shown to recapitulate genes imprinted at the blastocyst stage but no later. If
imprinting candidates are not found at this early stage, alternative models will be
required.
4.3.6 Alternative models for investigating the XPO embryonic
growth deficit
Whilst stem cells in vitro undoubtedly contribute a significant amount to our under-
standing of biological systems and, importantly, facilitate a reduction in the use of
live animals in research, it is sometimes challenging to accurately recapitulate the in
vivo phenotype in a plate or dish. In order to investigate the XPO embryonic growth
deficit question further, a number of in vivo options could complement the current
cell focused approach.
As it has previously been shown that the EPC of XPO conceptuses is significantly
smaller than the EPC of XX littermates (Jamieson et al., 1998), it would be useful
to reinvestigate this model with modern techniques. A reporter for Ascl2, expressed
only in the EPC of the extraembryonic tissue at E7.5 (Guillemot et al., 1994), could
be generated by CRISPR-Cas genome editing (Yang et al., 2013) and, following
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dissection of the conceptus, used to FACS sort the EPC cells for RNA-seq or pro-
teomic analysis.
A secondary alternative to access the same population would be to fix or freeze the
conceptuses and utilise laser capture microdissection (DeCarlo et al., 2011). This
technique would enable the isolation of the morphologically identifiable EPC cells
in the E7.5 conceptus for use in downstream RNA-seq or proteomic analysis.
A third model could be utilised for a direct comparison with in vitro derived mTSCs.
Using laser assisted microdissection on the blastocyst stage embryo, it is possible
to separate the mural TE from the polar TE and ICM. These two different cell
populations could then be dissociated into single cells for RNA-seq analysis. Us-
ing lineage specific marker genes such as Cdx2 and Eomes for the TE and Pou5f1
and Nanog for the ICM, it would be possible to bioinformatically separate the po-
lar TE/ICM population into trophectoderm and ICM (Blakeley et al., 2015); and
possibly further separate the ICM into epiblast and primitive endoderm. Finally,
differential gene expression analyses could be performed, both between genotypes,
as described for mTSCs during this study, and within embryos between cell types. It
has previously been shown that transcriptional differences exist between polar and
mural TE at E3.5 (Nakamura et al., 2015), and it would be interesting to observe if
these differences change with sex chromosome genotype.
4.3.7 Potential use of proteogenomics to further investigate the
XPO growth deficit phenotype
The identification and relative measurement of mRNA species by RNA-seq enables
the study of transcriptional activity within a given cell or tissue sample. By com-
paring transcriptomes between samples from different experimental conditions, we
are able to determine the impact of the condition on gene expression. RNA species
are not generally, however, the final effectors of cellular output; this task falls to
protein. Conservative estimates suggest that the correlation between cellular pro-
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tein concentration and abundance of their corresponding mRNA is around 40%
(de Sousa Abreu et al., 2009; Maier et al., 2009). The 60% variance is attributed to
post transcriptional, translational, and degradation regulation (Vogel and Marcotte,
2012). Recent work characterised human colon and rectal tumours by proteoge-
nomic analysis (Zhang et al., 2014). They noted that whilst copy number alterations
showed cis and trans effects on mRNA abundance, mRNA transcript abundance did
not generally predict protein abundance differences between tumours. The com-
bined study of mRNA and protein profiles helped the authors to prioritise candidate
driver genes, and provided functional context to genetic abnormalities, such as du-
plication of chromosome 20q (Zhang et al., 2014). Such a combined mRNA/protein
approach might enabled more effective identification of candidate genes when look-
ing to understand a complex phenotype, such as the growth deficit observed in XPO
embryos at E10.5.
Chapter 5
Assessing the contribution of
X-linked dosage sensitive genes to the
postnatal growth deficit in XO female
mice
5.1 Introduction
Short stature is one of the most recognisable features associated with Turner syn-
drome, and is a major cause of disability during childhood and adolescence (Kap-
pelgaard and Laursen, 2011; Lee and Conway, 2014). Haploinsufficiency of SHOX,
a gene located within PAR1, is likely a major contributor to the phenotype (Rao
et al., 1997; Ellison et al., 1997). SHOX is a transcription factor highly expressed
in chondrocytes and bone marrow fibroblasts (Rao et al., 1997; Ellison et al., 1997;
Rao et al., 2001; Aza-Carmona et al., 2011). Mutations in the gene are one of
the primary genetic causes of Leri-Weill syndrome, which itself encompasses a
short stature phenotype (Belin et al., 1998), and have also been associated with
many other cases of short stature (Marstrand-Joergensen et al., 2016; Fukami et al.,
2016). However, women with Turner syndrome are generally shorter than patients
5.2. Results 149
with mutations in SHOX, suggesting that other factors may contribute (Ross et al.,
2001; Fukami et al., 2016; Zinn and Ross, 1998).
Similar to Turner syndrome in humans, female mice with an XO karyotype are
smaller than those with a normal XX karyotype during early postnatal life (Bur-
goyne et al., 1983a). Although originally suggested to result from genomic imprint-
ing, this phenotype has been shown to be independent of the parental origin of the
X chromosome (Burgoyne et al., 2002). Furthermore, mice have no SHOX ortho-
logue, and their PAR is significantly reduced in size and gene content compared to
humans. Burgoyne and colleagues (2002) showed that female mice with one nor-
mal X chromosome and an additional PAR-only chromosome are small compared
to XX littermates. Interestingly, the addition of a second sex chromosome, in the
form of a Y chromosome lacking the sex determining gene Sry (XY-), fully rescued
the phenotype. The authors therefore concluded that haploinsufficiency for an X
linked gene that is located outside the PAR, and has a widely-expressed Y-linked
homologue, is the most likely cause of the growth deficit. This gene would also be
expected to escape XCI.
In this Chapter I set out to confirm the results from the Burgoyne et al. dataset, and
to identify the genes involved in the growth retardation phenotype. A small number
of candidates were highlighted following a Y-linked gene expression analysis and
RFLP assay to test for escape from XCI. I then sought to address each candidate’s
role in the XO postnatal growth deficit by creating mutant lines by CRISPR/Cas9
genome engineering.
5.2 Results
5.2.1 Recapitulation of previous results
I first sought to reproduce the results of Burgoyne et al. (2002) that, relative to
XX littermates, XPO and XMO female mice grow at a reduced rate during the first
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five weeks of postnatal life. In the Burgoyne et al. study, XO female mice with an
additional PAR, denoted XY*X, also grew at a reduced rate across the same period,
whereas XY- females grew at the same rate as XX littermates.
In order to generate XPO females alongside XX littermates, I crossed In(X)/X fe-
male mice with XYRIII males (Figure 5.1A(i)). In addition to XPO females, XX and
In(X)/X females were present in the offspring. It has previously been reported that
there is no difference in postnatal weight gain between XX and In(X)/X females,
so results were pooled (Burgoyne et al., 2002). XMO females were produced by
crossing XX female mice with XPaf Y* males (Figure 5.1B(i)). XO female mice
with an additional PAR (XY*X) were generated by crossing XX females with XY*
males (Figure 5.1C(i)). Finally, we generated XY- females by utilising a male with
this variant Y chromosome, in addition to an autosomal Sry transgene, crossed with
a wildtype female (Figure 5.1D(i)).
I first compared weights at birth. XPO females showed no significant birth weight
difference when compared with XX littermates (Table 5.1, p=3.86x10-1). Interest-
ingly, XMO females were significantly lighter than XX littermates at birth (Table
5.1, p=2.20x10-2), as were XY*X females (Table 5.1, p=6x10-3). XY- females were
significantly heavier than XX littermates at birth (Table 5.1, p=2.80x10-3),
In order to estimate the rate of growth across the periods 0-3 weeks and 3-5 weeks,
a regression line was fitted to the weight data for each animal. Relative to XX
littermates, XPO females grew at a reduced rate during the 0-3 week period (Fig-
ure 5.1A(ii), Table 5.2, p=2.00x10-2). XMO females (Figure 5.1B(ii), Table 5.2:
p=4.60x10-2) and XY*X females (Figure 5.1C(ii), Table 5.2: p=2.80x10-2) also
grew at a significantly reduced rate when compared to XX littermates between 0
and 3 weeks. In contrast, and consistent with previous results, XY- females showed
no difference in rate of growth when compared to XX littermates across the 0-3
week period (Figure 5.1D(i), Table 5.2: p=1.39x10-1).
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Across the 3-5 week period, XPO females grew at at a rate not significantly different
from XX littermates (p=7.12x10-1). Similarly, relative to XX littermates, XMO fe-
males (Table 5.2: p=3.16x10-1) and XY*X females (Table 5.2: p=2.64x10-1) grew
at an equivalent rate. Interestingly, XY- females slowed a slight, but significant,
reduction in weight gain during the 3-5 week period in comparison to XX litter-
mates (Table 5.2: p=3.60x10-2): this is in keeping with the trend shown previously
(Burgoyne et al., 2002). Figure 5.1E utilises MWD from XX to bring results from
all genotypes together. In summary, I confirmed that XO female mice grow at a
reduced rate relative to XX littermates during the 0-3 week period, and that this is
not a result of haploinsufficiency for PAR genes. I conclude that haploinsufficiency
for genes present on both the X and Y chromosomes, and that map outside the PAR,
is the most likely cause of a reduced rate of postnatal growth in XO mice.
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Figure 5.1: Recapitulation of postnatal growth retardation phenotype in XO female
mice. (A) (i) Mouse cross used to generate XX and XPO littermates, and (ii) body weight
data of these animals, measured weekly for five weeks. Each data point represents an indi-
vidual animal, and the line depicts the mean for each genotype. (B) (i) Mouse cross used
to generate XX and XMO littermates, and (ii) body weight data. (C) (i) Mouse cross used
to generate XX and XY*X littermates, and (ii) body weight data. (D) (i) Mouse cross used
to generate XX and XY-Sry littermates, and (ii) body weight data. (E) Mean weighted dif-
ference between genotypes indicated and XX littermates. Bars represent 95% confidence
intervals.
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Comparison Number Birth weight (g)
A v B na nb A B MWD±SE (g) Signif. of
MWD (p)
XX v XPO 17 6 1.719±0.040 1.699±0.376 0.020±0.045 3.86x10-1
XX v XMO 27 21 1.755±0.039 1.747±0.046 0.038±0.042 2.20x10-2
XX v XY*X 25 21 1.638±0.037 1.600±0.036 0.041±0.038 6.00x10-3
XX v XY- 26 38 1.610±0.035 1.675±0.032 -0.064±0.028 2.80x10-2
Table 5.1: Birth weight data compared by mean weighted difference (MWD)
Comparison Number 0-3 weeks: mean ±SE (g) 3-5 weeks: mean ±SE (g)
A v B na nb xAa xBa MWD±SE
(g)
Signif. of
MWD (P)
xAa xBa MWD±SE
(g)
Signif. of
MWD (p)
XX v XPO 17 6 4.034±0.117 3.860±0.210 0.190±0.072 2.10x10-2 4.121±0.277 4.202±0.184 0.226±0.157 7.12x10-1
XX v XMO 27 21 4.140±0.093 3.920±0.095 0.219±0.105 4.60x10-2 3.940±0.122 4.209±0.112 0.133±0.131 3.16x10-1
XX v XY*X 37 29 3.968±0.057 3.828±0.090 0.116±0.051 2.80x10-2 4.356±0.071 4.517±0.116 0.110±0.097 2.64x10-1
XX v XY- 26 38 3.741±0.086 3.848±0.064 0.081±0.092 1.39x10-1 4.762±0.131 4.508±0.109 0.270±0.101 3.60x10-2
Table 5.2: Means and mean weighted differences (MWD) for phasic weight gain between genotype comparisons shown in Figure 5.1. "a" represents
mean of means.
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5.2.2 Verification of potential postnatal growth retardation can-
didates
Next I sought to narrow down potential candidate genes for the haploinsufficiency
hypothesis. As elucidated previously (Burgoyne et al., 2002) and here, such genes
will not be imprinted, will not be present in the PAR, and the Y linked homologues
will likely exhibit widespread expression. I looked to confirm this pattern by using
RT-PCR to assay for expression of all 14 Y linked protein coding genes across mul-
tiple tissues representing ectoderm, mesoderm and endoderm (Figure 5.2). Eight
Y-linked genes showed expression exclusive to the testis (Zfy1, Ube1y1, Usp9y,
Zfy2, Sry, Ssty1, Ssty2, and Sly). Two genes showed expression in the testis and
limited expression outside the gonad (H2al2y and Rbmy1a1). The final four genes
(Kdm5d, Eif2s3y, Uty, and Ddx3y) showed widespread expression across tissues
derived from all three embryonic germ layers. These patterns were consistent with
previously reported data (Bellott et al., 2014).
Each of the broadly expressed Y linked genes has a conserved X linked homologue
in mouse (Disteche et al., 2002). This conservation not only applies to the mouse
sex chromosomes, but also across the eutherian clade, which has been taken to
suggest that levels of expression of these X-Y pairs might be important (Bellott
et al., 2014; Cortez et al., 2014). In XX female mice, the expression of most X
linked genes is controlled by XCI; though it is likely that dosage sensitive genes
such as the X linked genes in these X-Y pairs, will escape the chromosome wide
silencing. I looked to confirm that the X linked orthologue of each of the widely
expressed Y linked genes escapes XCI, as has been previously reported (Disteche
et al., 2002). I determined whether one or both alleles of Ddx3x, Eif2s3x, Kdm5c,
and Kdm6a was being expressed in adult XX female mice by restriction fragment
length polymorphism analysis (RFLP).
5.2. Results 156
Figure 5.2: Expression analysis of genes on the mouse Y chromosome by RT-PCR.
Relative positions of genes on the mouse Y chromosome are depicted by cartoon on the left
hand side. The positive control was adult wildtype mouse testis; the negative control was
testis from an adult male mouse lacking the Y chromosome but carrying Eif2s3y and Zfy2
transgenes.
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XCI is usually random in all adult somatic cells, such that either XM or XP could
be inactivated. As a result, on a tissue level, both alleles from every expressed gene
would be detected, regardless of whether genes are subject to or escape from XCI.
In order to isolate expression from potential XCI escapees only, I again utilised the
Xist mutant allele (Marahrens et al., 1997). The X chromosome carrying this allele
cannot be inactivated, and any detected expression from the second X chromosome
in XX females could be attributed to escape from XCI.
In order to differentiate between transcripts from the two different X chromosomes,
I used an F1 cross between strains bearing known single nucleotide polymorphisms
(SNPs) in the genes of interest. After amplifying the locus containing the SNP from
cDNA by PCR, I then digested the product with a restriction enzyme specific to one
of the variant nucleotides at the SNP. If the gene escaped XCI, I expected to see two
products after digest, i.e. one from each allele. If the gene was subject to XCI, I
expected to observe only a single product after digest, the product from the active
X chromosome.
Foxo4, a gene known to be subject to XCI, was assayed first as a negative control. I
amplified and digested PCR products from cDNA of the parental strains to test the
RFLP assay, expecting to observe a single, digested product in one strain, and a sin-
gle undigested product in the other strain. In both of the parental strains, following
digest, distinct bands were observed on the agarose gel (Figure 5.3A). As a result
the Xist mutation on the C57BL/6 X chromosome, the XX female F1 was expected
to express Foxo4 from the C57BL/6 X chromosome - the active X chromosome -
only. This expectation was fulfilled.
I then assayed Ddx3x, Eif2s3x, Kdm5c, and Kdm6a. If a gene escapes XCI, I ex-
pected to observe expression from both X chromosomes in the XX female F1, in the
form of two different allele specific bands. For each of Ddx3x, Eif2s3x, Kdm5c, and
Kdm6a, this expectation was fulfilled, in both brain and liver tissue samples (Fig-
ure 5.3A,B). I therefore confirmed that Ddx3x, Eif2s3x, Kdm5c, and Kdm6a escape
XCI across multiple tissues in the mouse. When compiled with the data showing
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presence and widespread expression of Y linked orthologues, I conclude that one
or more of these four candidates is most likely to be haploinsufficient in XO female
mice, resulting in a reduced rate of growth in the early postnatal period.
Figure 5.3: Restriction fragment length polymorphism analysis to confirm escape from
XCI in mouse brain and liver. (A) Agarose gels showing restriction enzyme digests of
cDNA from C57BL/6 (BL/6), PWD/PhK (PWD), and C57BL/6Xist- x PWD/PhK animals.
Arrowheads indicate two separate bands. (B) As (A), with cDNA from C57BL/6 (BL/6),
BALB/C, and C57BL/6Xist- x BALB/C animals (BL/6X-/BALB/C) animals.
5.2.3 The generation of mutant alleles by CRISPR Cas9 genome
engineering
I next looked to identify which of these genes mediates the postnatal growth re-
tardation phenotype by utilising individual knockout alleles for Kdm5c, Kdm6a,
Ddx3x and Eif2s3x. As all crosses described up to this point have utilised the MF1
mouse strain, I wanted to maintain consistency and reduce variation attributable to
strain specific effects (Latham, 1994) by utilising the same strain for the knockouts.
Whilst a number of mutant lines had already been published for Kdm6a, none used
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the MF1 strain. Rather than adopting a lengthy backcrossing strategy, I opted to
create new lines via CRISPR/Cas9 genome editing (Jinek et al., 2012; Cong et al.,
2013). Guide RNAs were designed utilising the MIT CRISPR Design Tool (Ran
et al., 2013), with the aims of removing the translation initiation site, whilst min-
imising off target mutations. Initially, each guide was shown to successfully cut the
target locus by digest of a PCR product containing the guide target sequence (Figure
5.4).
To assess guide efficiency, XY mESCs were then electroporated with each guide
validated individually, along with Cas9 mRNA. All guides for Ddx3x, Kdm5c, and
Kdm6a were able to create mutations in vitro, as assessed by either RFLP or Sanger
sequencing (Table 5.3). Targeting efficiency, measured as the percentage of all
picked clones carrying a mutation, ranged between 9.7% and 21.9% for Kdm6a,
Kdm5c, and Ddx3x guides. Eif2s3x proved more problematic, with the first two
guides yielding no mutant clones, and the third guide only one mutant from 40
clones screened. Guides that successfully cut PCR products and showed activity in
mESCs were microinjected into pronuclear stage MF1 mouse embryos by Genetic
Manipulation Services (Science Technology Platform at Francis Crick Institute),
and transferred to pseudopregnant females in order to generate stable mouse lines.
Lines generated for each gene will now be discussed in more detail.
Figure 5.4: Demonstrating sgRNA cutting of target genomic DNA. Agarose gel showing
Cas9 with sgRNA digest of PCR amplicons derived from target locus. Each PCR amplicon
is shown first as uncut (U), followed by results of a incubation with Cas9 and each guide
(sgRNA1,2 etc.) specific to the locus. Two different amplicons were utilised for Eif2s3x.
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Gene sgRNA name Mutant
clones/total
clones
Percentage
carrying a
mutation
Screening
method
Kdm6a Kdm6a 1 5/32 15.6 RFLP
Kdm6a 2 4/22 18.2 RFLP
Kdm5c Kdm5c 1 5/30 16.7 RFLP
Kdm5c 2 3/31 9.7 RFLP
Ddx3x Ddx3x 1 7/32 21.9 Sanger seq.
Ddx3x 2 5/28 17.9 Sanger seq.
Eif2s3x Eif2s3x 1 0/40 n/a Sanger seq.
Eif2s3x 2 0/40 n/a Sanger seq.
Eif2s3x 3 1/40 2.5 RFLP
Table 5.3: Guide efficacy as tested in XY mESCs
5.2.4 Kdm5c
Two lines carrying mutations in Kdm5c were generated and propagated. One line
carried a 189bp. deletion and the other a 166bp. deletion. Both mutant lines fea-
tured the removal of the translation initiation site (Figure 5.5A, red line) and, based
on sequencing evidence, also resulted in frameshift mutations within exon 1. All
four protein coding isoforms of Kdm5c were likely affected (Figure 5.5A, lower).
This loss of protein was confirmed by western blot (Figure 5.5B), using an antibody
raised to antigen from outside of the deleted region (Figure 5.5A, ’Ab’). I compared
females heterozygous for the mutant allele with wildtype females (Figure 5.5B +/-
and +/+ respectively), and expected to see a reduction in protein in the mutant: this
proved to be correct. I then compared males carrying only a mutant allele with wild-
type males (Figure 5.5B -/y, +/y, respectively), and expected to observe complete
absence of protein in the mutant: this also proved to be correct. I wanted to com-
pare homozygous mutant females with wildtype females, expecting to see complete
absence of protein in the homozygotes. However, I was unable to generate homozy-
gous mutant females. In summary, both mutations resulted in ablation of KDM5C
protein expression.
Next I wanted to check for the presence of off target mutations. I decided to proceed
with off target analysis for the 189bp. line only, as a single line was required for
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the weighing experiment. I chose to screen loci located within exons, and having
four or fewer mismatches between guide and target sequence. These were identi-
fied using the results from the MIT CRISPR Design Tool. The off target analysis
was performed on three male F1s that were used to generate all mutant animals for
future experiments. I also sequenced three unrelated wildtype males to capture any
background non specific mutations. No mutations were observed at any of the off
target loci screened, in either 189bp deletion males or wildtype males (Figure 5.5C),
based on PCR and next generation sequencing data. I conclude that I had success-
fully generated a Kdm5c mutant line with no detectable off target effects.
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Figure 5.5: Generation of mutant Kdm5c alleles by CRISPR. (A) Cartoon depiction of
the target locus. Wildtype (wt) sequence enables visualisation of the guide and PAM, along
with the annotated ATG (red line). Line 1 and line 2 show the origins of the mutations
generated following injection of Cas9+sgRNA into pronuclear stage mouse embryos. This
is contextualised below, with exons shown as orange boxes. Splice variants of the gene are
used to indicate positions of important functional domains, along with the predicted result
of the mutations on protein structure. (B) Western blot on protein extracted from brain of
seven day old pups with genotypes as indicated. The location of the epitope used to raise the
antibody is indicated by Ab in (A). GAPDH was used as a loading control. (C) Off target
screening by MiSeq sequencing of amplicon PCRs. The wildtype guide sequence and PAM
are shown on the top line, with predicted off target sequences, organised by increasing vari-
ation from the guide sequence (orange), shown below. On the right hand side, sequencing
results are summarised as filled boxes. Relative abundance of reads per individual animal
is depicted by fill level of the squares: for example, the each of the heterozygous females
shows 50:50 blue:orange to represent 50% read variation from wildtype. Three mutant
males from generation F1 and three unrelated wildtype males were sequenced. Amplicons
were sequenced to depths of between 200X and 10000X.
5.2.5 Kdm6a
A Kdm6a mutant line was generated harbouring a 285bp deletion in exon 1, just
downstream of the translation initiation site (Figure 5.6A). This deletion was pre-
dicted to result in a frameshift, leading to a premature stop codon 13 amino acids
after translation initiation and no protein product. I sought to verify this by western
blot, using an antibody raised to the C terminal end of KDM6A (Figure 5.6A, red
line). I compared protein extracted from wildtype female brain with heterozygous
mutant female brain, expecting to see a reduction in the intensity of the protein
band in the mutant. Surprisingly, there was no difference between wildtype and
heterozygous mutant females (Figure 5.6B). I also compared wildtype male with
hemizygous mutant male, expecting to detect no protein in the mutant. Once again,
there was no difference between wildtype and mutant. A number of alternative anti-
bodies were tested, but all gave multiple non specific bands under various different
conditions. The antibody presented in Figure 5.6B produced a single band of the
appropriate size, however, further work is required to confirm the specificity of the
blot.
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Despite not finding a difference at the protein level, I decided to look for a pheno-
type in my Kdm6a mutant line. I noted that I was not able to generate homozygous
mutant females, which was consistent with previous reports of mutations in Kdm6a
(Shpargel et al., 2012; Welstead et al., 2012). Furthermore, hemizygous mutant
males allele were smaller than XY littermates at birth (Figure 5.6C(i)). Although
this difference did not reach significance, it was again consistent with previous re-
ports. A subset of these animals were followed through to weaning at three weeks:
100% of the wildtype males survived, whereas only 22% of the hemizygous mutants
survived (Table 5.4). These phenotypic results were in complete agreement with the
literature, further questioning the specificity of the western blot, and showing that a
non functioning Kdm6a allele had been generated.
Finally, I screened three F1 males for off target mutations using the same approach
as that implemented for the Kdm5c line. No mutations were observed at any of
the loci sequenced (Figure 5.6C), and I conclude that the targeting of Kdm6a was
successful.
XY X-Y
Observed Expected Observed Expected
PN1 16 (0.53) 15 (0.5) 14 (0.47) 15 (0.5)
PN21 16 (0.53) 15 (0.5) 4 (0.13) 15 (0.5)
Table 5.4: Numbers of wildtype and Kdm6a hemizygous males recorded across five litters
produced from a wildtype male and a heterozygous mutant female cross. Expected numbers
and proportions based on male pups only, i.e. the null hypothesis of 50% XY and 50% X-Y
per litter.
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Figure 5.6: Generation of mutantKdm6a allele by CRISPR. (A) Cartoon depiction of the
target locus. Wildtype (wt) sequence enables visualisation of the guide and PAM, along with
the annotated ATG (red line). Line 1 shows the origin of the mutation generated following
injection of Cas9+sgRNA into pronuclear stage mouse embryos. This is contextualised
below, with exons shown as orange boxes. Splice variants of the gene are used to indicate
positions of important functional domains, along with the predicted result of the mutations
on protein structure. (B) Western blot on protein extracted from brain of seven day old pups
with genotypes as indicated. The location of the peptide sequence used to raise the antibody
is indicated by peptide in (A). GAPDH was used as a loading control. (C) Graph showing
birth weight of XY and X-Y pups: each point represents an individual, with mean and
95% CI as bars. P value is calculated from Student’s t. (D) Off target screening by MiSeq
sequencing of amplicon PCRs. The wildtype guide sequence and PAM are shown on the top
line, with predicted off target sequences, organised by increasing variation from the guide
sequence (orange), shown below. On the right hand side, sequencing results are summarised
as filled boxes. Relative abundance of reads per individual animal is depicted by fill level
of the squares: for example, the each of the heterozygous females shows 50:50 blue:orange
to represent 50% read variation from wildtype. Three mutant males from generation F1 and
three unrelated wildtype males were sequenced. Amplicons were sequenced to depths of
between 200X and 10000X.
5.2.6 Ddx3x
A 17bp deletion within exon 1 of Ddx3x was created, downstream of the translation
initiation site (Figure 5.7A). This mutation was predicted to result in the generation
of a premature stop codon after six amino acids. To verify that the protein was
no longer present (Figure 5.7B), western blot was performed using an antibody
raised to the whole protein. Wildtype female liver was compared with heterozygous
mutant female liver, and a reduction in DDX3X in the mutant tissue was expected.
A slight reduction in band intensity was observed. When wildtype XY male liver
was compared with hemizygous mutant male liver, complete absence of DDX3X in
the mutant was expected. Interestingly, only a slight reduction of DDX3X protein
was observed in the mutant. In contrast to the Kdm6a and Kdm5c mutant lines,
for Ddx3x I was able to generate homozygous mutant females (Figure 5.7B: -/-).
Contrary to predictions, tissue from these animals showed a marked depletion, but
not complete loss, of DDX3X protein band by western blot. Based on this result, I
concluded that I had generated a DDX3X knockdown line. No off target mutations
were observed in the three F1 females screened from this line (Figure 5.7C).
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Figure 5.7: Generation of mutant Ddx3x allele by CRISPR. (A) Cartoon depiction of the
target locus. Wildtype (wt) sequence enables visualisation of the guide and PAM, along with
the annotated ATG (red line), and alternative ATG (*). Line 1 shows the origin of the muta-
tion generated following injection of Cas9+sgRNA into pronuclear stage mouse embryos.
This is contextualised below, with exons shown as orange boxes. Splice variants of the gene
are used to indicate positions of important functional domains, along with the predicted re-
sult of the mutations on protein structure. (B) Western blot on protein extracted from brain
of seven day old pups with genotypes as indicated. The location of the peptide sequence
used to raise the antibody is indicated by peptide in (A). GAPDH was used as a loading
control. (C) Off target screening by MiSeq sequencing of amplicon PCRs. The wildtype
guide sequence and PAM are shown on the top line, with predicted off target sequences,
organised by increasing variation from the guide sequence (orange), shown below. On the
right hand side, sequencing results are summarised as filled boxes. Relative abundance of
reads per individual animal is depicted by fill level of the squares: for example, the each
of the heterozygous females shows 50:50 blue:orange to represent 50% read variation from
wildtype. Three mutant females from generation F1 and three unrelated wildtype females
were sequenced. Amplicons were sequenced to depths of between 200X and 10000X.
5.2.7 Eif2s3x
Due to the very high degree of similarity between the sequence around the transla-
tion initiation site of Eif2s3x and its Y linked homologue Eif2s3y, I instead chose to
target exon 7 of Eif2s3x (Figure 5.8A). Fewer live offspring were recovered when
injecting guides targeting Eif2s3x, compared to Kdm5c, Kdm6a, and Ddx3x. Only
two pups born from Eif2s3x injections carried frameshifted alleles. These were
found at very low frequency (Figure 5.8B, box), and were not transmitted in the
germ line. I considered two possibilities to explain these observations. Firstly, the
guide may not have been efficient at cutting in the context of the mouse embryo: in-
deed, efficiency appeared very low in mESCs (Table 5.3). Secondly, Eif2s3x could
be critical for early embryo development, and those embryos with a high percentage
of frameshift mutations did not survive. This loss of embryos could impact on the
development of embryos carrying wildtype or in frame alleles in the same uterus,
resulting in a failed pregnancy and explaining the relatively low number of pups
born.
To differentiate between the two hypotheses, 39 pronuclear stage embryos were in-
jected with guides targeting Eif2s3x and cultured in vitro for three days to E3.5.
15 embryos arrested before reaching the expected morphology of a blastocyst at
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E3.5, and seven of these failed to give analysable sequencing data. Of the 32 em-
bryos genotyped, all carried mutated alleles, with a very low proportion of wildtype
reads (Figure 5.8B). This demonstrated that the guide was highly mutagenic. I
also observed that the seven genotyped embryos that failed to develop to blastocyst
generally showed a higher proportion of frameshift alleles compared to those suc-
cessfully reaching this stage (51.4% vs. 30.8%). One embryo arrested at the morula
stage (E2.5) and contained only frameshift alleles, and one blastocyst stage embryo
had >99% of reads with frameshift mutations. I conclude that mutations in Eif2s3x
did not preclude the completion of pre implantation development, as assessed by
embryo morphology.
Finally, I attempted to elucidate the timing of embryonic lethality in Eif2s3x mu-
tants by utilising pronuclear injection, followed by embryo transfer, and harvest at
E6.5, E9.5 and E12.5. For each of the timepoints at least 50 injected embryos were
transferred (Table 5.5). Approximately 50% of recipient females were pregnant and
contained implantation sites in the uterus. 50% of these sites contained viable em-
bryos at E6.5, 29% at E9.5, and 50% at E12.5 (Table 5.5). The remaining sites
had supported implantation, but there was no embryonic tissue found at the time of
dissection due to conceptus reabsorption.
The vast majority of the morphologically normal embryos were entirely wildtype
(Figure 5.8B), based on genotyping by next generation sequencing. Two embryos
at E6.5 harboured frameshift alleles, but as a low proportion of the overall reads.
No frameshift alleles were detected at either E9.5 or E12.5, though in frame mu-
tations were picked up in three embryos at E9.5 and one embryo at E12.5. Taken
together, these data suggest that Eif2s3x plays a critical role in mouse embryonic
development. As I was unable to identify any mutants with significant contribution
from frameshift alleles later than E3.5, I concluded that these conceptuses fail peri
implantation.
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Transferred females Harvested embryos
Time Embryos
trans-
ferred
Pregnant Not
pregnant
Normal
morphology
(as % of
transferred)
Reabsorbed
(as % of
transferred)
E6.5 70 3 3 12 (17.1) 12 (17.1)
E9.5 51 2 1 5 (9.8) 12 (23.5)
E12.5 52 1 2 4 (7.7) 4 (7.7)
Table 5.5: Targeting Eif2s3x in mouse embryos. Microinjection and surgical transfers were
carried out by Sophie Wood and Katharine Mankelow in Genetic Manipulation Services.
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Figure 5.8: Generation of mutant Eif2s3x alleles by CRISPR. (A) Cartoon depiction of
the target locus. Wildtype (wt) sequence enables visualisation of the guide and PAM, which
is contextualised below, with exons shown as orange boxes. Splice variants of the gene
are used to indicate positions of important functional domains. (B) Graphical summary
of sequencing results following microinjection of Cas9 and sgRNA into pronuclear stage
mouse embryos, followed by harvest at times indicated. Each column represents a single
embryo with >200X coverage of the target locus. Mutations were categorised as indicated
by the colour scheme.
5.2.8 Haploinsufficiency for Kdm5c, Kdm6a, or Ddx3x does not
fully recapitulate the postnatal XO growth deficit
I next sought to utilise these new mutant alleles to test whether haploinsufficiency
for Kdm5c, Kdm6a, or Ddx3x would recapitulate the growth deficit phenotype ob-
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served in XO female mice. Eif2s3x was excluded as I was not able to generate a
mutant line, as described above.
In order to generate females heterozygous for a mutant allele alongside wildtype
female littermates, I crossed heterozygous females with wildtype males (Figure
5.9A(i), B(i), C(i)). Compared to XX littermates, Kdm5c heterozygous mutant fe-
males were lighter at birth, though this difference did not reach significance (Ta-
ble 5.6: p=6.90x10-2). Kdm6a heterozygous mutant females were not significantly
different in weight from XX littermates at birth (Table 5.6, p=4.46x10-1). Ddx3x
heterozygous mutant females were slightly, but not significantly, smaller than XX
littermates at birth (Table 5.7: p=4.67x10-1).
During the 0-3 week period, there was no significant difference in the rate of growth
between wildtype XX females and Kdm5c heterozygous mutant females (Figure
5.9A(ii), Table 5.7: p=1.68x10-1). There was also no significant difference in rate
of growth between XX females and Kdm6a heterozygous mutant females across
0-3 weeks (Figure 5.9B(ii), Table 5.7: p=4.80x10-1); and no significant difference
was found between wildtype XX females and Ddx3x heterozygous mutant females
across the same time period (Figure 5.9C(ii), Table 5.7: p=9.03x10-1).
Finally, I compared the rates of growth for heterozygous mutant females to XX
wildtype female littermates during the 3-5 week period. Kdm5c heterozygous mu-
tant females gained weight at a slightly reduced rate relative to XX littermates,
a difference that was borderline statistically significant (Table 5.7: p=5.30x10-2).
There was no difference in rate of growth between Kdm6a heterozygous mutant
females and their XX wildtype female littermates during this period (Table 5.7:
p=4.81x10-1). Interestingly, and similar to Kdm6a females, Ddx3x heterozygous
mutant females gained weight at a reduced rate compared to their XX wildtype fe-
male siblings (Table 5.7: p=3.00x10-2). These general trends were reflected when
analysing the mean weighted difference from wildtype XX female littermates for
each genotype at each timepoint (Figure 5.9D).
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Figure 5.9: Assessment of postnatal growth in heterozygous mutant females compared
to wildtype littermates. (A-C) Mating schemes to produce heterozygous mutant females
alongside wildtype littermates are depicted on the left hand side. Weight data are shown
on the right hand side, with each data point representing an individual animal at a single
time point. Coloured lines show the mean weight per timepoint for each genotype. (A)
shows Kdm5c; (B) shows Kdm6a; (C) shows Ddx3x. (E) Mean weighted difference between
genotypes indicated and XX littermates. Bars represent 95% confidence intervals.
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Comparison Number Birth weight (g)
A v B na nb A B MWD±SE (g) Signif. of
MWD (p)
XX v XXKdm5c- 38 33 1.669±0.032 1.596±0.033 0.080±0.033 6.90x10-2
XX v XXKdm6a- 27 43 1.650±0.044 1.612±0.026 0.023±0.025 4.46x10-1
XX v XXDdx3x- 19 20 1.735±0.028 1.688±0.029 0.034±0.035 4.67x10-1
Table 5.6: Birth weight compared by mean weighted difference (MWD) for XX vs. XX-
Comparison Number 0-3 weeks: mean ±SE (g) 3-5 weeks: mean ±SE (g)
A v B na nb xAa xBa MWD±SE
(g)
Signif. of
MWD (p)
xAa xBa MWD±SE
(g)
Signif. of
MWD (p)
XX v XXKdm5c- 38 33 4.140±0.088 4.074±0.073 0.093±0.067 1.68x10-1 4.780±0.220 4.550±0.174 0.274±0.138 5.30x10-2
XX v XXKdm6a- 27 43 4.212±0.173 4.095±0.154 0.060±0.085 4.80x10-1 4.570±0.238 4.549±0.172 0.066±0.092 4.81x10-1
XX v XXDdx3x- 19 20 3.615±0.200 3.638±0.195 0.013±0.114 9.03x10-1 5.029±0.209 4.712±0.222 0.298±0.130 3.00x10-2
Table 5.7: Means and mean weighted differences (MWD) for phasic weight gain between genotype comparisons shown in Figure 5.8. "a" represents
mean of means.
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5.3 Discussion
The results presented here show that XO female mice gain weight at a reduced rate
relative to their XX littermates during the first three weeks of postnatal life. This
effect is not attributable to imprinting, as it was observed in both XPO and XMO
females. Furthermore, the growth deficit remains following the addition of a sec-
ond PAR, and is only rescued by the presence of a second sex chromosome. These
data are consistent with previous data (Burgoyne et al., 2002), and implicated hap-
loinsufficiency for an X linked gene that escapes XCI and has a broadly expressed
Y linked homologue. There were, however, a number of inconsistencies with other
reports, primarily concerning birth weights.
5.3.1 Comparison of birth weight data
It has previously been reported that relative to XX females, XPO females are un-
derweight at birth (Burgoyne et al., 1983a, 2002), though here I found no signifi-
cant difference. These results likely reflect low sample size and reduced statistical
power. If the number of animals were increased, it is highly likely that standard
error would decrease and the magnitude of the difference between genotypes would
be more apparent, becoming statistically significant.
XMO and XY*X female embryos were significantly smaller than XX littermates at
birth, where no difference was reported previously (Burgoyne et al., 2002). Here, it
is unlikely that increasing sample size would have a significant effect on reducing
the standard error, the value of which is relatively in line with the standard error in
XX littermates for both genotypes. There are two further datasets with some rel-
evance to the current discrepancy. Thornhill & Burgoyne (1993) reported that at
E10.5, XMO embryos were significantly larger than XX littermates; and the same
observation was made at E17.5 (Ishikawa et al., 2003). Additionally, Ishikawa et al.
noted no difference between XX and XY*X embryo weights at E17.5, but XPO em-
bryos were significantly smaller than XX littermates. Taken together, these results
suggest that the birth weight deficit noted in XMO and XY*X females is unlikely
to be due to carryover of an in utero phenotype, though this cannot formally be
5.3. Discussion 177
excluded without collecting further data from E18.5. The discrepancy is also un-
likely to be the result of genetic differences between the animal cohorts, because
mice used in the present study were direct descendants of those used in the previ-
ous study, maintained on the same strain, and generated from the same crosses. It
is difficult to formally exclude whether unknown genetic differences were present
then, and/or are now present in these mice, and could impact on the results. I could
test this hypothesis, and therefore confirm an XMO and XY*X birth weight deficit,
by repeating the experiment in a different mouse strain.
5.3.2 XY- females at birth and post weaning
Two non significant trends in the Burgoyne et al. dataset became significant dif-
ferences in the present dataset. Burgoyne et al. reported that XY- females were
slightly heavier than XX littermates at birth, and here I utilised an increased sam-
ple size to show that this difference was statistically significant. Moreover, our
larger sample also showed that XY- females then lag behind XX littermates in rate
of growth during the 3-5 week period. These results could be due to a Y linked
acceleration effect during embryonic and perinatal growth, which then drops off
postnatally to the extent that a growth rate deficit ensues. Most Y chromosomes
have a mechanistically undefined accelerating effect on mouse embryonic develop-
ment, first identified at the pre implantation stages (Burgoyne, 1993; Tsunoda et al.,
1985). Increased growth relative to XX female littermates is carried over into the
postimplantation period, and has been shown present up to E17.5 (Ishikawa et al.,
1999). Analysis of birth weight data collected from XY males during the present
study extends this trend further, showing that XY males are also significantly larger
than XX females at birth (Table 5.8). Moreover, of most relevance here, XY- fe-
males are heavier than XX littermates at E10.5 (Burgoyne et al., 1995). In order to
test whether the increased birth weight results from a Y linked accelerating effect
in XY- females, a Y chromosome variant that lacks the preimplantation accelera-
tion could be modified by removal of Sry, using CRISPR Cas9 genome engineer-
ing, to generate XYRIII/- females. As described in Chapter 3, the RIII variant Y
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chromosome (Tease and Cattanach, 1989) has no effect on preimplantation growth
(Burgoyne, 1993), or indeed postimplantation growth up to E10.5 (Burgoyne et al.,
1995). XYRIII/- females would be of an equivalent weight at birth to XX littermates,
and there would be no lag in growth rate behind XX littermates during the 3-5 week
period.
Comparison Number Birth weight (g)
A v B na nb A B MWD±SE
(g)
Signif. of
MWD (p)
XX v XY 29 28 1.650±0.032 1.732±0.045 0.090±0.026 <1.00x10-5
Table 5.8: Birth weight compared by mean weighted difference (MWD) for XX vs. XY
5.3.3 Increasing the XO:XX weight difference
The magnitude of the difference in both absolute weights and rates of growth be-
tween XO females and XX littermates is very small, and this was acknowledged in
the previous report (Burgoyne et al., 2002). A proportional, reproducible increase
in this difference could increase the sensitivity of subsequent experiments to detect
potentially incremental contributions from Kdm5c, Kdm6a, Ddx3x, or Eif2s3x. This
might be achieved by more faithful modeling of the human phenotype, or through
adding a stressor to the experimental system that may preferentially impact on XO
embryos.
A significant proportion of the human Turner syndrome phenotype occurs as a re-
sult of haploinsufficiency of SHOX, a gene located within the PAR and involved
in chondrogenesis (Ellison et al., 1997; Rao et al., 1997, 2001). Whilst there is
no SHOX orthologue in the mouse, an orthologue for the closely related human
gene SHOX2 is present on chromosome 3 (Rovescalli et al., 1996) (Clement-Jones
et al., 2000). Mouse SHOX2 is 99% homologous to human SHOX2 at the amino
acid level, and shows very similar expression patterns (Blaschke et al., 1998; Sem-
ina et al., 1998). Shox2 mutations in mouse have been shown to result in embryonic
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lethality around E12.5, due to cardiac and vascular defects (Yu, 2005). Further work
targeting the mutation to the limb using a specific Cre driver revealed that complete
lack of the protein results in almost complete absence of humerus and femur (Cobb
et al., 2006). Whilst heterozygous Shox2 mutants had no obvious abnormal limb
phenotype, no quantitative data were provided (Cobb et al., 2006), and it would be
interesting to analyse these mice more thoroughly. Perhaps a Shox2 mutant would
synergise with the existing XO growth deficit, resulting in a more easily distinguish-
able phenotype. Such a model would further facilitate the detection of incremental
contributions from the haploinsufficiency candidates Kdm5c, Kdm6a, Ddx3x, and
Eif2s3x.
An alternative method to achieve a similar result would be caloric restriction of the
pregnant dam for a defined period during pregnancy. A 50% reduction in caloric in-
take from E12.5 to E18.5 has been shown to cause reduced weight in utero at E16.5
and birth, followed by a catch up at around 3-4 weeks (Jimenez-Chillaron et al.,
2005). Notably, there was also a significant reduction in litter size at birth, and
other physiological effects result from in utero under nutrition, such as glucose in-
tolerance (Jimenez-Chillaron et al., 2005). Taking these effects into consideration,
it would nevertheless be interesting to compare XO with XX females in undernour-
ished litters, as the physiological stress could have a more significant effect on those
already compromised by XO genotype. A previously described example of this ef-
fect highlights the preferential loss of embryos carrying a single paternal X over
XX littermate in the context of an XO uterine environments (Hunt, 1991).
5.3.4 The postnatal growth phenotype of heterozygous females
mutant for Kdm5c, Kdm6a, or Ddx3x
One of the main aims of this chapter was to generate females heterozygous for each
of the haploinsufficiency hypothesis candidate genes, and assess for recapitulation
of the postnatal growth retardation phenotype. Whilst such females were generated
for three out of four genes, these animals did not fully reproduce the phenotype
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reported here and previously when comparing XO and XX littermates. Female
mice heterozygous for a mutation in either Kdm5c, Kdm6a, or Ddx3x were born
with a reduced weight relative to XX littermates, though the difference reached
borderline significance only for Kdm5c. There was no significant difference in rate
of growth between females heterozygous for either Kdm5c, Kdm6a, or Ddx3x and
XX littermates across the 0-3 week period. During 3-5 weeks, Ddx3x heterozygous
mutants gained weight at a significantly reduced rate relative to their XX siblings.
The difference in rate of growth was borderline significant for Kdm5c heterozygous
mutants relative to XX littermates and there was no difference in Kdm6a mutants.
These observations could be explained by a number of factors, including the impact
of random XCI on escapee expression, the need for mutants carrying mutations in
all four genes concurrently, or an incorrect hypothesis.
XX female mice undergo XCI, inactivating one X chromosome in every somatic
cell. Most X linked genes are subject to this process, though a small number escape
and are expressed from both X chromosomes, often in specific tissues and/or at a
set developmental time (Disteche et al., 2002). We showed here, as has also been
shown previously, that Kdm5c, Kdm6a, Ddx3x, and Eif2s3x, all escape XCI in two
different adult tissues. Extensive data in the literature extend this to multiple tissues
throughout the embryo and adult, across developmental time (Li and Carrel, 2008;
Berletch et al., 2015; Disteche, 2016; Balaton and Brown, 2016). Interestingly, a
number of these escapees show significant female expression bias at the RNA and
protein levels, implying that two active copies of the gene results in higher expres-
sion (Reinius et al., 2012; Xu et al., 2002, 2008a,b; Isensee et al., 2007). However,
it seems that expression from the escapee alleles on the active X chromosome is
not equivalent to alleles on the inactive X chromosome. For example, Kdm5c ex-
pression was lower from the inactive X chromosome at between E6.5 and E13.5,
though this difference reduced to almost 50:50 in adult tissues, as assayed by sin-
gle nucleotide primer extension assay (Lingenfelter et al., 1998). More recent work
utilising RNA-seq has shown decreased relative Kdm5c expression from the inactive
X chromosome in 4 cell through to early blastocyst stage pre implantation embryos
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(Deng et al., 2014). Using the same technique, similar patterns were observed in
adult tissues for Kdm5c, Kdm6a, Ddx3x, and Eif2s3x (Berletch et al., 2015), and
this has also been noted in microarray data (Reinius et al., 2012). Taken together,
these data show that escapee genes are expressed more highly in XX females when
compared to XY males, and a significantly higher proportion of the total transcripts
originate from the active allele.
This XX:XY comparison should theoretically be similar to the XX:XO compari-
son regarding escapee gene expression, as both have a single X chromosome. If
expression of a given escapee from the active X chromosome is arbitrarily repre-
sented as 1.0, and from the inactive X chromosome as 0.5, total expression in XX
female somatic cells is 1.5 (Figure 5.10). In XO female somatic cells, there is no
XCI, therefore expression from the single active X chromosome is 1.0, and total
expression is 1.0 (Figure 5.10). XX- females have two genetically distinct X chro-
mosomes (due to the mutation) and, as a result, each somatic cell will inactivate one
of these two X chromosomes at random: the mouse is mosaic. 50% of cells will
inactivate the mutant X chromosome, therefore expression from the active wildtype
X chromosome is 1.0 (Figure 5.10). In the other 50% of somatic cells, the mutant X
chromosome will remain active, with expression of 0, and inactivation of the wild-
type X chromosome leads to expression equivalent of the inactive X chromosome
in XX cells, i.e. 0.5 (Figure 5.10). When these two levels are averaged across the
animal, expression in XX- females is therefore expected to be lower than in XO
females, an arbitrary 0.75.
Whilst this example is purely theoretical, and does not take into account X chromo-
some upregulation (Sangrithi et al., 2017), or genome wide dosage modulation in
aneuploidies (Birchler, 2014), the difference could still partly explain the discrep-
ancy between observations of growth rate in XO females and XX- females. Were
this hypothesis to be correct, the presently described XX- females have lower ex-
pression of each given gene than XO females.
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Loss of a single copy of a single gene does not, in itself, appear enough to reproduce
the birth weight deficit or the 0-3 weeks rate of growth deficit, but may manifest as
the novel post weaning phenotype. I could test the hypothesis, and eliminate random
XCI as a variable, by making using of the Xist- allele (Marahrens et al., 1997).
XCI would become biased towards a specific, known X chromosome, allowing the
dissection of effects relating to expression of either a single wildtype allele, or a
single mutant allele. Such a model with multiple, reproducible expression levels
could also serve to facilitate greater understanding of the relationship between gene
dosage and phenotype, as these genes are widely acknowledged to be sensitive to
dosage modulation (Bellott et al., 2014; Cortez et al., 2014).
Figure 5.10: Model depicting XCI escapee expression in XX, XO, and XX- females.
Top: cartoon bar graphs representing arbitrary escapee expression levels from each
sex chromosome in XX, XO, and XX- female somatic cells. Bottom: Representation
of the composition of mice from which the above cells are taken, i.e. block colour =
100%.
Each of the heterozygous mutants used in the present study carries one mutant allele
for a single gene, although four genes have been identified and targeted as part of the
haploinsufficiency hypothesis. It therefore seems logical, and likely, that a female
carrying a mutation all four genes will recapitulate the XO phenotype to a greater
extent. Whilst this strategy was initially considered, the likelihood of being able to
generate enough female animals carrying four mutations on the same chromosome,
alongside wildtype littermates, to make biologically relevant conclusions is very
small. Instead, utilising the XY- female would be more straightforward (notwith-
standing the experiments proposed in 5.3.2), as the Y chromosome does not un-
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dergo recombination or XCI. Even taking into account the relatively poor breeding
performance of XY- females (A. Ojarikre, personal communication), these experi-
ments would undoubtedly be more achievable than the compound X linked mutant.
Generating mutations in Y linked homologues of the haploinsufficiency candidates
would also increased understanding of the roles of X:Y pairs not only in the con-
text of growth, but also more generally in terms of survival. I briefly touched on
this topic during the present chapter by demonstrating that Eif2s3x is essential for
postimplantation embryonic development (see 5.3.5).
5.3.5 Targeting and re targeting Eif2s3x
I was unable to generate a mutant line for the fourth candidate highlighted in the Y
expression and XCI escapee screens, Eif2s3x. After a number of initial in vivo at-
tempts, I failed to generate mutant pups, and doubted the veracity of the guide RNA.
I used injected embryos cultured to blastocyst primarily to test guide effectiveness
and confirm that mutations were being generated. Only secondarily was I interested
to see if there was any correlation between developmental progression and the mu-
tation suite observed following sequencing. Whilst I achieved the former, I did not
utilise a sufficient number of control embryos to report the success rate of culture
to the blastocyst stage of embryos injected with a scramble guide. It is clear that
the suite of mutations observed in preimplantation blastocysts is no longer present
in later stage embryos, and the embryos carrying such mutations must therefore be
eliminated prior to collection. However, based on the present blastocyst culture data
and paucity of control data, I cannot conclude whether this elimination occurs pre
or postimplantation, and further work is required.
The inability to generate a Eif2s3x mutant line was not surprising, given the re-
ported dosage sensitivity of the four haploinsufficiency candidates. However, it was
notable because targeting of Kdm5c, Kdm6a, and Ddx3x was almost immediately
successful in vivo. In hindsight, the apparently low success rate of the initial target-
ing of Eif2s3x in mESCs could be interpreted as highly efficient targeting of a gene
necessary for mESC survival. The discrepancy between success and failure is likely
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a result of different guide design strategies and efficiencies: a highly efficient guide
may increase the proportion of frameshift mutations (Haeussler et al., 2016), and
facilitate observation of the dominant phenotype, i.e. lethality, more often. In terms
of design, for this guide I targeted an exon in the centre of the coding sequence
instead of the initiator methionine (ATG), due to high homology between Eif2s3x
and Eif2s3x. Such a strategy may also be more efficient at ablating protein function
(Li et al., 2016).
I did not see any Eif2s3x mutant male animals born. It would be interesting to look
at the sex of the embryos analysed at E3.5, E6.5, E9.5 and E12.5, as I would expect
to see mutant males surviving over mutant females, given the presence of a 97%
similar homologue on the Y chromosome. Indeed, it has previously been shown
that Eif2s3x is able to partly compensate for the absence of its Y linked homologue
in spermatogenesis (Yamauchi et al., 2016). Based on the data presented here, no
Eif2s3x mutants with mutation suites reflecting those observed in the preimplanta-
tion embryo survived postimplanation development, let alone birth. I must there-
fore conclude that males and females are equally affected by the loss of Eif2s3x,
and Eif2s3y is not able to provide functional compensation. The roles of Kdm5c,
Kdm6a, and Ddx3x, and their Y linked homologues, in postnatal survival are the
subject of the next chapter.
Finally, as only a single guide sequence was utilised, and an off target screen was
not carried out, it is formally possible that the lethality phenotype observed could be
explained by an off target mutation. As methods for the detection of off target muta-
tions is a highly contentious area (Iyer et al., 2015; Haeussler et al., 2016; Schaefer
et al., 2017), the use of a number of different guides to achieve the same pheno-
type would provide the most robust confirmation. The work to re target Eif2s3x by
generating a conditional allele, followed by an off target screen, is ongoing.
Chapter 6
The contribution of X-Y homologous
genes to postnatal survival in the
mouse
6.1 Introduction
The mammalian sex chromosomes are thought to have originated from a pair of
autosomes around 180-200 million years ago (Cortez et al., 2014). The proto Y
chromosome evolved a dominant male determining locus, which resulted in the ac-
quisition of sexually antagonistic alleles nearby, and this in turn led to the suppres-
sion of recombination with the proto X (Wright et al., 2016). Over time, mammalian
Y chromosomes generally, and the mouse Y specifically, has lost, and gained, a sig-
nificant amount of gene-encoding DNA (Soh et al., 2014); though a small number
of genes have been conserved. These genes are the Y linked homologues of the
X linked genes targeted in Chapter 5: Ddx3y, Eif2s3y, Kdm5d, and Uty. Both X-Y
copies are broadly expressed, the X linked partner escapes XCI, and it is under more
intense purifying selection than neighbours on the X chromosome (Bellott et al.,
2014). Collectively, these characteristics suggest the longevity of X-Y pairs can be
attributed to selection pressure resulting from dosage sensitivity: copies have been
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maintained on both sex chromosomes because the organism cannot survive with
only a single copy. This is likely true for humans, evidenced by the X chromosome
monosomy Turner syndrome. Approximately 99% of XO female foetuses die in
utero, and those that survive are often mosaic for at least part of a second sex chro-
mosome (Cockwell et al., 1991; Hook and Warburton, 1983, 2014). In contrast, XO
female mice survive, albeit with a slight growth deficit (Chapter 5) and reduced fer-
tility (Burgoyne and Baker, 1981, 1985). The difference in survival between these
two mammalian species may result from the relatively small number of mouse X
linked genes that require two doses: there are only nine murine X-Y pairs, but 17
pairs in human (Bellott et al., 2014). The survival of XO female mice does, never-
theless, provide the opportunity to address X-Y pair functional divergence in mouse
using this model.
Our current understanding of X-Y pair divergence in the mouse stems from a num-
ber of transgenic mouse models. Male mice lacking the whole Y chromosome are
viable (Yamauchi et al., 2016). Yamauchi and colleagues showed that replacement
of the Y chromosome with transgenic copies of Eif2s3x and Sox9 could result in
males capable of siring offspring. In contrast, results from experiments targeting
X linked genes from X-Y pairs suggest functional divergence, as assessed by post-
natal survival. Numerous Kdm6a mutants have been published, and in all cases
homozygous mutant females die in utero (Lee et al., 2012; Wang et al., 2012; Sh-
pargel et al., 2012; Welstead et al., 2012; Mansour et al., 2012; Thieme et al., 2013).
Hemizygous mutant males showed reduced perinatal viability, and survivors exhib-
ited a lifelong growth deficit. Similarly, females carrying homozygous mutations
in Ddx3x die in utero, but in contrast to Kdm6a, hemizygous mutant males do not
survive beyond E6.5 (Chen et al., 2016a). Taken together, these data show that the
Y linked genes from X-Y pairs are no longer required for normal postnatal survival
in mouse; however, at least one copy of the X linked genes Ddx3x and Kdm6a are
necessary. In this Chapter, I looked to first confirm these results using the mutant
lines generated in house. I then utilised these animals, along with sex chromosome
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variant lines, to explore the functional redundancy of X-Y genes pairs in postnatal
survival.
6.2 Results
6.2.1 Kdm6a and Kdm5c are required for postnatal survival in
female mice
It has previously been shown that XX females homozygous for mutations in either
Kdm6a or Ddx3x die in utero (Lee et al., 2012; Shpargel et al., 2012; Welstead et al.,
2012; Chen et al., 2016a). I first sought to confirm this result, and test whether the
same conclusion could be applied to Kdm5c. To exclude XCI as a confounding
factor when comparing the postnatal survival of heterozygous mutant females with
homozygous mutant females, I used XO female mice, that do not undergo XCI. I
crossed a heterozygous mutant female with a XYO male (Burgoyne et al., 1998;
Odorisio et al., 1998), which could produce mutant X-O females along with wild-
type XO females within the same litter (Figure 6.1A; Table 6.5, Comparison 1).
I predicted that X-O females would not survive, consistent with previous data for
Kdm6a and Ddx3x. Such a result would serve to emphasise the importance of at
least one copy of each X linked gene from the X-Y gene pairs. I assayed survival
by genotyping pups at PN7. There were no Kdm6a X-O mutant females present, in
contrast to 27 XO wildtype females (Figure 6.1B, p=1.54x10-4; Table 6.1, adjusted
p=1.02x10-4). I conclude that at least one copy of Kdm6a is essential for postnatal
survival.
For Ddx3x I noted the survival of 12 Ddx3x X-O mutant females, compared with
3 XO wildtype females (Figure 6.1C, p=0.1207; Table 6.1, adjusted p=0.202). Al-
though the ratio of X-O mutant to XO wildtype females was undoubtedly impacted
by the low number of animals generated for the cross, the presence of any mutant
X-O mutant females was unexpected, based on previously reported data (Chen et al.,
2016b). This will be discussed further later.
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For Kdm5c, I recovered a single X-O mutant female at PN7, alongside 26 XO wild-
type females (Figure 6.1D, p=1.03x10-3; Table 6.1, adjusted p=1.21x10-3). In con-
clusion, in XO females, the loss of the single copy of Kdm6a and Kdm5c, but not
Ddx3x, compromises postnatal survival.
Number
Gene XO X-O adjusted p
Kdm6a 27 0 1.02x10-4
Ddx3x 3 12 2.02x10-1
Kdm5c 26 1 1.21x10-3
Table 6.1: Postnatal survival for XO vs X-O females.
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Figure 6.1: Postnatal survival of XO female mice carrying a single mutated allele,
relative to XO littermates. (A)(i) Mouse cross used to generate X-O and XO female
mice, and (ii) mosaic plot showing proportion of each genotype expected under the null
hypothesis. The Y axis represents the relative proportion of female:male as assessed by
gonadal sex, and the X axis breaks down the proportional contribution of each genotype
per gonadal sex. The hatched line shows 0.5 on the X axis. (B)(i) Number of animals per
genotype alive at postnatal day 7 for Kdm6a mutant line; numbers relate to genotypes in
equivalent location in A(i). The p value is derived from Fisher’s exact test. Orange ring
represents comparison of interest: see text. (C) As (B), for Ddx3x mutant line. (D) As (B),
for Kdm5c mutant line.
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6.2.2 Y linked genes partially compensate for loss of their X
linked homologues
Next I looked to determine whether Y linked genes from X-Y pairs could compen-
sate for loss of their X linked homologues. For this experiment, I wanted to compare
survival of XX homozygous mutant females to survival of X-Y hemizygous mutant
males. Given the results of the previous section, whereby Kdm6a and Kdm5c XO
mutant females did not survive, survival of any hemizygous mutant males would
suggest a degree of functional compensation. To generate homozygous mutant
females alongside hemizygous mutant males, heterozygous mutant females were
crossed with hemizygous mutant males (Figure 6.2A(i)).
For Kdm6a, as predicted, I observed no homozygous mutant females, and 9 hem-
izygous mutant males (Figure 6.2B, p=2.92x10-2; Table 6.2, adjusted p=4.50x10-2).
I conclude that the presence of the Y chromosome compensated for the loss of
Kdm6a.
Number
Gene X-X- X-Y adjusted p
Kdm6a 0 9 4.50x10-2
Ddx3x 8 26 1.73x10-2
Kdm5c 1 23 3.46x10-4
Table 6.2: Postnatal survival for X-X- vs X-Y animals
For Ddx3x, there were 8 homozygous mutant females, compared with 26 hemizy-
gous mutant males (Figure 6.2C, p=9.95x10-4; Table 6.2, adjusted p=1.73x10-2).
This showed that the presence of the Y chromosome compensated for the loss of
Ddx3x.
For Kdm5c, one homozygous mutant female was observed, compared with 23 hem-
izygous mutant males (Figure 6.2D, p=1.07x10-4; Table 6.2, adjusted p=3.46x10-4).
Taken together, these data suggested that the presence of a Y chromosome could
compensate for the loss of X linked genes Kdm6a, Ddx3x, and Kdm5c.
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In order to assess whether this compensation was complete or partial, I compared
the survival of hemizygous mutant males with wildtype males (Table 6.5, Compari-
son 3). Complete compensation was predicted to result in no difference in postnatal
survival between wildtype and hemizygous mutant males. I looked to crosses that
would enable a direct comparison between X-Y hemizygous mutant and XY wild-
type males. As data were available from the X-X x X-Y cross detailed in Figure
6.2, and the X-X x XY cross in Figure 6.3, a pool was created to increase statistical
power (Table 6.3).
For Kdm6a, hemizygous mutant males survived in significantly reduced numbers
compared to XY males (Table 6.3, p=1.00x10-2) as described previously (Lee et al.,
2012; Welstead et al., 2012; Shpargel et al., 2012) and in Chapter 5. I conclude that
loss of Kdm6a was not fully compensated for by its Y linked homologue, Uty.
Hemizygous males mutant for either Ddx3x or Kdm5c survived in fewer numbers
than XY wildtype males, though this difference did not reach significance (Table
6.3, p=2.89x10-1 and 3.31x10-1 respectively). Taken together, these data show that
Y linked genes Uty, Ddx3y and Kdm5d are able to at least partially compensate for
the loss of Kdm6a, Ddx3x, and Kdm5c, respectively. This compensation may be
more complete for the Kdm5c and Ddx3x, as there was no evidence of a significant
difference in postnatal survival between hemizygous mutant males and XY wildtype
males for these comparisons.
Number
Gene XY X-Y p
Kdm6a 52 20 1.00x10-2
Ddx3x 51 36 2.89x10-1
Kdm5c 77 59 3.31x10-1
Table 6.3: Postnatal survival for pooled XY vs X-Y males
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Figure 6.2: Postnatal survival of female mice carrying two mutated alleles, relative to
males with one mutated allele and an intact Y chromosome. (A)(i) Mouse cross used
to generate X-X-, XX-, X-Y, and XY wildtype littermates, and (ii) mosaic plot showing
proportion of each genotype expected under the null hypothesis. The Y axis represents the
relative proportion of female:male as assessed by gonadal sex, and the X axis breaks down
the proportional contribution of each genotype per gonadal sex. The hatched line shows
0.5 on the X axis. (B) (i) Number of animals per genotype alive at postnatal day 7 for
Kdm6a mutant line; numbers relate to genotypes in equivalent location in A(i). The p value
is derived from Fisher’s exact test. Orange ring represents comparison of interest: see text.
(C) As (B), for Ddx3x mutant line. (D) As (B), for Kdm5c mutant line.
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Figure 6.3: Postnatal survival of male and female mice carrying a single mutated al-
lele, relative to wildtype littermates. (A)(i) Mouse cross used to generate X-X, X-Y and
wildtype littermates, and (ii) mosaic plot showing proportion of each genotype expected
under the null hypothesis. The Y axis represents the relative proportion of female:male as
assessed by gonadal sex, and the X axis breaks down the proportional contribution of each
genotype per gonadal sex. The hatched line shows 0.5 on the X axis. (B)(i) Number of
animals per genotype alive at postnatal day 7 for Kdm6a mutant line; numbers relate to
genotypes in equivalent location in A(i). The p value is derived from Fisher’s exact test.
Coloured ring represents comparison of interest: see text. (C) As (B), for Ddx3x mutant
line. (D) As (B), for Kdm5c mutant line.
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6.2.3 Some Y linked genes can compensate for loss of their
X linked homologue independent of the hormonal mi-
lieu
Phenotypic sex differences between male and female mammals arise from the un-
equal effects of the sex chromosomes. Such effects can occur either directly, due
to differential gene expression from the X and Y chromosomes in XX and XY
non gonadal cells; or indirectly, via the gonads, resulting in hormonal differences
throughout life (Burgoyne and Arnold, 2016). In the previous experiment, I com-
pared postnatal survival between males and females without controlling for gonadal
sex, and thus not taking into account potential confounding effects of sex hormones.
I therefore looked to compare X-Y gene function within males and within females
separately.
As shown in Table 6.3, I had already established that hemizygous mutant males
survived in reduced numbers compared to wildtype males for all three mutant lines,
though this difference was only statistically significant for Kdm6a. I then looked
to test the female hormonal environment for the same X-Y pair effects. I assessed
whether the Y linked gene could compensate for the loss of its X linked homologue
within females.
For this experiment, I separated karyotypic sex from gonadal sex by using a male
carrying a Y chromosome engineered to lack the sex determining gene Sry, carry-
ing this gene instead as a transgene on an autosome (Gubbay et al., 1990). This
XYTdySry male (denoted XY- in Chapter 5) is thus able to produce four different
genotypes of sperm. Two of these genotypes will, following fertilisation, produce
female offspring, carrying either an X chromosome or a YTdy chromosome. The
two others will result in male offspring post fertilisation, and these sperm carry ei-
ther an X chromosome and the Sry transgene, or the YTdy chromosome and the Sry
transgene. I crossed this male with a female heterozygous for one of the mutant
alleles (Figure 6.4A(i,ii)). I compared postnatal survival in hemizygous mutant fe-
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males (X-YTdy) with XYTdy females (Table 6.5, Comparison 4). If the Y linked
gene could fully compensate, I would expect no significant difference in survival
between the two genotypes.
For Kdm6a, only one X-YTdy mutant female survived, whereas there were four
XYTdy females (Figure 6.4B(i,ii)). This cross also produced one hemizygous mu-
tant male and five wildtype males. I tentatively conclude that in both males and
females, the loss of Kdm6a is not fully compensated for by the presence of the Y
chromosome.
I did not recover any XYTdy control females from the Ddx3x cross, therefore no
conclusions can yet be drawn.
For Kdm5c, there was no significant difference in survival of X-YTdy mutant fe-
males survived compared to XYTdy females (Figure 6.4D(i,ii); Table 6.4, adjusted
p=9.20x10-1). Consistent with a previous cross (Figure 6.3D(i,ii)) there were fewer
surviving (X-YTdySry) mutant males than XYTdySry males, though again this differ-
ence was not significant (Table 6.3). I conclude from these data that in both males
and females, the loss of Kdm5c is fully compensated for by the presence of the Y
chromosome.
Gene Number p
XYTdyX-YTdy
Kdm6a 4 1 n/a
Ddx3x 0 2 n/a
Kdm5c 15 23 9.20x10-1
Table 6.4: Postnatal survival for pooled XYTdy vs X-YTdy females
The total number of animals used for each experiment described here was sub opti-
mal, partly due to the complexity of the mouse cross and the resulting eight possible
offspring genotypes. Taking into account this caveat, I conclude that in the female
hormonal environment Uty partially compensates for loss of its X linked homologue
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Kdm6a. Kdm5d appears to fully compensate for the loss of its X linked homologue
Kdm5c in the female hormonal environment. Further work is required to make any
conclusions regarding Ddx3y compensation for Ddx3x.
Number of copies
Comparison Genotype X
linked
allele
Y
linked
allele
Sum
X+Y
PAR Male
gonads
Wildtype XX 2 0 2 2 0
XY 1 1 2 2 1
1 XO 1 0 1 1 0
X-O 0 0 0 1 0
2 X-X- 0 0 0 2 0
X-Y 0 1 1 2 1
3 XY 1 1 2 2 1
X-Y 0 1 1 2 1
4 XYTdy 1 1 2 2 0
X-YTdy 0 1 1 2 0
Table 6.5: X-Y pair copy number summary for all comparisons
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Figure 6.4: Postnatal survival of XX and XY male, and XX and XY female mice car-
rying a single mutated allele, relative to wildtype littermates. (A)(i) Mouse cross used
to generate X-X, X-Y and wildtype littermates, and (ii) mosaic plot showing proportion
of each genotype expected under the null hypothesis. The Y axis represents the relative
proportion of female:male as assessed by gonadal sex, and the X axis breaks down the pro-
portional contribution of each genotype per gonadal sex. The hatched line shows 0.5 on the
X axis. (B) (i) Number of animals per genotype alive at postnatal day 7 for Kdm6a mutant
line; numbers relate to genotypes in equivalent location in A(i). The p value is derived from
Fisher’s exact test. Orange ring represents comparison of interest: see text. (C) As (B), for
Ddx3x mutant line. (D) As (B), for Kdm5c mutant line.
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6.3 Discussion
Around 180-200 million years ago, one chromosome from a pair of ancestral mam-
malian autosomes acquired a male determining locus, setting it on the path to be-
coming the present day Y chromosome via a process of degeneration and evolu-
tionary divergence. A small number of genes remained constant, and changed very
little, between the current X and Y chromosomes; and it has been suggested that
these genes were retained to maintain dosage.
6.3.1 The Ddx3x mutant allele is a hypomorph, not a knock-
out
Here, I have utilised mutant alleles generated previously (Chapter 5) to interrogate
the necessity of both members of these X-Y pairs in postnatal survival in mouse.
I have shown that at least one copy of Kdm6a is essential for survival; and this is
likely also true for Kdm5c and Eif2s3x. My data for Ddx3x are different to that pub-
lished by Chen and colleagues (2016). Their mutant allele consisted of an excised
block of 14 exons. In contrast, I removed 17bp within exon 1 of Ddx3x, which
was predicted to result in a frameshift and premature stop codon. Based on west-
ern blot data from homozygous female tissue, I conclude that the mutation resulted
in almost complete ablation of protein expression (Chapter 5, Fig. 5.7). Further-
more, homozygous mutant females showed significantly reduced survival compared
to X-Y males. Together, these data suggest that the 17bp mutation impairs DDX3X
protein function.
Interestingly, there are two alternative ATG sites downstream of the annotated
ATG, both in different reading frames (* in Chapter 5, Fig. 5.7). Whilst trans-
lation initiation sites can be accurately predicted using classical methods (Kozak,
1984), mutations have been associated with alternative translation products (Greene
et al., 2003). Moreover, recent work has suggested that mutations induced by
CRISPR/Cas can cause exon skipping, whereby the exon containing the deletion
is omitted from the final protein product (Kapahnke et al., 2016; Prykhozhij et al.,
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2017; Mou et al., 2017). Taken together, these data would suggest that an alterna-
tive translation initiation site or splicing event could be giving rise to reduced levels
of DDX3X expression in these mutant animals. This protein would function in a
similar way to the wildtype DDX3X protein, such that only a mild phenotype is
observed in females homozygous for the mutant allele. As this phenotype is in-
consistent with the published phenotype, I will use the data reported by Chen et al.
(2016) for further discussion of the roles of Ddx3x in postnatal survival.
6.3.2 Conservation of protein coding sequence does not equate
to conservation of gene function
Based on the results presented here, there exists a spectrum of functional divergence
between members of X-Y gene pairs in the mouse. Whilst Kdm5c undoubtedly
contributes to postnatal survival, this function can be at least partially, if not fully,
compensated for by the presence of the Y linked homologue Kdm5d in both males
and females. If at least one copy of either gene is present, the animal will survive.
This is in contrast to the evidence for Kdm6a, Ddx3x, and Eif2s3x. Regardless
of gonadal sex, the Y linked gene Uty can only partly compensate for loss of its X
linked homologue, Kdm6a. One copy of Ddx3x is essential for postnatal survival. In
the absence of Ddx3x, Ddx3y supports development until E6.5 in XY males (Chen
et al., 2016a). Further work is required to address the same question in hemizygous
mutant females. Finally, utilising the preliminary embryo data from Chapter 5,
Eif2s3x is also required in at least one copy for development to progress further
than E6.5.
Previous work has reported that X-Y pair genes are under more intense purify-
ing selection than other genes on the X chromosome, as evaluated by the ratio of
non synonymous to synonymous substitutions between human and mouse (Bellott
et al., 2014). Based on this result, it could be asserted that a high degree of protein
coding sequence conservation between X-Y pair genes would support functional
interchangeability. Interestingly, I have observed that there is a negative corre-
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lation between phenotype in hemizygous mutant males and amino acid sequence
homology in X-Y pairs (Table 6.6). Kdm5c and Kdm6a have moderate-high de-
grees of similarity to their Y linked homologues, and their loss of function gives
rise to a mild phenotype when the Y homologue is present. Ddx3x and Eif2s3x
are almost identical to their Y linked homologues at the amino acid level, and their
loss of function gives rise to a severe embryonic lethality phenotype when the Y
homologue is present. This suggests that, whilst homology in the protein coding
sequence is important to facilitate functional conservation, other factors certainly
contribute to the inability of these highly similar proteins to compensate for loss of
their homologue.
6.3.3 Differences in gene regulation likely underlie the apparent
functional differences in X-Y gene pairs
Recent work has begun to highlight the influence of cis and trans acting regulatory
mechanisms on gene expression and, therefore, phenotype. The concept of gene
regulation differences accounting for a significant proportion of phenotypic varia-
tion is not new (King and Wilson, 1975), however, the development of microarray
and RNA-seq technology has allowed a greater depth of study than was previously
possible. A well characterised example of this is alternative splicing, which can be
species, sex, organ or tissue specific (Blekhman et al., 2010; Merkin et al., 2012).
A mouse model of Down syndrome carrying a single human chromosome 21 was
shown to exhibit human specific exon skipping frequencies on this chromosome
(Barbosa-Morais et al., 2012). Such a result is likely explained by the activity of cis
acting regulatory elements specific to the human chromosome.
Of more direct relevance to X-Y pair genes is the evolution of testis specific expres-
sion by regulatory decay (Cortez et al., 2014). Across therian mammals, many Y
linked genes have undergone an almost complete reduction in expression in somatic
tissues than in the testis, thus becoming testis specific. Interestingly, the genes that
remained ubiquitously expressed, i.e. those from X-Y pairs, also have decreased
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expression levels (Cortez et al., 2014). This regulatory decay based reduction in
Y linked gene expression could potentially explain the observations that Ddx3y,
Eif2s3y and, to a certain extent Uty, cannot compensate for loss of X linked homo-
logues, despite a high degree of protein coding sequence similarity. Whilst all three
genes show widespread expression, the levels may not be equivalent to the X linked
copy. In support of this hypothesis, it was observed that in XO male mice, a single
transgenic copy of Eif2s3x could replace Eif2s3y in the initiation of spermatogene-
sis; but at least four transgenic copies were required for progression through meiosis
(Yamauchi et al., 2016). Kdm5d remains an anomaly; it is possible that this gene
has specifically evolved increased expression for an alternative function. A qRT-
PCR based approach assaying all four X-Y gene pairs across multiple tissues would
test this hypothesis and potentially show correlation.
In order to then determine the possible impact of an X chromosome based regula-
tory environment versus a Y chromosome based environment, a further experiment
would be to exchange the whole protein coding sequence of X and Y genes. Whilst
transgenic approaches have been used previously, these have typically utilised ran-
domly inserted BAC constructs, often in multiple copy arrays (Mazeyrat et al.,
2001). By taking advantage of the increased efficiency shown by CRISPR assisted
homologous recombination, it would be possible to replace, for example, the en-
dogenous protein coding sequence for Eif2s3x with the protein coding sequence
for Eif2s3y (Yoshimi et al., 2016). A conceptually similar experiment has previ-
ously been used to show that regulatory sequences immediately surrounding a gene
can directly control its expression, independent of the chromosomal context. BAC
based Kdm5c transgenes were inserted into multiple differences locations on the X
chromosome in single copies, and were able to escape XCI similar to the endoge-
nous gene (Li and Carrel, 2008). It would therefore be of significant interest to
observe how the Y linked gene sequence behaves within the X linked regulatory
context, and vice versa. Eventually, this would provide a focus for future work by
concisely addressing whether the survival phenotypes observed result from slight
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changes in protein coding sequence, or if we should increase efforts to understand
the sex chromosome gene regulatory landscape.
Gene X-Y male pheno-
type
XY pair amino acid
similarity (%)
Kdm5c Normal 76.6
Kdm6a Reduced viability 67.7
Ddx3x Embryonic lethal 90.2
Eif2s3x Embryonic lethal 97.9
Table 6.6: Phenotype: amino acid similarity correlation for X linked mutants
Multiple studies in recent years have focused on protein coding sequence varia-
tion between species in order to infer the evolutionary path of the mammalian sex
chromosomes (eg. Bellott et al., 2014; Cortez et al., 2014). We now know that
Kdm5d, Ddx3y and Uty are conserved across all eutherian mammals; with Eif2s3y
present in all non primate species, and possibly having been replaced by Eif1ay in
primates (Cortez et al., 2014; Hughes et al., 2015). When combined with signifi-
cantly increased annotation data on the X linked partners, ascribing functions such
as nucleic acid binding, transcription, and translation, we can infer that these genes
have been widely conserved, and maintain ubiquitous expression, because they reg-
ulate expression of target genes across the genome (Bellott et al., 2014). As I have
shown during this Chapter, significant homology at the protein coding level does
not, however, automatically lead to functional conservation. It is becoming increas-
ingly clear that changes in the regulation of gene expression may be of equal or
even greater importance than variation in protein coding sequence for understand-
ing speciation, or even intra species phenotypic differences between sexes. With
the ultimate goal of being able to predict how changes in sequences at regulatory
elements effect changes in gene expression, tractable model systems are required.
I believe that X-Y gene replacement model hypothesised here would provide the
opportunity to address some of these questions both in vitro and in vivo.
Chapter 7
Summary
In this thesis I have reported experiments I performed to begin to address the role of
the X chromosome in growth regulation in the mouse. This work was based around
the XO mouse, a model that has previously been shown to exhibit two distinct pe-
riods of growth deficit relative to XX littermates (Thornhill and Burgoyne, 1993;
Burgoyne et al., 2002).
In Chapter 3, I hypothesised that the growth deficit previously observed in XPO
embryos could result from inappropriate expression of Xist from the single X chro-
mosome. Using a previously published mutant Xist allele (Marahrens et al., 1997) I
found that, in the genetic absence of Xist, XPO embryos were still growth retarded
relative to XYRIII littermates. I concluded that Xist is not the cause of the growth
deficit, and put forward an alternative hypothesis that the phenotype could result
from differential expression of imprinted genes affecting embryonic growth. As
embryos with an active XM in extraembryonic tissue do not show the growth deficit
phenotype, and XPO embryos have only an active XP in extraembryonic tissue, I
suggested that an extraembryonic defect would be more likely than an embryonic
defect.
In Chapter 4, I used in vitro stem cell models to facilitate the search for candi-
date imprinted genes differentially expressed between XPO, XMO, and XX geno-
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types. Initially I derived cell lines from both extraembryonic and embryonic com-
partments, mTSCs and mESCs respectively, and the latter were differentiated to-
wards mEpiLCs in order to model the epiblast. I differentiated the mTSCs to model
terminally differentiated placental cells, and found no difference between the sex
chromosome genotypes in propensity towards or away from a given lineage.
Using RNA-seq followed by differential gene expression analysis, I identified a
small number of genes differentially expressed between genotypes within cell types
for both mESCs and mEpiLCs. Most interestingly, I highlighted around 3800 genes
differentially expressed between either XPO or XMO and XX mTSCs. These genes
were physically distributed across the whole genome, suggesting global transcrip-
tional dysregulation in the aneuploid state. There were potential confounding fac-
tors in the bioinformatic analysis that could change the current interpretation of the
results, and further work is undoubtedly warranted.
In Chapter 5, I set out to investigate the genetic basis underlying the postnatal
growth deficit of both XPO and XMO female mice. Firstly I recapitulated previ-
ous results: both XPO and XMO female mice had a period of reduced rate of growth
in the 0-3 week period, as did female mice with a single X chromosome and a sec-
ond copy of the PAR. I further confirmed that XY- females do not show the reduced
rate of growth. I then used RT-PCR and RFLP analyses to identify four candidate
genes on the mouse Y chromosome that may underlie this apparent rescue: Kdm5d,
Uty, Ddx3y, and Eif2s3y. I hypothesised that carrying only a single X linked copy
of these genes, as per the XO female, may be detrimental to the growth of the an-
imal. I used CRISPR-Cas genome editing to generate new mutant lines for the X
linked genes, aiming to compare XX females, carrying two copies of a given target
gene, with X-X females, carrying a single copy of the gene. The results for Kdm5c,
Kdm6a, or Ddx3x did not recapitulate the postnatal growth deficit phenotype, likely
due to a combination of factors, as discussed in the Chapter. I was not able to
generate a mutant line for Eif2s3x, and I found that embryos carrying mutations
in this gene do not survive beyond E6.5. This gene is therefore embryonic lethal,
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and not functionally compensated for by the presence of its Y linked homologue
Eif2s3y.
In Chapter 6, I sought to address functional conservation between X-Y gene pairs
on the mouse sex chromosomes, utilising the mutant models reported in Chapter 5.
It has previously been shown that at least one copy of both Kdm6a and Ddx3x are
required for postnatal survival, suggesting that the Y linked homologues of these
genes have functionally diverged from their former X linked pairing partners. (Sh-
pargel et al., 2012; Chen et al., 2016a). I confirmed that Kdm6a is required for
postnatal survival in females, and that Uty only partially compensates for the loss
of Kdm6a in males. Furthermore, I showed that Kdm5c is also required for post-
natal survival in females, whereas in males, Kdm5d fully compensates for loss of
Kdm5c. The data for Ddx3x were not consistent with the previously published phe-
notype, and this led me to conclude that the mutant allele reported in this thesis is a
hypomorph. Taken together with the results from Chapter 5 regarding Eif2s3x and
Chen and colleagues study on Ddx3x, I concluded that Kdm6a and Uty, Ddx3x and
Ddx3y, and Eif2s3x and Eif2s3y are functionally divergent in the mouse. In contrast,
Kdm5c and Kdm5d appear to have conserved function, as assessed by postnatal sur-
vival. Given that both the X and Y linked genes in the X-Y gene pairs are highly
similar at the amino acid level, it is likely that changes in gene regulation underlie
the functional divergence reported here.
In summary, I have generated data supporting a role for the X chromosome in both
embryonic and postnatal growth in the mouse, though further work is undoubt-
edly required to confirm the individual loci involved. I have also provided initial
evidence regarding the significance of sex chromosome aneuploidy in the mouse
placenta, and I am excited to continue investigations in this area. Finally, prelimi-
nary data addressing functional convergence between X-Y gene pairs suggest that
three of the four Y linked genes have diverged, and are no longer able to function-
ally compensate for loss of the X linked homologues. These results are at odds with
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recent hypotheses regarding mammalian sex chromosome evolution in the literature
(eg. Bellott et al., 2014), and certainly merit further work.
Appendix A
Cell culture media and solutions
Concentration(mM)
Component Follicle holdingmedium (FHM)
Potassium-
supplemented simplex
optimised medium
(KSOM)
NaCl 95 95
KH2PO4 2.5 2.5
MgSO4 0.2 0.2
Lactate 10 10
Pyruvate 0.2 0.2
Glucose 0.2 0.2
Glutamine 1 1
Bovine serum albumin 1mg/ml 1mg/ml
EDTA 0.01 0.01
NaHCO3 4 25
HEPES 20 n/a
CaCl2 1.71 1.71
Table A.1: Components of embryo culture media used in this thesis
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Medium Component Source Product code Volume Final conc.
2iLIF Penicillin-streptomycin Thermo Fisher Scientific
(Waltham, USA)
150700A973163 5ml 50U/ml and
50ug/ml
Glutamax Thermo Fisher Scientific
(Waltham, USA)
35050038 5ml 2mM
Human recombinant
serum albumin
Sigma-Aldrich (St Louis,
USA)
A9731 500ul 50ug/ml
PD 0325901 Axon Medchem (Gronin-
gen, Netherlands)
1408 167ul 1uM
CHIR 99021 Axon Medchem (Gronin-
gen, Netherlands)
1386 167ul 3uM
Human recombinant LIF Merck-Millipore() ESG1107 50ul 1000U/ml
2-mercaptoethanol Sigma-Aldrich (St Louis,
USA)
M6250 3ul 0.1uM
NDiff227 Cellartis/Takara-Clontech
(Tokyo, Japan)
Y40002 (to
500ml)
n/a
Trophoblast
stem cell
Foetal bovine serum Thermo Fisher Scientific
(Waltham, USA)
16000044 75ml 15% (v/v)
Penicillin-streptomycin Thermo Fisher Scientific
(Waltham, USA)
150700A973163 5ml 50U/ml and
50ug/ml
Sodium pyruvate Thermo Fisher Scientific
(Waltham, USA)
11360070 5ml 1mM
Recombinant human
FGF4
Peprotech (London, UK) 100-31 500ul 25ng/ml
Heparin Sigma-Aldrich (St Louis,
USA)
H3149 50ul 1ug/ml
2-mercaptoethanol Sigma-Aldrich (St Louis,
USA)
M6250 3ul 0.1uM
RPMI1640 +Glutamax Thermo Fisher Scientific
(Waltham, USA)
61870010 (to
500ml)
n/a
Mouse
embry-
onic
fibroblast
Foetal bovine serum Thermo Fisher Scientific
(Waltham, USA)
16000044 50ml 10% (v/v)
Penicillin-streptomycin Thermo Fisher Scientific
(Waltham, USA)
150700A973163 5ml 50U/ml and
50ug/ml
2-mercaptoethanol Sigma-Aldrich (St Louis,
USA)
M6250 3ul 0.1uM
DMEM +Glutamax Thermo Fisher Scientific
(Waltham, USA)
61965026 (to
500ml)
n/a
Table A.2: Components of cell culture media used in this thesis
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Solution Component Concentration
P1 Tris (pH8) 15mM
EDTA 10mM
RNAse A 100ug/ml
P2 NaOH 200mM
Sodium dodecyl sul-
phate
1%
P3 KOAc (pH5.5) 3M
2X saline sodium salt
(SSC)
NaCl 300mM
Na3C6H5O7 30mM
HCl to pH7.0
2X hybridisation buffer SSC 4X
Dextran sulphate 50%
Bovine serum albumin 2mg/ml
Vanadyl ribonucleoside 2mM
Radioimmunoprecipitation
assay (RIPA) buffer
Tris-Cl (pH8.0) 10mM
EDTA 1mM
EGTA 0.5mM
Triton-X100 1%
Sodium deoxycholate 0.1%
Sodium dodecyl sul-
phate
0.1%
NaCl 140mM
Phenylmethane sulpho-
nyl fluoride (PMSF)
1mM
Laemmli buffer Tris-Cl (pH6.8) 60mM
Sodium dodecyl sul-
phate
2%
Glycerol 10%
2-mercaptoethanol 5%
Bromophenol blue 0.01%
Western blot running
buffer
Tris base 3g/L
Glycine 14.4g/L
Sodium dodecyl sul-
phate
1g/L
Western blot transfer
buffer
Tris base 3g/L
Glycine 14.4g/L
Sodium dodecyl sul-
phate
50mg/L
Tris buffered
saline/Tween (TBS/T)
Tris-Cl (pH7.5) 20mM
NaCl 150mM
Tween-20 0.2%
KT lysis buffer Tris Cl (pH9.1) 67mM
(NH4)2SO4 16mM
MgCl2 3.5mM
Bovine serum albumin 150ug/ml
Proteinase K 800ug/ml
Triton-X100 0.5%
Table A.3: Components of solutions used in this thesis
Appendix B
Oligonucleotide sequences
Chapter Oligo Sequence Reference
3 InX_F CTGCAATGCCTGCTGTTTTA
InX_R CCGGAGTACAAAGGGAGTCA
Ymt2b_F CTGGAGCTCTACAGTGATGA Bishop and Hatat, 1987
Ymt2b_R CAGTTACCAATCAACACATCAC
Xist_mut_F TCTTTTTCTTTTGCCCATCG Marahrens et al., 1997
Xist_mut_R TACCGGTGGATGTGGAATGT
Xist_RT_F CGACCTATTCCCTTTGACGA
Xist_RT_R GTTGATCCTCGGGTCATTTA
GAPDH_RT_F TGTCGTGGAGTCTACTGGTG
GAPDH_RT_R TTCACACCCATCACAAACAT
Continued on next page
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4 Cdx2_F TCCTGCTGACTGCTTTCTGA
Cdx2_R CCCTTCCTGATTTGTGGAGA
Eomes_F GGAAGTGACAGAGGACGGTG
Eomes_R GCCGTGTACATGGAATCGTAG
Elf5_F GGACTCCGTAACCCATAGCA
Elf5_R TACTGGTCGCAGCAGAATTG
Tfap2c_F TGCACACAGGGTATTGAAAC
Tfap2c_R CGTCACCCACACAAACTAAA
Bmp4_F GAGTTTCCATCACGAAGAACA
Bmp4_R GCTCACATCGAAAGTTTCCC
Esrrb_F AACAGCCCCTACCTGAACCT
Esrrb_R CTCATCTGGTCCCCAAGTGT
Gata3_F GGGTTCGGATGTAAGTCGAG
Gata3_R CCACAGTGGGGTAGAGGTTG
Rhox4b_F AGGGAAGCACTCAGGACATG
Rhox4b_R TTTGTCCCATTCCACTGCTG
Syna_F TTGCAATCACACCTTTCAGC
Syna_R TGGTGTCCACAGACAGGGTA
Synb_F CTTTCCACCACCCATACGTT
Synb_R TGACCTTGAAGTGGGTAGGG
Snai1_F CACGCTGCCTTGTGTCTG
Snai1_R AGACTCTTGGTGCTTGTGGA
Gcm1_F CTGCCTCAGAACGTGAAAACG
Gcm1_R TTGTGGTTGTTGGTGTTGCG
Ascl2_F TAAGGGCTGAGCACCAGGAC
Ascl2_R CGTACCAGTCAAGGTGTGCTT
Continued on next page
216
Chapter Oligo Sequence Reference
Tpbpa_F CCAGCACAGCTTTGGACATCA
Tpbpa_R AGCATCCAACTGCGCTTCA
Pcdh12_F GCTGCTTTTGCGGAACGGAA
Pcdh12_R TTTGGGCTGGAATTGGCCCT
Hand1_F CAAGATCAAGACTCTGCGCC
Hand1_R TTAATCCTCTTCTCGCCGGG
Pl1_F GGAGCCTACATTGTGGTGGA
Pl1_R TCCCTATACACATCTGCGGC
Prl2c2_F TGCTCCTGGATACTGCTCCT
Prl2c2_R TGAGACAAACTGCCGGCTAA
Prl3d3_F GGCTCCGGAATGCAATTGTT
Prl3d3_R TCCCTATACACATCTGCGGC
Gapdh_qrt_F TGTCGTGGAGTCTACTGGTG
Gapdh_qrt_R TTCACACCCATCACAAACAT
Srp72_F GGAGTGAGGTGAACCGTTATG
Srp72_R AGGCAAACTACTTTACAGTGCAG
Ctsq_probe TAQMAN MM01349948_M1
Gapdh_probe TAQMAN MM99999915_G1
Srp72_probe TAQMAN MM01211622_G1
Nanog_F AGCAGATGCAAGAACTCTCCTC
Nanog_R AAGTTGGGTTGGTCCAAGTCT
Pou5f1_F CCCCAATGCCGTGAAGTTG
Pou5f1_R TCAGCAGCTTGGCAAACTGTT
Fgf5_F AAAGTCAATGGCTCCCACGAA
Fgf5_R CTTCAGTCTGTACTTCACT
Wnt3_F CAAGCACAACAATGAAGCAGGC
Continued on next page
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Wnt3_R TCGGGACTCACGGTGTTTCTC
Dnmt3b_F CTCGCAAGGTGTGGGCTTTTGTAAC
Dnmt3b_R CTGGGCATCTGTCATCTTTGCACC
Sox2_probe TAQMAN MM03053810_S1
5 Zfy1_RT_F CACGCAGTAGAGAGTGAGACC
Zfy1_RT_R GGTACTGTTTGGATTCAGGTC
Ube1y1_RT_F CTTACGAGCTCTGGAGCACTT
Ube1y1_RT_R CTTCTCAAAGTCAATGGGGTA
Kdm5d_RT_F GAGACCCGTGAGGCTCTAAC
Kdm5d_RT_R TTGAATCTCATTCACATCAGCA
Eif2s3y_RT_F GTACAGTAGCCGAAGGAGCTC
Eif2s3y_RT_R ACCACCTGGAGCAGCATACT
Uty_RT_F TTCTGGAAGGAGACAGAAAGC
Uty_RT_R GAACACCCCAATAATCTTCAGG
Ddx3y_RT_F GTTCGATGATCATGGTCGA
Ddx3y_RT_R CTTCATAGCCTTCAAAGCCTC
Usp9y_RT_F GGATGGTCAACTCTGGCTCTG
Usp9y_RT_R CTGATTAGCTTGCAATTTGGG
Zfy2_RT_F GGATGAGCCTAGCAAAACAG
Zfy2_RT_R CATAAGCTGCTGTCCATGC
H2al2y_RT_F CCGTGTAGATCGTTTCCTTG Royo et al., 2010
H2al2y_RT_R AGAGTTGGTGGAGCTGTTCC
Sry_RT_F GAGGGCCATGTCAAGCG
Sry_RT_R AGGTGCCCAGTGGGGATAT
Rbmy1a1_RT_F GCGTCTTCCAGAAGAGATGAGT
Rbmy1a1_RT_R GAGTGGTAATTGCCATAGTCACAG
Continued on next page
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Ssty1_RT_F GAGCCTGTCACCCAATGG
Ssty1_RT_R CCTCAGAGCCATCTTTCCTCTC
Ssty2_RT_F GCCATCATTCTAGGTCAACTG
Sly_RT_F TAAACAACCCAGCAATTGGT
Sly_RT_R GGTCCATGGACTTCTCATGC
Ddx3x_RFLP_F AAAGCCGCAGTTCTCCCG
Ddx3x_RFLP_R TGCTTGCTGTACTTCCTCCA
Kdm5c_RFLP_F AGAAGGAGCTGGGGTTGTAC
Kdm5c_RFLP_R AGCTGTAGAGGAGGCTGTTG
Kdm6a_RFLP_F AGCTGAAGGGAAAGTGGAGT
Kdm6a_RFLP_R AGCCCACTGAAATGCATTGT
Foxo4_RFLP_F AGCTCGGCAGGATGGAAG
Foxo4_RFLP_R GCCCATCCAGTAGCTCTAGA
Eif2s3x_RFLP_F ATCCCGTGTGCACAGAAGTA
Eif2s3x_RFLP_R GTTGGTGTGCTACTTTGGGG
Kdm5c_g1_F CACCGCCCCCTAAGCCCTTGACGGG
Kdm5c_g1_R AAACCCCGTCAAGGGCTTAGGGGGC
Kdm5c_g2_F CACCGGCGGCGCCATGCGTCCTTAA
Kdm5c_g2_R AAACTTAAGGACGCATGGCGCCGCC
Kdm5c_g1_T7 TTAATACGACTCACTATAGGCCCCCTAAGCCCTTGACGGG
Kdm5c_g2_T7 TTAATACGACTCACTATAGGGCGGCGCCATGCGTCCTTAA
Kdm5c_screen_F TTTCGCGATGTAGCCAAGAG
Kdm5c_screen_R AGGCTTCAGTAGTTGGGAGG
Kdm5c_geno_F TGTGGTGAGGTACAGAGGTG
Kdm5c_geno_R CGGCGATGGGTCTGATTTTC
Kdm5c_miseq_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTGTGGTGAGGTACAGAGGTG
Continued on next page
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Kdm5c_miseq_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTTTCGCGATGTAGCCAAGAG
Kdm6a_g1_F CACCGTGCGTTTCCATGAAATCCTG
Kdm6a_g1_R AAACCAGGATTTCATGGAAACGCAC
Kdm6a_g2_F CACCGGGTAGCGAGCGACACTCCGC
Kdm6a_g2_R AAACGCGGAGTGTCGCTCGCTACCC
Kdm6a_g1_T7 TTAATACGACTCACTATAGGTGCGTTTCCATGAAATCCTG
Kdm6a_g2_T7 TTAATACGACTCACTATAGGGGTAGCGAGCGACACTCCGC
Kdm6a_screen_F CCTTCACCTCTACCGCGTTA
Kdm6a_screen_R GACCCGTCCGTGCCAAAG
Kdm6a_miseq_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTCTGCCTTCACCTCTACC
Kdm6a_miseq_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCGTACCTGTCCAGTCCG
Ddx3x_g1_F CACCGAGTGGAAAATGCGCTCGGGC
Ddx3x_g1_R AAACGCCCGAGCGCATTTTCCACTC
Ddx3x_g2_F CACCGCGCGGCTCAGGCTCACCTGC
Ddx3x_g2_R AAACGCAGGTGAGCCTGAGCCGCGC
Ddx3x_g1_T7 TTAATACGACTCACTATAGGAGTGGAAAATGCGCTCGGGC
Ddx3x_g2_T7 TTAATACGACTCACTATAGGCGCGGCTCAGGCTCACCTGC
Ddx3x_screen_F GTAGCAGTCCTCCGAGTCG
Ddx3x_screen_R CATCCAGTCCCTCCAGAGC
Ddx3x_miseq_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGAGAGGAGGGCACACGTC
Ddx3x_miseq_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTCGGGCCAGGGACAATAC
Eif2s3x_g1_F CACCGCCGACAGGATCTCGCCACAT
Eif2s3x_g1_R AAACATGTGGCGAGATCCTGTCGGC
Eif2s3x_g2_F CACCGAAAGCCAGGGCCTACCAATG
Eif2s3x_g2_R AAACCATTGGTAGGCCCTGGCTTTC
Eif2s3x_g3_F CACCGTATGTAGGAACCGTAGCAGA
Continued on next page
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Eif2s3x_g3_R AAACTCTGCTACGGTTCCTACATAC
Eif2s3x_g1_T7 TTAATACGACTCACTATAGGCCGACAGGATCTCGCCACAT
Eif2s3x_g2_T7 TTAATACGACTCACTATAGGAAAGCCAGGGCCTACCAATG
Eif2s3x_g3_T7 TTAATACGACTCACTATAGGTATGTAGGAACCGTAGCAGA
Eif2s3x_screen_F TGAGTTTGAAATCTACAGGGGAC
Eif2s3x_screen_R AGAATCTTGATCGAGGGGCT
Eif2s3x_miseq_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGACTAATAAGAAGCACGGAAGAGT
Eif2s3x_miseq_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCTTTGTTAACTAGGCCCAGTG
Kdm5c_OT1_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTAAACAACCCTGGGCAGTG
Kdm5c_OT1_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGTCTAGCCAGGAGTGACAC
Kdm5c_OT2_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGACTCTCTGCACCTGACTCAC
Kdm5c_OT2_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGAAGGTGCCACTTGAACC
Kdm5c_OT3_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGCAGCTGGACACTAGCATTAC
Kdm5c_OT3_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAGGGCTGGAATGATGTTTACA
Kdm5c_OT4_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCAGGGCTGGTATCATCTCCA
Kdm5c_OT4_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATCATGAAGACCTGGGGCTT
Kdm5c_OT5_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTAGGCTGTAAAGTTTCGGGA
Kdm5c_OT5_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCAACAGTGCGGTGAATCC
Kdm5c_OT6_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCTGCCTTCTGTGTTATGCCC
Kdm5c_OT6_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATCCCAGACACTTCACCCAG
Kdm6a_OT1_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCTCCTTCCCTTCCCCATCTC
Kdm6a_OT1_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTTTCGTCTCCTCCTGCAGA
Kdm6a_OT2_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTGGGGCCTTCATTGTTTGTG
Kdm6a_OT2_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTTCCCAGGGCTCTCAAAGA
Kdm6a_OT3_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTGTTGGAACGCAGAGGTTTC
Kdm6a_OT3_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAGGAGTTTTCACACAGGCC
Continued on next page
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Kdm6a_OT4_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGGGACTGAGACTTTAGGCT
Kdm6a_OT4_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATACTGCAGCATTGACTCGC
Kdm6a_OT5_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAACCGAGTTCATGGTGGTGA
Kdm6a_OT5_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCAGAGCACATCCACAAATGA
Kdm6a_OT6_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAAACAAGTTTCAGGGCAGCC
Kdm6a_OT6_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAGTGCTGTGAAGACGACCT
Ddx3x_OT1_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGTGAGTGGTGATGTCTGTGT
Ddx3x_OT1_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCGATGCTCTGAGTGAAAAC
Ddx3x_OT2_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTTGACGTGGCCAGTAAAG
Ddx3x_OT2_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACAACTCCAGTACAGCCTCT
Ddx3x_OT3_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAAAAGCCCCACTCCAAAGC
Ddx3x_OT3_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGTCTTCCTTGCTGTGTGAG
Ddx3x_OT4_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCGGTAGCCTCCTCGTCAG
Ddx3x_OT4_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCCACTGCCCCTCTCTG
Ddx3x_OT5_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCTTGCTTTCCTTCGTCA
Ddx3x_OT5_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTTTGTGAGGTGCCCAACA
Ddx3x_OT6_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGCCAAGTCAGACAGAAGCCA
Ddx3x_OT6_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTGTGGTGGTGGGTAGGTC
Ddx3x_OT7_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCAGCCCACACTTCAGAATGG
Ddx3x_OT7_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCATTTGTGTCCCTGGCTTC
Appendix C
Antibodies and BACs
Antibody Species Supplier Product
code
Dilution
KDM5C
(JARID1C)
Rabbit mAb Cell Signaling Technol-
ogy (Boston, USA)
5361 1:1000
DDX3X Rabbit pAb Abcam (Cambridge, UK) ab128206 1:1000
KDM6A (UTX) Rabbit pAb Proteintech (Manchester,
UK)
23984 1:1000
GAPDH Rabbit pAb Abcam (Cambridge, UK) ab9485 1:10000
Anti rabbit, HRP
linked
Goat Cell Signaling (Boston,
USA)
7074S 1:4000
Anti mouse, HRP
linked
Goat Santa Cruz Biotechnol-
ogy (Dallas, USA)
sc-20005 1:4000
Table C.1: Antibodies used in this thesis
Target CHORI BAC clone
SLX (X chromosome) RP23 470D15
SLY (Y chromosome) RP24 502P05
PAR RP24 255O24
Table C.2: BAC clones used in this thesis
Appendix D
Colophon
This document was set in the Times Roman typeface using LATEX and BibTEX, com-
posed with a text editor.
Bibliography
Abidi, F. E., L. Holloway, C. A. Moore, D. D. Weaver, R. J. Simensen, R. E. Steven-
son, R. C. Rogers, and C. E. Schwartz
2008. Mutations in JARID1C are associated with X-linked mental retardation,
short stature and hyperreflexia. Journal of Medical Genetics, 45(12):787–793.
Adam, M. P. and L. Hudgins
2005. Kabuki syndrome: a review. Clinical Genetics, 67(3):209–219.
Adegbola, A., H. Gao, S. Sommer, and M. Browning
2008. A novel mutation in JARID1C/SMCX in a patient with autism spectrum
disorder (ASD). American Journal of Medical Genetics. Part A, 146A(4):505–
511.
Adler, D. A., E. I. Rugarli, P. A. Lingenfelter, K. Tsuchiya, D. Poslinski, H. D.
Liggitt, V. M. Chapman, R. W. Elliott, A. Ballabio, and C. M. Disteche
1997. Evidence of evolutionary up-regulation of the single active X chromosome
in mammals based on Clc4 expression levels in Mus spretus and Mus musculus.
Proceedings of the National Academy of Sciences of the United States of America,
94(17):9244–9248.
Agger, K., P. A. C. Cloos, J. Christensen, D. Pasini, S. Rose, J. Rappsilber, I. Is-
saeva, E. Canaani, A. E. Salcini, and K. Helin
2007. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene
regulation and development. Nature, 449(7163):731–734.
BIBLIOGRAPHY 225
Agulnik, A. I., M. J. Mitchell, J. L. Lerner, D. R. Woods, and C. E. Bishop
1994a. A mouse Y chromosome gene encoded by a region essential for sper-
matogenesis and expression of male-specific minor histocompatibility antigens.
Human Molecular Genetics, 3(6):873–878.
Agulnik, A. I., M. J. Mitchell, M. G. Mattei, G. Borsani, P. A. Avner, J. L. Lerner,
and C. E. Bishop
1994b. A novel X gene with a widely transcribed Y-linked homologue escapes
X-inactivation in mouse and human. Human Molecular Genetics, 3(6):879–884.
Aitken, R. J. and J. Graves
2002. Human spermatozoa: the future of sex. Nature, 415(6875):963–963.
Akimoto, C., H. Kitagawa, T. Matsumoto, and S. Kato
2008. Spermatogenesis-specific association of SMCY and MSH5. Genes to
Cells, 13(6):623–633.
Anderson, C. L. and C. J. Brown
2005. Epigenetic predisposition to expression of TIMP1 from the human inactive
X chromosome. BMC Genetics, 6(1):48.
Arcipowski, K. M., C. A. Martinez, and P. Ntziachristos
2016. Histone demethylases in physiology and cancer: a tale of two enzymes,
JMJD3 and UTX. Current Opinion in Genetics & Development, 36:59–67.
Ariumi, Y., M. Kuroki, K. Abe, H. Dansako, M. Ikeda, T. Wakita, and N. Kato
2007. DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA
Replication. Journal of Virology, 81(24):13922–13926.
Armoskus, C., D. Moreira, K. Bollinger, O. Jimenez, S. Taniguchi, and H.-W. Tsai
2014. Identification of sexually dimorphic genes in the neonatal mouse cortex
and hippocampus. Brain Research, 1562(C):23–38.
Aza-Carmona, M., D. J. Shears, P. Yuste-Checa, V. Barca-Tierno, A. Hisado-Oliva,
A. Belinchon, S. Benito-Sanz, J. I. Rodriguez, J. Argente, A. Campos-Barros,
BIBLIOGRAPHY 226
P. J. Scambler, and K. E. Heath
2011. SHOX interacts with the chondrogenic transcription factors SOX5
and SOX6 to activate the aggrecan enhancer. Human Molecular Genetics,
20(8):1547–1559.
Bacher, C. P., M. Guggiari, B. Brors, S. Augui, P. Clerc, P. Avner, R. Eils, and
E. Heard
2006. Transient colocalization of X-inactivation centres accompanies the initia-
tion of X inactivation. Nature Cell Biology, 8(3):293–299.
Bachtrog, D.
2014. Signs of Genomic Battlesin Mouse Sex Chromosomes. Cell, 159(4):716–
718.
Bachtrog, D., J. E. Mank, C. L. Peichel, M. Kirkpatrick, S. P. Otto, T.-L. Ashman,
M. W. Hahn, J. Kitano, I. Mayrose, R. Ming, N. Perrin, L. Ross, N. Valenzuela,
J. C. Vamosi, and The Tree of Sex Consortium
2014. Sex Determination: Why So Many Ways of Doing It? PLoS Biology,
12(7):e1001899–13.
Bailey, J. A., L. Carrel, A. Chakravarti, and E. E. Eichler
2000. Molecular evidence for a relationship between LINE-1 elements and X
chromosome inactivation: The Lyon repeat hypothesis. Proceedings of the Na-
tional Academy of Sciences of the United States of America, 97(12):6634–6639.
Balaton, B. P. and C. J. Brown
2016. Escape Artists of the X Chromosome. Trends in Genetics, 32(6):348–359.
Ballabio, A., R. Carrozzo, A. Gil, B. Gillard, N. Affara, M. A. Ferguson-Smith,
N. Fraser, I. Craig, M. Rocchi, and G. Romeo
1989. Molecular characterization of human X/Y translocations suggests their
aetiology through aberrant exchange between homologous sequences on Xp and
Yq. Annals of Human Genetics, 53(Pt 1):9–14.
BIBLIOGRAPHY 227
Banka, S., E. Howard, S. Bunstone, K. E. Chandler, B. Kerr, K. Lachlan, S. McKee,
S. G. Mehta, A. L. T. Tavares, J. Tolmie, and D. Donnai
2013. MLL2 mosaic mutations and intragenic deletion-duplications in patients
with Kabuki syndrome. Clinical Genetics, 83(5):467–471.
Banzai, M., K. Omoe, H. Ishikawa, and A. Endo
1995a. Viability, development and incidence of chromosome anomalies of preim-
plantation embryos from XO mice. Cytogenetics and Cell Genetics, 70(3-4):273–
277.
Banzai, M., K. Omoe, H. Ishikawa, and A. Endo
1995b. Viability, development and incidence of chromosome anomalies of preim-
plantation embryos from XO mice. Cytogenetic and Genome Research, 70(3-
4):273–277.
Barakat, T. S., F. Loos, S. van Staveren, E. Myronova, M. Ghazvini, J. A. Groote-
goed, and J. Gribnau
2014. The Trans-Activator RNF12 and Cis-Acting Elements Effectuate X Chro-
mosome Inactivation Independent of X-Pairing. Molecular Cell, 53(6):965–978.
Barbosa-Morais, N. L., M. Irimia, Q. Pan, H. Y. Xiong, S. Gueroussov, L. J. Lee,
V. Slobodeniuc, C. Kutter, S. Watt, R. Colak, T. Kim, C. M. Misquitta-Ali, M. D.
Wilson, P. M. Kim, D. T. Odom, B. J. Frey, and B. J. Blencowe
2012. The evolutionary landscape of alternative splicing in vertebrate species.
Science, 338(6114):1587–1593.
Barca-Tierno, V., M. Aza-Carmona, E. Barroso, D. Heine-Suner, D. Azmanov,
J. Rosell, B. Ezquieta, L. S. Montané, T. Vendrell, J. Cruz, F. Santos, J. I.
Rodríguez, J. Pozo, J. Argente, L. Kalaydjieva, R. Gracia, A. Campos-Barros,
S. Benito-Sanz, and K. E. Heath
2011. Identification of a Gypsy SHOX mutation (p.A170P) in Léri-Weill
dyschondrosteosis and Langer mesomelic dysplasia. European Journal of Hu-
man Genetics, 19(12):1218–1225.
BIBLIOGRAPHY 228
Barton, S. C., M. A. Surani, and M. L. Norris
1984. Role of paternal and maternal genomes in mouse development. Nature,
311(5984):374–376.
Barutcu, A. R., B. R. Lajoie, R. P. McCord, C. E. Tye, D. Hong, T. L. Messier,
G. Browne, A. J. van Wijnen, J. B. Lian, J. L. Stein, J. Dekker, A. N. Imbalzano,
and G. S. Stein
2015. Chromatin interaction analysis reveals changes in small chromosome and
telomere clustering between epithelial and breast cancer cells. Genome Biology,
Pp. 1–14.
Beach, R. R., C. Ricci-Tam, C. M. Brennan, C. A. Moomau, P.-h. Hsu, B. Hua,
R. E. Silberman, M. Springer, and A. Amon
2017. Aneuploidy Causes Non-genetic Individuality. Cell, 169(2):229–242.e21.
Beckham, C., A. Hilliker, A.-M. Cziko, A. Noueiry, M. Ramaswami, and R. Parker
2008. The DEAD-box RNA helicase Ded1p affects and accumulates in Saccha-
romyces cerevisiae P-bodies. Molecular Biology of the Cell, 19(3):984–993.
Belin, V., V. Cusin, G. Viot, D. Girlich, A. Toutain, A. Moncla, M. Vekemans,
M. Le Merrer, A. Munnich, and V. Cormier-Daire
1998. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nature
Genetics, 19(1):67–69.
Bellott, D. W., J. F. Hughes, H. Skaletsky, L. G. Brown, T. Pyntikova, T.-J.
Cho, N. Koutseva, S. Zaghlul, T. Graves, S. Rock, C. Kremitzki, R. S. Fulton,
S. Dugan, Y. Ding, D. Morton, Z. Khan, L. Lewis, C. Buhay, Q. Wang, J. Watt,
M. Holder, S. Lee, L. Nazareth, S. Rozen, D. M. Muzny, W. C. Warren, R. A.
Gibbs, R. K. Wilson, and D. C. Page
2014. Mammalian Y chromosomes retain widely expressed dosage-sensitive reg-
ulators. Nature, 508(7497):494–499.
BIBLIOGRAPHY 229
Bellott, D. W. and D. C. Page
2009. Reconstructing the evolution of vertebrate sex chromosomes. Cold Spring
Harbor Symposia on Quantitative Biology, 74(0):345–353.
Benchetrit, H., S. Herman, N. van Wietmarschen, T. Wu, K. Makedonski, N. Maoz,
N. Y. Tov, D. Stave, R. Lasry, V. Zayat, A. Xiao, P. M. Lansdorp, S. Sebban, and
Y. Buganim
2015. Extensive Nuclear Reprogramming Underlies Lineage Conversion into
Functional Trophoblast Stem-like Cells. Cell Stem Cell, 17(5):1–40.
Benito-Sanz, S., N. S. Thomas, C. Huber, D. Gorbenko del Blanco, D. G.
Del Blanco, M. Aza-Carmona, J. A. Crolla, V. Maloney, G. Rappold, J. Argente,
A. Campos-Barros, V. Cormier-Daire, and K. E. Heath
2005. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX
is associated with Leri-Weill dyschondrosteosis. American Journal of Human
Genetics, 77(4):533–544.
Berletch, J. B., W. Ma, F. Yang, J. Shendure, W. S. Noble, C. M. Disteche, and
X. Deng
2015. Escape from X Inactivation Varies in Mouse Tissues. PLoS Genetics,
11(3):e1005079–26.
Birchler, J. A.
2014. Facts and artifacts in studies of gene expression in aneuploids and sex
chromosomes. Chromosoma, 123(5):459–469.
Birtle, Z., L. Goodstadt, and C. Ponting
2005. Duplication and positive selection among hominin-specific PRAME genes.
BMC Genomics, 6:120.
Bishop, C. E. and D. Hatat
1987. Molecular cloning and sequence analysis of a mouse Y chromosome RNA
transcript expressed in the testis. Nucleic Acids Research, 15(7):2959–2969.
BIBLIOGRAPHY 230
Bishop, D. V., E. Canning, K. Elgar, E. Morris, P. A. Jacobs, and D. H. Skuse
2000. Distinctive patterns of memory function in subgroups of females with
Turner syndrome: evidence for imprinted loci on the X-chromosome affecting
neurodevelopment. Neuropsychologia, 38(5):712–721.
Blackburn, D. G. and A. F. Flemming
2011. Invasive implantation and intimate placental associations in a placen-
totrophic african lizard, Trachylepis ivensi (scincidae). Journal of Morphology,
273(2):137–159.
Blakeley, P., N. M. E. Fogarty, I. del Valle, S. E. Wamaitha, T. X. Hu, K. Elder,
P. Snell, L. Christie, P. Robson, and K. K. Niakan
2015. Defining the three cell lineages of the human blastocyst by single-cell
RNA-seq. Development, 142(20):3613–3613.
Blakeslee, A. F., J. Belling, and M. E. Farnham
1920. Chromosomal duplication and Mendelian phenomena in Datura mutants.
Science, 52(1347):388–390.
Blank, H. M., J. M. Sheltzer, C. M. Meehl, and A. Amon
2015. Mitotic entry in the presence of DNA damage is a widespread property of
aneuploidy in yeast. Molecular Biology of the Cell, 26(8):1440–1451.
Blaschke, K., K. T. Ebata, M. M. Karimi, J. A. Zepeda-Martínez, P. Goyal, S. Ma-
hapatra, A. Tam, D. J. Laird, M. Hirst, A. Rao, M. C. Lorincz, and M. Ramalho-
Santos
2013. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-
like state in ES cells. Nature, 500(7461):222–226.
Blaschke, R. J., A. P. Monaghan, S. Schiller, B. Schechinger, E. Rao, H. Padilla-
Nash, T. Ried, and G. A. Rappold
1998. SHOT, a SHOX-related homeobox gene, is implicated in craniofacial,
brain, heart, and limb development. Proceedings of the National Academy of
Sciences of the United States of America, 95(5):2406–2411.
BIBLIOGRAPHY 231
Blekhman, R., J. C. Marioni, P. Zumbo, M. Stephens, and Y. Gilad
2010. Sex-specific and lineage-specific alternative splicing in primates. Genome
Research, 20(2):180–189.
Blok, L. S., E. Madsen, J. Juusola, C. Gilissen, D. Baralle, M. R. F. Reijnders,
H. Venselaar, C. Helsmoortel, M. T. Cho, A. Hoischen, L. E. L. M. Vissers,
T. S. Koemans, W. Wissink-Lindhout, E. E. Eichler, C. Romano, H. Van Esch,
C. Stumpel, M. Vreeburg, E. Smeets, K. Oberndorff, B. W. M. van Bon, M. Shaw,
J. Gecz, E. Haan, M. Bienek, C. Jensen, B. L. Loeys, A. Van Dijck, A. M.
Innes, H. Racher, S. Vermeer, N. Di Donato, A. Rump, K. Tatton-Brown, M. J.
Parker, A. Henderson, S. A. Lynch, A. Fryer, A. Ross, P. Vasudevan, U. Kini,
R. Newbury-Ecob, K. Chandler, A. Male, S. Dijkstra, J. Schieving, J. Giltay,
K. L. I. van Gassen, J. Schuurs-Hoeijmakers, P. L. Tan, I. Pediaditakis, S. A.
Haas, K. Retterer, P. Reed, K. G. Monaghan, E. Haverfield, M. Natowicz, A. My-
ers, M. C. Kruer, Q. Stein, K. A. Strauss, K. W. Brigatti, K. Keating, B. K. Burton,
K. H. Kim, J. Charrow, J. Norman, A. Foster-Barber, A. D. Kline, A. Kimball,
E. Zackai, M. Harr, J. Fox, J. McLaughlin, K. Lindstrom, K. M. Haude, K. van
Roozendaal, H. Brunner, W. K. Chung, R. F. Kooy, R. Pfundt, V. Kalscheuer,
S. G. Mehta, N. Katsanis, T. Kleefstra, and T. D. Study
2015. Mutations in DDX3X are a common cause of unexplained intellectual dis-
ability with gender-specific effects on Wnt signaling. The American Journal of
Human Genetics, 97(2):343–352.
Bol, G. M., F. Vesuna, M. Xie, J. Zeng, K. Aziz, N. Gandhi, A. Levine, A. Irving,
D. Korz, S. Tantravedi, M. R. Heerma van Voss, K. Gabrielson, E. A. Bordt,
B. M. Polster, L. Cope, P. van der Groep, A. Kondaskar, M. A. Rudek, R. S.
Hosmane, E. van der Wall, P. J. van Diest, P. T. Tran, and V. Raman
2015a. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
EMBO Molecular Medicine, 7(5):1–23.
BIBLIOGRAPHY 232
Bol, G. M., M. Xie, and V. Raman
2015b. DDX3, a potential target for cancer treatment. Molecular Cancer,
14(1):188.
Bonomi, M., V. Rochira, D. Pasquali, G. Balercia, E. A. Jannini, A. Ferlin, and
Klinefelter ItaliaN Group (KING)
2017. Klinefelter syndrome (KS): genetics, clinical phenotype and hypogo-
nadism. Journal of endocrinological investigation, 40(2):123–134.
Borck, G., B.-S. Shin, B. Stiller, A. Mimouni-Bloch, H. Thiele, J.-R. Kim,
M. Thakur, C. Skinner, L. Aschenbach, P. Smirin-Yosef, A. Har-Zahav,
G. Nürnberg, J. Altmüller, P. Frommolt, K. Hofmann, O. Konen, P. Nürnberg,
A. Munnich, C. E. Schwartz, D. Gothelf, L. Colleaux, T. E. Dever, C. Kubisch,
and L. Basel-Vanagaite
2012. eIF2γ mutation that disrupts eIF2 complex integrity links intellectual dis-
ability to impaired translation initiation. Molecular Cell, 48(4):641–646.
Borensztein, M., L. Syx, K. Ancelin, P. Diabangouaya, C. Picard, T. Liu, J.-B.
Liang, I. Vassilev, R. Galupa, N. Servant, E. Barillot, A. Surani, C.-J. Chen, and
E. Heard
2017. Xist-dependent imprinted X inactivation and the early developmental con-
sequences of its failure. Nature Structural & Molecular Biology, 24(3):226–233.
Borsani, G., R. Tonlorenzi, M. C. Simmler, L. Dandolo, D. Arnaud, V. Capra,
M. Grompe, A. Pizzuti, D. Muzny, and C. Lawrence
1991. Characterization of a murine gene expressed from the inactive X chromo-
some. Nature, 351(6324):325–329.
Bouma, G. J., Q. J. Hudson, L. L. Washburn, and E. M. Eicher
2010. New Candidate Genes Identified for Controlling Mouse Gonadal Sex De-
termination and the Early Stages of Granulosa and Sertoli Cell Differentiation.
Biology of Reproduction, 82(2):380–389.
BIBLIOGRAPHY 233
Branco, M. R., M. King, V. Perez-Garcia, A. B. Bogutz, M. Caley, E. Fineberg,
L. Lefebvre, S. J. Cook, W. Dean, M. Hemberger, and W. Reik
2016. Maternal DNA Methylation Regulates Early Trophoblast Development.
Developmental Cell, 36(2):152–163.
Brandt, J., S. Schrauth, A.-M. Veith, A. Froschauer, T. Haneke, C. Schultheis,
M. Gessler, C. Leimeister, and J.-N. Volff
2005a. Transposable elements as a source of genetic innovation: expression and
evolution of a family of retrotransposon-derived neogenes in mammals. Gene,
345(1):101–111.
Brandt, J., A. M. Veith, and J. N. Volff
2005b. A family of neofunctionalized Ty3/gypsy retrotransposon genes in mam-
malian genomes. Cytogenetic and Genome Research, 110(1-4):307–317.
Brawand, D., M. Soumillon, A. Necsulea, P. Julien, G. Csárdi, P. Harrigan,
M. Weier, A. Liechti, A. Aximu-Petri, M. Kircher, F. W. Albert, U. Zeller,
P. Khaitovich, F. Grützner, S. Bergmann, R. Nielsen, S. Pääbo, and H. Kaess-
mann
2011. The evolution of gene expression levels in mammalian organs. Nature,
478(7369):343–348.
Bray, N. L., H. Pimentel, P. Melsted, and L. Pachter
2016. Near-optimal probabilistic RNA-seq quantification. Nature Biotechnology,
34(5):525–527.
Brockdorff, N., A. Ashworth, G. F. Kay, P. Cooper, S. Smith, V. M. McCabe, D. P.
Norris, G. D. Penny, D. Patel, and S. Rastan
1991. Conservation of position and exclusive expression of mouse Xist from the
inactive X chromosome. Nature, 351(6324):329–331.
Brook, C. G., G. Mürset, M. Zachmann, and A. Prader
1974. Growth in children with 45,XO Turner’s syndrome. Archives of disease in
childhood, 49(10):789–795.
BIBLIOGRAPHY 234
Brown, C. J., A. Ballabio, J. L. Rupert, R. G. Lafreniere, M. Grompe, R. Tonlorenzi,
and H. F. Willard
1991. A gene from the region of the human X inactivation centre is expressed
exclusively from the inactive X chromosome. Nature, 349(6304):38–44.
Bunt, J., N. A. Hasselt, D. A. Zwijnenburg, J. Koster, R. Versteeg, and M. Kool
2012. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medul-
loblastoma by maintaining their H3K27me3 levels. Acta Neuropathologica,
125(3):385–394.
Burgoyne, P. S.
1982. Genetic homology and crossing over in the X and Y chromosomes of
Mammals. Human Genetics, 61(2):85–90.
Burgoyne, P. S.
1993. A Y-chromosomal effect on blastocyst cell number in mice. Development,
117(1):341–345.
Burgoyne, P. S. and A. P. Arnold
2016. A primer on the use of mouse models for identifying direct sex chromo-
some effects that cause sex differences in non-gonadal tissues. Biology of Sex
Differences, 7(1):68.
Burgoyne, P. S. and T. G. Baker
1981. Oocyte depletion in XO mice and their XX sibs from 12 to 200 days post
partum. Journal of Reproduction and Fertility, 61(1):207–212.
Burgoyne, P. S. and T. G. Baker
1985. Perinatal oocyte loss in XO mice and its implications for the aetiology
of gonadal dysgenesis in XO women. Journal of Reproduction and Fertility,
75(2):633–645.
Burgoyne, P. S. and J. D. Biggers
1976. The consequences of X-dosage deficiency in the germ line: impaired de-
BIBLIOGRAPHY 235
velopment in vitro of preimplantation embryos from XO mice. Developmental
Biology, 51(1):109–117.
Burgoyne, P. S. and E. P. Evans
2000. A high frequency of XO offspring from X(Paf)Y* male mice: evidence
that the Paf mutation involves an inversion spanning the X PAR boundary. Cyto-
genetics and Cell Genetics, 91(1-4):57–61.
Burgoyne, P. S., E. P. Evans, and K. Holland
1983a. XO monosomy is associated with reduced birthweight and lowered weight
gain in the mouse. Journal of Reproduction and Fertility, 68(2):381–385.
Burgoyne, P. S., S. K. Mahadevaiah, J. Perry, S. J. Palmer, and A. Ashworth
1998. The Y* rearrangement in mice: new insights into a perplexing PAR. Cyto-
genetics and Cell Genetics, 80(1-4):37–40.
Burgoyne, P. S., O. A. Ojarikre, and J. M. A. Turner
2002. Evidence that postnatal growth retardation in XO mice is due to haploin-
sufficiency for a non-PAR X gene. Cytogenetic and Genome Research, 99(1-
4):252–256.
Burgoyne, P. S., P. Tam, and E. P. Evans
1983b. Retarded development of XO conceptuses during early pregnancy in the
mouse. Journal of Reproduction and Fertility, 68(2):387–393.
Burgoyne, P. S., A. R. Thornhill, S. K. Boudrean, S. M. Darling, C. E. Bishop, E. P.
Evans, B. Capel, and U. Mittwoch
1995. The Genetic Basis of XX-XY Differences Present before Gonadal Sex
Differentiation in the Mouse [and Discussion]. Philosophical Transactions of the
Royal Society B: Biological Sciences, 350(1333):253–261.
Calabrese, J. M., J. Starmer, M. D. Schertzer, D. Yee, and T. Magnuson
2015. A survey of imprinted gene expression in mouse trophoblast stem cells.
G3, 5(5):751–759.
BIBLIOGRAPHY 236
Carney, E. W., V. Prideaux, S. J. Lye, and J. Rossant
1993. Progressive expression of trophoblast-specific genes during formation of
mouse trophoblast giant cells in vitro. Molecular Reproduction and Development,
34(4):357–368.
Carrel, L., P. A. Hunt, and H. F. Willard
1996. Tissue and lineage-specific variation in inactive X chromosome expression
of the murine Smcx gene. Human Molecular Genetics, 5(9):1361–1366.
Carrel, L. and H. F. Willard
1999. Heterogeneous gene expression from the inactive X chromosome: an X-
linked gene that escapes X inactivation in some human cell lines but is inactivated
in others. Proceedings of the National Academy of Sciences of the United States
of America, 96(13):7364–7369.
Carrel, L. and H. F. Willard
2005. X-inactivation profile reveals extensive variability in X-linked gene ex-
pression in females. Nature, 434(7031):400–404.
Carver, E. A. and L. Stubbs
1997. Zooming in on the human-mouse comparative map: genome conservation
re-examined on a high-resolution scale. Genome Research, 7(12):1123–1137.
Castagné, R., M. Rotival, T. Zeller, P. S. Wild, V. Truong, D.-A. Trégouët, T. Mun-
zel, A. Ziegler, F. Cambien, S. Blankenberg, and L. Tiret
2011. The choice of the filtering method in microarrays affects the infer-
ence regarding dosage compensation of the active X-chromosome. PLoS ONE,
6(9):e23956.
Cattanach, B. M.
1961. XXY mice. Genetical Research, 2(01):156–158.
Cattanach, B. M.
1962. XO mice. Genetical Research, 3(03):487–490.
BIBLIOGRAPHY 237
Chang, P.-C., C.-W. Chi, G.-Y. Chau, F.-Y. Li, Y.-H. Tsai, J.-C. Wu, and Y.-H.
Wu Lee
2005. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-
associated hepatocellular carcinoma and is involved in cell growth control. Onco-
gene, 25(14):1991–2003.
Chao, C.-H., C.-M. Chen, P.-L. Cheng, J. W. Shih, A.-P. Tsou, and Y.-H. W. Lee
2006. DDX3, a DEAD box RNA helicase with tumor growth-suppressive prop-
erty and transcriptional regulation activity of the p21waf1/cip1 promoter, is a
candidate tumor suppressor. Cancer Research, 66(13):6579–6588.
Charlesworth, B.
2006. The evolutionary biology of sex. Current Biology, 16(17):R693–5.
Chen, C.-Y., C.-H. Chan, C.-M. Chen, Y.-S. Tsai, T. Y. Tsai, Y. H. Wu Lee, and
L.-R. You
2016a. Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in pla-
centation and embryogenesis. Human Molecular Genetics, 25(14):2905–2922.
Chen, G., J. P. Schell, J. A. Benitez, S. Petropoulos, M. Yilmaz, B. Reinius, Z. Alek-
seenko, L. Shi, E. Hedlund, F. Lanner, R. Sandberg, and Q. Deng
2016b. Single-cell analyses of X Chromosome inactivation dynamics and
pluripotency during differentiation. Genome Research, 26(10):1342–1354.
Chen, H., Z. K. Attieh, T. Su, B. A. Syed, H. Gao, R. M. Alaeddine, T. C. Fox,
J. Usta, C. E. Naylor, R. W. Evans, A. T. McKie, G. J. Anderson, and C. D. Vulpe
2004a. Hephaestin is a ferroxidase that maintains partial activity in sex-linked
anemia mice. Blood, 103(10):3933–3939.
Chen, T.-C., H. Waldmann, and P. J. Fairchild
2004b. Induction of dominant transplantation tolerance by an altered peptide
ligand of the male antigen Dby. Journal of Clinical Investigation, 113(12):1754–
1762.
BIBLIOGRAPHY 238
Chen, Z., Z. Liu, J. Huang, T. Amano, C. Li, S. Cao, C. Wu, B. Liu, L. Zhou, M. G.
Carter, D. L. Keefe, X. Yang, and L. Liu
2009. Birth of Parthenote Mice Directly from Parthenogenetic Embryonic Stem
Cells. Stem Cells, 27(9):2136–2145.
Chen, Z., J. Zang, J. Whetstine, X. Hong, F. Davrazou, T. G. Kutateladze, M. Simp-
son, Q. Mao, C.-H. Pan, S. Dai, J. Hagman, K. Hansen, Y. Shi, and G. Zhang
2006. Structural insights into histone demethylation by JMJD2 family members.
Cell, 125(4):691–702.
Cho, Y.-W., T. Hong, S. Hong, H. Guo, H. Yu, D. Kim, T. Guszczynski, G. R.
Dressler, T. D. Copeland, M. Kalkum, and K. Ge
2007. PTIP associates with MLL3- and MLL4-containing histone H3 ly-
sine 4 methyltransferase complex. The Journal of Biological Chemistry,
282(28):20395–20406.
Chomez, P., O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas
2001. An overview of the MAGE gene family with the identification of all human
members of the family. Cancer Research, 61(14):5544–5551.
Chow, J. C., C. Ciaudo, M. J. Fazzari, N. Mise, N. Servant, J. L. Glass, M. Attreed,
P. Avner, A. Wutz, E. Barillot, J. M. Greally, O. Voinnet, and E. Heard
2010. LINE-1 activity in facultative heterochromatin formation during X chro-
mosome inactivation. Cell, 141(6):956–969.
Christensen, J., K. Agger, P. A. C. Cloos, D. Pasini, S. Rose, L. Sennels, J. Rappsil-
ber, K. H. Hansen, A. E. Salcini, and K. Helin
2007. RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethy-
lated Lysine 4 on Histone 3. Cell, 128(6):1063–1076.
Chu, D. S., H. Liu, P. Nix, T. F. Wu, E. J. Ralston, J. R. Yates, III, and B. J. Meyer
2006. Sperm chromatin proteomics identifies evolutionarily conserved fertility
factors. Nature, 443(7107):101–105.
BIBLIOGRAPHY 239
Chureau, C., S. Chantalat, A. Romito, A. Galvani, L. Duret, P. Avner, and
C. Rougeulle
2011. Ftx is a non-coding RNA which affects Xist expression and chromatin
structure within the X-inactivation center region. Human Molecular Genetics,
20(4):705–718.
Chureau, C., M. Prissette, A. Bourdet, V. Barbe, L. Cattolico, L. Jones, A. Eggen,
P. Avner, and L. Duret
2002. Comparative sequence analysis of the X-inactivation center region in
mouse, human, and bovine. Genome Research, 12(6):894–908.
Cleaton, M. A. M., C. A. Edwards, and A. C. Ferguson-Smith
2014. Phenotypic Outcomes of Imprinted Gene Models in Mice: Elucidation of
Pre- and Postnatal Functions of Imprinted Genes. Annual Review of Genomics
and Human Genetics, 15(1):93–126.
Clement-Jones, M., S. Schiller, E. Rao, R. J. Blaschke, A. Zuniga, R. Zeller, S. C.
Robson, G. Binder, I. Glass, T. Strachan, S. Lindsay, and G. A. Rappold
2000. The short stature homeobox gene SHOX is involved in skeletal abnormal-
ities in Turner syndrome. Human Molecular Genetics, 9(5):695–702.
Coan, P. M., G. J. Burton, and A. C. Ferguson-Smith
2005. Imprinted genes in the placenta – A review. Placenta, 26:S10–S20.
Coate, J. E. and J. J. Doyle
2010. Quantifying Whole Transcriptome Size, a Prerequisite for Understanding
Transcriptome Evolution Across Species: An Example from a Plant Allopoly-
ploid. Genome Biology and Evolution, 2(0):534–546.
Cobb, J., A. Dierich, Y. Huss-Garcia, and D. Duboule
2006. A mouse model for human short-stature syndromes identifies Shox2 as an
upstream regulator of Runx2 during long-bone development. Proceedings of the
National Academy of Sciences of the United States of America, 103(12):4511–
4515.
BIBLIOGRAPHY 240
Cockwell, A., M. MacKenzie, S. Youings, and P. Jacobs
1991. A cytogenetic and molecular study of a series of 45,X fetuses and their
parents. Journal of Medical Genetics, 28(3):151–155.
Conesa, A., P. Madrigal, S. Tarazona, D. Gomez-Cabrero, A. Cervera, A. McPher-
son, M. W. Szczes´niak, D. J. Gaffney, L. L. Elo, X. Zhang, and A. Mortazavi
2016. A survey of best practices for RNA-seq data analysis. Genome Biology,
17(1):1–19.
Cong, L., F. A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P. D. Hsu, X. Wu,
W. Jiang, L. A. Marraffini, and F. Zhang
2013. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science,
339(6121):819–823.
Conway, E., E. Healy, and A. P. Bracken
2015. PRC2 mediated H3K27 methylations in cellular identity and cancer. Cur-
rent Opinion in Cell Biology, 37:42–48.
Cooper, D. W., J. L. VandeBerg, G. B. Sharman, and W. E. Poole
1971. Phosphoglycerate kinase polymorphism in kangaroos provides further ev-
idence for paternal X inactivation. Nature: New Biology, 230(13):155–157.
Corbel, C., P. Diabangouaya, A.-V. Gendrel, J. C. Chow, and E. Heard
2013. Unusual chromatin status and organization of the inactive X chromosome
in murine trophoblast giant cells. Development, 140(4):861–872.
Cordin, O., J. Banroques, N. K. Tanner, and P. Linder
2006. The DEAD-box protein family of RNA helicases. Gene, 367:17–37.
Correa, S. M., L. L. Washburn, R. S. Kahlon, M. C. Musson, G. J. Bouma, E. M.
Eicher, and K. H. Albrecht
2012. Sex Reversal in C57BL/6J XY Mice Caused by Increased Expression of
Ovarian Genes and Insufficient Activation of the Testis Determining Pathway.
PLoS Genetics, 8(4):e1002569–20.
BIBLIOGRAPHY 241
Cortez, D., R. Marin, D. Toledo-Flores, L. Froidevaux, A. Liechti, P. D. Waters,
F. Grützner, and H. Kaessmann
2014. Origins and functional evolution of Y chromosomes across mammals.
Nature, 508(7497):488–493.
Cotton, A. M., C.-Y. Chen, L. L. Lam, W. W. Wasserman, M. S. Kobor, and C. J.
Brown
2014. Spread of X-chromosome inactivation into autosomal sequences: role for
DNA elements, chromatin features and chromosomal domains. Human Molecu-
lar Genetics, 23(5):1211–1223.
Cremer, T., M. Cremer, S. Dietzel, S. Müller, I. Solovei, and S. Fakan
2006. Chromosome territories – a functional nuclear landscape. Current Opinion
in Cell Biology, 18(3):307–316.
Cross, J. C., Z. Werb, and S. J. Fisher
1994. Implantation and the placenta: key pieces of the development puzzle.
Science, 266(5190):1508–1518.
Curry, C. J., R. E. Magenis, M. Brown, J. T. Lanman, J. Tsai, P. O’Lague, P. Good-
fellow, T. Mohandas, E. A. Bergner, and L. J. Shapiro
1984. Inherited chondrodysplasia punctata due to a deletion of the terminal short
arm of an X chromosome. New England Journal of Medicine, 311(16):1010–
1015.
Dalgliesh, G. L., K. Furge, C. Greenman, L. Chen, G. Bignell, A. Butler, H. Davies,
S. Edkins, C. Hardy, C. Latimer, J. Teague, J. Andrews, S. Barthorpe, D. Beare,
G. Buck, P. J. Campbell, S. Forbes, M. Jia, D. Jones, H. Knott, C. Y. Kok, K. W.
Lau, C. Leroy, M.-L. Lin, D. J. McBride, M. Maddison, S. Maguire, K. McLay,
A. Menzies, T. Mironenko, L. Mulderrig, L. Mudie, S. O’Meara, E. Pleasance,
A. Rajasingham, R. Shepherd, R. Smith, L. Stebbings, P. Stephens, G. Tang,
P. S. Tarpey, K. Turrell, K. J. Dykema, S. K. Khoo, D. Petillo, B. Wondergem,
BIBLIOGRAPHY 242
J. Anema, R. J. Kahnoski, B. T. Teh, M. R. Stratton, and P. A. Futreal
2010. Systematic sequencing of renal carcinoma reveals inactivation of histone
modifying genes. Nature, 463(7279):360–363.
Davies, W., A. Isles, R. Smith, D. Karunadasa, D. Burrmann, T. Humby,
O. Ojarikre, C. Biggin, D. Skuse, P. Burgoyne, and L. Wilkinson
2005. Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects
on cognitive function in mice. Nature Genetics, 37(6):625–629.
De Plaen, E., O. De Backer, D. Arnaud, B. Bonjean, P. Chomez, V. Martelange,
P. Avner, P. Baldacci, C. Babinet, S. Y. Hwang, B. Knowles, and T. Boon
1999. A new family of mouse genes homologous to the human MAGE genes.
Genomics, 55(2):176–184.
de Sousa Abreu, R., L. O. Penalva, E. M. Marcotte, and C. Vogel
2009. Global signatures of protein and mRNA expression levels. Molecular
bioSystems, 5(12):1512–1526.
DeCarlo, K., A. Emley, O. E. Dadzie, and M. Mahalingam
2011. Laser Capture Microdissection: Methods and Applications. In Laser Cap-
ture Microdissection, G. I. Murray, ed., Pp. 1–15. Totowa, NJ: Humana Press.
DeChiara, T. M., E. J. Robertson, and A. Efstratiadis
1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell,
64(4):849–859.
Deckers, J. F. M. and P. H. W. Van der Kroon
1981. Some characteristics of the XO mouse (Mus musculus L.) I. Vitality:
Growth and metabolism. Genetica, 55(3):179–185.
Deckert, J., K. Hartmuth, D. Boehringer, N. Behzadnia, C. L. Will, B. Kastner,
H. Stark, H. Urlaub, and R. Lührmann
2006. Protein composition and electron microscopy structure of affinity-
purified human spliceosomal B complexes isolated under physiological condi-
tions. Molecular and Cellular Biology, 26(14):5528–5543.
BIBLIOGRAPHY 243
Dekker, J. and E. Heard
2015. Structural and functional diversity of Topologically Associating Domains.
FEBS Letters, 589(20 Pt A):2877–2884.
Deng, Q., D. Ramskold, B. Reinius, and R. Sandberg
2014. Single-Cell RNA-Seq Reveals Dynamic, Random Monoallelic Gene Ex-
pression in Mammalian Cells. Science, 343(6167):193–196.
Deng, X., J. B. Hiatt, D. K. Nguyen, S. Ercan, D. Sturgill, L. W. Hillier,
F. Schlesinger, C. A. Davis, V. J. Reinke, T. R. Gingeras, J. Shendure, R. H.
Waterston, B. Oliver, J. D. Lieb, and C. M. Disteche
2011. Evidence for compensatory upregulation of expressed X-linked genes in
mammals, Caenorhabditis elegans and Drosophila melanogaster. Nature Reviews
Genetics, 43(12):1179–1185.
Diez-Roux, G., S. Banfi, M. Sultan, L. Geffers, S. Anand, D. Rozado, A. Magen,
E. Canidio, M. Pagani, I. Peluso, N. Lin-Marq, M. Koch, M. Bilio, I. Cantiello,
R. Verde, C. De Masi, S. A. Bianchi, J. Cicchini, E. Perroud, S. Mehmeti,
E. Dagand, S. Schrinner, A. Nürnberger, K. Schmidt, K. Metz, C. Zwingmann,
N. Brieske, C. Springer, A. M. Hernandez, S. Herzog, F. Grabbe, C. Sieverding,
B. Fischer, K. Schrader, M. Brockmeyer, S. Dettmer, C. Helbig, V. Alunni, M.-A.
Battaini, C. Mura, C. N. Henrichsen, R. Garcia-Lopez, D. Echevarria, E. Puelles,
E. Garcia-Calero, S. Kruse, M. Uhr, C. Kauck, G. Feng, N. Milyaev, C. K.
Ong, L. Kumar, M. Lam, C. A. Semple, A. Gyenesei, S. Mundlos, U. Rade-
lof, H. Lehrach, P. Sarmientos, A. Reymond, D. R. Davidson, P. Dollé, S. E.
Antonarakis, M.-L. Yaspo, S. Martinez, R. A. Baldock, G. Eichele, and A. Bal-
labio
2011. A high-resolution anatomical atlas of the transcriptome in the mouse em-
bryo. PLoS Biology, 9(1):e1000582.
Disteche, C. M.
2012. Dosage compensation of the sex chromosomes. Annual Review of Genet-
ics, 46(1):537–560.
BIBLIOGRAPHY 244
Disteche, C. M.
2016. Dosage compensation of the sex chromosomes and autosomes. Seminars
in Cell & Developmental Biology, 56:9–18.
Disteche, C. M., G. N. Filippova, and K. D. Tsuchiya
2002. Escape from X inactivation. Cytogenetic and Genome Research, 99(1-
4):36–43.
Ditton, H. J., J. Zimmer, C. Kamp, E. Rajpert-De Meyts, and P. H. Vogt
2004. The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is
limited to the male germ cells by translation control. Human Molecular Genetics,
13(19):2333–2341.
Dixon, J. R., S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J. S. Liu, and
B. Ren
2012. Topological domains in mammalian genomes identified by analysis of
chromatin interactions. Nature, 485(7398):376–380.
Donohoe, M. E., S. S. Silva, S. F. Pinter, N. Xu, and J. T. Lee
2009. The pluripotency factor Oct4 interacts with Ctcf and also controls X-
chromosome pairing and counting. Nature, 460(7251):128–132.
Du, S., N. Itoh, S. Askarinam, H. Hill, A. P. Arnold, and R. R. Voskuhl
2014. XY sex chromosome complement, compared with XX, in the CNS confers
greater neurodegeneration during experimental autoimmune encephalomyelitis.
Proceedings of the National Academy of Sciences of the United States of America,
111(7):2806–2811.
Dubois, A., J. L. Deuve, P. Navarro, S. Merzouk, S. Pichard, P.-H. Commere,
A. Louise, D. Arnaud, P. Avner, and C. Morey
2014. Spontaneous reactivation of clusters of X-linked genes is associated with
the plasticity of X-inactivation in mouse trophoblast stem cells. Stem Cells,
32(2):377–390.
BIBLIOGRAPHY 245
Dubuc, A. M., M. Remke, A. Korshunov, P. A. Northcott, S. H. Zhan, M. Mendez-
Lago, M. Kool, D. T. W. Jones, A. Unterberger, A. S. Morrissy, D. Shih, J. Pea-
cock, V. Ramaswamy, A. Rolider, X. Wang, H. Witt, T. Hielscher, C. Hawkins,
R. Vibhakar, S. Croul, J. T. Rutka, W. A. Weiss, S. J. M. Jones, C. G. Eberhart,
M. A. Marra, S. M. Pfister, and M. D. Taylor
2012. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur
across subgroups in medulloblastoma. Acta Neuropathologica, 125(3):373–384.
Dupont, C., F. Loos, J. Kong-A-San, and J. Gribnau
2017. FGF treatment of host embryos injected with ES cells increases rates of
chimaerism. Transgenic Research, 26(2):237–246.
Eggan, K., A. Rode, I. Jentsch, C. Samuel, T. Hennek, H. Tintrup, B. Zevnik, J. Er-
win, J. Loring, L. Jackson-Grusby, M. R. Speicher, R. Kuehn, and R. Jaenisch
2002. Male and female mice derived from the same embryonic stem cell clone
by tetraploid embryo complementation. Nature Biotechnology, 20(5):455–459.
Ehrmann, I. E., P. S. Ellis, S. Mazeyrat, S. Duthie, N. Brockdorff, M. G. Mattei,
M. A. Gavin, N. A. Affara, G. M. Brown, and E. Simpson
1998. Characterization of genes encoding translation initiation factor eIF-2γ in
mouse and human: Sex chromosome localization, escape from X-inactivation
and evolution. Human Molecular Genetics, 7(11):1725–1737.
Eicher, E. M., D. W. Hale, P. A. Hunt, B. K. Lee, P. K. Tucker, T. R. King, J. T.
Eppig, and L. L. Washburn
1991. The mouse Y* chromosome involves a complex rearrangement, including
interstitial positioning of the pseudoautosomal region. Cytogenetics and Cell
Genetics, 57(4):221–230.
Eissenberg, J. C., M. G. Lee, J. Schneider, A. Ilvarsonn, R. Shiekhattar, and A. Shi-
latifard
2007. The trithorax-group gene in Drosophila little imaginal discs encodes a
BIBLIOGRAPHY 246
trimethylated histone H3 Lys4 demethylase. Nature Structural & Molecular Bi-
ology, 14(4):344–346.
Elliott, D. J.
2004. The role of potential splicing factors including RBMY, RBMX, hnRNPG-
T and STAR proteins in spermatogenesis. International Journal of Andrology,
27(6):328–334.
Ellis, N. and P. N. Goodfellow
1989. The mammalian pseudoautosomal region. Trends in Genetics, 5(12):406–
410.
Ellison, J. W., Z. Wardak, M. F. Young, P. G. Robey, M. Laig-Webster, and
W. Chiong
1997. PHOG, a candidate gene for involvement in the short stature of Turner
syndrome. Human Molecular Genetics, 6(8):1341–1347.
Emerson, J. J., H. Kaessmann, E. Betrán, and M. Long
2004. Extensive gene traffic on the mammalian X chromosome. Science,
303(5657):537–540.
Evans, E. P. and R. J. Phillips
1975. Inversion heterozygosity and the origin of XO daughters of Bpa/+female
mice. Nature, 256(5512):40–41.
Federici, F., A. Magaraki, E. Wassenaar, C. J. H. van Veen-Buurman, C. van de
Werken, E. B. Baart, J. S. E. Laven, J. A. Grootegoed, J. Gribnau, and W. M.
Baarends
2016. Round Spermatid Injection Rescues Female Lethality of a Paternally In-
herited Xist Deletion in Mouse. PLoS Genetics, 12(10):e1006358–24.
Ferguson-Smith, M. A.
1965. Karyotype-phenotype Correlations in Gonadal Dysgenesis and Their
Bearing on the Pathogenesis of Malformations. Journal of Medical Genetics,
2(2):142–155.
BIBLIOGRAPHY 247
Ficz, G., T. A. Hore, F. Santos, H. J. Lee, W. Dean, J. Arand, F. Krueger, D. Oxley,
Y.-L. Paul, J. Walter, S. J. Cook, S. Andrews, M. R. Branco, and W. Reik
2013. FGF signaling inhibition in ESCs drives rapid genome-wide demethylation
to the epigenetic ground state of pluripotency. Cell Stem Cell, 13(3):351–359.
Fieremans, N., H. Van Esch, T. de Ravel, J. Van Driessche, S. Belet, M. Bauters,
and G. Froyen
2015. Microdeletion of the escape genes KDM5C and IQSEC2 in a girl with
severe intellectual disability and autistic features. European Journal of Medical
Genetics, 58(5):324–327.
Ford, C. E., K. W. Jones, and P. E. Polani
1959a. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner’s
syndrome). Lancet, 1(7075):711–713.
Ford, C. E., P. E. Polani, J. H. Briggs, and P. M. Bishop
1959b. A presumptive human XXY/XX mosaic. Nature, 183(4667):1030–1032.
Foresta, C., A. Ferlin, and E. Moro
2000. Deletion and expression analysis of AZFa genes on the human Y chro-
mosome revealed a major role for DBY in male infertility. Human Molecular
Genetics, 9(8):1161–1169.
Freriks, K., H. J. L. M. Timmers, R. T. Netea-Maier, C. C. M. Beerendonk, B. J.
Otten, J. A. E. M. van Alfen-van der Velden, M. A. F. Traas, H. Mieloo, G. W.
H. J. F. L. van de Zande, L. H. Hoefsloot, A. R. M. M. Hermus, and D. F. C. M.
Smeets
2013. Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal
mosaicism and Y chromosomal derivatives in patients with Turner syndrome.
European Journal of Medical Genetics, 56(9):497–501.
Fudenberg, G. and M. Imakaev
2017. FISH-ing for captured contacts: towards reconciling FISH and 3C. Nature
Methods, 14(7):673–678.
BIBLIOGRAPHY 248
Fukami, M., A. Seki, and T. Ogata
2016. SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic
Short Stature. Molecular Syndromology, 7(1):3–11.
Fukuda, A., A. Mitani, T. Miyashita, T. Sado, A. Umezawa, and H. Akutsu
2016. Maintenance of Xist Imprinting Depends on Chromatin Condensation
State and Rnf12 Dosage in Mice. PLoS Genetics, 12(10):e1006375–24.
Fukuda, A., M. Tanino, R. Matoba, A. Umezawa, and H. Akutsu
2015. Imbalance between the expression dosages of X-chromosome and autoso-
mal genes in mammalian oocytes. Scientific Reports, 5:14101.
Fukuda, A., J. Tomikawa, T. Miura, K. Hata, K. Nakabayashi, K. Eggan,
A. Umezawa, and H. Akutsu
2014. The role of maternal-specific H3K9me3 modification in establishing im-
printed X-chromosome inactivation and embryogenesis in mice. Nature Commu-
nications, 5:1–14.
Garbelli, A., S. Beermann, G. Di Cicco, U. Dietrich, and G. Maga
2011. A Motif Unique to the Human Dead-Box Protein DDX3 Is Important
for Nucleic Acid Binding, ATP Hydrolysis, RNA/DNA Unwinding and HIV-1
Replication. PLoS ONE, 6(5):e19810.
Gardner, R. L., V. E. Papaioannou, and S. C. Barton
1973. Origin of the ectoplacental cone and secondary giant cells in mouse blas-
tocysts reconstituted from isolated trophoblast and inner cell mass. Journal of
Embryology and Experimental Morphology, 30(3):561–572.
Gaspar, N. J., T. G. Kinzy, B. J. Scherer, M. Hümbelin, J. W. Hershey, and W. C.
Merrick
1994. Translation initiation factor eIF-2. Cloning and expression of the hu-
man cDNA encoding the gamma-subunit. The Journal of Biological Chemistry,
269(5):3415–3422.
BIBLIOGRAPHY 249
Gayen, S., E. Maclary, E. Buttigieg, M. Hinten, and S. Kalantry
2015. A Primary Role for the Tsix lncRNA in Maintaining Random X-
Chromosome Inactivation. Cell Reports, 11(8):1251–1265.
Gaztelumendi, N. and C. Nogués
2014. Chromosome Instability in mouse Embryonic Stem Cells. Scientific Re-
ports, 4(1):154–8.
Gee, S. L. and J. G. Conboy
1994. Mouse erythroid cells express multiple putative RNA helicase genes ex-
hibiting high sequence conservation from yeast to mammals. Gene, 140(2):171–
177.
Glynn, L. M. and C. A. Sandman
2011. Prenatal Origins of Neurological Development. Current Directions in
Psychological Science, 20(6):384–389.
Gontan, C., E. M. Achame, J. Demmers, T. S. Barakat, E. Rentmeester, W. van
Ijcken, J. A. Grootegoed, and J. Gribnau
2012. RNF12 initiates X-chromosome inactivation by targeting REX1 for degra-
dation. Nature, 485(7398):386–390.
Goto, Y. and N. Takagi
1998. Tetraploid embryos rescue embryonic lethality caused by an additional
maternally inherited X chromosome in the mouse. Development, 125(17):3353–
3363.
Goto, Y. and N. Takagi
2000. Maternally inherited X chromosome is not inactivated in mouse blastocysts
due to parental imprinting. Chromosome Research, 8(2):101–109.
Grafodatskaya, D., B. H. Chung, D. T. Butcher, A. L. Turinsky, S. J. Goodman,
S. Choufani, Y.-A. Chen, Y. Lou, C. Zhao, R. Rajendram, F. E. Abidi, C. Skin-
ner, J. Stavropoulos, C. A. Bondy, J. Hamilton, S. Wodak, S. W. Scherer, C. E.
BIBLIOGRAPHY 250
Schwartz, and R. Weksberg
2013. Multilocus loss of DNA methylation in individuals with mutations in the
histone H3 Lysine 4 Demethylase KDM5C. BMC Medical Genomics, 6(1):1–1.
Grant, J., S. K. Mahadevaiah, P. Khil, M. N. Sangrithi, H. Royo, J. Duckworth, J. R.
McCarrey, J. L. VandeBerg, M. B. Renfree, W. Taylor, G. Elgar, R. D. Camerini-
Otero, M. J. Gilchrist, and J. M. A. Turner
2012. Rsx is a metatherian RNA with Xist-like properties in X-chromosome
inactivation. Nature, 487(7406):254–258.
Greenberg, M. V. C., J. Glaser, M. Borsos, F. E. Marjou, M. Walter, A. Teissandier,
and D. Bourc’his
2017. Transient transcription in the early embryo sets an epigenetic state that
programs postnatal growth. Nature Genetics, 49(1):110–118.
Greene, M. E., G. Mundschau, J. Wechsler, M. McDevitt, A. Gamis, J. Karp, S. Gur-
buxani, R. Arceci, and J. D. Crispino
2003. Mutations in GATA1 in both transient myeloproliferative disorder and
acute megakaryoblastic leukemia of Down syndrome. Blood Cells, Molecules &
Diseases, 31(3):351–356.
Greenfield, A., L. Carrel, D. Pennisi, C. Philippe, N. Quaderi, P. Siggers, K. Steiner,
P. P. Tam, A. P. Monaco, and H. F. Willard
1998. The UTX gene escapes X inactivation in mice and humans. Human Molec-
ular Genetics, 7(4):737–742.
Greenfield, A., D. Scott, D. Pennisi, I. Ehrmann, P. Ellis, L. Cooper, E. Simpson,
and P. Koopman
1996. An H–YDb epitope is encoded by a novel mouse Y chromosome gene.
Nature Genetics, 14(4):474–478.
Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Münsterberg,
N. Vivian, P. Goodfellow, and R. Lovell-Badge
1990. A gene mapping to the sex-determining region of the mouse Y chromo-
BIBLIOGRAPHY 251
some is a member of a novel family of embryonically expressed genes. Nature,
346(6281):245–250.
Gubbay, J., N. Vivian, A. Economou, D. Jackson, P. Goodfellow, and R. Lovell-
Badge
1992. Inverted repeat structure of the Sry locus in mice. Proceedings of the
National Academy of Sciences of the United States of America, 89(17):7953–
7957.
Guillemot, F., T. Caspary, S. M. Tilghman, N. G. Copeland, D. J. Gilbert, N. A.
Jenkins, D. J. Anderson, A. L. Joyner, J. Rossant, and A. Nagy
1995. Genomic imprinting of Mash2, a mouse gene required for trophoblast
development. Nature Genetics, 9(3):235–242.
Guillemot, F., A. Nagy, A. Auerbach, J. Rossant, and A. L. Joyner
1994. Essential role of Mash-2 in extraembryonic development. Nature,
371(6495):333–336.
Guo, J., P. Zhu, C. Wu, L. Yu, S. Zhao, and X. Gu
2003. In silico analysis indicates a similar gene expression pattern between hu-
man brain and testis. Cytogenetic and Genome Research, 103(1-2):58–62.
Guo, J. H., Q. Huang, D. J. Studholme, C. Q. Wu, and Z. Zhao
2005. Transcriptomic analyses support the similarity of gene expression between
brain and testis in human as well as mouse. Cytogenetic and Genome Research,
111(2):107–109.
Gupta, V., M. Parisi, D. Sturgill, R. Nuttall, M. Doctolero, O. K. Dudko, J. D. Mal-
ley, P. S. Eastman, and B. Oliver
2006. Global analysis of X-chromosome dosage compensation. Journal of Biol-
ogy, 5(1):3.
Habibi, E., A. B. Brinkman, J. Arand, L. I. Kroeze, H. H. D. Kerstens, F. Matarese,
K. Lepikhov, M. Gut, I. Brun-Heath, N. C. Hubner, R. Benedetti, L. Altucci, J. H.
BIBLIOGRAPHY 252
Jansen, J. Walter, I. G. Gut, H. Marks, and H. G. Stunnenberg
2013. Short Article. Cell Stem Cell, 13(3):360–369.
Habuchi, H., N. Nagai, N. Sugaya, F. Atsumi, R. L. Stevens, and K. Kimata
2007. Mice Deficient in Heparan Sulfate 6- O-Sulfotransferase-1 Exhibit Defec-
tive Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic
Lethality. The Journal of Biological Chemistry, 282(21):15578–15588.
Habuchi, H., M. Tanaka, O. Habuchi, K. Yoshida, H. Suzuki, K. Ban, and K. Ki-
mata
2000. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase
having different specificities for hexuronic acid adjacent to the targeted N-
sulfoglucosamine. The Journal of Biological Chemistry, 275(4):2859–2868.
Hadjantonakis, A. K., L. L. Cox, P. P. Tam, and A. Nagy
2001. An X-linked GFP transgene reveals unexpected paternal X-chromosome
activity in trophoblastic giant cells of the mouse placenta. genesis, 29(3):133–
140.
Haeussler, M., K. Schönig, H. Eckert, A. Eschstruth, J. Mianné, J.-B. Renaud,
S. Schneider-Maunoury, A. Shkumatava, L. Teboul, J. Kent, J.-S. Joly, and J.-
P. Concordet
2016. Evaluation of off-target and on-target scoring algorithms and integration
into the guide RNA selection tool CRISPOR. Genome Biology, Pp. 1–12.
Haig, D. and M. Westoby
1989. Parent-specific gene expression and the triploid endosperm. The American
Naturalist, 134(1):147–155.
Hamlett, W. C.
1989. Evolution and morphogenesis of the placenta in sharks. Journal of Exper-
imental Zoology Part A: Ecological Genetics and Physiology, 252(S2):35–52.
BIBLIOGRAPHY 253
Hassold, T., F. Benham, and M. Leppert
1988. Cytogenetic and molecular analysis of sex-chromosome monosomy. Amer-
ican Journal of Human Genetics, 42(4):534–541.
Hassold, T., E. Kumlin, N. Takaesu, and M. Leppert
1985. Determination of the parental origin of sex-chromosome monosomy using
restriction fragment length polymorphisms. American Journal of Human Genet-
ics, 37(5):965–972.
Hassold, T., D. Pettay, A. Robinson, and I. Uchida
1992. Molecular studies of parental origin and mosaicism in 45,X conceptuses.
Human Genetics, 89(6):647–652.
Hayashi, K., H. Ohta, K. Kurimoto, S. Aramaki, and M. Saitou
2011a. Reconstitution of the mouse germ cell specification pathway in culture by
pluripotent stem cells. Cell, 146(4):519–532.
Hayashi, K., H. Ohta, K. Kurimoto, S. Aramaki, and M. Saitou
2011b. Reconstitution of the Mouse Germ Cell Specification Pathway in Culture
by Pluripotent Stem Cells. Cell, 146(4):519–532.
Hayashi, K. and M. Saitou
2013. Generation of eggs from mouse embryonic stem cells and induced pluripo-
tent stem cells. Nature Protocols, 8(8):1513–1524.
Heard, E., C. Kress, F. Mongelard, B. Courtier, C. Rougeulle, A. Ashworth,
C. Vourc’h, C. Babinet, and P. Avner
1996. Transgenic mice carrying an Xist-containing YAC. Human Molecular
Genetics, 5(4):441–450.
Heard, E., F. Mongelard, D. Arnaud, and P. Avner
1999a. Xist yeast artificial chromosome transgenes function as X-inactivation
centers only in multicopy arrays and not as single copies. Molecular and Cellular
Biology, 19(4):3156–3166.
BIBLIOGRAPHY 254
Heard, E., F. Mongelard, D. Arnaud, C. Chureau, C. Vourc’h, and P. Avner
1999b. Human XIST yeast artificial chromosome transgenes show partial X in-
activation center function in mouse embryonic stem cells. Proceedings of the
National Academy of Sciences of the United States of America, 96(12):6841–
6846.
Hemberger, M.
2002. The role of the X chromosome in mammalian extra embryonic develop-
ment. Cytogenetic and Genome Research, 99(1-4):210–217.
Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi,
H. Tomizawa, K. Takeda, and S. Akira
2002. Small anti-viral compounds activate immune cells via the TLR7
MyD88–dependent signaling pathway. Nature Immunology, 3(2):196–200.
Henery, C. C., J. B. Bard, and M. H. Kaufman
1992. Tetraploidy in mice, embryonic cell number, and the grain of the develop-
mental map. Developmental Biology, 152(2):233–241.
Herz, H. M., L. D. Madden, Z. Chen, C. Bolduc, E. Buff, R. Gupta, R. Davuluri,
A. Shilatifard, I. K. Hariharan, and A. Bergmann
2010. The H3K27me3 Demethylase dUTX Is a Suppressor of Notch-
and Rb-Dependent Tumors in Drosophila. Molecular and Cellular Biology,
30(10):2485–2497.
Himeno, E., S. Tanaka, and T. Kunath
2008. Isolation and manipulation of mouse trophoblast stem cells. Current Pro-
tocols in Stem Cell Biology, Chapter 1:Unit 1E.4.
Hofstetter, C., J. M. Kampka, S. Huppertz, H. Weber, A. Schlosser, A. M. Mu ller,
and M. Becker
2016. Inhibition of KDM6 activity during murine ESC differentiation induces
DNA damage. Journal of Cell Science, 129(4):788–803.
BIBLIOGRAPHY 255
Holm, S.
1979. A simple sequentially rejective multiple test procedure. Scandinavian
journal of statistics, 6(2):65–70.
Hong, S., Y.-W. Cho, L.-R. Yu, H. Yu, T. D. Veenstra, and K. Ge
2007. Identification of JmjC domain-containing UTX and JMJD3 as histone H3
lysine 27 demethylases. Proceedings of the National Academy of Sciences of the
United States of America, 104(47):18439–18444.
Hook, E. B. and D. Warburton
1983. The distribution of chromosomal genotypes associated with Turner’s syn-
drome: livebirth prevalence rates and evidence for diminished fetal mortality and
severity in genotypes associated with structural X abnormalities or mosaicism.
Human Genetics, 64(1):24–27.
Hook, E. B. and D. Warburton
2014. Turner syndrome revisited: review of new data supports the hypothesis
that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an
origin by mitotic loss. Human Genetics, 133(4):417–424.
Horton, J. R., A. K. Upadhyay, H. H. Qi, X. Zhang, Y. Shi, and X. Cheng
2009. Enzymatic and structural insights for substrate specificity of a family of
jumonji histone lysine demethylases. Nature Structural & Molecular Biology,
17(1):38–43.
Horvath, L. M., N. Li, and L. Carrel
2013. Deletion of an X-inactivation boundary disrupts adjacent gene silencing.
PLoS Genetics, 9(11):e1003952.
Hu, D. and J. C. Cross
2010. Development and function of trophoblast giant cells in the rodent placenta.
The International Journal of Developmental Biology, 54(2-3):341–354.
BIBLIOGRAPHY 256
Huang, J.-S., C.-C. Chao, T.-L. Su, S.-H. Yeh, D.-S. Chen, C.-T. Chen, P.-J. Chen,
and Y.-S. Jou
2004. Diverse cellular transformation capability of overexpressed genes in human
hepatocellular carcinoma. Biochemical and Biophysical Research Communica-
tions, 315(4):950–958.
Hughes, J. F., H. Skaletsky, L. G. Brown, T. Pyntikova, T. Graves, R. S. Fulton,
S. Dugan, Y. Ding, C. J. Buhay, C. Kremitzki, Q. Wang, H. Shen, M. Holder,
D. Villasana, L. V. Nazareth, A. Cree, L. Courtney, J. Veizer, H. Kotkiewicz, T.-J.
Cho, N. Koutseva, S. Rozen, D. M. Muzny, W. C. Warren, R. A. Gibbs, R. K.
Wilson, and D. C. Page
2012. Strict evolutionary conservation followed rapid gene loss on human and
rhesus Y chromosomes. Nature, 483(7387):82–86.
Hughes, J. F., H. Skaletsky, N. Koutseva, T. Pyntikova, and D. C. Page
2015. Sex chromosome-to-autosome transposition events counter Y-chromosome
gene loss in mammals. Genome Biology, 16(1):104.
Hughes, J. F., H. Skaletsky, T. Pyntikova, T. A. Graves, S. K. M. van Daalen, P. J.
Minx, R. S. Fulton, S. D. McGrath, D. P. Locke, C. Friedman, B. J. Trask, E. R.
Mardis, W. C. Warren, S. Repping, S. Rozen, R. K. Wilson, and D. C. Page
2010. Chimpanzee and human Y chromosomes are remarkably divergent in struc-
ture and gene content. Nature, 463(7280):536–539.
Hughes, J. F., H. Skaletsky, T. Pyntikova, P. J. Minx, T. Graves, S. Rozen, R. K.
Wilson, and D. C. Page
2005. Conservation of Y-linked genes during human evolution revealed by com-
parative sequencing in chimpanzee. Nature, 437(7055):100–103.
Hunt, P. A.
1991. Survival of XO mouse fetuses: effect of parental origin of the X chromo-
some or uterine environment? Development, 111(4):1137–1141.
BIBLIOGRAPHY 257
Huynh, K. D. and J. T. Lee
2003. Inheritance of a pre-inactivated paternal X chromosome in early mouse
embryos. Nature, 426(6968):857–862.
Inoue, A., L. Jiang, F. Lu, T. Suzuki, and Y. Zhang
2017. Maternal H3K27me3 controls DNA methylation-independent imprinting.
Nature, 547(7664):419–424.
Isensee, J., H. Witt, R. Pregla, R. Hetzer, V. Regitz-Zagrosek, and P. Ruiz Noppinger
2007. Sexually dimorphic gene expression in the heart of mice and men. Journal
of Molecular Medicine, 86(1):61–74.
Ishikawa, H., M. Banzai, and T. Yamauchi
1999. Developmental retardation of XO mouse embryos at mid-gestation. Jour-
nal of Reproduction and Fertility, 115(2):263–267.
Ishikawa, H., Á. Rattigan, R. Fundele, R. Fundele, P. S. Burgoyne, and P. S. Bur-
goyne
2003. Effects of sex chromosome dosage on placental size in mice. Biology of
Reproduction, 69(2):483–488.
Issaeva, I., Y. Zonis, T. Rozovskaia, K. Orlovsky, C. M. Croce, T. Nakamura,
A. Mazo, L. Eisenbach, and E. Canaani
2007. Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to
Alterations in Cell Adhesion and Growth. Molecular and Cellular Biology,
27(5):1889–1903.
Iurlaro, M., F. von Meyenn, and W. Reik
2017. DNA methylation homeostasis in human and mouse development. Current
Opinion in Genetics & Development, 43:101–109.
Ivanov, R., S. Hol, T. Aarts, A. Hagenbeek, E. H. Slager, and S. Ebeling
2005. UTY-specific TCR-transfer generates potential graft-versus-leukaemia ef-
fector T cells. British Journal of Haematology, 129(3):392–402.
BIBLIOGRAPHY 258
Iwase, S., F. Lan, P. Bayliss, L. de la Torre-Ubieta, M. Huarte, H. H. Qi, J. R. Whet-
stine, A. Bonni, T. M. Roberts, and Y. Shi
2007. The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Fam-
ily of Histone H3 Lysine 4 Demethylases. Cell, 128(6):1077–1088.
Iyer, V., B. Shen, W. Zhang, A. Hodgkins, T. Keane, X. Huang, and W. C. Skarnes
2015. Off-target mutations are rare in Cas9-modified mice. Nature Methods,
12(6):479–479.
Jackman, S. M., X. Kong, and M. E. Fant
2012. Plac1 (placenta-specific 1) is essential for normal placental and embryonic
development. Molecular Reproduction and Development, 79(8):564–572.
Jacobs, P., P. Dalton, R. James, K. Mosse, M. Power, D. Robinson, and D. Skuse
1997. Turner syndrome: a cytogenetic and molecular study. Annals of Human
Genetics, 61(Pt 6):471–483.
Jacobs, P. A.
1990. The role of chromosome abnormalities in reproductive failure. Reproduc-
tion, nutrition, development, Suppl 1:63s–74s.
Jacobs, P. A., A. G. Baikie, W. M. Brown, T. N. Macgregor, N. Maclean, and D. G.
Harnden
1959. Evidence for the existence of the human "super female". Lancet,
2(7100):423–425.
Jacobs, P. A., P. R. Betts, A. E. Cockwell, J. A. Crolla, M. J. Mackenzie, D. O.
Robinson, and S. A. Youings
1990. A cytogenetic and molecular reappraisal of a series of patients with
Turner’s syndrome. Annals of Human Genetics, 54(Pt 3):209–223.
Jacobs, P. A. and J. A. Strong
1959. A case of human intersexuality having a possible XXY sex-determining
mechanism. Nature, 183(4657):302–303.
BIBLIOGRAPHY 259
Jamieson, R. V., P. P. Tam, and M. Gardiner-Garden
1996. X-chromosome activity: impact of imprinting and chromatin structure.
The International Journal of Developmental Biology, 40(6):1065–1080.
Jamieson, R. V., S. S. Tan, and P. Tam
1998. Retarded postimplantation development of X0 mouse embryos: impact of
the parental origin of the monosomic X chromosome. Developmental Biology.
Jankowska, A. M., H. Makishima, R. V. Tiu, H. Szpurka, Y. Huang, F. Traina,
V. Visconte, Y. Sugimoto, C. Prince, C. O’Keefe, E. D. Hsi, A. List, M. A. Sek-
eres, A. Rao, M. A. McDevitt, and J. P. Maciejewski
2011. Mutational spectrum analysis of chronic myelomonocytic leukemia in-
cludes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Blood, 118(14):3932–3941.
Jensen, L. R., M. Amende, U. Gurok, B. Moser, V. Gimmel, A. Tzschach, A. R. Ja-
necke, G. Tariverdian, J. Chelly, J.-P. Fryns, H. Van Esch, T. Kleefstra, B. Hamel,
C. Moraine, J. Gecz, G. Turner, R. Reinhardt, V. M. Kalscheuer, H.-H. Ropers,
and S. Lenzner
2005. Mutations in the JARID1C gene, which is involved in transcriptional reg-
ulation and chromatin remodeling, cause X-linked mental retardation. American
Journal of Human Genetics, 76(2):227–236.
Ji, X., S. Jin, X. Qu, K. Li, H. Wang, H. He, F. Guo, and L. Dong
2015. Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell
invasion through inhibition BMP7 expression. BMC Cancer, 15(1):801.
Jiang, L., F. Schlesinger, C. A. Davis, Y. Zhang, R. Li, M. Salit, T. R. Gingeras, and
B. Oliver
2011. Synthetic spike-in standards for RNA-seq experiments. Genome Research,
21(9):1543–1551.
BIBLIOGRAPHY 260
Jiang, R., C. Hua, Y. Wan, B. Jiang, H. Hu, J. Zheng, B. K. Fuqua, J. L. Dunaief,
G. J. Anderson, S. David, C. D. Vulpe, and H. Chen
2015. Hephaestin and Ceruloplasmin Play Distinct but Interrelated Roles in Iron
Homeostasis in Mouse Brain. Journal of Nutrition, 145(5):1003–1009.
Jiang, W., J. Wang, and Y. Zhang
2013. Histone H3K27me3 demethylases KDM6A and KDM6B modulate defini-
tive endoderm differentiation from human ESCs by regulating WNT signaling
pathway. Cell Research, 23(1):122–130.
Jimenez-Chillaron, J. C., M. Hernandez-Valencia, C. Reamer, S. Fisher, A. Joszi,
M. Hirshman, A. Oge, S. Walrond, R. Przybyla, C. Boozer, L. J. Goodyear, and
M.-E. Patti
2005. Beta-cell secretory dysfunction in the pathogenesis of low birth weight-
associated diabetes: a murine model. Diabetes, 54(3):702–711.
Jin, C., J. Li, C. D. Green, X. Yu, X. Tang, D. Han, B. Xian, D. Wang, X. Huang,
X. Cao, Z. Yan, L. Hou, J. Liu, N. Shukeir, P. Khaitovich, C. D. Chen, H. Zhang,
T. Jenuwein, and J.-D. J. Han
2011. Histone demethylase UTX-1 regulates C. elegans life span by targeting the
insulin/IGF-1 signaling pathway. Cell Metabolism, 14(2):161–172.
Jinek, M., K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, and E. Charpentier
2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacte-
rial immunity. Science, 337(6096):816–821.
John, R. and M. Hemberger
2012. A placenta for life. Reproductive BioMedicine Online, 25(1):5–11.
Johnson, M. A., I. Hernandez, Y. Wei, and N. Greenberg
2000. Isolation and characterization of mouse probasin: An androgen-regulated
protein specifically expressed in the differentiated prostate. The Prostate,
43(4):255–262.
BIBLIOGRAPHY 261
Jones, D. T. W., N. Jäger, M. Kool, T. Zichner, B. Hutter, M. Sultan, Y.-J. Cho, T. J.
Pugh, V. Hovestadt, A. M. Stütz, T. Rausch, H.-J. Warnatz, M. Ryzhova, S. Ben-
der, D. Sturm, S. Pleier, H. Cin, E. Pfaff, L. Sieber, A. Wittmann, M. Remke,
H. Witt, S. Hutter, T. Tzaridis, J. Weischenfeldt, B. Raeder, M. Avci, V. Am-
stislavskiy, M. Zapatka, U. D. Weber, Q. Wang, B. Lasitschka, C. C. Bartholo-
mae, M. Schmidt, C. von Kalle, V. Ast, C. Lawerenz, J. Eils, R. Kabbe, V. Benes,
P. van Sluis, J. Koster, R. Volckmann, D. Shih, M. J. Betts, R. B. Russell,
S. Coco, G. Paolo Tonini, U. Schüller, V. Hans, N. Graf, Y.-J. Kim, C. Mono-
ranu, W. Roggendorf, A. Unterberg, C. Herold-Mende, T. Milde, A. E. Kulozik,
A. von Deimling, O. Witt, E. Maass, J. Rössler, M. Ebinger, M. U. Schuhmann,
M. C. Frühwald, M. Hasselblatt, N. Jabado, S. Rutkowski, A. O. von Bueren,
D. Williamson, S. C. Clifford, M. G. McCabe, V. Peter Collins, S. Wolf, S. Wie-
mann, H. Lehrach, B. Brors, W. Scheurlen, J. Felsberg, G. Reifenberger, P. A.
Northcott, M. D. Taylor, M. Meyerson, S. L. Pomeroy, M.-L. Yaspo, J. O. Kor-
bel, A. Korshunov, R. Eils, S. M. Pfister, and P. Lichter
2012. Dissecting the genomic complexity underlying medulloblastoma. Nature,
488(7409):100–105.
Jonkers, I., T. S. Barakat, E. M. Achame, K. Monkhorst, A. Kenter, E. Rentmeester,
F. Grosveld, J. A. Grootegoed, and J. Gribnau
2009. RNF12 Is an X-Encoded Dose-Dependent Activator of X Chromosome
Inactivation. Cell, 139(5):999–1011.
Jue, N. K., M. B. Murphy, S. D. Kasowitz, S. M. Qureshi, C. J. Obergfell, S. Elsisi,
R. J. Foley, R. J. O. Neill, and M. J. O. Neill
2013. Determination of dosage compensation of the mammalian X chromosome
by RNA-seq is dependent on analytical approach. BMC Genomics, 14(1):1–1.
Julien, P., D. Brawand, M. Soumillon, A. Necsulea, A. Liechti, F. Schütz, T. Daish,
F. Grützner, and H. Kaessmann
2012. Mechanisms and evolutionary patterns of mammalian and avian dosage
compensation. PLoS Biology, 10(5):e1001328.
BIBLIOGRAPHY 262
Kanai, Y., N. Dohmae, and N. Hirokawa
2004. Kinesin transports RNA: isolation and characterization of an RNA-
transporting granule. Neuron, 43(4):513–525.
Kapahnke, M., A. Banning, and R. Tikkanen
2016. Random Splicing of Several Exons Caused by a Single Base Change in the
Target Exon of CRISPR/Cas9 Mediated Gene Knockout. Cells, 5(4):45–12.
Kappelgaard, A.-M. and T. Laursen
2011. The benefits of growth hormone therapy in patients with Turner syn-
drome, Noonan syndrome and children born small for gestational age. YGHIR,
21(6):305–313.
Kaufman, M. H., S. C. Barton, and M. A. Surani
1977. Normal postimplantation development of mouse parthenogenetic embryos
to the forelimb bud stage. Nature, 265(5589):53–55.
Kaufman, M. H. and S. Webb
1990. Postimplantation development of tetraploid mouse embryos produced by
electrofusion. Development, 110(4):1121–1132.
Keverne, E. B.
2015. Genomic imprinting, action, and interaction of maternal and fetal genomes.
Proceedings of the National Academy of Sciences of the United States of America,
112(22):6834–6840.
Khil, P. P., N. A. Smirnova, P. J. Romanienko, and R. D. Camerini-Otero
2004. The mouse X chromosome is enriched for sex-biased genes not subject to
selection by meiotic sex chromosome inactivation. Nature Genetics, 36(6):642–
646.
Kim, D., B. Langmead, and S. L. Salzberg
2015. HISAT: a fast spliced aligner with low memory requirements. Nature
Methods, 12(4):357–360.
BIBLIOGRAPHY 263
Kim, I. W., A. C. Khadilkar, E. Y. Ko, and E. S. Sabanegh
2013. 47,XYY Syndrome and Male Infertility. Reviews in Urology, 15(4):188–
196.
King, M. C. and A. C. Wilson
1975. Evolution at two levels in humans and chimpanzees. Science,
188(4184):107–116.
Klinefelter, H. F., E. C. Reifenstein Jr, and F. A. Jr
1942. Syndrome characterized by gynecomastia, aspermatogenesis without A-
Leydigism, and increased excretion of follicle-stimulating hormone 1. The Jour-
nal of Clinical Endocrinology, 2(11):615–627.
Klose, R. J., E. M. Kallin, and Y. Zhang
2006. JmjC-domain-containing proteins and histone demethylation. Nature Re-
views Genetics, 7(9):715–727.
Kobayashi, S., Y. Fujihara, N. Mise, K. Kaseda, K. Abe, F. Ishino, and M. Okabe
2010. The X-linked imprinted gene family Fthl17 shows predominantly female
expression following the two-cell stage in mouse embryos. Nucleic Acids Re-
search, 38(11):3672–3681.
Kobayashi, S., A. Isotani, N. Mise, M. Yamamoto, Y. Fujihara, K. Kaseda,
T. Nakanishi, M. Ikawa, H. Hamada, K. Abe, and M. Okabe
2006. Comparison of Gene Expression in Male and Female Mouse Blasto-
cysts Revealed Imprinting of the X-Linked Gene, Rhox5/Pem, at Preimplantation
Stages. Current Biology, 16(2):166–172.
Kobayashi, S., Y. Totoki, M. Soma, K. Matsumoto, Y. Fujihara, A. Toyoda,
Y. Sakaki, M. Okabe, and F. Ishino
2013. Identification of an Imprinted Gene Cluster in the X-Inactivation Center.
PLoS ONE, 8(8):e71222.
BIBLIOGRAPHY 264
Koehler, K. E., E. A. Millie, J. P. Cherry, P. S. Burgoyne, E. P. Evans, P. A. Hunt,
and T. J. Hassold
2002. Sex-specific differences in meiotic chromosome segregation revealed by
dicentric bridge resolution in mice. Genetics, 162(3):1367–1379.
Koller, P. C. and C. D. Darlington
1934. The genetical and mechanical properties of the sex-chromosomes. Journal
of Genetics, 29(2):159–173.
Koo, G. C., S. S. Wachtel, K. Krupen-Brown, L. R. Mittl, W. R. Breg, M. Genel,
I. M. Rosenthal, D. S. Borgaonkar, A. D. Miller, and R. Tantravahi
1977. Mapping the locus of the HY gene on the human Y chromosome. Science,
198(4320):940.
Koopman, P., J. Gubbay, N. Vivian, P. Goodfellow, and R. Lovell-Badge
1991. Male development of chromosomally female mice transgenic for Sry. Na-
ture, 351(6322):117–121.
Kortschak, R. D., P. W. Tucker, and R. Saint
2000. ARID proteins come in from the desert. Trends in Biochemical Sciences,
25(6):294–299.
Koshio, J., H. Kagamu, K. Nozaki, Y. Saida, T. Tanaka, S. Shoji, N. Igarashi,
S. Miura, M. Okajima, S. Watanabe, H. Yoshizawa, and I. Narita
2013. DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an im-
munogenic target of cancer stem cells. Cancer Immunology, Immunotherapy,
62(10):1619–1628.
Kozak, M.
1984. Compilation and analysis of sequences upstream from the translational
start site in eukaryotic mRNAs. Nucleic Acids Research, 12(2):857–872.
BIBLIOGRAPHY 265
Kubaczka, C., C. Senner, M. J. Araúzo-Bravo, N. Sharma, P. Kuckenberg,
A. Becker, A. Zimmer, O. Brüstle, M. Peitz, M. Hemberger, and H. Schorle
2014. Derivation and Maintenance of Murine Trophoblast Stem Cells under De-
fined Conditions. Stem Cell Reports, 2(2):232–242.
Kubaczka, C., C. E. Senner, M. Cierlitza, M. J. Araúzo-Bravo, P. Kuckenberg,
M. Peitz, M. Hemberger, and H. Schorle
2015. Direct Induction of Trophoblast Stem Cells from Murine Fibroblasts. Cell
Stem Cell, 17(5):557–568.
Kunath, T., D. Arnaud, G. D. Uy, I. Okamoto, C. Chureau, Y. Yamanaka, E. Heard,
R. L. Gardner, P. Avner, and J. Rossant
2005. Imprinted X-inactivation in extra-embryonic endoderm cell lines from
mouse blastocysts. Development, 132(7):1649–1661.
Lahn, B. T.
1997. Functional Coherence of the Human Y Chromosome. Science,
278(5338):675–680.
Lahn, B. T. and D. C. Page
1997. Functional coherence of the human Y chromosome. Science,
278(5338):675–680.
Lahn, B. T. and D. C. Page
1999. Four evolutionary strata on the human X chromosome. Science,
286(5441):964–967.
Lan, F., P. E. Bayliss, J. L. Rinn, J. R. Whetstine, J. K. Wang, S. Chen, S. Iwase,
R. Alpatov, I. Issaeva, E. Canaani, T. M. Roberts, H. Y. Chang, and Y. Shi
2007. A histone H3 lysine 27 demethylase regulates animal posterior develop-
ment. Nature, 449(7163):689–694.
Lanfranco, F., A. Kamischke, M. Zitzmann, and E. Nieschlag
2004. Klinefelter’s syndrome. Lancet, 364(9430):273–283.
BIBLIOGRAPHY 266
Larizza, D., M. Martinetti, J. M. Dugoujon, C. Tinelli, V. Calcaterra, M. Cuccia,
L. Salvaneschi, and F. Severi
2002. Parental GM and HLA genotypes and reduced birth weight in patients
with Turner’s syndrome. Journal of Pediatric Endocrinology & Metabolism,
15(8):1183–1190.
Latham, K. E.
1994. Strain-specific differences in mouse oocytes and their contributions to
epigenetic inheritance. Development, 120(12):3419–3426.
Latham, K. E., B. Patel, F. D. Bautista, and S. M. Hawes
2000. Effects of X chromosome number and parental origin on X-linked gene ex-
pression in preimplantation mouse embryos. Biology of Reproduction, 63(1):64–
73.
Latham, K. E. and L. Rambhatla
1995. Expression of X-linked genes in androgenetic, gynogenetic, and normal
mouse preimplantation embryos. Developmental Genetics, 17(3):212–222.
Lazic, S. E. and L. Essioux
2013. Improving basic and translational science by accounting for litter-to-litter
variation in animal models. BMC Neuroscience, 14(1):37.
Lederer, D., B. Grisart, M. C. Digilio, V. Benoit, M. Crespin, S. C. Ghariani,
I. Maystadt, B. Dallapiccola, and C. Verellen-Dumoulin
2012. Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in
Three Patients with Kabuki Syndrome. American Journal of Human Genetics,
90(1):119–124.
Lee, J. T.
2002. Homozygous Tsix mutant mice reveal a sex-ratio distortion and revert to
random X-inactivation. Nature Genetics, 32(1):195–200.
BIBLIOGRAPHY 267
Lee, J. T., L. S. Davidow, and D. Warshawsky
1999. Tsix, a gene antisense to Xist at the X-inactivation centre. Nature Genetics,
21(4):400–404.
Lee, J. T. and N. Lu
1999. Targeted mutagenesis of Tsix leads to nonrandom X inactivation. Cell,
99(1):47–57.
Lee, J. T., W. M. Strauss, J. A. Dausman, and R. Jaenisch
1996. A 450 kb transgene displays properties of the mammalian X-inactivation
center. Cell, 86(1):83–94.
Lee, M. C. and G. S. Conway
2014. Turner’s syndrome: challenges of late diagnosis. The Lancet Diabetes &
Endocrinology.
Lee, M. G., J. Norman, A. Shilatifard, and R. Shiekhattar
2007a. Physical and functional association of a trimethyl H3K4 demethylase and
Ring6a/MBLR, a polycomb-like protein. Cell, 128(5):877–887.
Lee, N., J. Zhang, R. J. Klose, H. Erdjument-Bromage, P. Tempst, R. S. Jones, and
Y. Zhang
2007b. The trithorax-group protein Lid is a histone H3 trimethyl-Lys4 demethy-
lase. Nature Structural & Molecular Biology, 14(4):341–343.
Lee, S., M. K. Leach, S. A. Redmond, S. Y. C. Chong, S. H. Mellon, S. J. Tuck,
Z.-Q. Feng, J. M. Corey, and J. R. Chan
2012. A culture system to study oligodendrocyte myelination processes using
engineered nanofibers. Nature Methods, 9(9):917–922.
Lefebvre, L., S. Viville, S. C. Barton, F. Ishino, E. B. Keverne, and M. A. Surani
1998. Abnormal maternal behaviour and growth retardation associated with loss
of the imprinted gene Mest. Nature Genetics, 20(2):163–169.
BIBLIOGRAPHY 268
Leighton, P. A., R. S. Ingram, J. Eggenschwiler, A. Efstratiadis, and S. M. Tilghman
1995. Disruption of imprinting caused by deletion of the H19 gene region in mice.
Nature, 375(6526):34–39.
Leitch, H. G., K. R. McEwen, A. Turp, V. Encheva, T. Carroll, N. Grabole,
W. Mansfield, B. Nashun, J. G. Knezovich, A. Smith, M. A. Surani, and P. Ha-
jkova
2013. Naive pluripotency is associated with global DNA hypomethylation. Na-
ture Structural & Molecular Biology, 20(3):311–316.
Lewis, A., K. Green, C. Dawson, L. Redrup, K. D. Huynh, J. T. Lee, M. Hemberger,
and W. Reik
2006. Epigenetic dynamics of the Kcnq1 imprinted domain in the early embryo.
Development, 133(21):4203–4210.
Lewis, A., K. Mitsuya, D. Umlauf, P. Smith, W. Dean, J. Walter, M. J. Higgins,
R. Feil, and W. Reik
2004. Imprinting on distal chromosome 7 in the placenta involves repres-
sive histone methylation independent of DNA methylation. Nature Genetics,
36(12):1291–1295.
Li, B., V. Ruotti, R. M. Stewart, J. A. Thomson, and C. N. Dewey
2009a. RNA-Seq gene expression estimation with read mapping uncertainty.
Bioinformatics (Oxford, England), 26(4):493–500.
Li, H. L., P. Gee, K. Ishida, and A. Hotta
2016. Efficient genomic correction methods in human iPS cells using CRISPR-
Cas9 system. Methods, 101:27–35.
Li, L., E. B. Keverne, S. A. Aparicio, F. Ishino, S. C. Barton, and M. A. Surani
1999. Regulation of maternal behavior and offspring growth by paternally ex-
pressed Peg3. Science, 284(5412):330–333.
Li, N. and L. Carrel
2008. Escape from X chromosome inactivation is an intrinsic property of the
BIBLIOGRAPHY 269
Jarid1c locus. Proceedings of the National Academy of Sciences of the United
States of America, 105(44):17055–17060.
Li, Q., A. L. Brass, A. Ng, Z. Hu, R. J. Xavier, T. J. Liang, and S. J. Elledge
2009b. A genome-wide genetic screen for host factors required for hepatitis C
virus propagation. Proceedings of the National Academy of Sciences of the United
States of America, 106(38):16410–16415.
Li, Q., P. Zhang, C. Zhang, Y. Wang, R. Wan, Y. Yang, X. Guo, R. Huo, M. Lin,
Z. Zhou, and J. Sha
2014. DDX3X regulates cell survival and cell cycle during mouse early embry-
onic development. Journal of Biomedical Research, 28(4):282–291.
Li, Y. and R. R. Behringer
1998. Esx1 is an X-chromosome-imprinted regulator of placental development
and fetal growth. Nature Genetics, 20(3):309–311.
Lin, F., K. Xing, J. Zhang, and X. He
2012a. Expression reduction in mammalian X chromosome evolution re-
futes Ohno’s hypothesis of dosage compensation. Proceedings of the National
Academy of Sciences of the United States of America, 109(29):11752–11757.
Lin, H., V. Gupta, M. D. VerMilyea, F. Falciani, J. T. Lee, L. P. O’Neill, and B. M.
Turner
2007. Dosage Compensation in the Mouse Balances Up-Regulation and Silenc-
ing of X-Linked Genes. PLoS Biology, 5(12):e326.
Lin, Y., T. Wen, X. Meng, Z. Wu, L. Zhao, P. Wang, Z. Hong, and Z. Yin
2012b. The mouse Mageb18 gene encodes a ubiquitously expressed type I
MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-
F0 cells. Biochemical Journal, 443(3):779–788.
Linder, P.
2006. Dead-box proteins: a family affair–active and passive players in RNP-
remodeling. Nucleic Acids Research, 34(15):4168–4180.
BIBLIOGRAPHY 270
Linder, P., P. F. Lasko, M. Ashburner, P. Leroy, P. J. Nielsen, K. Nishi, J. Schnier,
and P. P. Slonimski
1989. Birth of the D-E-A-D box. Nature, 337(6203):121–122.
Lingenfelter, P. A., D. A. Adler, D. Poslinski, S. Thomas, R. W. Elliott, V. M.
Chapman, and C. M. Disteche
1998. Escape from X inactivation of Smcx is preceded by silencing during mouse
development. Nature Genetics, 18(3):212–213.
Liu, J., J. Henao-Mejia, H. Liu, Y. Zhao, and J. J. He
2011. Translational Regulation of HIV-1 Replication by HIV-1 Rev Cellular Co-
factors Sam68, eIF5A, hRIP, and DDX3. Journal of Neuroimmune Pharmacol-
ogy, 6(2):308–321.
Liu, N., S. A. Enkemann, P. Liang, R. Hersmus, C. Zanazzi, J. Huang, C. Wu,
Z. Chen, L. H. J. Looijenga, D. L. Keefe, and L. Liu
2010. Genome-wide gene expression profiling reveals aberrant MAPK and Wnt
signaling pathways associated with early parthenogenesis. Journal of Molecular
Cell Biology, 2(6):333–344.
Livak, K. J. and T. D. Schmittgen
2001. Analysis of Relative Gene Expression Data Using Real-Time Quantitative
PCR and the 2−∆∆CT Method. Methods, 25(4):402–408.
Liyanage, M., A. Coleman, S. du Manoir, T. Veldman, S. McCormack, R. B. Dick-
son, C. Barlow, A. Wynshaw-Boris, S. Janz, J. Wienberg, M. A. Ferguson-Smith,
E. Schrock, and T. Ried
1996. Multicolour spectral karyotyping of mouse chromosomes. Nature Genet-
ics, 14(3):312–315.
Lovell-Badge, R. and E. Robertson
1990. XY female mice resulting from a heritable mutation in the primary testis-
determining gene, Tdy. Development, 109(3):635–646.
BIBLIOGRAPHY 271
Lovén, J., D. A. Orlando, A. A. Sigova, C. Y. Lin, P. B. Rahl, C. B. Burge, D. L.
Levens, T. I. Lee, and R. A. Young
2012. Revisiting Global Gene Expression Analysis. Cell, 151(3):476–482.
Lyon, M. F.
1961. Gene action in the X-chromosome of the mouse (Mus musculus L.). Na-
ture, 190(4773):372–373.
Maclary, E., E. Buttigieg, M. Hinten, S. Gayen, C. Harris, M. K. Sarkar, S. Pu-
rushothaman, and S. Kalantry
2014. Differentiation-dependent requirement of Tsix long non-coding RNA in
imprinted X-chromosome inactivation. Nature Communications, 5:4209.
Maclean, J. A., A. Bettegowda, B. J. Kim, C.-H. Lou, S.-M. Yang, A. Bhardwaj,
S. Shanker, Z. Hu, Y. Fan, S. Eckardt, K. J. McLaughlin, A. I. Skoultchi, and
M. F. Wilkinson
2011. The rhox homeobox gene cluster is imprinted and selectively targeted for
regulation by histone h1 and DNA methylation. Molecular and Cellular Biology,
31(6):1275–1287.
MacLean, J. A., M. A. Chen, C. M. Wayne, S. R. Bruce, M. Rao, M. L. Meistrich,
C. Macleod, and M. F. Wilkinson
2005. Rhox: A New Homeobox Gene Cluster. Cell, 120(3):369–382.
Maclean, J. A., D. Lorenzetti, Z. Hu, W. J. Salerno, J. Miller, and M. F. Wilkinson
2006. Rhox homeobox gene cluster: recent duplication of three family members.
genesis, 44(3):122–129.
Mahadevaiah, S. K., T. Odorisio, D. J. Elliott, A. Rattigan, M. Szot, S. H. Laval,
L. L. Washburn, J. R. McCarrey, B. M. Cattanach, R. Lovell-Badge, and P. S.
Burgoyne
1998. Mouse homologues of the human AZF candidate gene RBM are expressed
in spermatogonia and spermatids, and map to a Y chromosome deletion inter-
BIBLIOGRAPHY 272
val associated with a high incidence of sperm abnormalities. Human Molecular
Genetics, 7(4):715–727.
Maier, T., M. Güell, and L. Serrano
2009. Correlation of mRNA and protein in complex biological samples. FEBS
Letters, 583(24):3966–3973.
Mak, W., J. Baxter, J. Silva, A. E. Newall, A. P. Otte, and N. Brockdorff
2002. Mitotically stable association of polycomb group proteins eed and enx1
with the inactive x chromosome in trophoblast stem cells. Current Biology,
12(12):1016–1020.
Mak, W., T. B. Nesterova, M. de Napoles, R. Appanah, S. Yamanaka, A. P. Otte,
and N. Brockdorff
2004. Reactivation of the paternal X chromosome in early mouse embryos. Sci-
ence, 303(5658):666–669.
Mamiya, N. and H. J. Worman
1999. Hepatitis C virus core protein binds to a DEAD box RNA helicase. The
Journal of Biological Chemistry, 274(22):15751–15756.
Manes, C. and P. Menzel
1981. Demethylation of CpG sites in DNA of early rabbit trophoblast. Nature,
293(5833):589–590.
Mansour, A. A., O. Gafni, L. Weinberger, A. Zviran, M. Ayyash, Y. Rais, V. Krupal-
nik, M. Zerbib, D. Amann-Zalcenstein, I. Maza, S. Geula, S. Viukov, L. Holtz-
man, A. Pribluda, E. Canaani, S. Horn-Saban, I. Amit, N. Novershtern, and J. H.
Hanna
2012. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic
reprogramming. Nature, 488(7411):409–413.
Marahrens, Y., B. Panning, J. Dausman, W. Strauss, and R. Jaenisch
1997. Xist-deficient mice are defective in dosage compensation but not spermato-
genesis. Genes & Development, 11(2):156–166.
BIBLIOGRAPHY 273
Marks, H., H. H. D. Kerstens, T. S. Barakat, E. Splinter, R. A. M. Dirks, G. van
Mierlo, O. Joshi, S.-Y. Wang, T. Babak, C. A. Albers, T. Kalkan, A. Smith,
A. Jouneau, W. de Laat, J. Gribnau, and H. G. Stunnenberg
2015. Dynamics of gene silencing during X inactivation using allele-specific
RNA-seq. Genome Biology, 16(1):1–20.
Marstrand-Joergensen, M. R., R. B. Jensen, L. Aksglaede, M. Duno, and A. Juul
2016. Prevalence of SHOX haploinsufficiency among short statured children.
Pediatric Research, 81(2):335–341.
Martin, G. R., C. J. Epstein, B. Travis, G. Tucker, S. Yatziv, D. W. Martin, S. Clift,
and S. Cohen
1978. X-chromosome inactivation during differentiation of female teratocarci-
noma stem cells in vitro. Nature, 271(5643):329–333.
Matsui, J., Y. Goto, and N. Takagi
2001. Control of Xist expression for imprinted and random X chromosome inac-
tivation in mice. Human Molecular Genetics, 10(13):1393–1401.
Mazeyrat, S. and M. J. Mitchell
1998. Rodent Y chromosome TSPY gene is functional in rat and non-functional
in mouse. Human Molecular Genetics, 7(3):557–562.
Mazeyrat, S., N. Saut, V. Grigoriev, S. K. Mahadevaiah, O. A. Ojarikre, A. Rattigan,
C. Bishop, E. M. Eicher, M. J. Mitchell, and P. S. Burgoyne
2001. A Y-encoded subunit of the translation initiation factor Eif2 is essential for
mouse spermatogenesis. Nature Genetics, 29(1):49–53.
Mazeyrat, S., N. Saut, M. G. Mattei, and M. J. Mitchell
1999. RBMY evolved on the Y chromosome from a ubiquitously transcribed
X-Y identical gene. Nature Genetics, 22(3):224–226.
McDonald, L. E., C. A. Paterson, and G. F. Kay
1998. Bisulfite genomic sequencing-derived methylation profile of the xist gene
throughout early mouse development. Genomics, 54(3):379–386.
BIBLIOGRAPHY 274
McGrath, J. and D. Solter
1984. Completion of mouse embryogenesis requires both the maternal and pa-
ternal genomes. Cell, 37(1):179–183.
Meaburn, K. J. and T. Misteli
2008. Locus-specific and activity-independent gene repositioning during early
tumorigenesis. The Journal of Cell Biology, 180(1):39–50.
Menke, D. B. and D. C. Page
2002. Sexually dimorphic gene expression in the developing mouse gonad. Gene
Expression Patterns, 2(3-4):359–367.
Merkin, J., C. Russell, P. Chen, and C. B. Burge
2012. Evolutionary dynamics of gene and isoform regulation in Mammalian
tissues. Science, 338(6114):1593–1599.
Merrick, W. C.
1992. Mechanism and regulation of eukaryotic protein synthesis. Microbiologi-
cal Reviews, 56(2):291–315.
Miller, J. R., S. Koren, and G. Sutton
2010. Assembly algorithms for next-generation sequencing data. Genomics,
95(6):315–327.
Minkovsky, A., T. S. Barakat, N. Sellami, M. H. Chin, N. Gunhanlar, J. Gribnau,
and K. Plath
2013. The pluripotency factor-bound intron 1 of Xist is dispensable for X chro-
mosome inactivation and reactivation in vitro and in vivo. Cell Reports, 3(3):905–
918.
Minkovsky, A., S. Patel, and K. Plath
2012. Concise review: Pluripotency and the transcriptional inactivation of the
female Mammalian X chromosome. Stem Cells, 30(1):48–54.
BIBLIOGRAPHY 275
Miyake, N., S. Mizuno, N. Okamoto, H. Ohashi, M. Shiina, K. Ogata, Y. Tsurusaki,
M. Nakashima, H. Saitsu, N. Niikawa, and N. Matsumoto
2012. KDM6A Point Mutations Cause Kabuki Syndrome. Human Mutation,
34(1):108–110.
Mohan, M., H.-M. Herz, and A. Shilatifard
2012. SnapShot: Histone lysine methylase complexes. Cell, 149(2):498–498.e1.
Monk, M. and M. I. Harper
1979. Sequential X chromosome inactivation coupled with cellular differentia-
tion in early mouse embryos. Nature, 281(5729):311–313.
Morales Torres, C., A. Laugesen, and K. Helin
2013. Utx is required for proper induction of ectoderm and mesoderm during
differentiation of embryonic stem cells. PLoS ONE, 8(4):e60020.
Morris, T.
1968a. The XO and OY chromosome constitutions in the mouse. Genetical
Research, 12(2):125–137.
Morris, T.
1968b. The XO and OY chromosome constitutions in the mouse. Genetics Re-
search, 12(2):125–137.
Moses, M. J., S. J. Counce, and D. F. Paulson
1975. Synaptonemal complex complement of man in spreads of spermatocytes,
with details of the sex chromosome pair. Science, 187(4174):363–365.
Motomura, K., M. Oikawa, M. Hirose, A. Honda, S. Togayachi, H. Miyoshi, Y. Ohi-
nata, M. Sugimoto, K. Abe, K. Inoue, and A. Ogura
2016. Cellular Dynamics of Mouse Trophoblast Stem Cells: Identification of a
Persistent Stem Cell Type1. Biology of Reproduction, 94(6):1–14.
Mou, H., J. L. Smith, L. Peng, H. Yin, J. Moore, X.-O. Zhang, C.-Q. Song, A. Sheel,
Q. Wu, D. M. Ozata, Y. Li, D. G. Anderson, C. P. Emerson, E. J. Sontheimer, M. J.
BIBLIOGRAPHY 276
Moore, Z. Weng, and W. Xue
2017. CRISPR/Cas9-mediated genome editing induces exon skipping by alter-
native splicing or exon deletion. Genome Biology, 18(108):1–8.
Mueller, F., A. Senecal, K. Tantale, H. Marie-Nelly, N. Ly, O. Collin, E. Basyuk,
E. Bertrand, X. Darzacq, and C. Zimmer
2013. FISH-quant: automatic counting of transcripts in 3D FISH images. Nature
Methods, 10(4):277–278.
Muller, H. J.
1914. A factor for the fourth chromosome in Drosophila. Science, 39(1016):906.
Nagano, T., J. A. Mitchell, L. A. Sanz, F. M. Pauler, A. C. Ferguson-Smith, R. Feil,
and P. Fraser
2008. The Air noncoding RNA epigenetically silences transcription by targeting
G9a to chromatin. Science, 322(5908):1717–1720.
Nagy, A., E. Gócza, E. M. Diaz, V. R. Prideaux, E. Iványi, M. Markkula, and
J. Rossant
1990. Embryonic stem cells alone are able to support fetal development in the
mouse. Development, 110(3):815–821.
Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder
1993. Derivation of completely cell culture-derived mice from early-passage
embryonic stem cells. Proceedings of the National Academy of Sciences of the
United States of America, 90(18):8424–8428.
Nakagawa, O., M. Arnold, M. Nakagawa, H. Hamada, J. M. Shelton, H. Kusano,
T. M. Harris, G. Childs, K. P. Campbell, J. A. Richardson, I. Nishino, and E. N.
Olson
2005. Centronuclear myopathy in mice lacking a novel muscle-specific pro-
tein kinase transcriptionally regulated by MEF2. Genes & Development,
19(17):2066–2077.
BIBLIOGRAPHY 277
Nakamura, T., Y. Yabuta, I. Okamoto, S. Aramaki, S. Yokobayashi, K. Kurimoto,
K. Sekiguchi, M. Nakagawa, T. Yamamoto, and M. Saitou
2015. SC3-seq: a method for highly parallel and quantitative measurement of
single-cell gene expression. Nucleic Acids Research, 43(9):e60–e60.
Nakayama, N., C.-y. E. Han, S. Scully, R. Nishinakamura, C. He, L. Zeni, H. Ya-
mane, D. Chang, D. Yu, T. Yokota, and D. Wen
2001. A Novel Chordin-like Protein Inhibitor for Bone Morphogenetic Proteins
Expressed Preferentially in Mesenchymal Cell Lineages. Developmental Biol-
ogy, 232(2):372–387.
Namekawa, S. H., B. Payer, K. D. Huynh, R. Jaenisch, and J. T. Lee
2010. Two-Step Imprinted X Inactivation: Repeat versus Genic Silencing in the
Mouse. Molecular and Cellular Biology, 30(13):3187–3205.
Naumova, A. K., M. Leppert, D. F. Barker, K. Morgan, and C. Sapienza
1998. Parental origin-dependent, male offspring-specific transmission-ratio dis-
tortion at loci on the human X chromosome. American Journal of Human Genet-
ics, 62(6):1493–1499.
Navarro, P., I. Chambers, V. Karwacki-Neisius, C. Chureau, C. Morey,
C. Rougeulle, and P. Avner
2008. Molecular Coupling of Xist Regulation and Pluripotency. Science,
321(5896):1693–1695.
Nesterova, T. B., C. E. Senner, J. Schneider, T. Alcayna-Stevens, A. Tattermusch,
M. Hemberger, and N. Brockdorff
2011. Pluripotency factor binding and Tsix expression act synergistically to re-
press Xist in undifferentiated embryonic stem cells. Epigenetics & Chromatin,
4(1):17.
Nguyen, D. K. and C. M. Disteche
2006. High expression of the mammalian X chromosome in brain. Brain Re-
search, 1126(1):46–49.
BIBLIOGRAPHY 278
Nicholson, J. M., J. C. Macedo, A. J. Mattingly, D. Wangsa, J. Camps, V. Lima,
A. M. Gomes, S. Dória, T. Ried, E. Logarinho, and D. Cimini
2015. Chromosome mis-segregation and cytokinesis failure in trisomic human
cells. eLife, 4:1315.
Niu, X., T. Zhang, L. Liao, L. Zhou, D. J. Lindner, M. Zhou, B. Rini, Q. Yan, and
H. Yang
2012. The von Hippel-Lindau tumor suppressor protein regulates gene expression
and tumor growth through histone demethylase JARID1C. Oncogene, 31(6):776–
786.
Niwa, H., Y. Toyooka, D. Shimosato, D. Strumpf, K. Takahashi, R. Yagi, and
J. Rossant
2005. Interaction between Oct3/4 and Cdx2 Determines Trophectoderm Differ-
entiation. Cell, 123(5):917–929.
Norris, D. P., N. Brockdorff, and S. Rastan
1991. Methylation status of CpG-rich islands on active and inactive mouse X
chromosomes. Mammalian Genome, 1(2):78–83.
Nowell, C. S., N. Bredenkamp, S. Tetélin, X. Jin, C. Tischner, H. Vaidya, J. M.
Sheridan, F. H. Stenhouse, R. Heussen, A. J. H. Smith, and C. C. Blackburn
2011. Foxn1 Regulates Lineage Progression in Cortical and Medullary Thymic
Epithelial Cells But Is Dispensable for Medullary Sublineage Divergence. PLoS
Genetics, 7(11):e1002348–16.
Odorisio, T., T. A. Rodriguez, E. P. Evans, A. R. Clarke, and P. S. Burgoyne
1998. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via
p53-independent apoptosis. Nature Genetics, 18(3):257–261.
Ohno, S. and T. S. Hauschka
1960. Allocycly of the X-chromosome in tumors and normal tissues. Cancer
Research, 20:541–545.
BIBLIOGRAPHY 279
Okamoto, I., D. Arnaud, P. Le Baccon, A. P. Otte, C. M. Disteche, P. Avner, and
E. Heard
2005. Evidence for de novo imprinted X-chromosome inactivation independent
of meiotic inactivation in mice. Nature, 438(7066):369–373.
Okamoto, I., A. P. Otte, C. D. Allis, D. Reinberg, and E. Heard
2004. Epigenetic dynamics of imprinted X inactivation during early mouse de-
velopment. Science, 303(5658):644–649.
Okamoto, I., C. Patrat, D. Thépot, N. Peynot, P. Fauque, N. Daniel, P. Diaban-
gouaya, J.-P. Wolf, J.-P. Renard, V. Duranthon, and E. Heard
2011. Eutherian mammals use diverse strategies to initiate X-chromosome inac-
tivation during development. Nature, 472(7343):370–374.
Okamoto, I., S. Tan, and N. Takagi
2000. X-chromosome inactivation in XX androgenetic mouse embryos surviving
implantation. Development, 127(19):4137–4145.
Ooi, S. K., D. Wolf, O. Hartung, S. Agarwal, G. Q. Daley, S. P. Goff, and T. H.
Bestor
2010. Dynamic instability of genomic methylation patterns in pluripotent stem
cells. Epigenetics & Chromatin, 3(1):17.
Otter, M., C. T. Schrander-Stumpel, and L. M. Curfs
2009. Triple X syndrome: a review of the literature. European Journal of Human
Genetics, 18(3):265–271.
Õunap, K., H. Puusepp-Benazzouz, M. Peters, U. Vaher, R. Rein, A. Proos,
M. Field, and T. Reimand
2012. A novel c.2T > C mutation of the KDM5C/JARID1C gene in one large
family with X-linked intellectual disability. European Journal of Medical Genet-
ics, 55(3):178–184.
BIBLIOGRAPHY 280
Owsianka, A. M. and A. H. Patel
1999. Hepatitis C virus core protein interacts with a human DEAD box protein
DDX3. Virology, 257(2):330–340.
Pal Bhadra, M.
2005. Gene Expression Analysis of the Function of the Male-Specific Lethal
Complex in Drosophila. Genetics, 169(4):2061–2074.
Palmer, S., J. Perry, D. Kipling, and A. Ashworth
1997. A gene spans the pseudoautosomal boundary in mice. Proceedings of the
National Academy of Sciences of the United States of America, 94(22):12030–
12035.
Park, C., L. Carrel, and K. D. Makova
2010. Strong purifying selection at genes escaping X chromosome inactivation.
Molecular Biology and Evolution, 27(11):2446–2450.
Park, S. H., S. G. Lee, Y. Kim, and K. Song
1998. Assignment of a human putative RNA helicase gene, DDX3, to human
X chromosome bands p11.3–>p11.23. Cytogenetics and Cell Genetics, 81(3-
4):178–179.
Park, S. H., Y. K. Shin, Y. H. Suh, W. S. Park, Y. L. Ban, H.-S. Choi, H. J. Park, and
K. C. Jung
2005. Rapid divergency of rodent CD99 orthologs: implications for the evolution
of the pseudoautosomal region. Gene, 353(2):177–188.
Passerini, V., E. Ozeri-Galai, M. S. de Pagter, N. Donnelly, S. Schmalbrock, W. P.
Kloosterman, B. Kerem, and Z. S. aacute
2016. The presence of extra chromosomes leads to genomic instability. Nature
Communications, 7:1–12.
Patrat, C., I. Okamoto, P. Diabangouaya, V. Vialon, P. Le Baccon, J. Chow, and
E. Heard
2009. Dynamic changes in paternal X-chromosome activity during imprinted
BIBLIOGRAPHY 281
X-chromosome inactivation in mice. Proceedings of the National Academy of
Sciences of the United States of America, 106(13):5198–5203.
Patro, R., G. Duggal, M. I. Love, R. A. Irizarry, and C. Kingsford
2017. Salmon provides fast and bias-aware quantification of transcript expres-
sion. Nature Methods, 14(4):417–419.
Payer, B.
2016. Developmental regulation of X-chromosome inactivation. Seminars in Cell
& Developmental Biology, 56:88–99.
Payer, B., M. Rosenberg, M. Yamaji, Y. Yabuta, M. Koyanagi-Aoi, K. Hayashi,
S. Yamanaka, M. Saitou, and J. T. Lee
2013. Tsix RNA and the germline factor, PRDM14, link X reactivation and stem
cell reprogramming. Molecular Cell, 52(6):805–818.
Peng, Y., J. Suryadi, Y. Yang, T. G. Kucukkal, W. Cao, and E. Alexov
2015. Mutations in the KDM5C ARID Domain and Their Plausible Association
with Syndromic Claes-Jensen-Type Disease. International Journal of Molecular
Sciences, 16(11):27270–27287.
Perinchery, G., M. Sasaki, A. Angan, V. Kumar, P. Carroll, and R. Dahiya
2000. Deletion of Y-chromosome specific genes in human prostate cancer. The
Journal of Urology, 163(4):1339–1342.
Pessia, E., T. Makino, M. Bailly-Bechet, A. McLysaght, and G. A. B. Marais
2012. Mammalian X chromosome inactivation evolved as a dosage-
compensation mechanism for dosage-sensitive genes on the X chromosome. Pro-
ceedings of the National Academy of Sciences of the United States of America,
109(14):5346–5351.
Petropoulos, S., D. Edsgärd, B. Reinius, Q. Deng, S. P. Panula, S. Codeluppi, A. P.
Reyes, S. Linnarsson, R. Sandberg, and F. Lanner
2016. Single-Cell RNA-Seq Reveals Lineage and X Chromosome Dynamics in
Human Preimplantation Embryos. Cell, 165(4):1–33.
BIBLIOGRAPHY 282
Pfeifer, G. P., S. D. Steigerwald, R. S. Hansen, S. M. Gartler, and A. D. Riggs
1990a. Polymerase chain reaction-aided genomic sequencing of an X
chromosome-linked CpG island: methylation patterns suggest clonal inheritance,
CpG site autonomy, and an explanation of activity state stability. Proceedings of
the National Academy of Sciences of the United States of America, 87(21):8252–
8256.
Pfeifer, G. P., R. L. Tanguay, S. D. Steigerwald, and A. D. Riggs
1990b. In vivo footprint and methylation analysis by PCR-aided genomic se-
quencing: comparison of active and inactive X chromosomal DNA at the CpG
island and promoter of human PGK-1. Genes & Development, 4(8):1277–1287.
Phillips, R. J. and M. H. Kaufman
1974. Bare-patches, a new sex-linked gene in the mouse, associated with a high
production of XO females: II. Investigations into the nature and mechanism of
the XO production. Genetical Research, 24(1):27–41.
Pimentel, H., N. L. Bray, S. Puente, P. Melsted, and L. Pachter
2017. Differential analysis of RNA-seq incorporating quantification uncertainty.
Nature Methods, 14(7):687–690.
Plass, C., S. M. Pfister, A. M. Lindroth, O. Bogatyrova, R. Claus, and P. Lichter
2013. Mutations in regulators of the epigenome and their connections to global
chromatin patterns in cancer. Nature Reviews Genetics, 14(11):765–780.
Plath, K., J. Fang, S. K. Mlynarczyk-Evans, R. Cao, K. A. Worringer, H. Wang,
C. C. de la Cruz, A. P. Otte, B. Panning, and Y. Zhang
2003. Role of histone H3 lysine 27 methylation in X inactivation. Science,
300(5616):131–135.
Poupon, V., B. Bègue, J. Gagnon, A. Dautry-Varsat, N. Cerf-Bensussan, and
A. Benmerah
1999. Molecular cloning and characterization of MT-ACT48, a novel mi-
BIBLIOGRAPHY 283
tochondrial acyl-CoA thioesterase. The Journal of Biological Chemistry,
274(27):19188–19194.
Power, M. A. and P. P. L. Tam
1993. Onset of gastrulation, morphogenesis and somitogenesis in mouse embryos
displaying compensatory growth. Anatomy and Embryology, 187(5):493–504.
Priolo, M., L. Micale, B. Augello, C. Fusco, F. Zucchetti, P. Prontera, V. Paduano,
E. Biamino, A. Selicorni, C. Mammì, C. Laganà, L. Zelante, and G. Merla
2012. Absence of deletion and duplication of MLL2 and KDM6A genes in a large
cohort of patients with Kabuki syndrome. Molecular Genetics and Metabolism,
107(3):627–629.
Prudhomme, J., A. Dubois, P. Navarro, D. Arnaud, P. Avner, and C. Morey
2015. A rapid passage through a two-active-X-chromosome state accompanies
the switch of imprinted X-inactivation patterns in mouse trophoblast stem cells.
Epigenetics & Chromatin, 8(1):52.
Prudhomme, J. and C. Morey
2015. Epigenesis and plasticity of mouse trophoblast stem cells. Cellular and
Molecular Life Sciences, 73(4):757–774.
Prykhozhij, S. V., S. L. Steele, B. Razaghi, and J. N. Berman
2017. A rapid and effective method for screening, sequencing and reporter verifi-
cation of engineered frameshift mutations in zebrafish. Disease Models & Mech-
anisms, 10(6):811–822.
Pugh, T. J., S. D. Weeraratne, T. C. Archer, D. A. P. Krummel, D. Auclair, J. Bochic-
chio, M. O. Carneiro, S. L. Carter, K. Cibulskis, R. L. Erlich, H. Greulich, M. S.
Lawrence, N. J. Lennon, A. McKenna, J. Meldrim, A. H. Ramos, M. G. Ross,
C. Russ, E. Shefler, A. Sivachenko, B. Sogoloff, P. Stojanov, P. Tamayo, J. P.
Mesirov, V. Amani, N. Teider, S. Sengupta, J. P. Francois, P. A. Northcott, M. D.
Taylor, F. Yu, G. R. Crabtree, A. G. Kautzman, S. B. Gabriel, G. Getz, N. Jäger,
D. T. W. Jones, P. Lichter, S. M. Pfister, T. M. Roberts, M. Meyerson, S. L.
BIBLIOGRAPHY 284
Pomeroy, and Y.-J. Cho
2012. Medulloblastoma exome sequencing uncovers subtype-specific somatic
mutations. Nature, 488(7409):106–110.
Radford, E. J., S. R. Ferrón, and A. C. Ferguson-Smith
2011. Genomic imprinting as an adaptative model of developmental plasticity.
FEBS Letters, 585(13):2059–2066.
Raefski, A. S. and M. J. O’Neill
2005. Identification of a cluster of X-linked imprinted genes in mice. Nature
Genetics, 37(6):620–624.
Ramathal, C., B. Angulo, M. Sukhwani, J. Cui, J. Durruthy-Durruthy, F. Fang,
P. Schanes, P. J. Turek, K. E. Orwig, and R. R. Pera
2015. DDX3Y gene rescue of a Y chromosome AZFa deletion restores germ cell
formation and transcriptional programs. Scientific Reports, 5:1–13.
Ran, F. A., P. D. Hsu, J. Wright, V. Agarwala, D. A. Scott, and F. Zhang
2013. Genome engineering using the CRISPR-Cas9 system. Nature Protocols,
8(11):2281–2308.
Ranke, M. B. and P. Saenger
2001. Turner’s syndrome. The Lancet, 358(9278):309–314.
Rao, E., R. J. Blaschke, A. Marchini, B. Niesler, M. Burnett, and G. A. Rappold
2001. The Leri-Weill and Turner syndrome homeobox gene SHOX encodes
a cell-type specific transcriptional activator. Human Molecular Genetics,
10(26):3083–3091.
Rao, E., B. Weiss, M. Fukami, A. Rump, B. Niesler, A. Mertz, K. Muroya,
G. Binder, S. Kirsch, M. Winkelmann, G. Nordsiek, U. Heinrich, M. H. Bre-
uning, M. B. Ranke, A. Rosenthal, T. Ogata, and G. A. Rappold
1997. Pseudoautosomal deletions encompassing a novel homeobox gene cause
growth failure in idiopathic short stature and Turner syndrome. Nature Genetics,
16(1):54–63.
BIBLIOGRAPHY 285
Rastan, S.
1982. Timing of X-chromosome inactivation in postimplantation mouse em-
bryos. Journal of Embryology and Experimental Morphology, 71:11–24.
Rebuzzini, P., T. Neri, G. Mazzini, M. Zuccotti, C. A. Redi, and S. Garagna
2008. Karyotype analysis of the euploid cell population of a mouse embryonic
stem cell line revealed a high incidence of chromosome abnormalities that varied
during culture. Cytogenetic and Genome Research, 121(1):18–24.
Rebuzzini, P., M. Zuccotti, C. A. Redi, and S. Garagna
2016. Chromosomal Abnormalities in Embryonic and Somatic Stem Cells. Cy-
togenetic and Genome Research, 147(1):1–9.
Reik, W., M. Constancia, A. Fowden, N. Anderson, W. Dean, A. Ferguson-Smith,
B. Tycko, and C. Sibley
2003. Regulation of supply and demand for maternal nutrients in mammals by
imprinted genes. The Journal of Physiology, 547(1):35–44.
Reinius, B., M. M. Johansson, K. J. Radomska, E. H. Morrow, G. K. Pandey,
C. Kanduri, R. Sandberg, R. W. Williams, and E. Jazin
2012. Abundance of female-biased and paucity of male-biased somatically ex-
pressed genes on the mouse X-chromosome. BMC Genomics, 13(1):607.
Renfree, M. B., S. Suzuki, and T. Kaneko-Ishino
2013. The origin and evolution of genomic imprinting and viviparity in mam-
mals. Philosophical transactions of the Royal Society of London. Series B, Bio-
logical sciences, 368(1609):20120151–20120151.
Richardson, B. J., A. B. Czuppon, and G. B. Sharman
1971. Inheritance of glucose-6-phosphate dehydrogenase variation in kangaroos.
Nature: New Biology, 230(13):154–155.
Riddell, S. R., M. Murata, S. Bryant, and E. H. Warren
2002. Minor histocompatibility antigens–targets of graft versus leukemia re-
sponses. International Journal of Hematology, 76 Suppl 2:155–161.
BIBLIOGRAPHY 286
Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, and G. K. Smyth
2015. limma powers differential expression analyses for RNA-sequencing and
microarray studies. Nucleic Acids Research, 43(7):e47–e47.
Robertson, E. J., M. J. Evans, and M. H. Kaufman
1983. X-chromosome instability in pluripotential stem cell lines derived from
parthenogenetic embryos. Journal of Embryology and Experimental Morphol-
ogy, 74:297–309.
Robinson, G., M. Parker, T. A. Kranenburg, C. Lu, X. Chen, L. Ding, T. N. Phoenix,
E. Hedlund, L. Wei, X. Zhu, N. Chalhoub, S. J. Baker, R. Huether, R. Kriwacki,
N. Curley, R. Thiruvenkatam, J. Wang, G. Wu, M. Rusch, X. Hong, J. Becks-
fort, P. Gupta, J. Ma, J. Easton, B. Vadodaria, A. Onar-Thomas, T. Lin, S. Li,
S. Pounds, S. Paugh, D. Zhao, D. Kawauchi, M. F. Roussel, D. Finkelstein, D. W.
Ellison, C. C. Lau, E. Bouffet, T. Hassall, S. Gururangan, R. Cohn, R. S. Fulton,
L. L. Fulton, D. J. Dooling, K. Ochoa, A. Gajjar, E. R. Mardis, R. K. Wilson,
J. R. Downing, J. Zhang, and R. J. Gilbertson
2012. Novel mutations target distinct subgroups of medulloblastoma. Nature,
488(7409):43–48.
Robles Valdés, C., V. del Castillo Ruiz, J. Oyoqui, N. Altamirano Bustamante,
M. de la Luz Ruiz Reyes, and R. Calzada León
2003. Growth, growth velocity and adult height in Mexican girls with Turner’s
syndrome. Journal of Pediatric Endocrinology & Metabolism, 16(8):1165–1173.
Rodriguez, T. A., D. B. Sparrow, A. N. Scott, S. L. Withington, J. I. Preis, J. Michal-
icek, M. Clements, T. E. Tsang, T. Shioda, R. S. P. Beddington, and S. L. Dun-
woodie
2004. Cited1 is required in trophoblasts for placental development and for em-
bryo growth and survival. Molecular and Cellular Biology, 24(1):228–244.
BIBLIOGRAPHY 287
Roeleveld, N., G. A. Zielhuis, and F. Gabreëls
1997. The prevalence of mental retardation: a critical review of recent literature.
Developmental Medicine and Child Neurology, 39(2):125–132.
Ross, J. L., C. Scott, P. Marttila, K. Kowal, A. Nass, P. Papenhausen, J. Abboudi,
L. Osterman, H. Kushner, P. Carter, M. Ezaki, F. Elder, F. Wei, H. Chen, and
A. R. Zinn
2001. Phenotypes Associated with SHOX Deficiency. The Journal of Clinical
Endocrinology and Metabolism, 86(12):5674–5680.
Ross, M. T., D. V. Grafham, A. J. Coffey, S. Scherer, K. McLay, D. Muzny,
M. Platzer, G. R. Howell, C. Burrows, and C. P. Bird
2005. The DNA sequence of the human X chromosome. Nature, 434(7031):325–
337.
Rossant, J. and J. C. Cross
2001. Placental development: lessons from mouse mutants. Nature Reviews
Genetics, 2(7):538–548.
Rossant, J., J. P. Sanford, V. M. Chapman, and G. K. Andrews
1986. Undermethylation of structural gene sequences in extraembryonic lineages
of the mouse. Developmental Biology, 117(2):567–573.
Rovescalli, A. C., S. Asoh, and M. Nirenberg
1996. Cloning and characterization of four murine homeobox genes. Pro-
ceedings of the National Academy of Sciences of the United States of America,
93(20):10691–10696.
Royo, H., G. Polikiewicz, S. K. Mahadevaiah, H. Prosser, M. Mitchell, A. Bradley,
D. G. de Rooij, P. S. Burgoyne, and J. M. A. Turner
2010. Evidence that meiotic sex chromosome inactivation is essential for male
fertility. Current Biology, 20(23):2117–2123.
BIBLIOGRAPHY 288
Rozen, S., H. Skaletsky, J. D. Marszalek, P. J. Minx, H. S. Cordum, R. H. Waterston,
R. K. Wilson, and D. C. Page
2003. Abundant gene conversion between arms of palindromes in human and ape
Y chromosomes. Nature, 423(6942):873–876.
Rugarli, E. I., D. A. Adler, G. Borsani, K. Tsuchiya, B. Franco, X. Hauge, C. Dis-
teche, V. Chapman, and A. Ballabio
1995. Different chromosomal localization of the Clcn4 gene in Mus spretus and
C57BL/6J mice. Nature Genetics, 10(4):466–471.
Rujirabanjerd, S., J. Nelson, P. S. Tarpey, A. Hackett, S. Edkins, F. L. Raymond,
C. E. Schwartz, G. Turner, S. Iwase, Y. Shi, P. A. Futreal, M. R. Stratton, and
J. Gecz
2010. Identification and characterization of two novel JARID1C mutations: sug-
gestion of an emerging genotype-phenotype correlation. European Journal of
Human Genetics : EJHG, 18(3):330–335.
Russell, L. B.
1961. Genetics of mammalian sex chromosomes. Science, 133(3467):1795–
1803.
Sado, T., M. H. Fenner, S.-S. Tan, P. Tam, T. Shioda, and E. Li
2000. X Inactivation in the Mouse Embryo Deficient for Dnmt1: Distinct Effect
of Hypomethylation on Imprinted and Random X Inactivation. Developmental
Biology, 225(2):294–303.
Sado, T., Y. Hoki, and H. Sasaki
2006. Tsix defective in splicing is competent to establish Xist silencing. Devel-
opment, 133(24):4925–4931.
Sado, T., Z. Wang, H. Sasaki, and E. LI
2001. Regulation of imprinted X-chromosome inactivation in mice by Tsix. De-
velopment, 128(8):1275–1286.
BIBLIOGRAPHY 289
Sakaue, M., H. Ohta, Y. Kumaki, M. Oda, Y. Sakaide, C. Matsuoka, A. Yamagiwa,
H. Niwa, T. Wakayama, and M. Okano
2010. DNA Methylation Is Dispensable for the Growth and Survival of the Ex-
traembryonic Lineages. Current Biology, 20(16):1452–1457.
Saldarriaga, W., H. Andrés García-Perdomo, J. Arango-Pineda, and J. Fonseca
2015. Karyotype versus genomic hybridization for the prenatal diagnosis of chro-
mosomal abnormalities: a metaanalysis. The American Journal of Obstetrics &
Gynecology, 212(3):330.e1–330.e10.
Samal, S. K., S. Routray, G. K. Veeramachaneni, R. Dash, and M. Botlagunta
2015. Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer.
Scientific Reports, 5:9982.
Sanger, R., P. Tippett, J. Gavin, P. Teesdale, and G. L. Daniels
1977. Xg groups and sex chromosome abnormalities in people of northern Euro-
pean ancestry: an addendum. Journal of Medical Genetics, 14(3):210–211.
Sangrithi, M. N., H. Royo, S. K. Mahadevaiah, O. Ojarikre, L. Bhaw, A. Sesay,
A. H. F. M. Peters, M. Stadler, and J. M. A. Turner
2017. Non-Canonical and Sexually Dimorphic X Dosage Compensation States
in the Mouse and Human Germline. Developmental Cell, 40(3):289–301.e3.
Santos, C., L. Rodriguez-Revenga, I. Madrigal, C. Badenas, M. Pineda, and M. Milà
2006. A novel mutation in JARID1C gene associated with mental retardation.
European Journal of Human Genetics, 14(5):583–586.
Santos-Reboucas, C. B., N. Fintelman-Rodrigues, L. R. Jensen, A. W. Kuss, M. G.
Ribeiro, M. Campos, Jr, J. M. Santos, and M. M. G. Pimentel
2011. A novel nonsense mutation in KDM5C/JARID1C gene causing intellectual
disability, short stature and speech delay. Neuroscience Letters, 498(1):67–71.
BIBLIOGRAPHY 290
Schaefer, K. A., W.-H. Wu, D. F. Colgan, S. H. Tsang, A. G. Bassuk, and V. B.
Mahajan
2017. Unexpected mutations after CRISPR–Cas9 editing in vivo. Nature Meth-
ods, 14(6):1–2.
Schoeftner, S., A. K. Sengupta, S. Kubicek, K. Mechtler, L. Spahn, H. Koseki,
T. Jenuwein, and A. Wutz
2006. Recruitment of PRC1 function at the initiation of X inactivation indepen-
dent of PRC2 and silencing. The EMBO Journal, 25(13):3110–3122.
Schultz, M. D., Y. He, J. W. Whitaker, M. Hariharan, E. A. Mukamel, D. Leung,
N. Rajagopal, J. R. Nery, M. A. Urich, H. Chen, S. Lin, Y. Lin, I. Jung, A. D.
Schmitt, S. Selvaraj, B. Ren, T. J. Sejnowski, W. Wang, and J. R. Ecker
2015. Human body epigenome maps reveal noncanonical DNA methylation vari-
ation. Nature, 523(7559):212–216.
Schulz, E. G., J. Meisig, T. Nakamura, I. Okamoto, A. Sieber, C. Picard, M. Boren-
sztein, M. Saitou, N. Blüthgen, and E. Heard
2014. The two active X chromosomes in female ESCs block exit from the
pluripotent state by modulating the ESC signaling network. Cell Stem Cell,
14(2):203–216.
Scott, D. M., I. E. Ehrmann, P. S. Ellis, C. E. Bishop, A. I. Agulnik, E. Simpson,
and M. J. Mitchell
1995. Identification of a mouse male-specific transplantation antigen, H-Y. Na-
ture, 376(6542):695–698.
Scott, I. C., L. Anson-Cartwright, P. Riley, D. Reda, and J. C. Cross
2000. The HAND1 Basic Helix-Loop-Helix Transcription Factor Regulates Tro-
phoblast Differentiation via Multiple Mechanisms. Molecular and Cellular Biol-
ogy, 20(2):530–541.
Sekiguchi, T., H. Iida, J. Fukumura, and T. Nishimoto
2004. Human DDX3Y, the Y-encoded isoform of RNA helicase DDX3, rescues
BIBLIOGRAPHY 291
a hamster temperature-sensitive ET24 mutant cell line with a DDX3X mutation.
Experimental Cell Research, 300(1):213–222.
Sekiguchi, T., Y. Kurihara, and J. Fukumura
2007. Phosphorylation of threonine 204 of DEAD-box RNA helicase DDX3 by
cyclin B/cdc2 in vitro. Biochemical and Biophysical Research Communications,
356(3):668–673.
Semina, E. V., R. S. Reiter, and J. C. Murray
1998. A new human homeobox gene OGI2X is a member of the most conserved
homeobox gene family and is expressed during heart development in mouse. Hu-
man Molecular Genetics, 7(3):415–422.
Sengoku, T. and S. Yokoyama
2011. Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A.
Genes & Development, 25(21):2266–2277.
Senner, C. E., F. Krueger, D. Oxley, S. Andrews, and M. Hemberger
2012. DNA methylation profiles define stem cell identity and reveal a tight
embryonic-extraembryonic lineage boundary. Stem Cells, 30(12):2732–2745.
Shao, C. and N. Takagi
1990. An extra maternally derived X chromosome is deleterious to early mouse
development. Development, 110(3):969–975.
Sharma, D. and J. Bhattacharya
2010. Evolutionary Constraints Acting on DDX3X Protein Potentially Interferes
with Rev-Mediated Nuclear Export of HIV-1 RNA. PLoS ONE, 5(3):e9613.
Sharman, G. B.
1971. Late DNA replication in the paternally derived X chromosome of female
kangaroos. Nature, 230(5291):231–232.
Sheardown, S., D. Norris, A. Fisher, and N. Brockdorff
1996. The mouse Smcx gene exhibits developmental and tissue specific variation
BIBLIOGRAPHY 292
in degree of escape from X inactivation. Human Molecular Genetics, 5(9):1355–
1360.
Shi, W., J. A. J. M. van den Hurk, V. Alamo-Bethencourt, W. Mayer, H. J. Winkens,
H.-H. Ropers, F. P. M. Cremers, and R. Fundele
2004. Choroideremia gene product affects trophoblast development and vascular-
ization in mouse extra-embryonic tissues. Developmental Biology, 272(1):53–65.
Shi, X., T. Hong, K. L. Walter, M. Ewalt, E. Michishita, T. Hung, D. Carney, P. Peña,
F. Lan, M. R. Kaadige, N. Lacoste, C. Cayrou, F. Davrazou, A. Saha, B. R.
Cairns, D. E. Ayer, T. G. Kutateladze, Y. Shi, J. Côté, K. F. Chua, and O. Gozani
2006. ING2 PHD domain links histone H3 lysine 4 methylation to active gene
repression. Nature, 442(7098):96–99.
Shibata, S. and J. T. Lee
2004. Tsix Transcription- versus RNA-Based Mechanisms in Xist Repression
and Epigenetic Choice. Current Biology, 14(19):1747–1754.
Shih, J.-W., T.-Y. Tsai, C.-H. Chao, and Y.-H. Wu Lee
2008. Candidate tumor suppressor DDX3 RNA helicase specifically represses
cap-dependent translation by acting as an eIF4E inhibitory protein. Oncogene,
27(5):700–714.
Shin, J., M. Bossenz, Y. Chung, H. Ma, M. Byron, N. Taniguchi-Ishigaki, X. Zhu,
B. Jiao, L. L. Hall, M. R. Green, S. N. Jones, I. Hermans-Borgmeyer, J. B.
Lawrence, and I. Bach
2010. Maternal Rnf12/RLIM is required for imprinted X-chromosome inactiva-
tion in mice. Nature, 467(7318):977–981.
Shin, J., M. C. Wallingford, J. Gallant, C. Marcho, B. Jiao, M. Byron, M. Bossenz,
J. B. Lawrence, S. N. Jones, J. Mager, and I. Bach
2014. RLIM is dispensable for X-chromosome inactivation in the mouse embry-
onic epiblast. Nature, 511(7507):1–10.
BIBLIOGRAPHY 293
Shpargel, K. B., T. Sengoku, S. Yokoyama, and T. Magnuson
2012. UTX and UTY Demonstrate Histone Demethylase-Independent Function
in Mouse Embryonic Development. PLoS Genetics, 8(9):e1002964.
Silva, J., W. Mak, I. Zvetkova, R. Appanah, T. B. Nesterova, Z. Webster, A. H. F. M.
Peters, T. Jenuwein, A. P. Otte, and N. Brockdorff
2003. Establishment of histone h3 methylation on the inactive X chromosome
requires transient recruitment of Eed-Enx1 polycomb group complexes. Devel-
opmental Cell, 4(4):481–495.
Simmons, D. G., A. L. Fortier, and J. C. Cross
2007. Diverse subtypes and developmental origins of trophoblast giant cells in
the mouse placenta. Developmental Biology, 304(2):567–578.
Simmons, D. G., D. R. C. Natale, V. Begay, M. Hughes, A. Leutz, and J. C. Cross
2008. Early patterning of the chorion leads to the trilaminar trophoblast cell
structure in the placental labyrinth. Development, 135(12):2083–2091.
Simon, M. D., S. F. Pinter, R. Fang, K. Sarma, M. Rutenberg-Schoenberg, S. K.
Bowman, B. A. Kesner, V. K. Maier, R. E. Kingston, and J. T. Lee
2014. High-resolution Xist binding maps reveal two-step spreading during X-
chromosome inactivation. Nature, 504(7480):465–469.
Simpson, A. J. G., O. L. Caballero, A. Jungbluth, Y.-T. Chen, and L. J. Old
2005. Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer,
5(8):615–625.
Simpson, E.
1986. The HY antigen and sex reversal. Cell, 44(6):813–814.
Simpson, E., P. Chandler, E. Goulmy, C. M. Disteche, M. A. Ferguson-Smith, and
D. C. Page
1987. Separation of the genetic loci for the H-Y antigen and for testis determina-
tion on human Y chromosome. Nature, 326(6116):876–878.
BIBLIOGRAPHY 294
Sinclair, A., P. Berta, M. Palmer, J. Hawkins, B. Griffiths, and M. S. Palmer
1990. A gene from the human sex-determining region encodes a protein with.
Nature, 346(6281):240–244.
Skaletsky, H., T. Kuroda-Kawaguchi, P. J. Minx, H. S. Cordum, L. Hillier, L. G.
Brown, S. Repping, T. Pyntikova, J. Ali, T. Bieri, A. Chinwalla, A. Delehaunty,
K. Delehaunty, H. Du, G. Fewell, L. Fulton, R. Fulton, T. Graves, S.-F. Hou,
P. Latrielle, S. Leonard, E. Mardis, R. Maupin, J. McPherson, T. Miner, W. Nash,
C. Nguyen, P. Ozersky, K. Pepin, S. Rock, T. Rohlfing, K. Scott, B. Schultz,
C. Strong, A. Tin-Wollam, S.-P. Yang, R. H. Waterston, R. K. Wilson, S. Rozen,
and D. C. Page
2003. The male-specific region of the human Y chromosome is a mosaic of
discrete sequence classes. Nature, 423(6942):825–837.
Skuse, D. H., R. S. James, D. V. Bishop, B. Coppin, P. Dalton, G. Aamodt-Leeper,
M. Bacarese-Hamilton, C. Creswell, R. McGurk, and P. A. Jacobs
1997. Evidence from Turner’s syndrome of an imprinted X-linked locus affecting
cognitive function. Nature, 387(6634):705–708.
Slavney, A., L. Arbiza, A. G. Clark, and A. Keinan
2016. Strong Constraint on Human Genes Escaping X-Inactivation Is Modulated
by their Expression Level and Breadth in Both Sexes. Molecular Biology and
Evolution, 33(2):384–393.
Smith, E. Y., C. R. Futtner, S. J. Chamberlain, K. A. Johnstone, and J. L. Resnick
2011. Transcription Is Required to Establish Maternal Imprinting at the
Prader-Willi Syndrome and Angelman Syndrome Locus. PLoS Genetics,
7(12):e1002422.
Soejima, H. and K. Higashimoto
2013. Epigenetic and genetic alterations of the imprinting disorder Beckwith-
Wiedemann syndrome and related disorders. Journal of Human Genetics,
58(7):402–409.
BIBLIOGRAPHY 295
Soh, Y. Q. S., J. Alföldi, T. Pyntikova, L. G. Brown, T. Graves, P. J. Minx, R. S. Ful-
ton, C. Kremitzki, N. Koutseva, J. L. Mueller, S. Rozen, J. F. Hughes, E. Owens,
J. E. Womack, W. J. Murphy, Q. Cao, P. de Jong, W. C. Warren, R. K. Wilson,
H. Skaletsky, and D. C. Page
2014. Sequencing the Mouse Y Chromosome Reveals Convergent Gene Acqui-
sition and Amplification on Both Sex Chromosomes. Cell, 159(4):800–813.
Solari, A. J.
1974. The behavior of the XY pair in mammals. International Review of Cytol-
ogy, 38(0):273–317.
Soma, M., Y. Fujihara, M. Okabe, F. Ishino, and S. Kobayashi
2014. Ftx is dispensable for imprinted X-chromosome inactivation in preimplan-
tation mouse embryos. Scientific Reports, 4:5181.
Soneson, C., M. I. Love, and M. D. Robinson
2015. Differential analyses for RNA-seq: transcript-level estimates improve
gene-level inferences. F1000 Research, 4:1521–19.
Soulat, D., T. Bürckstümmer, S. Westermayer, A. Goncalves, A. Bauch, A. Ste-
fanovic, O. Hantschel, K. L. Bennett, T. Decker, and G. Superti-Furga
2008. The DEAD-box helicase DDX3X is a critical component of the TANK-
binding kinase 1-dependent innate immune response. The EMBO Journal,
27(15):2135–2146.
Stavropoulos, N., N. Lu, and J. T. Lee
2001. A functional role for Tsix transcription in blocking Xist RNA accumula-
tion but not in X-chromosome choice. Proceedings of the National Academy of
Sciences of the United States of America, 98(18):10232–10237.
Stern, C.
1957. The Problem of Complete Y-Linkage in Man. American Journal of Human
Genetics, 9(3):147–166.
BIBLIOGRAPHY 296
Stransky, N., A. M. Egloff, A. D. Tward, A. D. Kostic, K. Cibulskis, A. Sivachenko,
G. V. Kryukov, M. S. Lawrence, C. Sougnez, A. McKenna, E. Shefler, A. H.
Ramos, P. Stojanov, S. L. Carter, D. Voet, M. L. Cortés, D. Auclair, M. F.
Berger, G. Saksena, C. Guiducci, R. C. Onofrio, M. Parkin, M. Romkes, J. L.
Weissfeld, R. R. Seethala, L. Wang, C. Rangel-Escareño, J. C. Fernandez-Lopez,
A. Hidalgo-Miranda, J. Melendez-Zajgla, W. Winckler, K. Ardlie, S. B. Gabriel,
M. Meyerson, E. S. Lander, G. Getz, T. R. Golub, L. A. Garraway, and J. R.
Grandis
2011. The mutational landscape of head and neck squamous cell carcinoma.
Science, 333(6046):1157–1160.
Su, C.-Y., T.-C. Lin, Y.-F. Lin, M.-H. Chen, C.-H. Lee, H.-Y. Wang, Y.-C. Lee, Y.-P.
Liu, C.-L. Chen, and M. Hsiao
2015. DDX3 as a strongest prognosis marker and its downregulation promotes
metastasis in colorectal cancer. Oncotarget, 6(21):18602–18612.
Sugawara, A., K. Goto, Y. Sotomaru, T. Sofuni, and T. Ito
2006. Current status of chromosomal abnormalities in mouse embryonic stem
cell lines used in Japan. Comparative medicine, 56(1):31–34.
Sugawara, O., N. Takagi, and M. Sasaki
1983. Allocyclic early replicating X chromosome in mice: Genetic inactivity and
shift into a late replicator in early embryogenesis. Chromosoma, 88(2):133–138.
Sun, C., C. T. Pager, G. Luo, P. Sarnow, and J. H. D. Cate
2010. Hepatitis C Virus Core-Derived Peptides Inhibit Genotype 1b Viral
Genome Replication via Interaction with DDX3X. PLoS ONE, 5(9):e12826.
Sun, M., L. Song, Y. Li, T. Zhou, and R. S. Jope
2008. Identification of an antiapoptotic protein complex at death receptors. Cell
death and differentiation, 15(12):1887–1900.
BIBLIOGRAPHY 297
Sun, M., T. Zhou, E. Jonasch, and R. S. Jope
2013a. Biochimica et Biophysica Acta. BBA - Molecular Cell Research,
1833(6):1489–1497.
Sun, S., B. C. Del Rosario, A. Szanto, Y. Ogawa, Y. Jeon, and J. T. Lee
2013b. Jpx RNA Activates Xist by Evicting CTCF. Cell, 153(7):1537–1551.
Sun, S., B. Payer, S. Namekawa, J. Y. An, W. Press, J. Catalan-Dibene, H. Sunwoo,
and J. T. Lee
2015. Xist imprinting is promoted by the hemizygous (unpaired) state in the male
germ line. Proceedings of the National Academy of Sciences of the United States
of America, 112(47):14415–14422.
Surani, M. A. and S. C. Barton
1983. Development of gynogenetic eggs in the mouse: implications for partheno-
genetic embryos. Science, 222(4627):1034–1036.
Surani, M. A., S. C. Barton, and M. L. Norris
1984. Development of reconstituted mouse eggs suggests imprinting of the
genome during gametogenesis. Nature, 308(5959):548–550.
Tada, T., Y. Obata, M. Tada, Y. Goto, N. Nakatsuji, S. Tan, T. Kono, and N. Takagi
2000. Imprint switching for non-random X-chromosome inactivation during
mouse oocyte growth. Development, 127(14):3101–3105.
Tahiliani, M., P. Mei, R. Fang, T. Leonor, M. Rutenberg, F. Shimizu, J. Li, A. Rao,
and Y. Shi
2007. The histone H3K4 demethylase SMCX links REST target genes to X-
linked mental retardation. Nature, 447(7144):601–605.
Takagi, N. and G. R. Martin
1984. Studies of the temporal relationship between the cytogenetic and biochem-
ical manifestations of X-chromosome inactivation during the differentiation of
LT-1 teratocarcinoma stem cells. Developmental Biology, 103(2):425–433.
BIBLIOGRAPHY 298
Takagi, N. and M. Sasaki
1975. Preferential inactivation of the paternally derived X chromosome in the
extraembryonic membranes of the mouse. Nature, 256(5519):640–642.
Takagi, N., O. Sugawara, and M. Sasaki
1982. Regional and temporal changes in the pattern of X-chromosome replication
during the early post-implantation development of the female mouse. Chromo-
soma, 85(2):275–286.
Tam, P. P.
1981. The control of somitogenesis in mouse embryos. Journal of Embryology
and Experimental Morphology, 65 Suppl:103–128.
Tam, P. P. L.
2003. Mouse embryonic chimeras: tools for studying mammalian development.
Development, 130(25):6155–6163.
Tanaka, S., T. Kunath, A. K. Hadjantonakis, A. Nagy, and J. Rossant
1998. Promotion of trophoblast stem cell proliferation by FGF4. Science,
282(5396):2072–2075.
Tavares, L., E. Dimitrova, D. Oxley, J. Webster, R. Poot, J. Demmers, K. Bezs-
tarosti, S. Taylor, H. Ura, H. Koide, A. Wutz, M. Vidal, S. Elderkin, and
N. Brockdorff
2012. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target
sites independently of PRC2 and H3K27me3. Cell, 148(4):664–678.
Tease, C. and B. M. Cattanach
1989. Sex chromosome pairing patterns in male mice of novel Sxr genotypes.
Chromosoma, 97(5):390–395.
Thieme, S., T. Gyarfas, C. Richter, G. Ozhan, J. Fu, D. Alexopulou, M. H. Muders,
I. Michalk, C. Jakob, A. Dahl, B. Klink, J. Bandola, M. Bachmann, E. Schrock,
BIBLIOGRAPHY 299
F. Buchholz, A. F. Stewart, G. Weidinger, K. Anastassiadis, and S. Brenner
2013. The histone demethylase UTX regulates stem cell migration and
hematopoiesis. Blood, 121(13):2462–2473.
Thornhill, A. R. and P. S. Burgoyne
1993. A paternally imprinted X chromosome retards the development of the early
mouse embryo. Development, 118(1):171–174.
Tian, D., S. Sun, and J. T. Lee
2010. The long noncoding RNA, Jpx, is a molecular switch for X chromosome
inactivation. Cell, 143(3):390–403.
Tian, G., U. Singh, Y. Yu, B. S. Ellsworth, M. Hemberger, R. Geyer, M. D. Stewart,
R. R. Behringer, and R. Fundele
2008. Expression and function of the LIM homeobox containing genes Lhx3 and
Lhx4 in the mouse placenta. Developmental Dynamics, 237(5):1517–1525.
Tie, F., R. Banerjee, P. A. Conrad, P. C. Scacheri, and P. J. Harte
2012. Histone Demethylase UTX and Chromatin Remodeler BRM Bind Directly
to CBP and Modulate Acetylation of Histone H3 Lysine 27. Molecular and Cel-
lular Biology, 32(12):2323–2334.
Traub, S., O. Demaria, L. Chasson, F. Serra, B. Desnues, and L. Alexopoulou
2012. Sex Bias in Susceptibility to MCMV Infection: Implication of TLR9. PLoS
ONE, 7(9):e45171–13.
Trent, S., A. Dennehy, H. Richardson, O. A. Ojarikre, P. S. Burgoyne, T. Humby,
and W. Davies
2012. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to atten-
tion deficit hyperactivity disorder. Psychoneuroendocrinology, 37(2):221–229.
Tsai, C.-L., R. K. Rowntree, D. E. Cohen, and J. T. Lee
2008. Higher order chromatin structure at the X-inactivation center via looping
DNA. Developmental Biology, 319(2):416–425.
BIBLIOGRAPHY 300
Tsunoda, Y., T. Tokunaga, and T. Sugie
1985. Altered sex ratio of live young after transfer of fast- and slow-developing
mouse embryos. Molecular Reproduction and Development, 12(3):301–304.
Tucker, K. L., C. Beard, J. Dausmann, L. Jackson-Grusby, P. W. Laird, H. Lei, E. LI,
and R. Jaenisch
1996. Germ-line passage is required for establishment of methylation and expres-
sion patterns of imprinted but not of nonimprinted genes. Genes & Development,
10(8):1008–1020.
Tunster, S. J., A. B. Jensen, and R. M. John
2013. Imprinted genes in mouse placental development and the regulation of fetal
energy stores. Reproduction, 145(5):R117–R137.
Turner, H. H.
1938. A syndrome of infantilism, congenital webbed neck, and cubitus valgus.
Endocrinology, 23(5):566–574.
Turner, J. M. A.
2007. Meiotic sex chromosome inactivation. Development, 134(10):1823–1831.
Tybulewicz, V. L. J.
2006. New techniques to understand chromosome dosage: mouse models of
aneuploidy. Human Molecular Genetics, 15(Review Issue 2):R103–R109.
Tzschach, A., S. Lenzner, B. Moser, R. Reinhardt, J. Chelly, J.-P. Fryns, T. Kleefs-
tra, M. Raynaud, G. Turner, H.-H. Ropers, A. Kuss, and L. R. Jensen
2006. Novel JARID1C/SMCX mutations in patients with X-linked mental retar-
dation. Human Mutation, 27(4):389–389.
Ullrich, O.
1930. Typical features and multiple malformations. European Journal of Pedi-
atrics, 49:271–276.
BIBLIOGRAPHY 301
Umlauf, D., Y. Goto, R. Cao, F. Cerqueira, A. Wagschal, Y. Zhang, and R. Feil
2004. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves
repressive histone methylation and recruitment of Polycomb group complexes.
Nature Genetics, 36(12):1296–1300.
Untergasser, A., H. Nijveen, X. Rao, T. Bisseling, R. Geurts, and J. A. M. Leunis-
sen
2007. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Re-
search, 35(Web Server issue):W71–4.
Urbach, A. and N. Benvenisty
2009. Studying Early Lethality of 45,XO (Turner’s Syndrome) Embryos Using
Human Embryonic Stem Cells. PLoS ONE, 4(1):e4175.
Vakilian, H., M. Mirzaei, M. Sharifi Tabar, P. Pooyan, L. Habibi Rezaee, L. Parker,
P. A. Haynes, H. Gourabi, H. Baharvand, and G. H. Salekdeh
2015. DDX3Y, a Male-Specific Region of Y Chromosome Gene,
May Modulate Neuronal Differentiation. Journal of Proteome Research,
14(9):150722163029001–10.
Van der Meulen, J., V. Sanghvi, K. Mavrakis, K. Durinck, F. Fang, F. Matthijssens,
P. Rondou, M. Rosen, T. Pieters, P. Vandenberghe, E. Delabesse, T. Lammens,
B. De Moerloose, B. Menten, N. Van Roy, B. Verhasselt, B. Poppe, Y. Benoit,
T. Taghon, A. M. Melnick, F. Speleman, H.-G. Wendel, and P. Van Vlierberghe
2015. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor
in T-cell acute lymphoblastic leukemia. Blood, 125(1):13–21.
van Haaften, G., G. L. Dalgliesh, H. Davies, L. Chen, G. Bignell, C. Greenman,
S. Edkins, C. Hardy, S. O’Meara, J. Teague, A. Butler, J. Hinton, C. Latimer,
J. Andrews, S. Barthorpe, D. Beare, G. Buck, P. J. Campbell, J. Cole, S. Forbes,
M. Jia, D. Jones, C. Y. Kok, C. Leroy, M.-L. Lin, D. J. McBride, M. Maddi-
son, S. Maquire, K. McLay, A. Menzies, T. Mironenko, L. Mulderrig, L. Mudie,
E. Pleasance, R. Shepherd, R. Smith, L. Stebbings, P. Stephens, G. Tang, P. S.
BIBLIOGRAPHY 302
Tarpey, R. Turner, K. Turrell, J. Varian, S. West, S. Widaa, P. Wray, V. P. Collins,
K. Ichimura, S. Law, J. Wong, S. T. Yuen, S. Y. Leung, G. Tonon, R. A. DePinho,
Y.-T. Tai, K. C. Anderson, R. J. Kahnoski, A. Massie, S. K. Khoo, B. T. Teh,
M. R. Stratton, and P. A. Futreal
2009. Somatic mutations of the histone H3K27 demethylase gene UTX in human
cancer. Nature Genetics, 41(5):521–523.
Vandamme, J., G. Lettier, S. Sidoli, E. Di Schiavi, O. Nørregaard Jensen, and A. E.
Salcini
2012. The C. elegans H3K27 Demethylase UTX-1 Is Essential for Normal Devel-
opment, Independent of Its Enzymatic Activity. PLoS Genetics, 8(5):e1002647.
Veith, A.-M., J. Klattig, A. Dettai, C. Schmidt, C. Englert, and J.-N. Volff
2006. Male-biased expression of X-chromosomal DM domain-less Dmrt8 genes
in the mouse. Genomics, 88(2):185–195.
Veitia, R. A. and J. A. Birchler
2010. Dominance and gene dosage balance in health and disease: why levels
matter! The Journal of Pathology, 220(2):174–185.
Vicoso, B. and B. Charlesworth
2006. Evolution on the X chromosome: unusual patterns and processes. Nature
Reviews Genetics, 7(8):645–653.
Vogel, C. and E. M. Marcotte
2012. Insights into the regulation of protein abundance from proteomic and tran-
scriptomic analyses. Nature Reviews Genetics, 5:1512–13.
Vogt, M. H., E. Goulmy, F. M. Kloosterboer, E. Blokland, R. A. de Paus,
R. Willemze, and J. H. Falkenburg
2000. UTY gene codes for an HLA-B60-restricted human male-specific minor
histocompatibility antigen involved in stem cell graft rejection: characterization
of the critical polymorphic amino acid residues for T-cell recognition. Blood,
96(9):3126–3132.
BIBLIOGRAPHY 303
Vulpe, C. D., Y. M. Kuo, T. L. Murphy, L. Cowley, C. Askwith, N. Libina,
J. Gitschier, and G. J. Anderson
1999. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron trans-
port, is defective in the sla mouse. Nature Genetics, 21(2):195–199.
Walport, L. J., R. J. Hopkinson, M. Vollmar, S. K. Madden, C. Gileadi, U. Opper-
mann, C. J. Schofield, and C. Johansson
2014. Human UTY(KDM6C) is a male-specific Nε-methyl lysyl demethylase.
Journal of Biological Chemistry, 289(26):18302–18313.
Wang, C., J.-E. Lee, Y.-W. Cho, Y. Xiao, Q. Jin, C. Liu, and K. Ge
2012. UTX regulates mesoderm differentiation of embryonic stem cells indepen-
dent of H3K27 demethylase activity. Proceedings of the National Academy of
Sciences of the United States of America, 109(38):15324–15329.
Wang, F., J. Shin, J. M. Shea, J. Yu, A. Boškovic´, M. Byron, X. Zhu, A. K. Shalek,
A. Regev, J. B. Lawrence, E. M. Torres, L. J. Zhu, O. J. Rando, and I. Bach
2016. Regulation of X-linked gene expression during early mouse development
by Rlim. eLife, 5:1765.
Wang, J., J. Mager, Y. Chen, E. Schneider, J. C. Cross, A. Nagy, and T. Magnuson
2001a. Imprinted X inactivation maintained by a mouse Polycomb group gene.
Nature Genetics, 28(4):371–375.
Wang, J., S. Vasaikar, Z. Shi, M. Greer, and B. Zhang
2017. WebGestalt 2017: a more comprehensive, powerful, flexible and interac-
tive gene set enrichment analysis toolkit. Nucleic Acids Research, Pp. 1–8.
Wang, P. J., J. R. McCarrey, F. Yang, and D. C. Page
2001b. An abundance of X-linked genes expressed in spermatogonia. Nature
Genetics, 27(4):422–426.
Wang, Q., J. Wei, P. Su, and P. Gao
2015. Histone demethylase JARID1C promotes breast cancer metastasis cells
BIBLIOGRAPHY 304
via down regulating BRMS1 expression. Biochemical and Biophysical Research
Communications, 464(2):659–666.
Wang, X., K. C. Douglas, J. L. VandeBerg, A. G. Clark, and P. B. Samollow
2014. Chromosome-wide profiling of X-chromosome inactivation and epige-
netic states in fetal brain and placenta of the opossum, Monodelphis domestica.
Genome Research, 24(1):70–83.
Wang, Z. Q., M. R. Fung, D. P. Barlow, and E. F. Wagner
1994. Regulation of embryonic growth and lysosomal targeting by the imprinted
Igf2/Mpr gene. Nature, 372(6505):464–467.
Warburton, P. E., J. Giordano, F. Cheung, Y. Gelfand, and G. Benson
2004. Inverted repeat structure of the human genome: the X-chromosome con-
tains a preponderance of large, highly homologous inverted repeats that contain
testes genes. Genome Research, 14(10A):1861–1869.
Warren, E. H., M. A. Gavin, E. Simpson, P. Chandler, D. C. Page, C. Disteche,
K. A. Stankey, P. D. Greenberg, and S. R. Riddell
2000. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.
Journal of Immunology, 164(5):2807–2814.
Waters, P. D., M. C. Wallis, and J. A. M. Graves
2007. Mammalian sex—Origin and evolution of the Y chromosome and SRY.
Seminars in Cell & Developmental Biology, 18(3):389–400.
Watson, E. D., M. Hughes, D. G. Simmons, D. R. C. Natale, A. E. Sutherland, and
J. C. Cross
2011. Cell-cell adhesion defects in Mrj mutant trophoblast cells are associated
with failure to pattern the chorion during early placental development. Develop-
mental Dynamics, 240(11):2505–2519.
Welshons, W. J. and L. B. Russell
1959. The Y-chromosome as the bearer of male determining factors in the mouse.
BIBLIOGRAPHY 305
Proceedings of the National Academy of Sciences of the United States of America,
45(4):560–566.
Welstead, G. G., M. P. Creyghton, S. Bilodeau, A. W. Cheng, S. Markoulaki, R. A.
Young, and R. Jaenisch
2012. X-linked H3K27me3 demethylase Utx is required for embryonic develop-
ment in a sex-specific manner. Proceedings of the National Academy of Sciences
of the United States of America, 109(32):13004–13009.
West, J. D., W. I. Frels, V. M. Chapman, and V. E. Papaioannou
1977. Preferential expression of the maternally derived X chromosome in the
mouse yolk sac. Cell, 12(4):873–882.
Wilsker, D., A. Patsialou, P. B. Dallas, and E. Moran
2002. ARID proteins: a diverse family of DNA binding proteins implicated in
the control of cell growth, differentiation, and development. Cell Growth & Dif-
ferentiation, 13(3):95–106.
Wisniewski, A., K. Milde, R. Stupnicki, and J. Szufladowicz-Wozniak
2007. Weight deficit at birth and Turner’s syndrome. Journal of Pediatric En-
docrinology & Metabolism, 20(5):607–613.
Wladimiroff, J. W., W. R. Bhaggoe, M. Kristelijn, T. E. Cohen-Overbeek, N. S.
Den Hollander, H. Brandenburg, and F. J. Los
1995. Sonographically determined anomalies and outcome in 170 chromosoma-
lly abnormal fetuses. Prenatal Diagnosis, 15(5):431–438.
Wolf, J. B. and R. Hager
2006. A Maternal–Offspring Coadaptation Theory for the Evolution of Genomic
Imprinting. PLoS Biology, 4(12):e380–6.
Wright, A. E., R. Dean, F. Zimmer, and J. E. Mank
2016. How to make a sex chromosome. Nature Communications, 7:1–8.
BIBLIOGRAPHY 306
Wu, J., J. Ellison, E. Salido, P. Yen, T. Mohandas, and L. J. Shapiro
1994. Isolation and characterization of XE169, a novel human gene that escapes
X-inactivation. Human Molecular Genetics, 3(1):153–160.
Wu, J. A., B. L. Johnson, Y. Chen, C. T. Ha, and G. S. Dveksler
2008. Murine Pregnancy-Specific Glycoprotein 23 Induces the Proangiogenic
Factors Transforming-Growth Factor Beta 1 and Vascular Endothelial Growth
Factor A in Cell Types Involved in Vascular Remodeling in Pregnancy1. Biology
of Reproduction, 79(6):1054–1061.
Wutz, A., T. P. Rasmussen, and R. Jaenisch
2002. Chromosomal silencing and localization are mediated by different domains
of Xist RNA. Nature Genetics, 30(2):167–174.
Wysocka, J., T. Swigut, H. Xiao, T. A. Milne, S. Y. Kwon, J. Landry, M. Kauer,
A. J. Tackett, B. T. Chait, P. Badenhorst, C. Wu, and C. D. Allis
2006. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with
chromatin remodelling. Nature, 442(7098):86–90.
Xiong, Y., X. Chen, Z. Chen, X. Wang, S. Shi, X. Wang, J. Zhang, and X. He
2010. RNA sequencing shows no dosage compensation of the active X-
chromosome. Nature Genetics, 42(12):1043–1047.
Xu, J.
2005. Preparation, culture, and immortalization of mouse embryonic fibroblasts.
Current Protocols in Molecular Biology, Chapter 28:Unit 28.1.
Xu, J., P. S. Burgoyne, and A. P. Arnold
2002. Sex differences in sex chromosome gene expression in mouse brain. Hu-
man Molecular Genetics, 11(12):1409–1419.
Xu, J., X. Deng, and C. M. Disteche
2008a. Sex-specific expression of the X-linked histone demethylase gene Jarid1c
in brain. PLoS ONE, 3(7):e2553.
BIBLIOGRAPHY 307
Xu, J., X. Deng, R. Watkins, and C. M. Disteche
2008b. Sex-specific differences in expression of histone demethylases Utx and
Uty in mouse brain and neurons. The Journal of Neuroscience, 28(17):4521–
4527.
Xu, J., R. Watkins, and A. P. Arnold
2006. Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but
not protein in mouse brain. Gene Expression Patterns, 6(2):146–155.
Xu, N., M. E. Donohoe, S. S. Silva, and J. T. Lee
2007. Evidence that homologous X-chromosome pairing requires transcription
and Ctcf protein. Nature Genetics, 39(11):1390–1396.
Xue, F., X. C. Tian, F. Du, C. Kubota, M. Taneja, A. Dinnyes, Y. Dai, H. Levine,
L. V. Pereira, and X. Yang
2002. Aberrant patterns of X chromosome inactivation in bovine clones. Nature
Genetics, 31(2):216–220.
Yamanaka, Y., F. Lanner, and J. Rossant
2010. FGF signal-dependent segregation of primitive endoderm and epiblast in
the mouse blastocyst. Development, 137(5):715–724.
Yamauchi, Y., J. M. Riel, V. Ruthig, and M. A. Ward
2015. Mouse Y-Encoded Transcription Factor Zfy2 Is Essential for Sperm For-
mation and Function in Assisted Fertilization. PLoS Genetics, 11(12):e1005476.
Yamauchi, Y., J. M. Riel, V. A. Ruthig, E. A. Ortega, M. J. Mitchell, and M. A.
Ward
2016. Two genes substitute for the mouse Y chromosome for spermatogenesis
and reproduction. Science, 351(6272):514–516.
Yang, F., T. Babak, J. Shendure, and C. M. Disteche
2010. Global survey of escape from X inactivation by RNA-sequencing in mouse.
Genome Research, 20(5):614–622.
BIBLIOGRAPHY 308
Yang, H., H. Wang, C. S. Shivalila, A. W. Cheng, L. Shi, and R. Jaenisch
2013. One-Step Generation of Mice Carrying Reporter and Conditional Alleles
by CRISPR/Cas-Mediated Genome Engineering. Cell, 154(6):1–14.
Yedavalli, V. S. R. K., C. Neuveut, Y.-H. Chi, L. Kleiman, and K.-T. Jeang
2004. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE
export function. Cell, 119(3):381–392.
Ying, Q.-L., J. Wray, J. Nichols, L. Batlle-Morera, B. Doble, J. Woodgett, P. Cohen,
and A. Smith
2008. The ground state of embryonic stem cell self-renewal. Nature,
453(7194):519–523.
Yoshimi, K., Y. Kunihiro, T. Kaneko, H. Nagahora, B. Voigt, and T. Mashimo
2016. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in
zygotes. Nature Communications, 7:1–10.
Yu, L.
2005. Shox2-deficient mice exhibit a rare type of incomplete clefting of the
secondary palate. Development, 132(19):4397–4406.
Zechner, U., M. Hemberger, M. Constância, A. Orth, I. Dragatsis, A. Lüttges,
H. Hameister, and R. Fundele
2002. Proliferation and growth factor expression in abnormally enlarged placen-
tas of mouse interspecific hybrids. Developmental Dynamics, 224(2):125–134.
Zechner, U., M. Reule, A. Orth, F. Bonhomme, B. Strack, Guénet, H. Hameister,
and R. Fundele
1996. An X-chromosome linked locus contributes to abnormal placental devel-
opment in mouse interspecific hybrid. Nature Genetics, 12(4):398–403.
Zechner, U., M. Wilda, H. Kehrer-Sawatzki, W. Vogel, R. Fundele, and H. Hameis-
ter
2001. A high density of X-linked genes for general cognitive ability: a run-away
process shaping human evolution? Trends in Genetics, 17(12):697–701.
BIBLIOGRAPHY 309
Zhang, B., S. Kirov, and J. Snoddy
2005. WebGestalt: an integrated system for exploring gene sets in various bio-
logical contexts. Nucleic Acids Research, 33(Web Server issue):W741–8.
Zhang, B., J. Wang, XiaojingWang, J. Zhu, Q. Liu, Z. Shi, M. C. Chambers, L. J.
Zimmerman, K. F. Shaddox, S. Kim, S. R. Davies, S. Wang, PeiWang, C. R.
Kinsinger, R. C. Rivers, H. Rodriguez, R. R. Townsend, M. J. C. Ellis, S. A. Carr,
D. L. Tabb, R. J. Coffey, R. J. C. Slebos, D. C. Liebler, and t. N. CPTAC
2014. Proteogenomic characterization of human colon and rectal cancer. Nature,
513(7518):382–387.
Zhao, J., B. K. Sun, J. A. Erwin, J. J. Song, and J. T. Lee
2008. Polycomb proteins targeted by a short repeat RNA to the mouse X chro-
mosome. Science, 322(5902):750–756.
Zhao, L., T. Svingen, E. T. Ng, and P. Koopman
2015. Female-to-male sex reversal in mice caused by transgenic overexpression
of Dmrt1. Development, 142(6):1083–1088.
Zhou, J., E. M. Goldberg, N. A. Leu, L. Zhou, D. A. Coulter, and P. J. Wang
2014. Respiratory failure, cleft palate and epilepsy in the mouse model of human
Xq22.1 deletion syndrome. Human Molecular Genetics, 23(14):3823–3829.
Zhou, J., J. R. McCarrey, and P. J. Wang
2013. A 1.1-Mb Segmental Deletion on the X Chromosome Causes Meiotic
Failure in Male Mice. Biology of Reproduction, 88(6):159–159.
Zinn, A. R. and J. L. Ross
1998. Turner syndrome and haploinsufficiency. Current Opinion in Genetics &
Development, 8(3):322–327.
Zuffardi, O., P. Maraschio, F. Lo Curto, U. Müller, A. Giarola, and L. Perotti
1982. The role of Yp in sex determination: new evidence from X/Y transloca-
tions. American Journal of Medical Genetics, 12(2):175–184.
BIBLIOGRAPHY 310
Zvetkova, I., A. Apedaile, B. Ramsahoye, J. E. Mermoud, L. A. Crompton, R. John,
R. Feil, and N. Brockdorff
2005. Global hypomethylation of the genome in XX embryonic stem cells. Na-
ture Genetics, 37(11):1274–1279.
